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Transformation of BALB/c-3T3 Cells:
V. Transformation Responses of 168
Chemicals Compared with Mutagenicity in
Salmonella and Carcinogenicity in Rodent
Bioassays
by Edwin J. Matthews,' Judson W. Spalding,2 and
Raymond W. Tennant2
This report describes the activities of 168 chemicals tested in a standard transformation assay using
A-31-1-13 BALB/c-3T3 cells. The data set includes 84 carcinogens, 77 noncarcinogens, and 7research chemicals.
Carcinogens included 49 mutagens and 35 nonmutagens; noncarcinogens included 24 mutagens and 53
nonmutagens. The transformation assay did not use an exogenous activation system, thus, all chemical
responses depended on the inherent target cell metabolic capacity where metabolic activation was required.
The upper dose limit was 100 milli-osmolar because the assay could not discriminate active and inactive
chemicals tested above this concentration. Certain physicochemical properties resulted in technical problems
that affected chemical biological activity. For example, chemicals that reacted with plastic were usually
nonmutagenic carcinogens. Similarly, chemicals thatwere insoluble in medium, orbound metals, were usually
nonmutagenic and nontransforming.
Multifactorial data analyses revealed that the transformation assay discriminated between nonmutagenic
carcinogens and noncarcinogens; it detected 64% ofthe carcinogens and only 26% ofthe noncarcinogens. In
contrast, the transformation assay detected most mutagenic chemicals, including 94% of the mutagenic
carcinogens and 70% of the mutagenic noncarcinogens. Thus, transformation or Salmonella typuimurium
mutagenicity assays could not discriminate mutagenic carcinogens from mutagenic noncarcinogens. Data
analyses also revealed that mutagenic chemicals were more cytotoxic than nonmutagenic chemicals; 88% of
the mutagens had an LD,,, < 5 mM, whereas half of the nonmutagens had an LD,,, > 5 mM. Binary data
analyses ofthe same data setrevealed thatthetransformation assay and rodent bioassay had aconcordance of
71%, a sensitivity forcarcinogens of80.0%, and a specificity for detecting noncarcinogens of60%. In contrast,
Salmonella mutagenicity assays and rodent bioassays had a concordance of 63%, a sensitivity of 58%, and a
specificity of 69%. The transformation assay complemented the Salmonella mutagenesis assay in the
identification of nonmutagenic carcinogens; thus, the two assays had a combined 83% sensitivity for all
carcinogens and a 75% specificity for nonmutagenic noncarcinogens.
Introduction
Recent investigations supported by the National Tox-
icology Program (NTP) have revealed that many chemical
carcinogens were not detected in Salmonella typhimurium
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mutagenesis assays (1-4). These carcinogens have been
operationally classified as either nongenotoxic or non-
mutagenic carcinogens, based on their activity in the
Salmonella assay (1-4). While some of the nonmutagenic
carcinogens induced chromosomal aberrations (ABS) and
sister chromatid exchanges (SCE) in Chinese hamster
ovary cells (CHO), or TK+'- mutations in mouse lym-
phoma (ML) L5178Y cells, the chemicals were not consis-
tentlyactiveinallthree assays (4). Furthermore, thethree
genotoxicity assays all detected as many nonmutagenic
noncarcinogens as nonmutagenic carcinogens (4). Thus,
there is a continuing need to develop a short term, in vitro
assaywithwhich to selectivelycharacterizenonmutagenic
carcinogens.3MATTHEWS ETAL.
The National Institute of Environmental Health Sci-
ences (NIEHS) has supported research programs using
different cell transformation assay systems because such
assays demonstrate phenotypes that respond to carcino-
gen treatments and mimic certain events in the multistep
process of chemical carcinogenesis in vivo (5-8). The
BALB/c-3T3 transformation assay was one ofthe assays
evaluated because chemical-induced morphologically
transformed cells are easily recognized and induced at
relatively high frequencies in this assay (7,9-12). Further-
more, normal BALB/c-3T3 cells have been demonstrated
to be biologically different from chemical-induced trans-
formed cells isolated from a type III focus. Whereas
normal BALB/c-3T3 cellswere nonmalignant and growat
low frequencies in soft agar, transformed cells readily
grew in soft agar and were tumorigenic in vivo (7,11,13).
This report summarizes the results we obtained in
testing 168 chemicals in a standard BALB/c-3T3 cell
transformation assay protocol. The protocol was devel-
opedin thislaboratory (10,14), anditdiffered substantially
fromthemethodfirst described byKakunaga (7) and that
currently recommended by government agencies (6,15).
Our method modified the standard assay design to
enhance the sensitivity for detection of chemical-induced
transformation (14,16). The improved sensitivity was
achieved without using an exogenous activation system;
thus, all chemical responses were dependent on the inher-
ent metabolic capability of the BALB/c-3T3 cells. Each
chemical was tested in two or more experiments, and a
total of 110 experiments were conducted over a 2.5-year
period. The majority of the 168 test chemicals were
selectedfromthe NTPdatabase of301chemicalstested in
rodent bioassay (3); thus, the chemical structures and
biological activities of most of these chemicals in several
assaysystemswasreadilyavailableforcomparativeanaly-
ses (1-4).
The 168 test chemicals in this data setincluded compar-
able numbers of chemicals with three different biological
activities (carcinogenicity, cytotoxicity, andmutagenicity).
For example, the data set contained roughly equal num-
bers ofcarcinogens and noncarcinogens, as well as muta-
genic and nonmutagenic chemicals. Furthermore, this
data set also included many examples of nonmutagenic
carcinogens as well as mutagenic noncarcinogens. Cur-
rently both groups of chemicals reduce our ability to
predict carcinogenicity in rodents using in vitro tests for
genotoxicity. Finally, this set contained many examples of
cytotoxic and noncytotoxic chemicals that differed in their
carcinogenic and mutagenic activities. The only chemicals
testedinthe assaythatwereomitted fromthispaperwere
24 chemicals with unknown carcinogenicity, which were
reported separately (14), 10 polycyclic aromatic hydrocar-
bons (unpublished data), and 21 test chemicals with a
unique technical problem. The 21 chemicals rapidly
reacted with plastic culture vessels at treatment dose
concentrations that were tested for transforming activity
and will have to be evaluated separately in a chemical-
resistant culture vessel. Taken together, none of the test
chemical responses detected during this investigation
were either selectively, or arbitrarily, omitted from this
report.
This study included a major effort to determine the
appropriate upper dose limit for the BALB/c-3T3 cell
transformation assayandtoinvestigatetherelationshipof
chemicalcytotoxicitytotransformation,mutagenicity,and
carcinogenicity. Currently most in vitro genotoxicity
assays using cultured mammalian cells employ an arbi-
trary upper dose limit of 5-10 mg/mL. This decision
creates two problems. Because test chemicals havewidely
different molecular weights, the 5-10 mg/mL limit repre-
sents a high physiological treatment dose for some chemi-
cals and a relatively lower dose for other chemicals. We
avoided this problem by analyzing chemical activities in
terms of treatment doses expressed in millimolar (mM)
concentrations. In addition, the use of an arbitrary dose
limit inhibits one from determining the actual upper dose
limit. For the purpose of this investigation, the actual
upper dose limit of an assay was defined as the dose at
which the assaycould not discriminate active and inactive
test chemicals. This upper dose limit can only be deter-
minedwhen all chemicals aretested atcomparable ranges
of cytotoxic responses. This report will provide evidence
that the actual upper dose limit for noncytotoxic test
chemicals was equivalent to a treatment dose of100 milli-
osmolar (mOsM).
The statistical methods used in this report to evaluate
the activities ofchemicals in one or more experiments, as
well as those used to weight and rank-order chemical
transformation responses, havebeen described previously
(17-18). These methods were developed because transfor-
mation experiments had different statistical sensitivities
(17) and different detection sensitivities for chemical-
inducedtransformation(18).Thestatisticalweightingpro-
cedures used mean and rank t-statistics (18), and these
methodssolvedthreedataanalysisproblems. First, statis-
ticallyweighted chemical responses provided an unbiased
method for comparing responses in two independent
experiments and could be used to determine whether
chemical activities detected in two consecutive experi-
mentswerereproducible. Second,thestatisticalweighting
procedure provided an easy and unbiased method for
combining the data for a chemical tested in two or more
trials. Third, rank-ordered and statistically weighted
chemical responses provide a very sensitive means of
comparing biological activities of small sets of chemicals.
Thisreportdoesnotpresentasingletablewithallofthe
test chemicals and their transformation responses. Abin-
ary presentation of positive and negative test chemical
responses was too simplistic and masked the multifac-
torial activities ofchemicals inthis database. Thus, binary
procedures were only used to demonstrate that the data
set had a comparable distribution of chemicals to that of
other NTP data sets. In contrast, multifactorial pro-
cedures were used to compare the activities of chemicals
that shared selected biological activities. Multifactorial
comparisons of groups of chemicals were examined for
many different correlations between biological properties
before they were presented in the format of the tables
containedherein.
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Materials and Methods
Cell Culture
Theinvestigations in this reportused theA31-1-13 clone
of BALB/c-3T3 cells (19,20). The materials and methods
used to culture the cells have been previously reported in
detail (10) and are summarizedinpart I oftheseinvestiga-
tions (17).
Standard Clonal Survival Assay
The standard clonal survival assay was used to a)
estimate the cytotoxic activity of a test chemical, b) select
treatment doses for the preliminary co-culture clonal sur-
vival assay, c) assess the reproducibility of the chemical-
induced cytotoxic responses, and d) determine the relative
shift in test chemical cytotoxic responses between high-
and low-densitycell cultures. The standard clonal survival
assayusinglow-density cultures ofBALB/c-3T3 cells was
conducted according to our modification (10,14) of the
method described by Kakunaga (7). Briefly, 200 wild type
(WT) cells were seeded in either 60-mm culture dishes (or
25-cm2 culture flasks), and chemical treatment doses were
applied totriplicateculturesfor48hrbeginning2daysafter
seeding. After a total culture period of 8 days, the vessels
were washed, fixed in methanol, stained with Giemsa, and
colonies of cells were hand tabulated according to the pro-
cedure described in part IV ofthese investigations (14).
Co-culture Clonal Survival Assay
The co-culture clonal survival assay was used to a)
select chemical treatment doses for transformation
assays, b) assess the reproducibility of chemical-induced
cytotoxic responses, and c) verify that the test chemical
and positive control treatment doses were cytotoxic in the
transformation assay. Theprocedureusedforthe co-culture
clonal survival assay has been previously reported in detail
(11,13) and is summarized in part III ofthis series (21).
Transformation Assay
Chemical-induced transformation of BALB/c-3T3 cells
wasevaluatedin astandardtransformation assayprotocol
that has been reported in detail (10) and is summarized in
part IV of this series (14). Briefly, each transformation
assay contained three components: a standard clonal sur-
vival assay (10,14), a co-culture clonal survival assays (21),
and a transformation assay (10,14). In each experiment,
chemial-induced transformation was detected in 18-20
vessels/dose seeded with 3.2 x 104 cells/vessel. Chemical
doses were applied to cell cultures for 48 hr, days 2-4,
using standard procedures (14). Atotal ofthree to six test
chemicals were included in each transformation experi-
ment, and each chemical was tested at four treatment
dosesin two or moreindependenttrials. Theprocedure for
selecting the four doses has been described in part IV of
these investigations (14), and the doses covered a range of
cytotoxic responses of approximately 10-100% relative
cloning efficiency (RCE).
Transformation Assay Acceptance and
Evaluation Criteria
A complete explanation of the transformation assay
acceptance and evaluation criteria for a test chemical
evaluatedinasingletrialorinmultipletrialsisprovidedin
part IV of this investigation (14). Briefly, a test chemical
evaluated in one experiment had one of four possible
transformation responses: sufficientpositive (SP), limited
activity (LA), sufficient negative (SN), and limited nega-
tive(LN).Briefly, anSPtransformationresponserequired
that a test chemical response was statistically significant
at two or more consecutive treatment doses. In contrast,
an LAtransformation responserequiredthatatestchem-
ical response was statistically significant at either one
treatment dose alone atthe 99% confidence level or attwo
consecutive doses at the 95% confidence level. An SN
transformation response required that a test chemical
response did nothave a statistically significantincreasein
transformation responses at any of the four treatment
doses. An LN transformation response occurred under
two different circumstances. First, the four test chemical
treatment doses did not induce a statistically significant
transformation response; however, in contrast to an SN
transformation response,thetestchemicaltreatments did
not have a significant cytotoxic response. Therefore,
higher concentrations of the test chemical could have
induced a significant cytotoxic response, and this could
have resulted in a statistically signiflcant transformation
response. Second, the test chemical had the equivalent of
an SN transformation response; however, the positive
control for the transformation experiment was inactive
and did not induce a statistically significant response.
Evaluation ofTransformed Foci
ThemethodusedtoevaluatetransformedfociofBALB/
c-3T3 cells has been reported in detail (10) and is summa-
rized in part IV (14) of these investigations. Briefly, the
number of type I-III transformed foci of BALB/c-3T3
cellswereidentifiedmicroscopicallyusingpublished crite-
ria (6-8,12,17), and type III foci had three phenotypic
properties: piling and overlapping cells, disorientation of
cells at the periphery ofthe focus, and invasion oftrans-
formed cells into a contact-inhibited monolayer of WT
cells. Iype I and II foci also appeared in many different
sizes, but they lacked one or more ofthe three phenotypic
properties ofthe type III transformed focus.
Handling ofTest Chemicals
Many chemicals in this investigation had physicochemi-
cal properties that could have potentially interfered with
them being adequately tested in the BALB/c-3T3 cell
transformation assay (Table 1). Therefore, procedures
were developed to ensure that all test chemicals would be
consistentlyand adequatelyevaluated, andtheprocedures
are described in detail in part IV of these investigations
(14).
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Table 1. Cytotoxicity of168 test chemicals.a
Group ofchemicals LD50 No.
1. Cytotoxic < 5mM 114
2. Noncytotoxic 5 mM-100 mOsM 43
3. Very noncytotoxic > lOOmOsM 11
Abbreviations: LD50, lethal dose for 50% of the cells; mOsM, milli-
osmolar; no., number ofchemicals in a subgroup ofchemicals.
aChemical-induced, cytotoxic response data for this table were
obtained from Tables Al and A4.
Statistical Analyses and Mathematical
Models
Mathematical Transformation of Focus Data. The
methodused to determine the distribution ofspontaneous
transformedfoci ofBALB/c-3T3 cells hasbeenpreviously
reported (10,11) andis described in detailinpart I ofthese
investigations (17).
Significance of Transformation Responses. The
methodsused to determine the statistical significance ofa
chemical-induced transformation response has been
described in detail in part IV of these investigation (14).
Briefly, the significance was determined using analysis of
variance (F-test) and modified Student's t-tests, and the
computations were performed using SAS software (22).
Method for Rank-Ordering Test Chemical Transfor-
mation Responses. The method used to rank-order test
chemical transformation responses on the basis of the
significance of their activity in the transformation assay
has been described in detail in part IVofthese investiga-
tions (14). Briefly, the significance of the test chemical
response was observed tovaryproportionally tothe mag-
nitudeofthet-statistic, andthet-statisticwasindependent
of the absolute spontaneous transformation response of
thesolventcontrol.Theaveragesignificanceofeachchem-
ical transformation response, or mean t-statistic, was
calculated by averaging the t-statistics of the four test
chemical, (or two positive control) treatment doses. TPeat-
ment doses with <5% RCE and incomplete monolayers
were deleted, and negative t-statistics were arbitrarily
assigned the value ofzero. This mean t-statistic was used
to rank order chemical transformation responses in indi-
vidual experiments. The test chemical activity in two or
more experimental trials was assessed using a weighted
therankt-statistic. Itwas calculated usingallthe t-statis-
tics for test chemical treatments in two or more experi-
mental trials (see Tables A3 and A6 for actual and
estimated rank t-statistics of168 chemical transformation
responses). Examples ofthese calculations areprovided in
Results.
Effect of Statistical Sensitivity on Detection Sen-
sitivity forBaP. Both the magnitude ofthe spontaneous
and the benzo[a]pyrene (BaP) transformation response
varied among the 110 experiments included in this investi-
gation (17,18). Variable spontaneous transformation
responses resulted in experiments with different statisti-
cal sensitivity to detect test chemical responses (17) and
different detection sensitivity for BaP (18).
Experiments with significantly low statistical sen-
sitivity were demonstrated to have a low detection sen-
sitivity for BaP (18). Therefore, these experiments had a
high probability ofunderestimating the activity and rank
t-statisticsoftestchemicals. Incontrast,experimentswith
normal or significantly high statistical sensitivity had
normal detection sensitivity for BaP (18). To compensate
for the diminished sensitivity to detect chemical-induced
transformation, the rank t-statistic was multiplied by a
correction factor to obtain an estimated rank t-statistic
(14). Example calculations usingthe actual rank t-statistic
and the correction factorto determine the estimated rank
t-statistics are provided in Tables A3 and A6.
Test Chemicals
The 43 cytotoxic, mutagenic carcinogens evaluated in
this investigation were tested either as coded test chemi-
cals (marked with an asterisk below) or as uncoded test
chemicals. In addition, five chemicals were tested as both
coded and uncoded (dichlorvos, C. I. basic red 9-HCl, HC
red 3, dimethyl morpholinophosphoramidate, and methyl
carbamate). Thefollowing39testchemicalswere supplied
by Radian Corporation (Houston, TX): *2-amino-4-nitro-
phenol; *2-amino-5-nitrophenol; benzidine-2HCl; 2-bi-
phenylamine; 4-biphenylamine; 4-chloro-o-phenylenedi-
amine; 3-(chloromethyl)pyridine-HCl; 4-chloro-o-tolui-
dine-HCl; 5-chloro-o-toluidine; *C. I. acid orange 3; C. I.
basicred9-HCl; *C. I.basicred9-HCl; *C. I.disperseblue
1; C. I. disperse yellow 3; C. I. solvent yellow 14; cytem-
bena; 1,2-dibromo-3-chloropropane; 2,6-dichloro-p-
phenylenediamine; 1,3-dichloropropene; dichlorvos;
*dichlorvos; diglycidyl resorcinol ether; 2,4-dinitro-
toluene; epichlorohydrin; *1,2-epoxybutane; 1,2-
epoxypropane; ethylene dibromide; HC blue 1; *iodinated
glycerol;melphalan; *N-methyl-o-acrylamide; 4,4-methyl-
enedianiline; 2-naphthylamine; *nitrofurantoin; *nitro-
furazone; 2-nitro-p-henylenediamine; 4,4-oxydianiline;
quinoline; selenium sulfide; o-toluidine; and ziram. Three
chemicalswerepurchasedfromSigmaChemicalCompany
(St. Louis, MO): acetylaminofluorene, 5-azacytidine, and
N-methyl-N'-nitro-N-nitrosoguanidine. One chemical,
acrylonitrile, waspurchased fromAldrich Chemical Com-
pany (Milwaukee, WI).
The 21 cytotoxic, mutagenic, noncarcinogens evaluated
in this investigation were all supplied by Radian Corpora-
tion (Houston, TX): 4-acetylaminofluorene; 4'-(chloro-
acetyl)acetanilide; 2(chloromethyl)pyridine-HCl;
3-chloro-p-toluidine; coumaphos; dimethoate; 2,4-
dimethoxyaniline-HCl; HC blue 2; HC red 3; *HC red 3;
8-hydroxyquinoline; malaoxon; 1-naphthylamine; N-(1-
naphthyl)ethylenediamine-2HCl; 1-nitronaphthalene;
4-nitro-o-phenylenediamine; 3-nitropropionic acid;
p-phenylenediamine-2HCl; *N-phenyl-2-naphthylamide;
2,3,5,6-tetrachloro-4-nitroanisole; tetraethylthiuram di-
sulfide; and 2,6-toluenediamine-2HCl.
Nineteen of 20 cytotoxic, nonmutagenic carcinogens
evaluated in this investigation were supplied by Radian
Corporation: allylisothiocyanate; allylisovalerate; *chlor-
endic acid; *chlorinated paraffins C23, 43% chlorine (also
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chlorowax 40); *chlorinated paraffins 60% chlorine (also
chlorowax 500c); 3-chloro-2-methylpropene; *dimethyl-
vinyl chloride; cinnamyl anthranilate; ethyl acrylate; iso-
phorone; *D-limonene; *malonaldehyde, sodium salt; *2-
mercaptobenzothiazole; methapyrilene-HCl; polybromin-
ated biphenyl mixture; reserpine; tris(2-ethylhexyl)-
phosphate; and *4-vinylcyclohexene. One chemical,
diethylstilbestrol, was purchased from Aldrich, and one
chemical, trisodium salt, was purchased from Sigma.
The 30 cytotoxic, nonmutagenic noncarcinogens evalu-
ated in this investigation were all supplied by Radian:
anilazine; L-ascorbic acid; bisphenol A; carbromal;
*chlorpheniramine-maleate; C. I. acid red 14; C. I. acid
yellow 73; *ephedrine sulfate; *erythromycin stearate;
ethoxylated dodecyl alcohol; ethylenediamine tetraacetic
acid, trisodium salt; eugenol; geranyl acetate; *4-
hexylresorcinol; D,L-menthol; methoxychlor; *methyldopa
sesquihydrate; methylphenidate-HCL; *oxytetracycline-
HCl; phenol; *phenylephrine-HCl; propyl gallate;
*rotenone; sodium diethyldithiocarbamate; stannous
chloride; *tetracycline-HCl; *tetrakis(hydroxymethyl)-
phosphonium chloride; *tetrakis(hydroxymethyl)phos-
phonium sulfate; triphenyltin hydroxide; and *xylenes
(mixed).
Fourteen of 21 noncytotoxic, carcinogens evaluated in
this investigation were supplied by Radian: 11-
aminoundecanoic acid; DC red no. 9; *decabromodiphenyl-
oxide; di(2-ethylhexyl)adipate; di(2-ethylhexyl)phthalate;
diethanolnitrosamine; dimethyl hydrogen phosphite;
dimethyl methyl phosphonate; dimethylmorpholinophos-
phoramidate; *dimethylmorpholinophosphoramidate; eth-
ylene thiourea; melamine; methyl carbamate; *methyl
carbamate; monuron; and 2,4- and 2,6-toluene diisothio-
cyanate. Six chemicals were purchased from Sigma:
3-amino-1,2,4-triazole; cyclamate, sodium salt;
diethylnitrosamine; dimethylnitrosamine; phenobarbital,
sodium salt; and saccharin, sodium salt. One chemical,
hexamethylphosphoramide, was purchased from Aldrich.
The 26 noncytotoxic noncarcinogens evaluated in this
investigation were supplied by Radian: aldicarb;
*ampicillin trihydrate; o-anthranilic acid; benzoin; *ben-
zyl alcohol; caprolactam; 2-chloroethanol; (2-chloroethyl)-
trimethylammonium chloride; C. I. acid orange 10;
dimethyl terephthalate; diphenylhydantoin; FD&Cyellow
no. 6; D-mannitol; *methyl methacrylate; molybdenum
trioxide; 4-nitroanthranilic acid; *penicillin VK+; phthal-
amide; phthalic anhydride; *roxarsone; sodium(2-
ethylhexyl) alcohol sulfate; sulfisoxazole; 3-sulfolene;
tetrahydrofuran; titanium dioxide; and witch hazel.
The sevenvery noncytotoxic chemicals evaluated in this
investigation were allsupplied bythree companies: Sigma,
Fisher Scientific, and U.S. Industrial Products.
Results
Range of Cytotoxic Responses of 168
Chemicals
A co-culture clonal survival assaywas used to measure
the cytotoxic responses of 168 chemicals (21), and each
chemical was tested in two or more experiments. The
cytotoxic responses ofindividual chemicals are presented
in detail in Tables Al and A4. The data set had a range of
cytotoxic responses of over 7 logs. The most cytotoxic
chemical was ziram, and it had an average cytotoxic
response, orLD50, of0.0000373mM. Based on amolecular
weight of 305.81, this concentration was equivalent to
approximately 0.0114 ,ug/mL. The least cytotoxic chemical
was witch hazel, and it had an LD50 estimated at approx-
imately 540 mM.
The 168 chemicals were arbitrarily divided into three
groups according to their relative cytotoxic responses:
group1,cytotoxicchemicalswithanLD50 < 5mM;group2
noncytotoxic chemicals with an LD50 5 mM-100 mOsM;
and group 3, very noncytotoxic chemicals with an LD50 >
100mOsM(Table1).Therewere114 cytotoxicchemicals, 43
noncytotoxic chemicals and 11verynoncytotoxic chemicals
(see Table 1). Chemical cytotoxic responses were divided
into groups 1-3 based on three empirical observations.
First, using the appropriate solvent vehicles, nearly all
cytotoxic chemicals could be tested at treatment doses
either at or belowtheir solubility limit in culture medium.
In contrast, manynoncytotoxic chemicals had tobetested
at treatment doses above their solubility limit to obtain
cytotoxicity to the BALB/c-3T3 cells. Second, many
cytotoxic chemicals (LD50 < 5 mM) were consistently
inactive in the transformation assay; however, few non-
cytotoxic chemicals (LD50> 5 mM) were inactive ifthey
werefullysolubleinculturemedium.Thus,thesolubilityof
noncytotoxic test chemicals clearly correlated theirpoten-
tial activity in the transformation assay, and nearly all of
the noncytotoxic chemicals thatwereinactiveinthe trans-
formation assay had solubility problems in culture
medium. Third, mutagenic and nonmutagenic test chemi-
cals had very different profiles of cytotoxic responses.
Mostmutagenic chemicalswerecytotoxicchemicals,while
only half of the nonmutagenic chemicals were cytotoxic.
Datasupportingthisobservationwillbepresentedlaterin
this report.
Distribution of Cytotoxic Responses among
Carcinogens and Noncarcinogens
The cytotoxic responses of carcinogenic and noncar-
cinogenic chemicals were compared in the data set of 168
chemicals (Table 2). This set of chemicals included 84
carcinogens and 77 noncarcinogens, and the remaining 7
test chemicals were model chemicals that had not been
evaluated in the NTP rodent bioassay. These analyses of
the data revealed that the data set contained a balanced
distribution ofcytotoxicresponses amongthecarcinogens
and noncarcinogens. Furthermore, the data set contained
many examples ofcytotoxic and noncytotoxic carcinogens
and noncarcinogens (Table 2). Thus, these data demon-
strated that in vitro cytotoxicity of chemicals to BALB/
c-3T3 cells neither correlated with nor predicted their in
vivo carcinogenic activity.
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lable 2. Cytotoxicity ofcarcinogens versus noncarcinogens.a
Type ofchemical LD50 No. %
Cytotoxic chemicals
Carcinogens < 5mM 63 55.3
Noncarcinogens < 5mM 51 44.7
Noncytotoxic chemicals
Carcinogens 5 mM-100 mOsM 21 44.7
Noncarcinogens 5 mM-100 mOsM 26 55.3
Total chemicals
Carcinogens 84 52.2
Noncarcinogens 77 47.8
Abbreviations: LD50, lethal dose for 50% of the cells; mOsM, milli-
osmolar; no., number of chemicals in a subgroup; %, percentage of
chemicals in a subgroup (e.g., 63/63 + 51 = 52.2%).
aChemical-induced, cytotoxic response data for this table were
obtained from Tables Al and A4.
Upper Dose Limit ofthe Transformation
Assay
This investigation did not use an arbitrary upper dose
limit of5-10 mg/mL for the BALB/c-3T3 cell transforma-
tion assay. All chemicals were tested over a comparable
range of cytotoxicity of 0-100% RCE, and the data from
these experiments were retrospectivelyused to determine
an empirical upper dose limit. In addition, the concentra-
tion of test chemical treatment doses was expressed in
millimoles, and not in micrograms per milliliter because
the 168 test chemicals had molecularweights that ranged
from 46.07 for ethanol to approximately 1200 for ethoxy-
lated dodecyl alcohol.
The upper dose limit of the BALB/c-3T3 cell transfor-
mation assay was set at 100mOsM based on two empirical
observations in this investigation. First, we observed that
the test chemicals that were the least cytotoxic to the
target cells all had an LD50 over a narrow range of240-
504 mOsM (see Tables 3 and A4). Second, all of the very
noncytotoxic chemicals were active in the transformation
assay(AppendixH). Furthermore, each ofthesechemicals
began to induce significant transforming activity at an
average concentration of 134 mOsM (Table 3). Optimal
Table 3. Cytotoxic and transformation responses of
seven very noncytotoxic test chemicals.a
Cytotoxicity
response,
LD,O, mOsM Name
Transformation
response, mOsM
Maximum Minimum
Acetone 257 176 102
Dimethyl sulfoxide 507 563 141
Ethanol 429 257 150
Glycerol 401 340 136
Sodium chloride 288 262 154
Sucrose 240 300 150
Urea 254 208 104
Average 339 301 134
Abbreviations: LD50, lethal dose for 50% of the cells; mOsM, milli-
osmolar.
aChemical cytotoxic response data for this table were obtained by
plotting cytotoxic and transformation response datacontained inAppen-
dix H.
induction of transforming activity occurred at slightly
higher treatment dose concentrations that were close to
the chemical's LD50 dose. Taken together, the BALB/
c-3T3 cell transformation assay could not discriminate
active and inactive chemicals when they were tested at
concentrations above about 134 mOsM; thus, the actual
dose limit for the data set of168 chemicals was set at 100
mOsM.
Physicochemical Properties of168
Chemicals
We were concerned in this investigation that uncon-
trolled test chemical technical problems could affect the
activity of a chemical in the transformation assay. This
concern arose because most of the 168 chemicals in this
investigation had physicochemical properties that could
potentially have caused technical problems when they
weretestedinaninvitroassayusingculturedmammalian
cells (refer to chemical technical problems listed in Tables
Al and A4). Fortunately, the majority of the technical
problems were avoided by using specific techniques to
handle the test chemicals [see Materials and Methods in
part IV ofthis series (14)].
Nevertheless, sixtypes oftechnical problemswere diffi-
cult to control in this investigation, and each of these
problems couldhaveinfluencedtheresultsinthese experi-
ments (Table 4). First, 21 chemicals reacted with plastic
polystyrene culture vessels; thus, treatment times were
reducedfrom48 hrtominutes. The chemicalreactionwith
plastic was unusual in that it occurred after the chemical
was completely dissolved in the aqueous environment.
Because this problem could onlybe overcome through the
use of chemical-resistant culture vessels such as glass
bottles, these chemicals were not included in this investi-
gation.Acompletelistofthe21chemicalsisprovidedinthe
Discussion. Second and third, 56 chemicals were oxidized
by air and 15 chemicals reacted with water; thus, the
BALB/c-3T3 cellswereexposed to notonlytheparenttest
chemical, but also its oxidized and hydrolyzed byproducts.
Fourth, eight chemicals reacted with biochemicals; thus,
theycould have combined with biochemicals in the culture
medium or biochemicals within the target cells. Fifth,
seven chemicals bound different metal salts; thus, they
could have complexed with critical metals in either the
culture medium or the target cell. Finally, over halfofthe
chemicals had solubility problems in an aqueous environ-
ment. Fortunately, the use oforganic solvents in conjunc-
tion with the nonionic surfactant pluronic F68 (14,23)
resulted in most of these chemicals being soluble at con-
centrations that induced cytotoxicity to the BALB/c-3T3
cells. Nevertheless, 14 test chemicals could not be solubil-
ized andwere insoluble at aportion or all ofthe treatment
dose concentrations used to test for cytotoxic and trans-
forming activities.
Thus, we predicted that any one of the six technical
problems could have affected detection of chemical-
induced transformation of BALB/c-3T3 cells. Further-
more, we anticipated thatthe same six technical problems
might also have affected detection of mutagenicity in
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Salmonella assays and carcinogenicity in rodent bioassay.
Therefore, we examined sets of chemicals with the six
technical problems to determine whether any ofthe prob-
lems correlated with the expression of carcinogenicity,
mutagenicity, and transformation. If a chemical technical
problem had either no effect or a random effect on a
biological activity, then there would be equal distributions
of active and inactive chemicals with this problem (i.e.,
ratio of active/inactive chemicals = 1.00). Conversely, if a
technical problem had a consistent effect on the biological
activity, then the distribution ofactive and inactive chemi-
calswouldbealtered (i.e.,ratio ofactive/inactive chemicals
<1.00 or >1.00).
The results of these comparisons are summarized in
Thble 4. It was found that two of the technical problems,
reactionwith air andwater, had no significant effect on all
threebiological activities. Threeadditionaltechnicalprob-
lems had no effect oncarcinogenicity, buttheywere corre-
lated with suppressed detection of transformation and
mutagenic activities. For example, chemicals with severe
solubility problems and chemicals that bound metal salts
Table 4. Effect oftest chemical technical problems on biological
activities ofcarcinogenicity, mutagenicity and transformation.
Biological activitya
Carcinogenicity
Transformation
Mutagenicity
Test chemical
technical problemsb
Reacts with plastic
Reacts with water
Reacts with biochemicals
Reacts with air
Solubility problem
Binds metal salts
Reacts with biochemicals
Reacts with water
Binds metal salts
Reacts with air
Solubility problem
Reacts with plastic
Reacts with biochemicals
Reacts with air
Reacts with water
Solubility problem
Binds metal salts
Reacts with plastic
Relative effectc
3.49d
1.47
1.38
1.22
1.09
1.08
3.00d
1.77
1.29
1.26
0.393d
0.000d,e
2.43d
1.38
1.08
0.574d
0.246d
0.105d
aThe three biological activities included carcinogenicity in rodent
bioassay, mutagenicity in Salmonella, and transformation in BALB/c-
3T3 cells.
bTest chemicals in this investigation had several difficult problems: 56
chemicals were oxidized upon exposure to air; 21 chemicals reacted with
plastic; 15 chemicals reacted with water; 14 chemicals had severe sol-
ubility problems in culture medium that was not corrected by the use of
pluronic F68; 8 chemicals reacted with biochemicals (i.e., alkylating
agents andchemicals thatreacted withalcohols andaminegroups); and 7
chemicals bound metal salts.
'When a technical problem had no effect on the biological property, it
resulted in a relative effect of1.00 (i.e., equal ratio ofinactive and active
chemicals). When a technical problem correlated with an enhanced
biologicalactivity,itresultedin arelativeeffect > 2.00.Conversely,when a
technical problem correlated with a decreased biological activity, it
resulted in arelative effect < 0.500.
dChemicalswith relative effects either >2.00 or <0.500.
eBecause the 21 chemicals thatreactedwithplastic could notbe tested
for transformation, they were all arbitrarily considered inactive to get a
relative effect of0.000.
tended to be inactive in both BALB/c-3T3 transformation
and Salmonella mutagenicity assays. Conversely, chemi-
cals that reacted with biochemicals tended to be active in
bothmutagenicityandtransformationassays. Incontrast,
onlyoneofthetechnicalproblemshadaneffectonallthree
biological properties of carcinogenicity, transformation,
and mutagenicity. Nearly all of the 21 chemicals that
reacted with plastic culture vessels in BALB/c-3T3 cyto-
toxicity assays (unpublished observations) were carcino-
genic, and they did not induce either transformation or
mutagenicity in Salmonella. Thus, the presence of this
technical problem significantly correlated with these
chemicals being nonmutagenic carcinogens in rodent bio-
assay.
Transformation-Responses of168 Chemicals
Variability among spontaneous transformation re-
sponses resulted in experiments with different statistical
sensitivities to detect chemical-induced transformation
responses (17). Likewise,variabilityamongBaPresponses
demonstrated that individual experiments had different
detectionsensitivitiesforBaP(18).Thus,individualexperi-
mentshaddifferentsensitivitiestomeasuretestchemical-
induced transformation responses. Therefore, the
responses oftest chemicals in the BALB/c-3T3 cell trans-
formation assay were evaluated in terms of the rank-
ordered sensitivity of individual experiments to detect
both spontaneous and BaP-induced transformation
responses (14,17,18).
In the current study, the 168 chemicals were tested in
two or more transformation assay experiments. The
resultsofindividualexperimentsforeachtestchemicalare
provided in detail in Appendices B-H. In addition, a
summaryoftransformation responses ofall the chemicals
arepresentedinsummaryTablesA2andA5. Explanations
forthedifferentresponsecalls andevaluationcriteriafora
single transformation assay experiment have been
reported (14) and are summarized in Materials and
Methods. The final determination of the rank-ordered
activity ofeach chemical is summarized in Tables A3 and
A6.Themethodusedforcombiningtheactivities ofchemi-
calstestedintwo ormoreexperiments has beendiscussed
in detail in part IV of these investigations (14). For the
readerwho isinterestedinthe cumulative dataassociated
with anindividual testchemical, anarrativedescriptionof
the activities ofindividual chemicals isprovided inAppen-
dixA. To facilitate comparative analyses ofchemicalswith
different biological activities, the same sequence ofchemi-
cals has been presented within each of the tables of
Appendix A.
Comparison ofCarcinogenicity with
Mutagenicity and Transformation
Responses
Thedatasetof161carcinogens andnoncarcinogenswas
compared to the activities of different sets of chemicals
tested in other NTP investigations (1-4). In these binary
analyses, the concordance ofeach assaywas compared to
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Table 5. Correlation of rodent bioassay carcinogenicity and
Salmonella mutagenicity data.a
Carcinogenicity Mutagenicity No.
Carcinogenic Mutagenic 49
Noncarcinogenic Nonmutagenic 53
Carcinogenic Nonmutagenic 35
Noncarcinogenic Mutagenic 24
Concordance = 49 +53/161 = 63.4%
Sensitivity = 49/ 84 = 58.3%
Specificity = 53/ 77 = 68.8%
No., number of chemicals in a subgroup.
aThe computations for this table were made using data obtained from
Tables A3 and A6.
Table 6. Correlation ofrodent bioassay carcinogenicity
and BALB/c-3T3 transformation data.a
Carcinogenicity Transformation No.
Carcinogenic Transforming 64
Noncarcinogenic Nontransforming 40
Carcinogenic Nontransforming 16
Noncarcinogenic Transforming 27
Concordance = 64 +40/147 = 70.7%
Sensitivity = 64/80 = 80.0%
Specificity = 40/67 = 59.7%
No., number ofchemicals in a subgroup.
aThe computations in this table excluded 4 carcinogens and 10 noncar-
cinogens that had an indeterminate transformation response (Tibles A3
and A6).
the rodent bioassay using a chi-square method. In this
databasetheconcordance ofSalmonellamutagenicitydata
with rodent bioassaywas 63.4% (Table 5). Using the same
group ofchemicals, Salmonella assays had a sensitivity to
detectcarcinogens of58.3% and aspecificityfordetecting
noncarcinogens of68.8%.Thus, thisdatabasewas compar-
able to other NTP data sets (1-4), and it contained alarge
number ofnonmutagenic carcinogens and mutagenic non-
carcinogens.
Transformation datawere also analyzed usingthe same
method, and the concordance ofBALB/c-3T3 transforma-
tionresponses was compared to carcinogenicity datafrom
rodentbioassay(Table6).Thetransformation assayexhib-
ited a concordance with the rodent bioassay of 70.7%,
which was 7.3% higher than Salmonella (i.e., 70.7 versus
63.4%). Likewise, the transformation assay also had a
21.7%highersensitivityforcarcinogens (i.e., 80.0%versus
58.3%) and a 9.2% lower specificity for detecting noncar-
cinogens (i.e., 59.7% versus 68.9%) compared to Salmo-
nella assays.
Correlation ofTest Chemical Cytotoxicity
with Mutagenicity
Binarycomparisons oftheresponses of147chemicals in
BALB/c-3T3 transformation and 161 chemicals in Salmo-
nellamutagenicityassaysrevealedthatthedatafromboth
assays had a high concordance with rodent bioassay
(Tables 5 and 6). However, this database contained a
disproportionate numberofcytotoxic,versusnoncytotoxic,
test chemicals (see Table 2). Thus, the concordance ofthe
transformation and Salmonellamutagenesis assays might
have been affected by the relative cytotoxicity of the test
chemicals. Becausethenumberofcarcinogens andnoncar-
cinogens was roughly equal in both of these groups of
chemicals, the correlation of test chemical cytotoxicity
with mutagenicity in Salmonella and rodent bioassay car-
cinogenicity could be directly compared.
The correlation of test chemical cytotoxicity to BALB/
c-3T3 cells with mutagenicity in Salmonella assays was
examined first (Table 7). These multifactorial analyses
revealed that Salmonella mutagenicity was highly corre-
lated with chemical cytotoxicity. About 88% of the muta-
genic chemicals had an LD50 < 5 mM, including both
mutagenic carcinogens and noncarcinogens. In contrast,
chemical cytotoxicitywas notcorrelatedwith carcinogeni-
city; about 57% of both carcinogens and noncarcinogens
were cytotoxic. Thus, cytotoxicity of the test chemical to
BALB/c-3T3 cells correlated most with its capacity to
induce mutations in Salmonella (Table 8). In contrast,
cytotoxicity did not correlate with either the induction of
transformation in BALB/c-3T3 cells or carcinogenicity in
the rodentbioassay (Table 8). Thus, the in vivo capability
of a chemical to induce tumors in rodents was not corre-
lated with its in vitro cytotoxicity to a cultured mam-
malian cell.
Taken together, these data showed that amongthe four
biological variables in this investigation (i.e., carcinogeni-
city, cytotoxicity, mutagenicity, and transformation), the
highest correlation of variables was observed for results
from BALB/c-3T3 transformation assayswith rodentbio-
assay (70.7% concordance) and Salmonella mutagenicity
assays (69.8% concordance) (Table 8). A less significant
correlation was noted for BALB/c-3T3 cytotoxicity and
Salmonella mutagenicity (63.4% concordance) and car-
cinogenicity and Salmonella mutagenicity (63.4% concor-
dance). All other binary comparison ofvariables were not
significantly correlated.
Comparison ofMutagenicity and
Transformation
Because BALB/c-3T3 cell transformation and Salmo-
nella mutagenicity assay data both exhibited a high con-
cordance with rodent bioassay data, it was of interest to
see whether the two assays detected the same profile of
chemicals. If the two assays were to detect the same
chemicals, this result would imply, but not prove, that the
BALB/c-3T3 transformation assay was detecting pri-
marily mutagenic test chemicals. Thus, a mutation at a
geneforthetransformed cellphenotypewouldbethemost
likely explanation ofthe activity ofchemicals in the assay.
When the BALB/c-3T3 transformation response data
was compared to the Salmonella assay data, the transfor-
mation assay was observed to detect 92.5% of the muta-
genic carcinogens and approximately 70% of the
mutagenic noncarcinogens (Table 9). These data demon-
strated that the transformation assay detected a high
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Table 7. Correlation of BALB/c-3T3 cytotoxicity with Salmonella mutagenicity and rodent bioassay carcinogenicity.'
Cytotoxicity Mutagenicity Carcinogenicity No. %
73 Mutagens
Cytotoxic Mutagenic 43 Carcinogens + 21 noncarcinogens 64 87.7
Noncytotoxic Mutagenic 6 Carcinogens + 3 noncarcinogens 9 12.3
88 Nonmutagens
Cytotoxic Nonmllutageinic 20 CaIcinogens + 30 noncarcinogens 50 56.8
Noncytotoxic Nonmutagenic 15 Carcinogens + 23 noncaicinogens 38 43.2
Cytotoxicity versus mutagenicity
Concordance =43 +21 + 15 + 23/64 + 9 + 50+ 38 = 102/161=63.4%
Sensitivity = 43 + 21 /64 + 50 = 64/114= 56.1%
Specificity 15 + 23 / 9 + 38= 38/ 47 =80.9%
Cytotoxicity versus carcinogenicity
Concordance =43 + 20 + 3 + 23 / 64 + 9 + 50 + 38= 89/161 = 55.3%
Sensitivitv =43 + 20 / 43 +6 + 20 + 15= 63/ 84 =75.0%
Specificity 3 + 23 / 21 + 3 + 30 + 23= 26/ 77=33.8%
Abbreviations: No., number of chemicals in a subgroup; %, percentage of the chemicals in a subgroup (e.g., 43 + 21/64 87.7%).
"The data for this table were obtained from Tables A3 and A6.
percentage ofmutagenic carcinogens and mutagenic non-
carcinogens. Mostofthemutagenic noncarcinogens inthis
group were analogues of known carcinogens, and they all
had DNA reactive structural alerts (1-4). Thus, neither
the BALB/c-3T3 assay nor the Salmonella mutagenesis
assays were able to distinguish mutagenic carcinogens
from mutagenic noncarcinogens. Fortunately, the fre-
quency of mutagenic noncarcinogens in rodent bioassays
has been relatively small.
Table 8. Concordance of carcinogenicity, transformation,
mutagenicity, and cytotoxic data."
Concorcdance
Biological property % (relative significance)
Carcinogenicity versus
Transformation 70.7 XXXXXXXXXXXXXXXXXXXXX
Mutagenicity 63.4 XXXXXXXXXXXXX
Cytotoxicity 55.3 XXXXX
Contriol 50.0 -
Tnansformation veisus
Carcinogenicity 70.7 XXXXXXXXXXXXXXXXXXXXX
Mutagenicity 69.8 XXXXXXXXXXXXXXXXXXXX
Cytotoxicity 55.3 XXXXXX
Control 50.0 -
Mutagenicity versus
Transfor-mation 69.8 XXXXXXXXXXXXXXXXXXXX
Carcinogenicity 63.4 XXXXXXXXXXXXX
Cytotoxicity 63.4 XXXXXXXXXXXXX
Control 50.0 -
Cytotoxicity versus
Mutagenicity 63.4 XXXXXXXXXXXXX
Transformation 56.0 XXXXXX
Carcinogenicity 55.3 XXXXX
Control 50.0 -
Abbreviations: %Y, the percentage of concordance between the two
biological proper-ties.
"The concordance ofeach biological activity with the remaining three
biological activities is presented as percentage and as a bar graph. A
concordance of 50%° is the control (-) and each X is equivalent to 1%
concordance over the control.
Detection of Nonmutagenic Carcinogens
Because the BALB/c-3T3 transformation assay did not
detectall ofthemutagenic carcinogens (Table 9) butit had
a higher sensitivity to detect carcinogens than Salmonella
(Table 8), the transformation assay must have detected a
substantial number of nonmutagenic carcinogens. This
data setincluded 35 nonmutagenic carcinogens,whichwas
41.7% of the total of 84 carcinogens. The nonmutagenic
carcinogens were approximately equally divided between
cytotoxic and noncytotoxic chemicals. A total of 20 of 35
carcinogens were cytotoxic, and 15 of 35 chemicals were
noncytotoxic chemicals.
Table 9. Detection of mutagenic chemicals by the
standard BALB/c-3T3 transformation assay.
Mutagenicity/carcinogenicity Transformation No. %
Cytotoxic chemicals (LD5,1 < 5 mM)
Mutagenic/carcinogenic Transfoirming 37/40 92.5
Mutagenic/noncarcinogenic Transforming 13/20 65.5
Noncytotoxicchemicals(LD50> 5mM)
Mutagenic/carcinogenic Transforming 6/6 100.
Mutagenic/noncarcinogenic Transforming 3/3 100.
Total chemicals
Mutagenic/carcinogenic Transforming 43/46 93.5
Mutagenic/noncarcinogenic Transforming 16/23 69.6
Concordance 43 + 7/69 = 72.5%
Sensitivity 43/46 = 93.5%
Specificity 7/23 = 30.4%
Abbreviations: no., ratio ofthe number ofchemicals in a subgroup that
induced significant transformation riesponses versus the total number of
chemicals in the subgroup; %, the ratio of chemicals expressed as a
percentage (e.g., 37/40 = 92.5%); LD50, lethal (lose for 50% ofthe cells.
aData for this table were obtained from Tables A3 and A6. The
computations in this table excluded 4 carcinogens and 10 noncarcinogens
that had an indeterminate transformation response.
'A total of only 7 chemicals were mutagenic, noncarcinogenic, and
nontransforming (i.e., 23 - 16 = 7).
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Table 10. Detection ofnonmutagenic carcinogens by the
Standard BALB/c-3T3 transformation assay.a
Mutagenicity/carcinogenicity Transformation No. %
Cytotoxic chemicals (LD50 < 5mM)
Nonmutagenic/carcinogenic Transforming 10/19 52.6
Nonmutagenic/noncarcinogenic Transforming 6/26 23.1
Noncytotoxic chemicals(LD50 2 5mM)
Nonmutagenic/carcinogenic Transforming 11/14 78.6
Nonmutagenic/noncarcinogenic Transforming 5/16 31.3
Total chemicals
Nonmutagenic/carcinogenic Transforming 21/33 63.6
Nonmutagenic/noncarcinogenic Transforming 11/42 26.2
Concordance = 21 +31/75 = 69.3%
Sensitivity = 21/33 = 63.6%
Specificity = 31/42 = 73.8%
Abbreviations: no., ratio ofthe number ofchemicals in a subgroup that
induced significant transformation responses versus the total number of
chemicals in the subgroup; %, the ratio of chemicals expressed as a
percentage (e.g., 10/19 = 52.6%); LD50, lethal dose for 50% ofthe cells.
aData for this table were obtained from Tables A3 and A6. The
computations in this table excluded carcinogens and noncarcinogens that
had an indeterminate transformation response.
bA total of 31 chemicals were nonmutagenic, noncarcinogenic and
nontransforming (i.e., 42 - 11 = 31).
The capability ofthe BALB/c-3T3 assay to detect non-
mutagenic carcinogens is summarized in Table 10. These
data revealed that there was a high concordance of69.3%
between nonmutagenic carcinogens detected in rodent
bioassay and transformation responses measured in the
transformation assay. In addition, the transformation
assay had a sensitivity for detecting nonmutagenic car-
cinogens of 63.6% (21/33), and a high specificity for not
detectingnoncarcinogens of73.8%(31/42). Thenumberof
nonmutagenic carcinogens used in these analyses was 33
out ofa total of35 because 2 chemicals had an indetermi-
nate activity (Tables A3 and A6).
Comparison ofthe Relative Carcinogenic
Activity ofMutagenic and Nonmutagenic
Carcinogens
The relative carcinogenic activityofchemicals inrodent
bioassayhasbeenevaluated interms oftheirlevelofeffect
(1-3). The most active carcinogens induced tumors at one
or more tissue sites in both species of rodents and were
defined as having a level A effect (Table 11). In contrast,
carcinogens with lower activities induced tumors in only
one species, and theywere evaluated as having level B, C,
or D effects. Finally, chemicals that did not induce a
significant tumor response were evaluated as having an
equivocal activity (level E) or as being inactive (level F).
Occasionally, a chemical was evaluated as having an inde-
terminate activity, because it has not been evaluated in a
rodent bioassay that fulfilled all ofthe required prerequi-
sites.
The relative level of activity of mutagenic and non-
mutagenic carcinogens in rodent bioassay has also been
compared (1,3). Ashby and Tennant (1,3) concluded that
mutagenic carcinogens in general induced more multi-site
Table 11. Relative activity ofcarcinogens in rodent bioassays.a
Level of
Activity effect Species Tissues
Carcinogenic
High A 2 1 or more
High B 1 2 or more
Low C 1 1 tissue/both sexes
Low D 1 1 tissue/i sex
Noncarcinogenic
Equivocal E
Inactive F
aAmethod for estimating the relative activity ofcarcinogens in rodent
bioassay as reported by Ashby and Tennant (1,3).
and trans-species effects in the rodent bioassay than
nonmutagenic carcinogens. Furthermore, they found evi-
dence that mutagenic carcinogens induced tumors in a
different profile of tissues sites than nonmutagenic car-
cinogens (1). Thus, it was ofinterest to determinewhether
the mutagenic and nonmutagenic carcinogens included in
the these investigations had a comparable profile of
activities as previously reported. It was also ofinterest to
determine whether the BALB/c-3T3 cell transformation
assay selectively detected carcinogens of either high or
low activity.
The results ofthese analyses are presented in Table 12.
They confirmed the reported observation that the major-
ity of the 49 mutagenic carcinogens in this investigation
had a relatively high level ofeffect in the rodent bioassay
(i.e., 37 were A or B versus 12 that were C or D; Tables A3
and A6). In addition, a total of 74% of the carcinogens
detected by Salmonella and in the BALB/c-3T3 transfor-
mation assay had a level A or B effect. In contrast, the 35
nonmutagenic carcinogens in this investigation contained
roughly equal numbers of chemicals with a high or low
level ofeffect (i.e., 19 were A or B and 16 were C or D). In
this group the BALB/c-3T3 transformation assay prefer-
Table 12. Correlation oflevel ofeffect ofcarcinogenicity with
BALB/c-3T3 transformation responses.a
Level ofeffect
Transformation No. AB No. CD % AB
46 Mutagenic carcinogens
Transforming 32 11 74.4
Nontransforming 3 0
33 Nonmutagenic carcinogens
Transforming 13 8 61.9
Nontransforming 6 6
79 Total carcinogens
Transforming 45 19 70.3
Nontransforming 9 6
Abbreviations: no. AB, number ofthe chemicals with a level ofeffectA
or B (C or D) of the subgroup of chemicals; % AB, percentage of
chemicals with level ofeffect A or B (e.g., 32/26 + 11 = 74.4%).
aThe data for this table were obtained fromTables A3 and A6. (Note:
threeofthemutagenic carcinogens andtwoofthenonmutagenic carcino-
genshadindeterminate activityandwere notincludedintheseanalyses.)
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entiallydetected62%ofthecarcinogenswith ahighAorB
level ofeffect.
Discussion
There were five accomplishments of this investigation.
First, we were able tovalidate the use ofthe BALB/c-3T3
transformation assay and demonstrate that it selectively
detected carcinogenic, versus noncarcinogenic, testchem-
icals. The datafromthis study showthatthe BALB/c-3T3
cell transformation assay exhibits a somewhat higher
concordance with the rodent bioassay than Salmonella
mutagenicity data, i.e., 70.7versus 63.4% (Tables 5 and 6).
Thus, both of these assays selectively detected carcino-
gens versus noncarcinogens in this data set. However, the
BALB/c-3T3 transformation assay also detected a large
number of noncarcinogenic chemicals that were active in
Salmonella mutagenesis assays (i.e., mutagenic noncar-
cinogens). Thus, neither assay could discriminate most
matched pairs ofcarcinogens and noncarcinogens, which
have very similar chemical structures. Nearly all of the
matchedpairs ofcarcinogens and noncarcinogens, such as
2- and 3-chloromethylpyridine, were active inboth assays.
The only matched pairs which were discriminated by
BALB/c-3T3 transformation assays were the active car-
cinogens 2-acetylaminofluorene and BaP and the inactive
noncarcinogens 4-acetylaminofluorene and benzo[e]-
pyrene (unpublished observation). One matched pair, HC
blue 1 and 2, had either an inactive or an indeterminate
activity in the transformation assay.
Second, the data obtained in this investigation demon-
stratethatthe BALB/c-3T3 cell transformation assaycan
be used to selectively detect some carcinogens that were
inactive in the Salmonella mutagenesis assays (i.e., non-
mutagenic carcinogens). There were a total of 53 non-
mutagenic carcinogens selected for evaluation in the
transformation assay; however, only 35 chemicals were
tested. Theactivities oftheremaining 18 chemicalswillbe
discussedbelow. Amongthe 35 chemicals thatwere tested
in the standard transformation assay, 21 chemicals were
active, including 10 of 19 cytotoxic and 11 of 14 non-
cytotoxicchemicalsand2chemicalsthathad anindetermi-
nate activity (Table 10). Of the remaining 12 inactive,
nonmutagenic carcinogens, 3 carcinogens (i.e., cinnamyl
anthraniliate, methapyrilene, and reserpine) have been
demonstrated to be active in a new BALB/c-3T3 cell
transformation assay that uses noncytotoxic treatment
doses of the test chemical (unpublished data). In this
protocoltheBALB/c-3T3 cells areexposedcontinuouslyto
multiple chemical treatment doses, and the assay is only
used to evaluate the activities of cytotoxic test chemicals
(LD50 < 5 mM). The remaining six cytotoxic, non-
mutagenic carcinogens that were inactive (e.g., allyl iso-
valerate, chlorowax 40, chlorowax 500, D-liminone, tris(2-
ethylhexyl)phthalate, and 4-vinylcyclohexene) and one
equivocal (e.g., 2-mercaptobensothiazole) transformation
responseawaitfurthertestingwiththemultipletreatment
(MTA) assay. In contrast, the four noncytotoxic, non-
mutagenic, carcinogens could not be evaluated in this
assay: decabromodiphenyloxide, di(2-ethylhexyl)adipate,
di(2-ethylhexyl)phthalate, and monuron. These carcino-
gens had severe solubility problems in culture medium,
and they were noncytotoxic at treatment dose well above
their solubility limit.
Takentogether, the Salmonellamutagenesis assays and
the standard BALB/c-3T3 transformation assay were
complementaryand detected83.3% (70/84) ofthe carcino-
gens in this investigation, including 21 nonmutagenic car-
cinogens. Ofthe remaining 14 nonmutagenic carcinogens,
10 were cytotoxic and were eligible for evaluation in the
BALB/c-3T3 MTAassay.Threeofthese 10chemicals have
alreadybeenshowntobeactiveinaMTAprotocolthathas
a high sensitivity to detect carcinogenic test chemicals.
Thus, only four noncytotoxic, nonmutagenic carcinogens
with severe solubility problems in culture medium would
be predicted to lack activity in the two assays. The sacri-
ficeinspecificityinusingthetwo assayscouldbe to detect
all 24 mutagenic noncarcinogens and approximately 26%
ofthe nonmutagenic noncarcinogens.
An additional group of 18 nonmutagenic carcinogens
were originally selected to be tested in the BALB/c-3T3
cell transformation assay. However, these chemicals were
part of a group of 21 chemicals that reacted with poly-
styrene,plasticculturevessels (Table4);thus,thesechem-
icals could not be evaluated in the standard transformation
assay. This reaction occurred at concentrations that were
completely soluble in culture medium and used as treat-
ment doses to detect cytotoxic and transforming activity
(Table 4). While most of these chemicals had severe sol-
ubility problems in culture medium, they were all com-
pletely soluble in culture medium supplemented with plur-
onic F68. Thus, these chemicals reacted with polystyrene
while they were in solution in water. These chemicals are
distinguishable from chemicals such as acetone that react
with polystyrene as a neat chemical, but not when it is
dissolved in culture medium.
Amongthis group of21 testchemicals thatreactedwith
polystyrene, Salmonella detected only one weak positive
(1,2-dichloropropane). An additional chemical, bis(2-
chloro-1-methylethyl)ether, had a minor structural alert
(3). Ofthe remaining 19 chemicals, 17 were nonmutagenic
carcinogens: benzene; benzyl acetate; bromodichloro-
methane; bromoform; butyl benzyl phthalate; p-chlo-
roaniline; chlorobenzene; chlorodibromomethane; diallyl
phthalate; 1,4-dichlorobenzene; methylene chloride; pen-
tachloroethane; safrole; 1,1,1,2-tetrachloroethane; tetra-
chloroethylene; 1,1,1-trichloroethane; and trichloroethyl-
ene (1-3). There were only 2 noncarcinogens in the group
of 21 chemicals (N-butyl chloride and 1,2-dichloro-
benzene). It should be noted that one of these chemicals,
benzene, has been reported by Fitzgeral et al. to induce
significant transformation ofBALB/c-3T3 cells when the
cells were treated in chemical-resistant glass dishes (25).
Third, we were able to determine the actual upper dose
limit for testing chemicals in the BALB/c-3T3 cell trans-
formation assay. To achieve this goal, we tested all ofthe
noncytotoxic chemicals at very high treatment doses to
determine the point at which the assay could not dis-
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tinguish active and inactive chemicals. Furthermore, we
tested a number of chemicals with solubility problems in
culture medium at concentrations far exceeding their sol-
ubility limit. The results of these experiments revealed
that the upper dose limit for the standard transformation
assaywas 100mOsMbecause all oftheleastcytotoxic test
chemicals induced significant transforming activity at
treatment dose concentrations of about 134 mOsM or
higher(Table3). Intheprocess ofconductingtheseexperi-
ments we discovered that many of the chemicals which
were tested at doses far above their solubility limit in
culture mediumwere inactive inthe transformation assay.
In fact, noncytotoxic chemicalswith solubilityproblems in
culture medium were far less likely to be active in the
transformation assay then chemicals that were freely
soluble in culture medium (Table 4).
Fourth, we were able to ascertain that most of the
chemicals tested in the standard BALB/c-3T3 transfor-
mation assay induced reproducible transformation
responses. To accomplish this goalwe tested all chemicals
in two or more experiments. In addition, five chemicals
were tested as both coded and uncoded test chemicals:
C. I. basicred 9, dichlorvos, dimethylmorpholinophosphor-
amidate, HC red 3, and methyl carbamate. The results of
these experiments showed that the cytotoxic responses of
the paired chemicals were nearly identical (Thbles Al and
A4). Likewise, the transformation responses ofall 5 pairs
of chemicals were not significantly different from one
another (Tables A2 andA5). Both sources ofdimethylmor-
pholinophosphoramidate, HCred3, andmethylcarbamate
were active inthetransformation assay, and C. I.basicred
no 9 was inactive. The uncoded source of dichlorvos was
inactive inthe transformation assay, and the coded source
of the chemical was evaluated as having an equivocal
response.
Test chemical transformation responses were also
observed tobeveryreproducible forthe total group of168
chemicals tested to at least two consecutive trials. Atotal
of 82.7% (139/168) chemicals were clearly active or inac-
tiveinthetransformation assay(TablesA3 andA6). Ofthe
remaining 29 test chemicals, 8.9% (15/168) of the chemi-
cals were evaluated as having weakly active or equivocal
activities in the transformation assay. Thus, only 8.3%
(14/168) of the chemicals had an indeterminate activity
which resulted from different transformation responses
being detected in two consecutive experiments. Therefore,
themajorityofthe chemicals tested inthetransformation
assay had reproducible activities detected in two consecu-
tive experiments.
The fifth accomplishment ofthis investigation has been
to use the computer-automated structural evaluation soft-
ware system (CASE) to investigate quantitative
structure-activity relationships (QSAR) for BALB/c-3T3
transformation response data (unpublished observations).
Because a combined database of205 chemicals tested in a
standardBALB/c-3T3transformation assaywasavailable
[i.e., 168 chemicals in the current study, 24 chemicals in
part IV of this series (14), and 13 polycyclic aromatic
hydrocarbons (unpublished observations)], sufficient data
were available to investigate a possible correlation of
induction of transformation with specific portions of the
chemical structure (i.e., biophores). This investigation
revealed that the induction of transformation response
datawas significantly correlated withthepresence ofonly
13 biophores; conversely, just four biophobes were associ-
atedwith the inhibition oftransformation. In addition, the
study showed that the four biophobes were present on
manyofthe 14chemicalswhichhadindeterminate activity
in the transformation assay. In a companion investigation,
CASE utilized theBALB-c-3T3 cell cytotoxicity datafrom
the co-culture clonal survival assay to investigate QSAR
for chemical-induced cytotoxic responses. This investiga-
tion revealed that a limited number of biophores were
highlycorrelatedwith certain chemicals beingcytotoxic to
BALB/c-3T3 and other cultured mammalian cells [unpub-
lished observations (26)]. QSAR investigations have deter-
mined that a limited number of biophores are highly
correlated with the induction ofcytotoxicity and transfor-
mation, and this information can be used to predict
cytotoxic and transformation responses of chemicals
untested in the BALB/c-3T3 transformation assay.
In conclusion, oneofthemajorgoals ofthe NTPGenetic
Toxicology program during the 1980s has been to develop
and evaluate in vitro assays that selectively detect car-
cinogenic chemicals thatwereinactiveinSalmonellamuta-
genesis assays. If such assays could be developed, they
could be used to investigate invitro biological activities in
common amongthe active chemicals and thereby lead to a
clearer understanding ofthe mechanism(s) bywhich non-
mutagenic carcinogens are carcinogenic in rodent bio-
assays. This reportand the companion investigations have
demonstrated progress in achieving this goal. The data in
this report showthatthe majority ofthe 35 nonmutagenic
carcinogens (21/35) were selectively detected in a stan-
dard BALB/c-3T3 transformation assay. In addition,
CASE has identified chemical fragments of each of the
nonmutagenic carcinogens that significantly correlated
with the effects of the chemical in the transformation
assay. Therefore, it nowfeasible to investigate the several
different nonmutagenic carcinogens to determine the
mechanism(s) bywhich they induced a permanent change
in the transformed phenotype of BALB/c-3T3 cells. It is
hoped that these investigations will help to close the
current gap in our understanding of in vitro and in vivo
chemical carcinogenesis.
Theopinionsexpressed inthispaperaresolelythoseofthe authorsand
do not necessarily reflect the positions of the U.S. Food and Drug
Administration.
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Appendix A
Cytotoxic, Mutagenic Carcinogens
2-Acetylaminofluorene. 2-Acetylaminofluorene was a
potent level A carcinogen (Table A3) with no serious
technicalproblems reported (TableAl). It wascytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 0.171
mM (TableAl). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 83 and 89/110, respectively;
the detection sensitivities forBaPoftrails 1 and 2 were 70
and 87/110, respectively (TableA2). The testchemical had
an SP transformation response in two consecutive experi-
ments. 2-Acetylaminofluorene was evaluated as very
active in the transformation assay, and its actual and
estimated rankt-statistics were3.12and4.67,respectively
(Table A3).
Acrylonitrile. Acrylonitrile was a level B carcinogen
(Table A3). This chemical had one serious technical prob-
lem, because it was reported to be oxidized upon exposure
to air (TableAl). It was cytotoxic to the BALB/c-3T3 cells
and had an average LD50 of 0.337 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 52 and 41/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 79 and 83/110,
respectively (TableA2). In both trials the chemical had an
LAtransformation responses.Acrylonitrile was evaluated
as having had weak activity in the transformation assay.
Its actual and estimated rank t-statistics were 3.75 and
4.35, respectively (Table A3).
2-Amino-4-Nitrophenol. 2-Amino-4-nitrophenol was a
relatively weak level D carcinogen (Table A3). It had one
difficult technical problem, because it is oxidized upon
exposure to air (Table Al). It was cytotoxic to the BALB/
c-3T3 cells with an average LD50 of0.933 mM (Table Al).
The statistical sensitivities oftransformation assay trials
1 and 2 were 13 and 56/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 66 and 109/110,
respectively (Table A2). In trials 1 and 2 the chemical had
SN transformation responses. However, there were two
problemswiththe secondtransformation experiment. The
test chemical cytotoxic response in the second experiment
did not have a large cytotoxic shift as noted in previous
experiments, and the detection sensitivity was very lowin
the experiment. Therefore, the test chemical should be
tested in a third experiment to properly evaluate its
activity in the transformation assay. 2-Amino-5-nitro-
phenol was therefore evaluated as having had an indeter-
minate activityinthetransformation assay. Its actual and
estimated rank t-values were both 0.00 (Table A3).
2-Amino-5-Nitrophenol. 2-Amino-5-nitrophenol was a
relatively weak level D carcinogen (Table A3). It had one
difficult technical problem, because it is oxidized upon
exposure to air (Table Al). It was cytotoxic to the BALB/
c-3T3 cells with an average LD50 of0.409 mM (Table Al).
The statistical sensitivities oftransformation assay trials
1-3 were 71, 43 and 21/110, respectively; the detection
sensitivites for BaP of trials 1-3 were 23, 9 and 53/110,
respectively (TableA2). In apreliminarytrial 1 the chemi-
calhad aSNtransformationresponse. Intrials2and3the
chemical had SP transformation responses. 2-Amino-5-
nitrophenol wastherefore evaluated as active in thetrans-
formation assay. Its actual and estimated rank t-statistics
were both 5.94 (Table A3).
5-Azacytidine. 5-Azacytidine was a level D carcinogen
(Table A3) with no serious technical problems reported
(Table Al). Itwas very cytotoxic to the BALB/c-3T3 cells
with an average LD50 of 0.00463 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 45 and 101/110, respectively; the detection
sensitivities forBaPoftrials 1 and 2were 38 and 104/110,
respectively (Table A2). In trials 1 and 2 the chemical had
an SP transformation response. 5-Azacytidine was evalu-
ated as oneofthemostactivechemicalsinthetransforma-
tion assay. Its actual and estimated rank t-statistics were
12.8 and 16.8, respectively (Table A3).
Benzidine-2HC1. Benzidine-2HClwasalevelAcarcino-
gen (Table A3). It had one serious technical problem
becauseitwas reported tobecome oxidized upon exposure
to air (TableAl). Itwas cytotoxic to the BALB/c-3T3 cells
with anaverage LD50of0.121 mM(TableAl).Thestatisti-
calsensitivities oftransformationassaytrials 1 and2were
30 and 34/110, respectively; the detection sensitivities for
BaPoftrials 1 and2were4and45/110,respectively(Table
A2). Intrial 1 and2thechemicalhadanSPtransformation
response. Benzidine-2HCl was evaluated as active in the
transformation assay. Its actual and estimated rank t-sta-
tistics were both 3.38 (Table A3).
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Table Al. Cytotoxic responses of 114 cytotoxic chemicals.
Cytotoxic Responsesb
Test Chemicala Physicochemical Properties (millimolar LD50)
Co-culture
Name CAS No. M.W. 1 2 3 Assay
43 Mutagenic Carcinogens
Group I. Moderately Cytotoxic Ch4
5-chloro-o-toluidine
C. I. disperse yellow 3 2N
1,2-epoxybutane
1,2-epoxypropane
ethyLenedi bromide
HC blue 1
iodinated glycerol
4,4-methylenedianiline
N-methyl-o-acrylamide
2-naphthylamine
quinolmne
o-toluidine
enicaIs
95-79-4 141.61
832-40-8 269.31
106-88-7 72.11
75-56-9 58.08
106-93-4 187.88
784-94-3 256.31
634-39-9 260.
101-77-9 271.21
924-42-5 101.11
91-59-8 143.18
91-22-5 129.16
95-53-4 107.16
S DFC
S DFC
a. ac, al, o
0
L c ai, a, b, bc, ls, mh,
0, p, ts
L C a, ai, b, bc, mc, mh,
msc, o, p, r
L DFC b, Is, met, o, p, r
S DFC ai,
L C
S DFC
S FC
S CF
L DFC
L DFC
Is
ai, Ls
ls, ts, 0
a, ai, O,
a, ls, msc, o, p
a, ai, 0, p, r
1.69
1.50
1.45
1.60
1.69
1.96
3.47
1.56
1.75
1.59
4.09
4.33
Group II. Cytotoxic Chemicals
2-acetylaminofluorene 53-96-3
acrylonitrile 107-13-1
2-amino-4-nitrophenol 99-57-0
2-amino-5-nitrophenol 121-88-0
benzidine-2HCl 531-85-1
2-biphenylamine 90-41-5
4-biphenylamine 92-67-1
4-chloro-o-toluidine-HCl 3165-93-3
C. I. acid orange 3 6373-74-6
C. I. disperse blue 1 2475-45-8
C. I. solvent yellow 14 842-07-9
1,2-dibromo-3-chloropropane 96-12-8
2,6-dichloro-p-phenylenediamine 609-20-1
1,3-dichloropropene 542-75-6
dichlorvos uncoded 62-73-7
(676384)
2,4-dinitrotoluene 121-14-2
epichlorohydrin 106-89-8
nitrofurantoin 67-20-9
2-nitro-p-phenylenediamine 5307-14-2
4,4-oxydianiline 101-80-4
selenium sulfide 7446-34-6
Group 111. Verv Cytotoxic Chemicals
5-azacytidine 320-67-2
4-chloro-o-phenylenediamine 95-83-0
3-(chloromethyl)pyridine-HCl 6959-48-4
C. I. basic red 9-HCl uncoded 569-61-9
(947733)
cytembena 21739-91-3
diglycidyl resorcinol ether 101-90-6
melphalan 148-82-3
N-methyl-N-nitro-
N'-nitrosoguanidine 70-25-7
nitrofurazone 59-87-0
ziram 137-30-4
223.3
53.06
154.13
154.13
257.18
169.22
169.23
178.07
453.41
268.3
248.30
236.35
177.0
110.98
220.98
182.14
92.53
238.16
153.16
200.24
111.02
244.2
142.59
164.04
323.83
307.09
222.26
305.23
147.1
198.14
305.81
S DFC
L DC
S DFC
S DFC
S DFC
S DFC
S DFC
L DFC
S DFC
S FC
S AFC
L DFC
S DFC
L DFC
L DC
S DCF
L DC
S DFC
S DFC
S DFC
S CF
S DC
S DFC
S C
S FC
S C
L DCF
S FC
S DC
S DFC
S DFC
ai, v,
a, ac, ai, ls, o, ts
ai, Is, ts,
ai, Is
mel, o,
ai, O,
a, ac, ai, o
Sp, ts
Is, o, sp
b, met, r
ai, Is, ts
a, hc, met, o, tc
a, b, met, p, ru, w
o, r, ts
ai, a, b, c, msc, o, w
a, b, ls, met, o, ts
ai, ls, o
ail, Is, o,
ts,
ai, k, 1, o
a, o,
alk
Is, ts, w
ls, ts, w
Is
a, b, met
21 Mutagenic Non-Carcinogens
Group I. Moderately Cytotoxic Chemicals
4-acetylaminofluorene 28322-02-3
3-chloro-p-toluidine 95-74-9
2,4-dimethoxyaniline-HCL 54150-69-5
HC blue 2 33229-34-4
HC red 3 (uncoded) 2871-01-4
(coded)
223.29
141.60
189.66
285.34
197.22
S DFC
S DFC
S DFC
S C
S FC
sp
a, ach, ai, l, o
ai
4.07
1.17
1.13
5.21
3.72
4.50
(Continued on nextpage)
0.171
0.337
0.933
0.409
0.121
0.421
0.479
0.650
0.102
0.240
0.199
0.401
0.921
0.280
0.145
0.140
0.917
0.364
0.106
0.947
0.270
0.125
0.00463
0.0318
0.0756
0.00281
0.00216
0.153
0.00416
0.00120
0.0154
0.0515
0.0000373
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Table Al. Continued.
Cytotoxic Responsesb
Test Chemicala Physicochemical Properties (millimolar LD50)
Co-culture
Name CAS No. M.W. 1 2 3 Assay
3-nitropropionic acid
2,6-toluenediamine-2HCl
Group II. Cytotoxic Chemicals
2-(chloromethyl)pyridine-HCl
coumaphos
dimethoate
malaoxon
1 -naphthylamine
N-(1-naphthyl)ethylenediamine
-2HCl
1-nitronaphthalene
4-nitro-o-phenylenediamine
N-phenyl-2-naphthylamide
504-88-1 119.08 S C a, ai, b, o
15481-70-6 195.11 S C -
6959-47-3
56-72-4
60-51-5
1634-78-2
134-32-7
1465-25-4
86-57-7
99-56-9
135-88-6
Group III. Very Cytotoxic Chemicals
4'-(chloroacetyl)acetanilide 140-49-8
8-hydroxyquinoline 148-24-3
p-phenylenediamine-2HCl 624-18-0
2,3,5,6-tetrachloro-4- 2438-88-2
nitroanisole
tetraethylthiuram disulfide 97-77-8
164.04
362.78
229.27
314.32
143.18
259.18
173.17
153.14
219.30
211.66
145.16
181.07
290.91
296.54
S DC
S DFC
L DFC
L DC
S DFC
S DFC
0
b, a
b, v
ai, v
a, ai l, 0
a, ach, l, o
S DFC a, o, r
S DFC a, ac, ai, ls r
S DFC ai, L
S DFC -
S DC l, m, o
s c ai, l, o
S DFC -
S DFC 0
1.23
4.11
0.118
0.218
0.602
0.468
0.506
0.125
0.464
0.292
0.195
0.00336
0.00251
0.0712
0.0437
0.0000583
Group I. ModerateI y
allyl isovalerate
chlorendic acid
chlorowax 40
chlorowax 500
dimethylvinyl chloride
isophorone
malonaldehyde, sodium salt
nitrilotriacetic acid
4-vinylcyclohexene
20 Non-Mutagenic
Cytotoxic ChemnicaIs
2835-39-4
115-28-6
108171-27-3
108171-26-2
513-37-1
78-59-1
24382-04-5
139-13-9
100-40-3
142.22
388.83
560.
415.
90.55
138.23
94.05
257.1
108.20
Carcinogens
L DFC
S DFC
L FC
L AFC
L DFC
L DFC
S C
S C
L DFC
m
b, l, o, r, ts
l, o, r, ts
ai, b, o, l, t, v
0, t, v
l, vts
m
ai, o, ts
GrouP II. Cytotoxic Chemicals
3-chloro-2-methylpropene 563-47-3
D-limonene 5989-27-5
2-mercaptobenzothiazole 149-30-4
methapyrilene-HCl 135-23-9
polybrominated biphenyl mixture 67774-32-1
tris(2-ethylhexyl)phosphate 78-42-2
Group III. Very Cytotoxic Chemica7s
allyl isothiocyanate 57-06-7
cinnamyl anthranilate 87-29-6
diethylstilbestrol 56-53-1
ethyl acrylate 140-88-5
reserpine 50-55-5
carbromal
C. I. acid red 14
C. I. acid yellow 73
ephedrine sulfate
ethylenediamine tetraacetic
acid, trisodium salt
D,L-menthol
methylphenidate-HCl
phenol
77-65-6
3567-69-9
518-47-8
134-72-5
150-38-9
15356-70-4
298-59-9
108-95-2
99.55
136.24
167.25
297.88
627.59
434.65
99.16
253.32
268.34
100.12
608.70
237.10
502.44
376.
428.54
358.22
156.27
269.80
94.11
L DFC b,
L DFC a,
S DFC a,
S C
-
S DFC l,
L DFC o
o , l, t, v, W
ai,I, o, ts
of w
sp
L DFC a, al, b, o, v, w
S DFC ai, ald, I
S DFC
L DC a, b, o, pi, v, W
S DC ai, l, o, r
Non -Carcinogens
S
S
S S
S
DFC
C
ai, I
C 0
C l, ts
FC m
S DFC o, oc
S C
-
S/L C a, ai, b, l. o. oc. S, ts
0.662
0.988
0.130
0.812
0.291
0.338
0.00712
0.0947
0.0858
0.0746
0.0133
3.60
3.38
4.65
1.53
1.89
4.63
5.63
3.29
4.51
4.07
1.43
1.58
4.74
5.18
3.74
5.98
3.88
30 Non-Mutagenic
Group I. Moderately Cytotoxic Chenicals
(Continued on nextpage)
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Table Al. Continued.
Cytotoxic Responsesb
Test Chekicala Physicochemical Properties (mi11 imolar LD50)
Co-culture
Name CAS No. M.W. 1 2 3 Assay
phenytephrine-HCL 61-76-7 203.67 S C a, ai, ach, lI o, ts 3.52
tetracycline-HCL 64-75-5 480.94 S FC ail, l, o, ts 3.24
xylenes, mixed 1330-20-7 106.17 L DFC o, ts 3.20
Group II. Cytotoxic Chenicals
L-ascorbic acid 50-81-7 176.14 S C ail, lI, m, oc, r 0.363
bisphenot A 80-05-7 228.29 S DFC ach, o 0.147
chlorpheniramine-maleate 113-92-8 390.87 S C - 0.287
eugenoL 97-53-0 164.20 L DFC ai, b, t, o, ts, v 0.875
geranyt acetate 105-87-3 196.32 L DFC - 0.302
4-hexylresorcinol 136-77-6 194.27 L DFC ach, l, o, ts 0.103
oxytetracyctine-HCL 2058-46-0 496.90 S FC l, ts, W 0.523
Group III. Very Cytotoxic Chemicals
anilazine 101-05-3 275.53 S DFC b, mo 0.0475
erythromycin stearate 643-22-1 1018.59 S AFC a 0.0746
ethoxylated dodecyl alcohoL 9002-92-0 -1200.00 L DC b, o, v 0.0172
methoxychlor 72-43-5 345.66 S DFC L, mo, o 0.0978
methyldopa sesquihydrate 555-30-6 238.24 S DFC b, ts 0.0810
propyl gallate 121-79-9 212.20 S DFC a, b, i, r 0.0631
rotenone 83-79-4 394.43 S AFC ai, b, l, o, ts 0.000464
sodium diethytdithiocarbamate 148-18-5 171.27 S C a, o 0.000142
stannous chloride 7772-99-8 189.60 S DC al, am, b, mo, o 0.0285
tetrakis(hydroxymethyL) 124-64-1 190.58 L C b, o, ts 0.00825
phosphonium chic-ide
tetrakis(hydroxymethyl) 55566-30-8 406.32 L C b, o 0.00438
phosphonium suLfate
triphenyltin hydroxide 76-87-9 367.03 S FC a, l, ts 0.000134
Abbreviations: CAS No., Chemical Abstract Service registry number; LD., lethal dose for 50% ofthe cells; M.W, molecular weight.
Abbreviations for Test Chemical Physiochemical Properties: Physicochemical considered in this study included: [1] physical state (S = solid; L =
liquid); [2] solventvehicle (D = dimethyl sulfoxide, C = culturemedium, F = pluronicF68,A = acetone, E = ethanol) and [3] technical problems. The
technical problems included test chemicals thatwere a = reactivewithacids; ac = reactivewith acid chlorides and acidanhydrides; ai = reactivewith
air; al = reactive with alcohols; alk = alkylating agent and reactswith labile hydrogen; b = reactswithbases; bc = reacts withbiochemicals (amino,
hydroxyl, andcarboxyl groups); hc = reactswithhalogenated chemicals; k = reactswithalphaketoacids; ls = lightsensitive; m = bindsmetals; mel
= reactswith hexachloro- andtrichloromelamine; met = reactswith metals(aluminum,iron,magnesium, potassium, sodium, tin orzinc); mh = metal
halides; msc = reacts with miscellaneous organic chemicals (i.e., alpha-aminoethanol, chlorosulfonic acid,ethyleneimine, linseed oil, maleicanhydride,
oleum, orK-tert-butyloxide); o = reactswithoxidizingagents;p = reactswithplastics;pi = polymerizationinitiators; r = reactswithreducingagents;
ru = reactswithrubber; sp = solubilityprobleminculturemedium;tc = reactswiththiocyanates; ts = temperaturesensitive;vts = verytemperature
sensitive; v = volatile at 37°C; and w = reacts with water [refer to MATERIALS and METHODS].
aTestChemical: TablesAl andA3 contain 168chemicalsalongwiththeirindividual CASregistrynumberand molecularweight. The chemicalswere
divided into groups ofchemicals thatcorrespond to the groups ofchemicals thatwerecompared in differenttextTables 1-12.Thus, the chemicalswere
dividedinto twogroups,including 114cytotoxic testchemicals (LD50 < 5.0mM)presented inTableAl, and53noncytotoxic chemicals(LD50 > 5.0mM)
presented inTableA4.The 114cytotoxic chemicalsinTableAl weresubdividedintogroups of43mutageniccarcinogens, 21 mutagenicnoncarcinogens,
20 nonmutagenic carcinogens, and 30nonmutagenic noncarcinogens. The 53noncytotoxic testchemicals inTable A4 were subdivided into groups of21
carcinogens, 26 noncarcinogens and 7 model very noncytotoxic chemicals. In addition, all ofthe cytotoxic test chemicals were separated into three
groups, including: group I, moderately cytotoxic test chemicals [LD50 1-5mM]; group II, cytotoxic chemicals [LD50 0.1-1.0 mM]; and group III, very
cytotoxicchemicals [LD50 < 0.1 mM]. Inaddition,thistablepresentsimportantphysicochemicalpropertiesthatinfluencedtheprocedureusedintesting
the chemicals.
bCytotoxic Response: The co-culture clonal survival assaydesign used to detectthecytotoxic response ofthe testchemical is described in Materials
andMethods.Thecytotoxicresponses ofchemicalsinindividualexperiments aresummarizedintermsofthemillimolar(mM)LD50treatmentdosethat
resulted in 50% survival ofthe chemically-treated cells relative to the survival ofuntreated orsolventcontrol treated cell cultures. The LD50cytotoxic
response ofeach chemical in Tables Al and A4 is an average oftwo or more experiments with the chemical. The molecularweight ofeach chemical is
provided in order that treatment doses could be converted from mM to ,ug/mL. For example, based upon the molecularweight of 141.61, the LD50
detected for the first chemical in Table Al, 5-chloro-o-toluidine, was 1.69 mM or 239 ,ug/mL.
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Table A2. Ifansformation responses of 114 cytotoxic chemicals.
Transformation
Chemicala Spontaneousc Responseb
Foci/Vessel: Benzo(a)pyrened Test Chemical
e
Name Exp. No. Rank Order Call : Rank Order Call : mean t-statistic
43 Mutagenic Carcinogens
Active Chemicals
2-acetylaminoflourene 1 (17)
2 (24)
acrylonitrile 1 (86)
2 (92)
2-amino-5-nitrophenol 1 (62)
2 (83)
3 (93)
4 (103)
5-azacytidine 1 (6)
2 (11)
benzidine-2HCl 1 (43)
2 (52)
2-biphenylamine 1 (33)
2 (52)
4-biphenylamine 1 (35)
2 (53)
3-(chloromethyl)pyridine- 1 (14)
HCl 2 (22)
4-chloro-o-phenylenediamine 1 (13)
2 (20)
3 (101)
4-chloro-o-toluidine-HCl 1 (81)
2 (92)
5-chloro-o-toLuidine 1 (81)
2 (92)
C. I. acid orange 3 1 (70)
2 (87)
C. I. disperse blue 1 1 (73)
2 (97)
3 (107)
C. I. solvent yellow 14 1 (7)
2 (67)
3 (IP17)
4 (IP18)
cytembena 1 (70)
2 (83)
1,2-dibromo-3-chloropropane 1 (23)
2 (27)
3 (102)
selenium sulfide 1 (7)
2 (11)
3 (97)
.327 83
.308 89
.464 52
.579 41
6.02 3***
.351 71
.416 43
.874 21
.431 45
.301 101
1.05 30
1.09 34
1.04 49
1.09 34
1.97 14
2.78 11*
.213 99
.893 36
.201 96
.368 81
.260 62
7.36 2***
.597 41
7.36 2***
.597 41
.526 47
.346 63
.274 80
.414 54
2.95 5**
.135 105*
.085 107**
.411 -99
.189 -105*
.526 47
.351 71
.661 66
.555 78
.697 27
.135 105*
.301 101
.414 54
SP 70
SP 87***
SP 79*
SP 83*
SN 110***
SP 23**
SP 9***
SP 53
SP 38
SP 104**
SP 4***
SP 45
SP 24**
SP 45
SP 72
SP 39
SP 82*
SP 28
SP 86***
SP 22***
SP 48
SP 2***
SP 83*
SP 2***
SP 83*
SP 43
SP 101***
SP 89**
SP 44
SP 46
SP 69
SP 106***
SP -37
SP -39
SP 43
SP 23**
SP 81
SP 58
SP 63
SP 69
SP 104***
SP 44
SP 4.15
SP 2.08
LA 5.36
LA 2.14
LN .000
SN .575
SP 5.41
SP 11.8
Sp 16.7
SP 9.03
SP 4.54
SP 2.22
SP 2.63
SP 3.79
LA 2.21
SP 2.51
LA 1.35
SP 2.77
LN .870
SP 2.76
SP 8.92
SP 7.18
SP 4.44
SP 3.57
SP 5.38
LA 1.55
SP 4.23
SP 3.53
SN .405
SN .000
SP 3.52
SP 4.64
LA 2.16
SP 3.43
LA 4.34
SP 7.12
LN .333
SP 6.36
SP 4.83
SP J3.34
SN .223
SP 2.24
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Table A2. Continued.
Transformation
Chemicala Spontaneousc Responseb
Foci/Vessel: Benzo(a)pyrened Test Chemical
e
Name Exp. No. Rank Order Call : Rank Order Call : mean t-statistic
0-toluidine
zi ram
1 (16)
2 (25)
3 (98)
1 (77)
2 (91)
Chemical with an Equivocal Activity
dichtorvos 1 (68)
(uncoded) 2 (DRI5)
3 (98)
dich lorvos
(coded)
.344 87
.101 106*
.618 59
.972 17
.322 56
.226
1.27
.618
1 (78)
2 (90)
SP 64
SP 51
SP 17***
SP 6***
SP 109***
98
-72
59
3.28 9*
1.95 15
SP 60
NA
SP 17***
SP 37
SP 21**
LA .900
SP 9.28
SP 4.31
LA 1.17
SP 4.10
SN .460
LA 3.51
SN .000
SN .697
SP 2.66
Inactive Chemicals
C. I. basic red 9-HCl
(uncoded)
C. I. basic red 9-HCI
(coded)
2,4-dini trotoluene
1 (48)
2 (66)
3 (DRI4)
1 (73)
2 (95)
1 (46)
2 (55)
3 (DRI2)
Chemicals with an Indeterminate Activity
2-amino-4-nitrophenoL 1 (63)
2 (91)
3 (NA)
C. I. disperse yellow 3 1 (71)
2 (91)
3 (NA)
.537 64
.056 108**
.668 -82
.274 80
2.84 8*
.384 88
.129 104*
.503 -88
1.92 13
.322 56
1.06 24
.322 56
Chemicals with an Indeterminate Activity
HC blue 1 1 (15) .186 100 SP
2 (21) .347 79 SP
3 (DRI2) .503 88
4 (NA)
21 Mutagenic Non-Carcinogens
Active Chemicals
2- (ch loromethyl )pyridine-
HCl
3-chloro-p-toluidine
coumaphos
dimethoate
HC red 3
1 (14)
2 (22)
1 (81)
2 (92)
1 (30)
2 (95)
3 (99)
1 (41)
2 (94)
1 (40)
2 (57)
.213 99
.893 36
7.36 2***
.597 41
.787
2.847
.586
40
8*
33
.274 90
1.52 18
.533 60
.278 86
(Continued on nextpage)
84*
99***
SP
SP
NA
SP 89**
SP 29
SP 77
SP 90***
NA
SN .353
SN .700
SN .000
SN .098
SN .000
SN 1.57
SN .478
SN .000
SP
LA
SP
LA
66
109
10**
109***
42
75
NA
SP 82
SP 28*
SP 2***
SP 83*
SN .000
SN .000
SN .000
SN .155
SN 1.51
SN .725
SP 3.09
SP 2.36
SP 2.77
SP 2.60
SP 3.92
SN .000
SP 3.75
SP 7.60
LA 1.24
SP 5.39
SP 2.50
SP 2.77
SP 54
SP 29
SP 14**
SP 13***
SP 31
SP 27*
SP 74
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Table A2. Continued.
Transformation
Chemical' Spontaneous' Responseb
Foci/Vessel: Benzo(a)pyrened Test Chemical
e
Name Exp. No. Rank Order Call : Rank Order Call : mean t-statistic
HC red 3 (260886) 1 (61) .222 93 SP 1OO*** LA 1.61
2 (99) .586 33 SP 14** SP 9.58
malaoxon 1 (16) .344 87 SP 64 LA 4.17
2 (25) .101 106* SP 51 SP 9.46
1-naphthylamine 1 (13) .201 96 SP 86*** SP 2.66
2 (19) .357 77 SP 67 SP 2.97
4-nitro-o-phenylenediamine 1 (14) .213 99 SP 82 SP 3.83
2 (18) .663 46 SP 80* LA 1.27
3-nitropropionic acid 1 (39) .427 82 SP 18*** SP 3.90
2 (85) .588 67 SP 78 SP 5.47
p-phenylenediamine-2HCL 1 (37) .631 58 SP 55 SP 3.81
2 (89) .492 51 SP 50 SP 2.27
N-phenyL-2-naphthylamide 1 (61) .222 93 SP 100*** SP 4.79
2 (87) .346 63 SP 101*** SP 3.71
tetraethyLthiuram disulfide 1 (80) 3.024 10* SP 5*** SP 4.60
2 (93) .416 43 SP 9*** SP 2.92
2,6-toluenediamine 1 (29) .606 68 SP 40 SP 3.89
2 (44) 1.52 23 SP 11*** SP 10.0
4'-(chtoroacetyl)- 1 (37) .631 58 SP 55 LA 1.85
acetanilide 2 (95) 2.84 8* SP 29 LA 1.46
2,4-dimethoxyaniline 1 (34) 2.51 7* SP 56 SP 5.95
2 (87) .346 63 SP 101*** SN 1.32
3 (97) .414 54 SP 44 SN .960
8-hydroxyquinoline 1 (3) .285 94 SP 91*** SP 2.46
2 (9) .149 102* SP 95*** SN .170
3 (28) .818 39 SP 68 SN .128
N-(1-naphthyl)ethylene- 1 (38) .496 69 SP 12*** LA .957
diamine-2HCl 2 (87) .346 63 SP 101*** LA 2.31
2,3,7,8-tetrachloro-4- 1 (29) .606 68 SP 40 LA 2.47
nitroanisoLe 2 (93) .416 43 SP 9*** LA 1.70
Inactive Chemicals
HC blue 2 1 (5) .035 110*** SP 107*** LA 4.31
2 (10) .053 109** SP 103*** SN 1.43
Chemicals with an Indeterminate Activity
4-acetytaminofluorene 1 (12) .160 103* SP 73 LN .963
2 (17) .327 83 SP 70 LN 1.64
1-nitronaphthalene 1 (33) 1.04 49 SP 24** SN .000
2 (87) .346 63 SP 101*** SP 2.53
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Table A2. Continued.
Transformation
Chemicala Spontaneousc Responseb
Foci/Vessel: Benzo(a)pyrened Test Chemicale
Name Exp. No. Rank Order Call : Rank Order Call : mean t-statistic
2,6-dichloro-p-phenylene-
diamine
1,3-dichloropropene
diglycidyl resorcinol
ether
epichLorohydrin
1,2-epoxybutane
1,2-epoxypropane
ethylene dibromide
iodinated glycerol
melphalan
N-methyl-0-acrylamide
4,4-methylenedianiline
N-methyl-N'-nitro-N-
nitrosoguanidine
2-naphthylamine
nitrofurantoin
nitrofurazone
2-nitro-p-phenylene-
diamine
4,4-oxydianiline
quinoline
1 (32)
2 (54)
1 (79)
2 (94)
3 (104)
1 (6)
2 (12)
1 (68)
2 (DRI5)
1 (79)
2 (104)
3 (108)
1 (72)
2 (88)
1 (74)
2 (92)
1 (74)
2 (106)
1 (80)
2 (96)
1 (70)
2 (85)
1 (40)
2 (55)
1 (93)
2 (IP2)
1 (13)
2 (26)
1 (61)
2 (93)
1 (71)
2 (77)
3 (87)
1 (15)
2 (21)
3 (96)
1 (1)
2 (8)
1 (16)
2 (27)
3 (31)
4 (104)
1.99 19
.265 91
5.12 4**
1.52 18
.878 26
.348 45
.160 103*
.226 98
1.27 -72
5.12 4**
.878 26
1.17 20
.289 70
.406 57
.657 32
.597 41
.657 32
1.30 28
3.02 10*
.660 31
.526 47
.313 67
.533 60
.129 104*
.416 43
1.13 -54
.201 96
.907 37
.222 93
.416 43
1.06 24
.972 17
.346 63
.186 100
.347 79
.660 31
1.44 25
2.19 16
.344 87
.555 78
.930 42
.,878 26
SP 34
SP 85
SP 1
SP 31
SP 93**
SP 38
SP 73
SP 60
NA
SP 1***
SP 93***
SP 19**
SP 41
SP 88***
SP 108***
SP 83*
SP 108***
SP 15***
SP 5***
SP 52
SP 43
SP 78
SP 27*
SP 90***
SP 9***
NA
SP 86***
SP 20***
SP 100oo
SP 9***
SP 10***
SP 6***
SP 101***
SP 42
SP 75
SP 52
SP 36
SP 7***
SP 64
SP 58
SP 25*
SP 93***
SP 2.50
SP 2.03
SP 3.11
SN .000
LA 1.75
SP 15.2
SP 6.66
LA 2.38
SP 3.47
LN NA
SP 3.64
SP 2.50
SP 4.04
SP 4.93
SP 8.53
SP 2.83
SP 6.04
SN 1.31
LA 1.37
SP 4.81
LA 1.53
SP 3.88
SP 1.93
SP 1.82
SP 10.1
SP 7.52
SP 3.33
SP 3.99
SN .778
SP 4.25
LN .000
SP 3.26
SP 4.99
SP 4.21
SN 1.38
SP 4.38
SP 1.81
SP 3.72
LN .000
LN .000
LA 1.93
SP 3.96
(Continued on nextpage)
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T!able A2. Continued.
Transformation
Chemicala Spontaneousc Responseb
Foci/Vessel: Benzo(a)pyrened Test Chemical
e
Name Exp. No. Rank Order Call : Rank Order Call : mean t-statistic
Active Chemicals
aLlyl isothiocyanate
chlorendic acid
3-chloro-2-methylpropene
diethylsti lbestrol
dimethylvinyl chloride
ethyl acrylate
isophorone
malonaldehyde, sodium salt
nitrilotriacetic acid
polybrominated biphenyl
mixture
Chemical with an Equivocal
2-mercaptobenzothiazole
Inactive Chemicals
allyl isovalerate
chlorowax 40
chlorowax 500
cinnamyl anthranilate
D-limonene
methapyrilene-HCl
20
1 (41)
2 (98)
1 (63)
2 (83)
1 (29)
2 (31)
1 (42)
2 (96)
1 (76)
2 (102)
1 (23)
2 (36)
1 (25)
2 (36)
3 (104)
1 (75)
2 (97)
1(73)
2 (99)
1 (20)
2 (28)
Activity
1 (62)
2 (77)
3 (89)
1 (23)
2 (27)
3 (31)
4 (102)
1 (76)
2 (104)
1 (74)
2 (90)
1 (2)
2 (9)
3 (DFR3)
1 (72)
2 (76)
3 (88)
1 (40)
2 (54)
3 (DRI4)
Non-Mutagenic
.274 90
.226 98
1.92 13
.351 71
3.28 9*
.406 57
.861 55
.660 31
1.79 12*
.697 27
.661 66
.424 74
.101 106*
.424 74
.878 26
.882 21
.414 54
.274 80
.586 33
.368 81
.818 39
6.02 3*
.970 17
.492 51
.661 66
.555 78
.930 42
.697 27
1.79 12*
.878 26
.657 32
1.95 15
.660 53
.149 102*
.424 -92
.289 70
1.79 12*
.406 57
.533 60
.265 91
.668 -82
Carcinogens
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
LA
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
NA
SP
SP
SP
SP
SP
NA
13**
60
66
23**
37
88**
8**
52
98**
63
81
35
51
35
93**
26*
44
89**
14**
22**
68
1 10***
6*
50
81*
58
25*
63
98***
93**
108**
21 *
30
95**
41
98**
88**
27*
85
LA 1.62
SP 4.09
SP 1.96
LA 2.01
LA 1.62
SP 2.66
LA 2.22
SP 3.38
LA 1.45
SP 3.74
LA 2.49
SP 6.02
LN .203
SP 3.46
SP 2.06
SP 1.92
LA 1.55
SP 2.46
SP 8.41
SP 2.22
SP 1.64
LN .000
LA 1.23
LA 1.22
LN .080
LN .055
SN .591
LA 2.35
LA .850
SN .078
SN .185
SN .000
SN .010
SN .000
SN .000
LN 1.02
SN .473
SN .000
SN .000
SN .417
SN .000
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Table A2. Continued.
Transformation
Chemicala Spontaneous' Responseb
Foci/Vessel: Benzo(a)pyrened Test Chemical
e
Name Exp. No. Rank Order Call : Rank Order Call : mean t-statistic
reserpine
tris(2-ethylhexyl)phosphate
4-vinylcyclohexene
1 (1)
2 (8)
3 (DR3)
1 (88)
2 (98)
1 (74)
2 (110)
1.44
2.19
.424
.406
.618
.657
.609
25
16
-92
57
59
32
38
SP
SP
NA
SP
SP
SP
SP
36
7***
88***
17***
108***
16***
LA 1.38
SN .000
SN .887
SN .000
SN .000
SN .000
SN .000
Active Chemicals
C. I. acid red 14
phenol
propyl gallate
sodium diethyldithio-
carbamate
Weakly Active Chemicals
carbromal
chlorpheniramine-maleate
....................................
Chemicals with an Equivocal Activity
anilazine 1 (29)
2 (85)
Chemicals with an Equivocal Activity
tetrakis(hydroxymethyl) 1 (72)
phosphonium chloride 2 (90)
3 (98)
Inactive Chemicals
L-ascorbic acid
bisphenol A
C. I. acid yellow 73
ephedrine sulfate
erythromycin stearate
1 (4)
2 (11)
1 (2)
2 (8)
3 (IP17)
4 (IP18)
1 (77)
2 (83)
1 (71)
2 (77)
3 (89)
1 (71)
2 (89)
30 Non-Mutagenic Non-Carcinogens
1 (30)
2 (45)
1 (76)
2 (90)
1 (3)
2 (9)
1 (38)
2 (96)
1 (35)
2 (44)
1 (70)
2 (85)
40
35
12*
15
94
102*
69
31
.787
.732
1.79
1.95
.285
.149
.496
.660
1.97
1.52
.526
.313
SP 54
SP 57
SP 26*
SP 21**
SP 91***
SP 95***
SP 12***
SP 52
14
23
47
67
SP 72
SP 11***
SP 43
SP 78
SP 40
SP 78
.606 68
.313 67
70
15
59
SP 2.26
SP 2.05
SP 10.5
SP 4.60
SP 2.42
LA .958
SP 3.37
SP 2.52
SN .673
SP 3.94
SN .000
SP 1.97
LA 1.09
LA 2.81
SN .288
SP 3.53
SN .000
SN .300
SN .348
SN .060
LA 1.15
SN .393
SN .000
SN .000
SN .065
LN .810
SN .000
SN .320
SN .000
SN .163
SP 41
SP 21**
SP 17***
.289
1.95
.618
1.51
.301
.660
2.196
.411
.789
.972
.351
1.061
.972
.492
1.06
.492
50
101
53
16
-99
-105*
17
71
24
17
51
24
51
SP 59
SP 104***
SP 30
SP 7***
SP -37
SP -39
SP 6***
SP 23***
SP 10***
SP 6***
SP 50
SP 10***
SP 50
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Table A2. Continued.
Transformation
Chemicala Spontaneous' Responseb
Foci/Vessel: Benzo(a)pyrened Test Chemicale
Name Exp. No. Rank Order Call : Rank Order Call : mean t-statistic
Inactive Chemicals Continued
ethoxytated dodecyl alcohol 1 (82) 8.01 1*** SP 3*** SN .000
2 (90) 1.95 15 SP 21** SN .583
ethylenediamine tetraacetic 1 (73) .274 80 SP 89*** LA 2.49
acid, trisodium salt 2 (85) .313 67 SP 78 SN .810
geranyl acetate 1 (84) .511 44 SP 65 SN .530
2 (92) .597 41 SP 83* SN .090
4-hexylresorcinol 1 (63) 1.92 13 SP 66 SN .000
2 (85) .313 67 SP 78 LA .920
D,L-menthol 1 (18) .663 46 SP 80* SN .215
2 (24) .308 89 SP 87*** SN .083
methoxychlor 1 (37) .631 58 SP 55 SN .705
2 (89) .492 51 SP 50 LA 1.26
methyLdopa sesquihydrate 1 (75) .882 21 SP 26* LA 1.67
2 (91) .322 56 SP 109*** SN .600
methylphenidate-HCl 1 (48) .537 64 SP 84* SN 1.31
2 (57) .278 86 SP 74 SN .780
oxytetracycline-HCl 1 (73) .274 80 SP 89*** SN .000
2 (103) .874 22 SP 53 SN .000
3 (107) 2.95 5*** SP 46 SN .000
phenylephrine-HCl 1 (73) .274 80 SP 89** SN .385
2 (105) .581 29 SP 97*** SN .260
rotenone 1 (75) .882 21 SP 26* SN .000
2 (96) .660 31 SP 52 SN .510
stannous chloride 1 (19) .357 77 SP 67 SN .175
2 (26) .907 37 SP 20*** SN 1.38
tetracycline-HCl 1 (71) 1.06 24 SP 10*** SN .000
2 (89) .492 51 SP 50 SN .043
tetrakis(hydroxymethyl) 1 (72) .289 70 SP 41 SN .125
phosphonium sulfate 2 (84) .511 44 SP 65 # SN .000
xylenes, mixed 1 (72) .289 70 SP 41 SN .000
2 (100) .268 73 SP 49 SN .945
Chemicals with an Indeterminate Activity
eugenol 1 (74) .657 32 SP 108*** LN 1.88
2 (94) 1.52 18 SP 31 SN .000
triphenyltin hydroxide 1 (39) .427 82 SP 18*** SN .828
2 (93) .416 43 SP 9*** SP 3.27
General Abbreviations: Exp. No., experiment number; NA, not available.
Abbreviations for Transformation Responses: SP, sufficient positive; LA, limited activity; SN, sufficient negative; LN, limited negative.
aThe 114 cytotoxic chemicals in Table A2 are identical to those in TableAl, and they are subdivided into groups of43 mutagenic carcinogens, 21
mutagenic noncarcinogens, 20 nonmutagenic carcinogens, and 30 nonmutagenicnoncarcinogens. bTlansformation Response: This table presents a summary ofthe spontaneous, BaP, and test chemical transformation responses detected in two or
more experiments per test chemical. The assay design and procedures used in the standard transformation assay are described in the Materials and
Methods. The transforming activities ofindividual chemical treatment doses (i.e., focus data), as well as the individual transformation responses (i.e.,
type IIIfoci/vessel), areprovidedindetailintheAppendices B-H.Appendices B, C, D, E, F, Gand H contain theactivities ofthe43cytotoxic,mutagenic
carcinogens; 21 cytotoxic, mutagenic noncarcinogens; 20 cytotoxic, nonmutagenic carcinogens; 30 cytotoxic, nonmutagenic, noncarcinogens; 21
noncytotoxic carcinogens; 26 noncytotoxic noncarcinogens; and 7 very noncytotoxic model test chemicals.
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Table A2. Continued.
'SpontaneousTransformation Response: The method used to calculate the spontaneous transformation response, as well as the positive control and
test chemical responses, is explained in the Materials and Methods. The transformation responses are expressed as type III foci/vessel and were
calculated using a loglo mathematical transformation procedure. The arithmetic value for foci/vessel in this table is the antilog of the log,( mean
transformation response minus one. The procedure for rank ordering the spontaneous responses from 110 experiments is based upon the different
statistical sensitivities of transformation experiments with different spontaneous responses is explained in the Statistical Sensitivity versus
Spontaneous Response section ofthe Materials and Methods. Experiments with high spontaneous responses had a high statistical sensitivityand have
relativelylowrank-order numbers. Forexample, 2-amino-5-nitrophenol had ahigh spontaneous response of6.02foci/vessel in experiment 62,which had
a high statistical sensitivity and rank ordernumber 3/110. Conversely, experiments with a low statistical sensitivity had high rank-order numbers. For
example, C.I. solvent yellow 14 had a low spontaneous response of0.085 foci/vessel in experiment 67, which had a low statistical sensitivity and high
rank-order number 107/110.
*Significant spontaneous or BaP transformation response, 0.01 < p < 0.05.
**Significant transformationresponse, 0.001 < p -- 0.01.
***Significant transformation response, p < 0.001.
dIBenzo(a)pyrene Transformation Response. The method used to call individual transformation experiments is described in detail in Materials and
Methods. The method used to rank orderthe BaP transformation riesponses from the 110 experiments is based upon statistical comparison ofthe BaP
transformation at the two treatment doses detected in an individual experiment with the median historical activity of the assay. This procedure is
described in the Detection Sensitivity versus Benzo(a)pyrene Transformation Response section ofthe Materials and Methods. The riational for rank-
ordering the experiments is analogous to that described for the spontaneous transformation responses (refer to footnote c above).
"Test Chemical Transformation Response: The method used to call individual experiments is described in detail in Materials and Methods, and the
abbreviations forthe calls are provided above. The significance ofthe transformation responses ofindividual chemical treatmentdoses were calculated
using SAS statistical software (22). The mean t-statistic represents the average of the t-statistics of the four test chemical treatment doses in the
experiment. The t-statistics forindividual chemical treatment doseswhichwereused to calculate themean t-statisticareprovided in theAppendices B-
H.
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Table A3. Rank-ordered potency ofthe transformation responses of 114 cytotoxic chemicals compared to rodent bioassay activities.
Test Chemical Rodent Bioassayb Transformation Responsec
Level of Activity Rank t-statistic
Name High Low None Actual Estimatedd
43YMutagenic Carcinogens
Total Active Chemicals [92.5%]e
Active Chemicals
5-azacytidine D 12.8 16.8
diglycidyl resorcinol ether A 9.31 11.0
N-methyl-N-nitro-N'-nitrosoguanidine A 10.3 10.3
ethylenedibromide A 5.68 6.82
2-amino-5-nitrophenol D 5.94 5.94
cytembena B 5.93 5.93
4-chloro-o-phenylenediamine A 5.84 5.84
1,2-dibromo-3-chloropropane A 5.59 5.74
o-toluidine A 4.83 5.62
4-chloro-O-toluidine-HCl c 5.61 5.61
C. I. solvent yellow 14 C 3.52 5.34
1,2-epoxypropane A 4.48 5.21
2-acetylaminofluorene A 3.12 4.67
acrylonitrile B 3.75 4.35
epichlorohydrin A 3.03 4.22
2-nitro-p-phenylenediamine D 3.60 4.13
nitrofurazone A 4.12 4.12
2-naphthylamine B 3.66 3.98
5-chloro-o-toluidine B 3.92 3.92
iodinated glycerol A 3.68 3.68
melphalan A 3.66 3.66
benzidine-2HCL A 3.38 3.38
C. I. acid orange 3 D 2.89 3.34
N-methyl-O-acrylamide B 3.10 3.31
2-biphenytamine D 3.21 3.21
1,2-epoxybutane B 2.99 2.99
quinoline C 2.94 2.94
selenium sulfide A 1.92 2.78
ziram D 2.72 2.72
4,4-oxydianiline A 2.60 2.60
nitrofurantoin A 2.26 2.52
4,4-methylenedianiline A 1.87 2.39
4-biphenylamine A 2.38 2.38
2,6-dichloro-p-phenylenediamine C 2.26 2.35
3-(chloromethyl)pyridine-HCl A 2.06 2.29
1,3-dichloropropene A 1.77 1.77
C. I. disperse blue 1 C 1.31 (7.08) 1.31
...................................................................................................
Total Inactive Chemicals [7.5%]e
Chemicals with Equivocal Activity
dichlorvos (uncoded) A F 1.49 1.66
(coded) A F 1.68 1.68
Inactive Chemicals
C. I. basic red 9-HCl (uncoded) A .41 .65
(coded) A .05 .05
2,4-dinitrotoluene B .73 1.19
Chemicals with an Indeterrninate Activtr
2-amino-4-nitrophenol D .00 .00
C. I. disperse yellow 3 A .07 .07
HC blue 1 A 1.72 2.40
(Continued on nextpage)
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Table A3. Continued.
Test Chemical Rodent Bioassayb Transformation Responsec
Level of Activity Rank t-statistic
Name High Low None Actual Estimatedd
21 Mutagenic Non-Carcinogens
Total Active Chemicals [65.0%]
Active Chemicals
malaoxon F 8.14 11.4
2,6-toluenediamine-2HCl F 6.95 6.95
N-phenyl-2-naphthylamine E 4.25 6.90
3-nitropropionic acid E 4.69 5.22
HC red 3 (AVG.) 4.12 4.54
(coded) E 5.60 6.11
(uncoded) E 2.64 2.96
1-naphthylamine F 2.82 4.18
coumaphos F 4.12 4.12
tetraethylthiuram disulfide F 3.88 3.88
4-nitro-o-phenylenediamine F 2.54 3.54
dimethoate F 3.31 3.31
3-chloro-p-toluidine F 3.26 3.26
p-phenylenediamine-2HCl F 3.04 3.04
2-(chloromethyl)pyridine-HCl F 2.56 2.85
...................................................................................................
Total Inactive Chemicals [35.0%]
Chemicals with Equivocal ActivitY
2,4-dimethoxyaniline-HCL F 3.06 3.06
2,3,5,6-tetrachloro-4-nitroanisole F 2.08 2.08
N-(1-naphthyl)ethylenediamine-2HCl F 1.64 1.83
4'-(chloroacetyl)acetanilide F 1.65 1.65
8-hydroxyquinoline F .78 1.16
Inactive Chemical
HC blue 2 F 1.80 3.51
Inactive Chemical (Indeterminate Activity)
4-acetylaminofLuorene F (I) 1.30 1.94
*----------.---------------------------------------------------------------------------------------
Chemicals with an Indeterminate Activity
1-nitronaphthalene F 1.45 1.56
20 Non-Mutagenic Carcinogens
Total Active Chemicals [52.6%]
Active Chemicals
nitrilotriacetic acid A 5.86 5.86
ethyl acrylate A 4.51 5.25
allyl isothiocyanate D 2.86 3.39
diethylstilbestrol A 2.91 2.91
isophorone D 2.76 2.86
dimethylvinyl chloride A 2.59 2.59
3-chloro-2-methylpropene A 2.14 2.14
chlorendic acid A 1.98 1.98
polybrominated biphenyl mixture A 1.93 1.93
malonaldehyde, sodium salt c 1.87 (5.81) 1.87
.................... ...............................................................................
Total Inactive Chemicals [47.4%]
(Continued on nextpage)
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Table A3. Continued
Test Chemical RodentBioassayb Transformation Responsec
Level of Activity Rank t-statistic
Name High Low None Actual Estimatedd
Chemical with Equivocal Activity
2-mercaptobenzothiazole C 1.23 1.23
Inactive Chemica is
allyl isovalerate A 1.65 1.65
D-limonene D .24 .27
reserpine A .24 .24
methapyrilene-HCI C .14 .17
chlorowax 500 A .06 .06
cinnamyl anthranilate A .004 .005
tris(2-ethylhexyl)phosphate D .00 .00
4-vinylcyclohexene D .00 .00
...................................................................................................
Chemica7s with an Indeteryninate Activity
chlorowax 40 D .46 .48
30 Non-Mutagenic Non-Carcinogens
Total Active Chemicals [20.0%]
Active Chemicals
phenol F 7.60 7.60
propyl gallate E 1.70 2.95
sodium diethyLdithiocarbamate F 2.94 2.94
C. I. acid red 14 F 2.15 2.15
Weakly Active Chemicals
carbromal F 2.26 2.26
chlorpheniramine-maleate F 1.18 1.26
*--------.--...-...--.--------.....................................--........--....................
Total Inactive Chemicals [80.0%]
Chemicals with Equivocal Activity
aniLazine F 1.82 2.09
tetrakis(hydroxymethyl) F 1.27 1.27
phosphonium chloride
Inactive Chemicals
ethylenediamine tetraacetic acid, Na3 F 1.41 2.01
methylphenidate-HCl I 1.05 1.47
methyLdopa sesquihydrate E 1.21 1.21
methoxychlor F 1.08 1.08
bisphenol A E .79 .79
stannous chloride E .78 .78
xylenes, mixed F .47 .50
4-hexylresorcinol E .46 .47
L-ascorbic acid F .32 .46
phenylephrine-HCl F .31 .42
geranyl acetate F .35 .37
ethoxylated dodecyl alcohol F (I) .29 .29
rotenone E .26 .26
D,L-menthol F .16 .22
ephedrine sulfate F .16 .16
erythromycin stearate F .08 .08
tetrakis(hydroxymethyl)phosphonium S04 F .083 .083
C. I. acid yellow 73 I .030 .030
tetracycline-HCl F .021 .021
oxytetracycline-HCl E .000 .000
(Continued on nextpage)
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lable A3. Continued.
Test Chemical Rodent Bioassayb Transformation Response'
Level of Activity Rank t-statistic
Name High Low None Actual Estimatedd
Chernicals with an Indeterminate Activity
triphenyLtin hydroxide F 1.64 1.64
eugenot E 1.07 1.07
aTest Chemical: The 114 cytotoxic chemicals in Table A3 are identical to those in TableAl, and they are subdivided into groups of43 mutagenic
carcinogens, 21 mutagenic noncarcinogens, 20 nonmutagenic carcinogens, and 30 nonmutagenic noncarcinogens.
bRodent Bioassay Level ofActivity: The relative carcinogenic activity ofchemicals in rodentbioassay hasbeen described in terms ofthe chemical's
level of effect (1,3). The highest level A corresponds to chemicals that cause cancer in both mice and rats at one or more sites, and level B refers to
chemicalsthatcausecanceratmultiplesitesinonespeciesofrodent. LevelCincludes chemicalscarcinogenicatonesiteinbothsexesofonespecies,and
D includes chemicals carcinogenic atone site in onlyonesexofasingle species. Level E chemicals that onlyequivocal evidence ofcarcinogenic activity.
Finally, level F includes both noncarcinogens and chemicals that had inadequate carcinogenicity studies.
cTransformation Response Rank t-statistic: The method used to calculate the significance oftest chemical transformation responses employed SAS
statistical software (22) and is described in detail in Materials and Methods. The correct t-statistics ofeach treatment dose ofthe test chemical in a
single experiment arepresented in theAppendices B-H, and these t-statisticswereaveraged to determinethemean t-statistic ofthe testchemical for
the experiment (refer toTable A2). The mean t-statistics fortwo orexperiments foreach chemicalwasweighted accordingto the numberoftreatment
doses evaluated and averaged to determine the actual rank t-statistic presented in this table. Forexample, the actual rank t-statistic of5-azacytidine
transformation responses in experiments 6 and 11 is equal to 12.8[i.e, 8.36 + 9.11 + 15.3 + 33.9 (Exp. 6) + 14.7 + 16.5 + 4.21 + .70 (Exp. 11)/8 =
12.8; Appendix B].
dEstimated Rank t-statistic: Theestimated rank t-statistic isused toestimateboth the historicalbehaviorofthetestchemical in thetransformation
assay, aswell aspredictingthefuturebehavior orthe chemical. Itiscalculated bycorrectingtheactualrankt-statistic. Thedatapresented inTableA2
showed thatindividual experiments hadverydifferent rank-ordered sensitivities to detectchemical-induced transformation. Therefore, the estimated
rank t-statistic modified the actual rank t-statistic to correct for differences in the sensitivities ofindividual experiments. The method uses the rank
ordered sensitivity ofindividual experiments to detect spontaneous and BaP-induced transformation, and an example calculation is provided below.
Themostactivetestchemical,5-azacytidine, had statistical sensitivities forspontaneoustransformation responsesof45and 101/110forexperiments
6 and 11, respectively, and detection sensitivities for BaP of38 and 104/110 (TableA2). Therefore, the average rank order ofthe two experiments was
72.0(i.e.,45 + 101 + 38 + 104/4 = 72). Foratotal of 110experiments, the median experiment has an automatic average rank order of55.0 (i.e., 110/2 =
55.0). Therefore, the correction factorforthe experimental sensitivity to detect chemical transformation was 72.0/55.0 or 1.31. Because the correction
factor hadbeen more than one, the actual rank t-statisticwould havebeen multiplied bythe correction factorto obtain the estimated rank t-statistic of
16.8. Ajustification for this correction factor has been reported (18), and it is explained in the Materials and Methods.
ePercentage (%) ofActive Chemicals: Active chemicals included chemicals with active and weakly active transformation responses. In contrast,
inactive chemicals included chemicals with equivocal and inactive transformation responses. Chemicals with an indeterminate activity have to be
retested in anadditional experimentinordertodeterminetheiractivityinthestandardtransformationassay. Therefore,chemicalswithindeterminate
transformation responseswereomittedfromthecomputationofthepercentage (%)ofthetotalchemicalsthatwereeitheractiveorinactiveintheassay.
Mutagenic Carcinogens
2-Biphenylamine. 2-Biphenylamine was a relatively
weak level D carcinogen (TableA3)with no serioustechni-
cal problems reported (Table Al). However, an isomer of
the chemical, 4-biphenylamine, has been reported to be
oxidized upon exposure to air. It was cytotoxic to the
BALB/c-3T3 cells with an average LD50 of 0.421 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1 and 2 were 49 and 34/110, respectively; the
detection sensitivitiesforBaP oftrials 1 and2 were24 and
45/110, respectively(Tlable A2). In trial 1 and 2 the chemical
had a SP transformation response. 2-Biphenylamine was
evaluated as active in the transformation assay. Its actual
and estimated rank t-statistics were both 3.21 (Table A3).
4-Biphenylamine. 4-Biphenylamine was a level A car-
cinogen (Table A3). It had one difficult technical problem
because it was reported to become oxidized upon exposure
to air (Table Al). It was cytotoxic to the BALB/c-3T3 cells
with an average LD50 of.479 mM (Table Al). The statisti-
cal sensitivities of transformation assay trials 1 and 2 were
14 and 11/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 72 and 39/110, respectively
(TableA2). In apreliminarytrial 1 thechemicalhad an LA
transformationresponse. Intrial2thechemicalhadanSP
transformation response. 4-Biphenylamine was evaluated
as active in the transformation assay. Its actual and
estimated rank t-statistics were both 2.38 (Table A3).
4-Chloro-o-Phenylenediamine. 4-Chloro-o-phenyl-
enediamine was a potent levelA carcinogen (TableA3). It
hadonedifficulttechnicalproblembecauseitwasreported
tobecome oxidized upon exposure to air(TableAl). Itwas
very cytotoxic to the BALB/c-3T3 cells with an average
LD50of0.0318mM (TableAl).The statistical sensitivities
oftransformation assaytrials 1-3 were 96, 81 and 62/110,
respectively; the detection sensitivities for BaP of trials
1-3 were 86, 22 and 48/110, respectively (Table A2). In a
preliminarytrial 1, thechemicalhad aLNtransformation
response because the test chemical treatment doses did
not induce significant cytotoxic activity. In trials 2 and 3
the chemical had an SP transformation response.
4-Chloro-o-phenylenediamine was evaluated as active in
the transformation assay. Its actual and estimated rank
t-statistics were both 5.84 (Table A3).
375MATTHEWS ET AL.
3-(Chloromethyl)pyridine-HCl. 3-(Chloromethyl)pyri-
dine-HCl was a potent levelA carcinogen (Table A3) with
no serious technical problems reported (Table Al). Itwas
very cytotoxic to the BALB/c-3T3 cells with an average
LD50 of0.0756mM (TableAl). The statistical sensitivities
oftransformation assaytrials 1 and 2were 99 and36/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 82 and 28/110, respectively (Table A2). In a
preliminarytrial 1 thechemicalhadanLAtransformation
response. Intrial2thechemicalhadanSPtransformation
response. 3-(Chloromethyl)pyridine-HCl was evaluated as
active in the transformation assay. Its actual and esti-
mated rank t-statistics were 2.06 and 2.29, respectively
(Table A3).
4-Chloro-o-Toluidine-HCl. 4-Chloro-o-toluidine-HCl
was arelativelyweaklevelCcarcinogen (TableA3)withno
serious technical problems reported (Table Al). However,
an isomer of the chemical, 5-chloro-o-toluidine, has been
reported to be oxidized upon exposure to air (TableAl). It
was cytotoxic to the BALB/c-3T3 cells with an average
LD50 of0.650 mM (Table Al). The statistical sensitivities
oftransformation assay trials 1 and 2 were 2 and 41/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2were2 and83/110, respectively (TableA2). Intrial 1
and 2 the chemical had an SP transformation response.
4-Chloro-o-toluidine-HCl was evaluated as active in the
transformation assay. Its actualandestimatedrankt-sta-
tistics were both 5.61 (Table A3).
5-Chloro-o-Toluidine. 5-Chloro-o-toluidine was a
potent level B carcinogen (Table A3). It had one serious
technical problem because it was reported to become
oxidized upon exposure to air (Table Al). It was moder-
ately cytotoxic to the BALB/c-3T3 cells with an average
LD50of1.69 mM (TableAl). The stalistical sensitivities of
transformation assay trials 1 and 2 were 2 and 41/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2were 2 and83/110, respectively (TableA2). In trial 1
and 2 the chemical had an SP transformation response.
5-Chloro-o-toluidine was evaluated as active in the trans-
formation assay. Its actual and estimated rank t-statistics
were both 3.92 (Table A3).
C. I.AcidOrange 3. C. I. Acid orange 3was arelatively
weaklevelDcarcinogen (TableA3)with no serioustechni-
cal problems reported (Table Al). It was cytotoxic to the
BALB/c-3T3 cells with an average LD50 of 0.102 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1 and 2 were 47 and 63/110, respectively; the
detection sensitivities forBaPoftrials 1 and2were43and
101/110, respectively (Table A2). In a preliminary trial 1
the chemical had an LAtransformation response. In trial
2 the chemical had an SP transformation response. C. I.
acid orange 3 was evaluated as active in the transforma-
tion assay. Its actual and estimated rank t-statistics were
2.89 and 3.34, respectively (Table A3).
C. I. BasicRed9-HCI. C. I. Basicred 9-HCl was one of
five chemicals that was tested as both a coded and an
uncodedtestchemicalinthisinvestigation. Itwas apotent
level A carcinogen (Table A3) with no serious technical
problemsreported (TableAl).Bothchemicalsampleswere
very cytotoxic to the BALB/c-3T3 cells with an
average LD50 of0.00281 and 0.00216 mM (Table Al). For
the uncoded test chemical, the statistical sensitivities of
transformation assay trials 1-3 were 64, 108 and 82/110,
respectively; the detection sensitivities for BaP of trials
1-3 were 84, 99 and NA/110, respectively (Table A2). For
the coded test chemical, the statistical sensitivities of
trials 1 and2were80and8/110; thedetection sensitivities
for BaP were 89 and 29/110, respectively. The coded and
uncoded test chemical had SN transformation responses
in a total of5 trials. Therefore, C. I. basic red 9-HCl was
evaluated as inactive in the transformation assay. The
actual and estimated rank t-statistics ofthe uncoded test
chemical were 0.41 and 0.65, respectively (Table A3). The
actual and estimated rank t-statistics of the coded test
chemical were both 0.05 (Table A3). Taken together, the
coded and uncoded test chemicals had nearly identical
cytotoxic and transforming activities in the BALB/c-3T3
cell transformation assay.
C. LDisperseBlue 1. C. 1. Disperseblue 1 was alevelC
carcinogen (Table A3). It had one difficult technical prob-
lem. Itwas insoluble in culture medium at a portion ofthe
treatment doses thatwere used to evaluate both cytotoxic
and transformingactivity (TableAl). In addition, thistest
chemical was observed to bind to the target cells, and it
could not be removed using the standard washing pro-
cedure. It was cytotoxic to the BALB/c-3T3 cells with an
average LD50 of 0.240 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1-3were 80, 54
and5/110, respectively; the detection sensitivities forBaP
of trials 1-3 were 89, 44 and 46/110, respectively (Table
A2). In a preliminary trial 1, the chemical had a SP type
III focus transformation response. In trials 2 and 3, the
chemical had a SN type III transformation response. In
contrast, the test chemical had an SP type I-III transfor-
mation response for all three trials. Thus, this test chemi-
cal had the unusual and consistent capability ofinducing
verysignificantlevels oftype I and IIfoci, butnotfortype
IIIfoci.This type oftransformationresponseis sharedby
two other carcinogens, asbestos and polybrominated
biphenyl mixture. Taken together, C. I. acid orange 3 was
evaluated asweaklyactiveinthetransformation assay. Its
actual and estimated rank t-statistics for the type III
transformation response were both 1.31; however, the
actual and estimated rank t-statistics for the type I-III
response were both 7.08 (Table A3).
C. I. Disperse Yellow 3. C. I. Disperse yellow 3 was a
level A carcinogen (Table A3) with no serious technical
problemsreported (TableAl). Itwasmoderatelycytotoxic
totheBALB/c-3T3 cellswith an average LD50of1.50mM
(Table Al). The statistical sensitivities oftransformation
assay trials 1 and 2 were 24 and 56/110, respectively; the
detection sensitivities forBaPoftrials 1 and2were 10and
109/110, respectively (Table A2). In trials 1 and 2 the
chemical had an SN transformation response. C. I. dis-
perse yellow 3 was evaluated as having had an indetermi-
nate activity in the transformation assay. Its actual and
estimated rank t-statistics were both 0.07 (Table A3).
C. I. Solvent Yellow 14. C. I. Solvent yellow 14 was a
relatively weak level C carcinogen (Table A3). It was
insoluble at a portion of the treatment doses that were
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evaluated for both cytotoxic and transforming activities
(Table Al). It was cytotoxic to the BALB/c-3T3 cells with
an average LD50 Of 0.199 mM (Table Al). The statistical
sensitivities of transformation assay trials 1-4 were 105,
107, 99 and 105/110, respectively; the detection sen-
sitivities for BaP oftrials 1-4were 69, 106,37, and39/110,
respectively (Table A2). In trials 1, 2 and 4 the chemical
had SP transformation responses. In trial 3 the chemical
had an LA transformation response. The test chemical
was evaluated in more than two experiments, because it
was used as a model test chemical in the development of
additional assay protocols. C. I. solvent yellow 14 was
evaluated as active in the transformation assay. Its actual
and estimated rankt-statistics were3.52 and 5.34, respec-
tively (Table A3).
Cytembena. Cytembenawas alevelBcarcinogen(Table
A3) with no serious technical problems reported (Table
Al). It was cytotoxic to the BALB/c-3T3 cells with an
average LD50 of 0.153 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2were47
and 71/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 43 and 23/110, respectively
(TableA2). Inapreliminarytrial 1 thechemical had an LA
transformationresponse. Intrial2thechemicalhadanSP
transformation response. Cytembena was evaluated as
active in the transformation assay. Its actual and esti-
mated rank t-statistics were both 5.93 (Table A3).
1,2-Dibromo-3-Chloropropane. 1,2-Dibromo-3-chloro-
propanewasapotentlevelAcarcinogen (TableA3)withno
serious technical problems reported (Table Al). It was
cytotoxic totheBALB/c-3T3 cellswith an averageLD50of
0.401 mM (Table Al). The statistical sensitivities oftrans-
formation assaytrials 1-3 were 66, 78 and 27/110, respec-
tively; the detection sensitivities forBaPoftrials 1-3were
81,58and63/110,respectively(TableA2). Inapreliminary
trial 1, the test chemical had an LN transformation
response, because the chemical treatment doses were
noncytotoxic to the target cells. In trials 2 and 3 the
chemical had an SP transformation response. 1,2-
Dibromo-3-chloropropane was evaluated as active in the
transformation assay. Its actual and estimated rank t-sta-
tistics were 5.59 and 5.74, respectively (Table A3).
2,6-Dichloro-p-Phenylenediamine. 2,6-Dichloro-
p-phenylenediamine was arelativelyweak level Ccarcino-
gen (Table A3). It had one difficult technical problem
because itwasreported tobecome oxidized upon exposure
to air(Tlable Al). Itwas cytotoxic to the BALB/c-3T3 cells
with anaverageLD50of0.921 mM(TableAl).The statisti-
calsensitivities oftransformation assaytrials 1 and2were
19 and 91/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 34 and 85/110, respectively
(Table A2). In trials 1 and 2 the chemical had an SP
transformation response. 2,6-Dichlorop-phenylenedi-
aminewasevaluated as activeinthetransformation assay.
Its actual and estimated rank t-statistics were 2.26 and
2.35, respectively (Table A3).
1,3-Dichloropropene. 1,3-Dichloropropene was apotent
level A carcinogen (Table A3) with no serious technical
problems reported (Table Al). It was cytotoxic to the
BALB/c-3T3 cells with an average LD50 of 0.280 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1-3 were 4, 18 and 26/110, respectively; the
detection sensitivities for BaP oftrials 1-3 were 1, 31 and
93/110,respectively(TableA2). Inapreliminarytrial 1 the
chemical had a SP transformation response, and in trial 2
the chemical had a SN transformation response. Because
theseresponseswere disparate and significantlydifferent
from one another, the test chemical was evaluated in a
thirdtrial. InthethirdexperimentthechemicalhadanLA
transformation response. 1,3-Dichloropropene was evalu-
ated as weakly active in the transformation assay. Its
actual and estimated rank t-statistics were both 1.77,
respectively (Table A3).
Dichlorvos. Dichlorvos was one of five chemicals that
wastestedasbothacodedandanuncodedtestchemicalin
this investigation. It was evaluated as a noncarcinogen is
its first rodent bioassay trial; however, itwas determined
in a second trialusinga differentroute ofexposure tobe a
potent level A carcinogen (Table A3). This test chemical
had one difficult technical problem because it was rapidly
hydrolyzed in water (Table Al). Both chemical samples
were cytotoxic to the BALB/c-3T3 cells with an average
LD50 of0.145 and 0.140 mM (Table Al). For the uncoded
test chemical, the statistical sensitivities of transforma-
tion assay trials 1-3 were 98, 72 and 59/110, respectively;
thedetectionsensitivitiesforBaPoftrials 1-3were60, NA
and 17/110, respectively (Table A2). For the coded test
chemical, the statistical sensitivities oftrials 1 and 2were
9 and 15/110, the detection sensitivities for BaP were 37
and 21/110, respectively. The uncoded test chemical had
SN transformation responses in 2 trials and an LAtrans-
formation response in one trial. The coded test chemical
had an SN transformation response in a preliminary trial
and an SP transformation response in trial 2. The mean
t-statistics of the SP and LA transformation responses
were not significantly different from the corresponding
SN responses, which showed that the test chemical
activity in the assaywas relatively weak. Taken together,
dichlorvos was evaluated as having had equivocal activity
in the transfonnation assay. The actual and estimated
rank t-statistics of the uncoded test chemical were 1.49
and 1.66,respectively(TableA3).Theactualandestimated
rank t-statistics ofthe coded test chemical were both 1.68
(Table A3). Taken together, the coded and uncoded test
chemicals had nearlyidentical cytotoxic and transforming
activities in the BALB/c-3T3 cell transformation assay.
DiglycidylResorcinol Ether. Diglycidyl resorcinol ether
wasapotentlevelAcarcinogen(TableA3).Itisanalkylating
chemical; thus, itcould reactwith labile hydrogen atoms not
only on DNA, but also on a variety of biochemicals in the
culture medium (Table Al). It was very cytotoxic to the
BALB/c-3T3 cells with an average LD50 of 0.00416 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1 and 2 were 45 and 103/110, respectively; the
detection sensitivities for BaP oftrials 1 and 2 were 38 and
73/110,respectively(TableA2). Intrials 1 and2thechemical
had an SP transformation response. Diglycidyl resorcinol
etherwasevaluatedasoneofthemostactivechemicalsinthe
transformation assay. Its actualandestimatedrankt-statis-
tics were 9.31 and 11.0, respectively (Table A3).
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2,4-Dinitrotoluene. 2,4-Dinitrotoluene is a relative
potent level B carcinogen (Table A3) with no serious
technicalproblems reported (TableAl). Itwas cytotoxicto
the BALB/c-3T3 cells with an average LD50 of0.917 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1-3 were 88, 104 and 88/110, respectively; the
detection sensitivities forBaP oftrials 1-3were 77, 90and
NA/110, respectively (Table A2). In a preliminary trial 1
thechemicalhad anLAtransformation response. Intrials
1-3 the chemical had SN transformation responses. 2,4-
Dinitrotoluene was evaluated as inactive in the transfor-
mation assay. Its actual and estimated rank t-statistics
were 0.73 and 1.19, respectively (Table A3).
Epichlorohydrin. Epichlorohydrin was a level A car-
cinogen (Table A3). Ithad two serious technical problems,
because itwasreported tobecome oxidized upon exposure
to air and it reacts with water (Table Al). Itwas cytotoxic
tothe BALB/c-3T3 cellswith an average LD50of.364mM
(Table Al). The statistical sensitivities of transformation
assay trials 1 and 2 were 98 and 72/110, respectively; the
detection sensitivitiesforBaPoftrials 1 and2were60and
NA/110, respectively (Table A2). In a preliminary trial 1
the chemical had an LAtransformation response. In trial
2 the chemical had an SP transformation response. Epi-
chlorohydrinwasevaluatedasactiveinthetransformation
assay. Its actual and estimated rank t-statistics were 3.03
and 4.22, respectively (Table A3).
1,2-Epoxybutane. 1,2-Epoxybutane was a relatively
weaklevelDcarcinogen (TableA3). Itwasreported tobe a
highly reactive chemical (Table Al), and it reacts with
carboxyl and hydroxyl groups found on constituent bio-
chemicals in culture medium, aswell as in the target cells.
Itwas moderately cytotoxic to the BALB/c-3T3 cells with
an average LD50 of 1.45 mM (Table Al). The statistical
sensitivities oftransformation assay trials 1-3 were 4, 26
and 20/110, respectively; the detection sensitivities for
BaPoftrials 1-3were 1,93 and 19/110, respectively (Table
A2). In a preliminary trial 1 the chemical had an LN
transformation response because the chemical treatment
doses were too high and completely cytotoxic to the cells.
In trials 2 and 3 the chemical had SP transformation
responses. 1,2-Epoxybutanewasevaluated as activeinthe
transformation assay. Its actual and estimated rank t-sta-
tistics were both 2.99 (Table A3).
1,2-Epoxypropane. 1,2-Epoxypropane was a potent
levelA carcinogen (TableA3). Ithad one difficult technical
problem because itwas reported to become oxidized upon
exposure to air (Table Al). It was moderately cytotoxic to
the BALB/c-3T3 cells with an average LD50 of 1.60 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1 and 2 were 70 and 57/110, respectively; the
detectionsensitivities forBaPoftrials 1 and2were41 and
88/110, respectively (Table A2). In trials 1 and 2 the
chemical had an SP transformation response. 1,2-
Epoxypropane was evaluated as active in the transforma-
tion assay. Its actual and estimated rank t-statistics were
4.48 and 5.21, respectively (Table A3).
EthyleneDibromide. Ethylene dibromide was alevelA
carcinogen (Table A3). It was reported to be highly reac-
tive chemical, but none of these problems were serious
(TableAl). ItwasmoderatelycytotoxictotheBALB/c-3T3
cells with an average LD50 of 1.69 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 32 and 41/110, respectively; the detection
sensitivities forBaPoftrials 1 and 2were 108and83/110,
respectively (Table A2). In trials 1 and 2 the chemical had
an SP transformation response. Ethylene dibromide was
evaluated as active in the transformation assay. Its actual
and estimated rankt-statisticswere 5.68 and 6.82, respec-
tively (Table A3).
HC Blue 1. HC Blue 1 was a level A carcinogen (Table
A3). It had one difficult technical problem because it was
reported to become oxidized upon exposure to air (Table
Al). It was cytotoxic to the BALB/c-3T3 cells with an
average LD50 of 1.96 mM (Table Al). The statistical sen-
sitivities of transformation assay trials 1-3 were 100, 79
and 88/110, respectively; the detection sensitivities for
BaP of trials 1-3 were 42, 75 and NA/110, respectively
(Table A2). In trials 1 and 2 the chemical had an SN
transformation response. Ordinarily this chemical would
not have been tested in a third experiment, but it was
selected as a model chemical with an inactive response in
thetransformation assay. Inthethirdexperiment,thetest
chemical had an SP transformation response. This dispa-
rate transformation response could have been caused by
the different sample batches of test chemicals that were
tested in experiments 1 and 2versus experiment 3. There-
fore, the test chemical has to be tested in a fourth experi-
mental trial. HC blue 1 was evaluated as having had an
indeterminate activity in the transformation assay. Its
actual and estimated rank t-statistics were 1.72 and 2.40,
respectively (Table A3).
Iodinated Glycerol. Iodinated glycerol was a level A
carcinogen (Table A3) with no serious technical problems
reported (Table Al). It was moderately cytotoxic to the
BALB/c-3T3 cellswithanaverage LD50of3.47mM(Table
Al). The statistical sensitivities of transformation assay
trials 1 and 2 were 32 and 28/110, respectively; the detec-
tion sensitivities for BaP of trials 1 and 2 were 108 and
15/110, respectively (Table A2). In a preliminary trial 1
the chemical had an SP transformation response. In
trial 2 the chemical had an SN transformation response.
The disparate transformation responses were examined
further, and themean t-statistics ofthe two experiments
were not significantly different from one another. In
addition, therewas adose-related increase in testchem-
ical activity in the experiment with an SN response at
treatment doses that were comparable to that inducing
an SP response. Taken together, iodinated glycerol was
evaluated as weakly active in the transformation assay.
Its actual and estimated rankt-statistics wereboth3.68,
respectively (Table A3).
Melphalan. Melphalan was a levelA carcinogen (Table
A3). It had one serious technical problem because it was
reported to react with water (Table Al). It was very
cytotoxictotheBALB/c-3T3 cellswith an averageLD50of
0.00120 mM (Table Al). The statistical sensitivities of
transformation assay trials 1 and 2 were 10 and 31/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 5 and 52/110, respectively (Table A2). In a
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preliminarytrial 1 thechemicalhadanLAtransformation
response. Intrial2thechemicalhadanSPtransformation
response. Melphalan was evaluated as active in the trans-
formation assay. Its actual and estimated rank t-statistics
were both 3.66, respectively (Table A3).
N-Methyl-o-Acrylamide. N-Methyl-o-acrylamide is a
level B carcinogen (Table A3) with no insurmountable
technicalproblems (TableAl). Itwasmoderatelycytotoxic
tothe BALB/c-3T3 cellswith an average LD50of1.75mM
(Table Al). The statistical sensitivities of trials 1 and 2
were 47 and 67/110, respectively; the detection sen-
sitivities for BaP of trials 1 and 2 were 43 and 78/110,
respectively (TableA2). In apreliminarytrial 1 the chemi-
cal had an LA transformation response. In trial 2 the
chemical had an SP transformation response.
N-Methyl-o-acrylamide was evaluated as active in the
transformation assay. Its actual and estimated rankt-sta-
tistics were 3.10 and 3.31, respectively (Table A3).
4,4-Methylenediamine. 4,4-Methylenediamine was a
potent level A carcinogen (Table A3). It had one difficult
technical problem because it was reported to become
oxidized upon exposure to air (Table Al). It was moder-
ately cytotoxic to the BALB/c-3T3 cells with an average
LD50of1.56mM (TableAl). The statistical sensitivities of
transformation assay trials 1 and 2 were 60 and 104/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 27 and 90/110, respectively (Table A2). In
trials 1 and 2 the chemical had an SP transformation
response. 4,4-Methylenedianiline was evaluated as active
inthetransformation assay. Its actual and estimatedrank
t-statistics were 1.87 and 2.39, respectively (Table A3).
N-Methyl-N'-Nitro-N-Nitrosoguanidine. N-Methyl-N'-
Nitro-N-Nitrosoguanidine was a potent level A carcino-
gen (Table A3). It had one serious technical problem
because it reacts with water (Table Al). It was very
cytotoxic totheBALB/c-3T3 cellswith an average LD50of
0.0154mM(TableAl).Thestatistical sensitivities oftrans-
formation assaytrials 1 and 2were 43 and 54/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were9andNA/lO, respectively (TableA2). Intrials 1 and
2 the chemical had an SP transformation response.
N-Methyl-N'-nitro-N-nitrosoguanidine was one of the
most active chemicals in the transformation assay. Its
actual and estimated rank t-statistics were both 10.3
(Table A3).
2-Naphthylamine. 2-Naphthylamine was a level B car-
cinogen (Table A3). It had one serious technical problem
because itwasreported tobecome oxidized upon exposure
toair(TableAl). ItwasmoderatelycytotoxictotheBALB/
c-3T3 cells with an average LD50 of 1.59 mM (Table Al).
The statistical sensitivities oftransformation assay trials
1 and 2 were 96 and 37/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 86 and 20/110,
respectively (Table A2). In trials 1 and 2 the chemical had
an SP transformation response. 2-Naphthylamine was
evaluated as active in the transformation assay. Its actual
and estimated rankt-statisticswere 3.66 and 3.98, respec-
tively (Table A3).
Nitrofurantoin. Nitrofurantoin was a potent level A
carcinogen (Table A3). It was reported to be a highly
reactive chemical, but none of the problems were serious
(Table Al). It was cytotoxic to the BALB/c-3T3 cells with
an average LD50 of 0.106 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2were 93
and 43/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 100 and 9/110, respectively
(TableA2). In apreliminarytrial 1 the chemicalhad an SN
transformation response. Intrial2thechemicalhadanSP
transformation response. The disparate transformation
responses were examined further, and the mean t-statis-
ticsofthetwoexperimentswere notsignificantlydifferent
from one another. In addition, there was a dose-related
increaseintestchemicalactivityintheexperimentwithan
SN response at treatment doses that were comparable to
thatinducing an SPresponse. Takentogether, nitrofuran-
toin was evaluated as having had weak activity in the
transformation assay. Its actual and estimated rankt-sta-
tistics were 2.26 and 2.52, respectively (Table A3).
Nitrofurazone. Nitrofurazone was a potent level A
carcinogen (Table A3) with no serious technical problems
reported (Table Al). It was very cytotoxic to the BALB/
c-3T3 cellswith an average LD50 of0.0515 mM (TableAl).
The statistical sensitivities oftransformation assay trials
1-3 were 24, 17 and 63/110, respectively; the detection
sensitivities for BaP of trials 1 and 2 were 10, 6 and
101/110, respectively (Table A2). In a preliminary trial 1
the chemical had an LNtransformation response, because
the chemical treatment doses were too cytotoxic. In trials
2 and 3 the chemical had an SP transformation response.
Nitrofurazone was evaluated as active in the transforma-
tion assay. Its actual and estimated rank t-statistics were
both 4.12, respectively (Table A3).
2-Nitro-p-Phenylenediamine. 2-Nitro-p-phenylene-
diamine was a relatively weak level D carcinogen (Table
A3). It had one difficult technical problem because it was
reported to become oxidized upon exposure to air (Table
Al). It was cytotoxic to the BALB/c-3T3 cells with an
average LD50 of 0.947 mM (Table Al). The statistical
sensitivities of transformation assay trials 1-3 were 100,
79 and 31/110, respectively; the detection sensitivities for
BaP of trials 1-3 were 42, 75 and 52/110, respectively
(TableA2). In apreliminarytrial 1 the chemical had an SP
transformation response. In trial 2 the chemical had an
SN transformation response. The disparate transforma-
tion responses were examined further, and the mean
t-statistics of the two experiments were significantly dif-
ferent from one another. Therefore, the chemical was
tested in a third trial, and the activity in this experiment
was evaluated as an SP. There was no obvious reason for
the absence of activity of the test chemical in the second
experiment. Taken together, 2-nitro-p-phenylenediamine
was evaluated as active in the transformation assay. Its
actual and estimated rank t-statistics were 3.60 and 4.13,
respectively (Table A3).
4,4-Oxydianiline. 4,4-Oxydianiline was apotentlevelA
carcinogen (Table A3). It had one serious technical prob-
lem, because it was reported to become oxidized upon
exposure to air (Table Al). It was cytotoxic to the BALB/
c-3T3 cells with an average LD50 of0.270 mM (Table Al).
The statistical sensitivities of trials 1 and 2 were 25 and
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16/110, respectively; the detection sensitivities for BaP of
trials 1 and2were36and7/110,respectively(TableA2). In
trials 1 and 2 the chemical had an SP transformation
response. 4,4-Oxydianiline was evaluated as active in the
transformation assay. Its actual andestimated rankt-sta-
tistics were both 2.60 (Table A3).
Quinoline. Quinoline was a level C carcinogen (Table
A3). It was reported to be a highly reactive chemical, but
none of the problems were serious (Table Al). It was
moderately cytotoxic to the BALB/c-3T3 cells with an
average LD50 of4.09 mM (Table Al). The statistical sen-
sitivities oftransformation assaytrials 1-4were 87, 78, 42
and 26/110, respectively; the detection sensitivities for
BaP oftrials 1-4 were 64, 58, 25 and 93/110, respectively
(Table A2). In trials 1 and 2 the chemical had an LN
transformation response because the chemical treatment
dosesdidnotinduceasignificantcytotoxicactivity. Intrial
3 the chemical had an LA transformation response, and
trial 4 the response was evaluated as an SP. Quinolinewas
evaluated as active in the transformation assay. Its actual
and estimated rank t-statistics were both 2.94 (Table A3).
SeleniumSulfide. Selenium sulfidewasapotentlevelA
carcinogen (Table A3) with no serious technical problems
reported (Table Al). It was cytotoxic to the BALB/c-3T3
cells with an average LD50 of 0.125 mM (Table Al). The
statistical sensitivities of transformation assay trials 1-3
were 105, 101 and 54/110, respectively; the detection
sensitivities for BaP oftrials 1-3 were 69, 104 and 44/110,
respectively (TableA2). Inapreliminarytrial 1,thechemi-
cal had an SP transformation response. In trial 2, the
chemical had an SN transformation response. The dispa-
rate transformation responses were examined further,
and the mean t-statistics of the two experiments were
significantly different from one another. Therefore, the
test chemical had to be tested in a third experiment, and
the activityin this trialwasevaluated as an SR Therewas
no obvious explanation for the disparate transformation
responses in second experiment, verses the experiments 1
and 3. Taken together, selenium sulfide was evaluated as
weakly active in the transformation assay. Its actual and
estimated rankt-statistics were 1.92and2.78,respectively
(Table A3).
o-Toluidine. o-Toluidinewas apotentlevelAcarcinogen
(TableA3). Ithad onedifficulttechnicalproblembecauseit
was reported to become oxidized upon exposure to air
(TableAl). ItwasmoderatelycytotoxictotheBALB/c-3T3
cells with an average LD50 of 4.33 mM (Table Al). The
statistical sensitivities of transformation assay trials 1-3
were 87, 106 and 59/110, respectively; the detection sen-
silivities for BaP oftrials 1 and 2 were 64, 51 and 17/110,
respectively (TableA2). In apreliminary trial 1 the chemi-
cal had an LA transformation response. In trial 2 the
chemicalhad anSPtransformation response,butitdidnot
induce a significant increase in type I and II foci (data not
presented). Becauseofthisunusualactivity,thetestchem-
icalwas tested in athird trial. Inthe third experiment the
chemicalresponsewasevaluated as anSP. Takentogether,
o-toluidine was evaluated as active in the transformation
assay. Its actual and estimated rank t-statistics were 4.83
and 5.62, respectively (Table A3).
Ziram. Ziram is a relatively weak level D carcinogen
(Table A3) with no serious technical problems reported
(TableAl). Itwasthemostcytotoxicchemicalinthisgroup
oftestchemicals, andithad an average LD50 of0.0000373
mM (TableAl). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 17 and 56/110, respectively;
the detection sensitivities for BaP oftrials 1 and 2 were 6
and 109/110,respectively(TableA2). In apreliminarytrial
1 the chemical had an LA transformation response. In
trial 2 the chemical had an SP transformation response.
Ziramwas evaluated as activeinthetransfonnation assay.
Its actual and estimated rank t-statistics were both 2.72
(Table A3).
Cytotoxic, Mutagenic Noncarcinogens
4-Acetylaminonuorene. 2-Acetylaminofluorene is a
levelF(I) noncarcinogen because ithas notbeen evaluated
in a complete rodent bioassay (Table A3). It had one
difficulttechnical problem, because ithad asolubilitylimit
in culture medium supplemented with pluronic F68 of200
pLg/ml (Table Al). The test chemical was moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 estimated to be over 900 ,ug/ml or about 0.07 mM
(Table Al). Thus, the LD50 was considerably above the
solubility limit of the test chemical. The statistical sen-
sitivities oftransformation assay trials 1 and 2 were 103
and 83/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 73 and 70/110, respectively
(Table A2). The test chemical had an LN transformation
response in both experiments, and it was tested at treat-
ment doses that were both above and below its solubility
limit. Taken together, 4-acetylaminofluorene was evalu-
atedas aninactivechemicalwith anindeterminateactivity
inthetransformation assay. Its actual andestimatedrank
t-statistics were 1.30 and 1.49, respectively (Table A3).
4'-(Chloroacetyl)acetanilide. 4'-(Chloroacetyl)-
acetanilide is alevelFnoncarcinogen (TableA3). Ithad no
insurmountable technical problems (Table Al). The test
chemical was very cytotoxic to the BALB/c-3T3 cells and
had an average LD50 of 0.00336 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 58 and 8/110, respectively; the detection sen-
sitivities for BaP of trials 1 and 2 were 55 and 29/110,
respectively (Table A2). In trials 1 and 2 the test chemical
had LA transformation responses. 4'-(Chloroacetyl)-
acetanilide evaluated as having equivocal activity in the
transformation assay, and its actual and estimated rank
t-statistics were both 1.65 (Table A3).
2-(Chloromethyl)pyridine-HCI. 2-(Chloromethyl)-
pyridine is a level F noncarcinogen (Table A3). It had no
insurmountable technical problems (Table Al). The test
chemical was cytotoxic to the BALB/c-3T3 cells and had
an average LD50 of 0.118 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2were 99
and 36/110, respectively; the detection sensitivities for BaP
oftrials 1 and 2were 82 and28/110, respectively(TableA2).
In trials 1 and 2 the test chemical had SP transformation
responses. 2-(Chloromethyl)pynidine was evaluated as
active in the transformation assay, and its actual and
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estimated rankt-statistics were2.56and2.85,respectively
(Table A3).
3-Chloro-p-Toluidine. 3-Chloro-p-toluidine is a level F
noncarcinogen (Table A3). It had one difficult technical
problem. It was reported to become oxidized upon expo-
sure to air, and itwas exposed to air duringthe treatment
period (Table Al). The test chemical was moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of1.17mM (TableAl). The statistical sensitivities of
transformation assay trials 1 and 2 were 2 and 41/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were2and83/110,respectively(TableA2). Intrials 1
and 2 the test chemical had SP transformation responses.
3-Chloro-p-toluidine was evaluated as active in the trans-
formationassay,anditsactualandestimatedrankt-statis-
tics were both 3.26 (Table A3).
Coumaphos. Coumaphos is a level F noncarcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of 0.218 mM (Table
Al). The statistical sensitivities of transformation assay
trials 1-3were40,8and33/110, respectively; thedetection
sensitivities for BaP oftrials 1-3 were 54, 29 and 14/110,
respectively (Table A2). The test chemical had an SN
transformation response in the first experiment, and an
SP response in the second experiment. Because the mean
t-statistics ofthetransformation responsesinthefirsttwo
experimentswere significantly differentfrom oneanother,
thetestchemicalwasevaluatedinathirdtrial. Inthethird
experiment the test chemical had an SP transformation
response. Coumaphoswasevaluated asactiveinthetrans-
formation assay,anditsactualandestimatedrankt-statis-
tics were both 4.12 (Table A3).
Dimethoate. Dimethoate is a level F noncarcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of 0.602 mM (Table
Al). The statistical sensitivities of transformation assay
trials 1 and 2 were 90 and 18/110, respectively; the detec-
tion sensitivities for BaP of trials 1 and 2 were 13 and
31/110, respectively (Table A2). The test chemical had an
LA transformation response in the first experiment, and
an SPresponse inthe secondexperiment. Dimethoatewas
evaluated as active in the transformation assay, and its
actual and estimated rank t-statistics were both 3.31
(Table A3).
2,4-Dimethoxcyaniline-HCI. 2,4-Dimethoate is alevelF
noncarcinogen (TableA3). It had no insurmountable tech-
nical problems (Table Al). The test chemical was moder-
ately cytotoxic to the BALB/c-3T3 cells and had an
average LD50 of 1.13 mM (Table Al). The statistical sen-
sitivities oftransformation assaytrials 1-3 were 7, 63 and
54/110, respectively; the detection sensitivities for BaP of
trials 1-3were 56, 101 and44/110, respectively (TableA2).
Thetestchemical had aSPtransformation responseinthe
first experiment, and a SN response in the second experi-
ment. Because the mean t-statistics ofthe transformation
responses in the first two experiments were significantly
different from one another, the test chemical was evalu-
ated in a third trial. The test chemical had a SN transfor-
mation response in the third experiment. 2,4-Dimethoxy-
aniline was evaluated as having had equivocal activity in
the transformation assay, and its actual and estimated
rank t-statistics were both 3.06 (Table A3).
HCRed3. HC red 3 was one offive chemicals thatwas
tested asbothacodedandanuncodedtestchemicalinthis
investigation. It is a level E noncarcinogen (Table A3). It
had noinsurmountable technicalproblems (TableAl). The
test chemical was moderately cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of 3.72 mM as a
uncoded test chemical and 4.50 mM as a coded chemical
(Table Al). For the uncoded test chemical the statistical
sensitivities oftransformation assaytrials 1 and2were60
and 86/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 27 and 74/110, respectively
(TableA2). Intrials 1 and2 theuncoded test chemicalhad
SPtransformation responses. Forthe coded testchemical
the statistical sensitivities oftransformation assaytrials 1
and 2 were 93 and 33/110, respectively; the detection
sensitivities for BaP were 100 and 14, respectively. The
codedtestchemicalhad an LAtransformationresponsein
the first experiment, and an SP transformation response
inthe second experiment. Boththeuncoded and thecoded
HC Red 3 were evaluated as active in the transformation
assay. The coded test chemical actual estimated rank
t-statistics were 5.60 and 6.11, respectively; the uncoded
test chemical actual and estimated rank t-statistics were
2.64 and 2.96, respectively (Table A3).
8-Hydroxyquinoline. 8-Hydroxyquinoline is a level F
noncarcinogen (Table A3). It had one difficult technical
problembecause itwasreported to combinewith different
metal salts (Table Al). Thus, it could have combined with
metal saltsinFBSand EMEMmedium. Thetestchemical
was very cytotoxic to the BALB/c-3T3 cells and had an
average LD50 of 0.00251 mM (Table Al). The statistical
sensitivities of transformation assay trials 1-3 were 94,
102and39/110,respectively; thedetection sensitivities for
BaP of trials 1-3 were 91, 95 and 68/110, respectively
(Table A2). The test chemical had an SP transformation
response in the first experiment, and an SN response in
the second experiment. Because the mean t-statistics of
thetransformation responses ofthefirsttwo experiments
were significantlydifferentfrom one anotherthe chemical
wasevaluatedin athirdtrial.ThetestchemicalhadanSN
transformation response in the third experiment.
8-Hydroxyquinoline was evaluated as having equivocal
activity in the transformation assay, and its actual and
estimatedrankt-statisticswere0.78and 1.16,respectively
(Table A3).
Malaoxon. Malaoxon is a level F noncarcinogen (Table
A3). Ithad one difficult technicalproblem. Itwasreported
to become oxidized upon exposure to air, and it was
exposedtoairduringthetreatmentperiod (TableAl).The
test chemical was cytotoxic to the BALB/c-3T3 cells and
had an average LD50 of0.468 mM (TableAl). The statisti-
calsensitivities oftransformationassaytrials 1 and2were
87and 106/110,respectively; thedetection sensitivitiesfor
BaP of trials 1 and 2 were 64 and 51/110, respectively
(Table A2). The test chemical had an LA transformation
responseinthefirstexperiment, andanSPresponseinthe
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second experiment. Malaoxon was evaluated as active in the
transformation assay, and its actual and estimated rank
t-statistics were 8.14 and 11.4, respectively (Table A3).
I-Naphthylamine. 1-NaphthylamineisalevelFnoncar-
cinogen (Table A3). It had one difficult technical problem.
It was reported to become oxidized upon exposure to air,
and it was exposed to air during the treatment period
(Table Al). The test chemical was cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of0.506 mM (Table
Al). The statistical sensitivities of transformation assay
trials 1 and 2 were 96 and 77/110, respectively; the detec-
tion sensitivities for BaP of trials 1 and 2 were 86 and
67/110, respectively (Table A2). In trials 1 and 2 the test
chemical had SP transformation responses. 1-Naphthyl-
aminewasevaluated as activeinthetransformation assay,
anditsactualandestimatedrankt-statisticswere2.82and
4.18, respectively (Table A3).
N-(1-Naphthyl)ethylenediamine-2HCI. N-(1-Naph-
thyl)ethylenediamine-2HCl is a level F noncarcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of 0.125 mM (Table
Al). The statistical sensitivities of transformation assay
trials 1 and 2 were 69 and 63/110, respectively; the detec-
tion sensitivities for BaP of trials 1 and 2 were 12 and
101/110, respectively (Table A2). In trials 1 and 2 the test
chemical had LA transformation responses. N-(1-naph-
thyl)ethylenediamine-2HCl evaluated as having equivocal
activity in the transformation assay, and its actual and
estimatedrankt-statisticswere 1.64and 1.83,respectively
(Table A3).
I-Nitronaphthalene. 1-Nitronaphthalene is a level F
noncarcinogen (Table A3). It had no insurmountable tech-
nicalproblems (TableAl). The testchemicalwas cytotoxic
totheBALB/c-3T3 cells andhad an average LD50of0.464
mM (TableAl). The statistical sensitivities oftransforma-
tion assaytrials 1 and 2 were 49 and 63/110, respectively;
the detection sensitivities forBaPoftrials 1 and 2were 24
and 101/110, respectively (Tlable A2). The test chemical
had an SN transformation response in the first experi-
ment, and an SP response in the second experiment.
Becausethemeant-statisticresponses ofthetwotransfor-
mation experiments were significantly different from one
another, this chemical has to be tested in a third trial. In
the absence of these data 1-nitronaphthalene was evalu-
ated as havinghad an indeterminate activity in the trans-
formation assay, and its actual and estimated rank
t-statistics were 1.45 and 1.56, respectively (Table A3).
4-Nitro-o-Phenylenediamine. 4-Nitro-o-phenylenedi-
amine is a level F noncarcinogen (Table A3). It had one
difficult technical problem. It was reported to become
oxidized upon exposure to air, and it was exposed to air
duringthe treatmentperiod (TableAl). The test chemical
was cytotoxic totheBALB/c-3T3 cells and had an average
LD50 of0.292 mM (Table Al). The statistical sensitivities
oftransformation assaytrials 1 and 2were 99 and46/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were82and80/110,respectively(TableA2).Thetest
chemical had an SP transformation response in the first
experiment, and an LAresponse inthesecondexperiment.
4-Nitro-o-phenylenediaminewasevaluatedasactiveinthe
transformation assay, and its actual and estimated rank
t-statistics were 2.54 and 3.54, respectively (Table A3).
3-NitropropionicAcid. 3-Nitropropionicacidis alevelE
noncarcinogen (Table A3). It had one difficult technical
problem. It was reported to become oxidized upon expo-
sure to air, and itwas exposed to air duringthe treatment
period (Table Al). The test chemical was moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of1.23 mM (TableAl). The statistical sensitivities of
transformation assay trials 1 and 2 were 82 and 67/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were 18and78/110,respectively(TableA2). Thetest
chemical had an SP transformation response in the first
and second experiments. 3-Nitropropionic acid was evalu-
ated as active in the transformation assay, and its actual
and estimated rankt-statisticswere 4.69 and 5.22, respec-
tively (Table A3).
p-Phenylenediamine-2HCI. p-Phenylenediamine-
2HCl is a level F noncarcinogen (Table A3). It had one
difficult technical problem. It was reported to become
oxidized upon exposure to air, and it was exposed to air
during the treatmentperiod (Table Al). The testchemical
was very cytotoxic to the BALB/c-3T3 cells and had an
average LD50 of 0.0712 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and 2were58
and 51/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 55 and 50/110, respectively
(Table A2). In trials 1 and 2 the test chemical had SP
transformation responses.p-Phenylenediamine-2HCIwas
evaluated as active in the transformation assay, and its
actual and estimated rank t-statistics were both 3.04
(Table A3).
N-Phenyl-2-Naphthylamide. N-Phenyl-2-naphthyl-
amide is a level F noncarcinogen (Table A3). It had one
difficult technical problem. It was reported to become
oxidized upon exposure to air, and it was exposed to air
during the treatmentperiod (TableAl). The testchemical
was cytotoxic to theBALB/c-3T3 cells and had an average
LD50 of 0.195 mM (Table Al). The statistical sensitivities
oftransformation assaytrials 1 and 2were 93 and 63/110,
respectively; the detection sensitivities for BaP of trials 1
and2were 100and 101/110,respectively(TableA2). Intrials
1 and 2 the test chemical had SP transformation responses.
N-Phenyl-2-naphthylamide was evaluated as active in the
transformation assay, and its actual and estimated rank
t-statistics were 4.25 and 6.90, respectively (Table A3).
2,3,5,6-Tetrachloro-4-Nitroanisole. 2,3,5,6-Tetra-
chloro-4-nitroanisole is alevelFnoncarcinogen (TableA3).
It had no insurmountable technical problems (Table Al).
The test chemical was very cytotoxic to the BALB/c-3T3
cells and had an average LD50 of 0.0437 mM (Table Al).
The statistical sensitivities oftransformation assay trials
1 and 2 were 68 and 43/110, respectively; the detection
sensitivities for BaP of trials 1 and 2 were 40 and 9/110,
respectively (Table A2). In trials 1 and 2 the test chemical
had LA transformation responses. 2,3,5,6,-Tetrachloro-4-
nitroanisole was evaluated as having equivocal activity in
the transformation assay, and its actual and estimated
rank t-statistics were both 2.08 (Table A3).
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Tetraethylthiuram Disulfide. Tetraethylthiuram dis-
ulfide is a level F noncarcinogen (Table A3). It had one no
insurmountable technical problems (Table Al). The test
chemical was very cytotoxic to the BALB/c-3T3 cells and
had an average LD50 of 0.0000583 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 10 and 43/110, respectively; the detection
sensitivities for BaP of trials 1 and 2 were 5 and 9/110,
respectively (Table A2). In trials 1 and 2 the test chemical
had SP transformation responses. Tetraethylthiuram dis-
ulfidewas evaluated as active in the transformation assay,
and its actual and estimated rank t-statistics were both
3.88 (Table A3).
2,6-Toluenediamine-2HCl. 2,6-Toluenediamine-2HCl is
a level Fnoncarcinogen (Table A3). It had no insurmount-
able technical problems (Table Al). The test chemical was
moderately cytotoxic to the BALB/c-3T3 cells and had an
average LD50 of 4.11 mM (Table Al). The statistical sen-
sitivities oftransformation assaytrials 1 and 2 were 68 and
23/110, respectively; the detection sensitivities for BaP of
trials 1 and 2were40 and 11/110,respectively(TableA2). In
trials 1 and 2 the test chemical had SP transformation
responses. 2,6-Toluenediamine-2HCI was evaluated as
active in the transformation assay, and its actual and
estimated rank t-statistics were both 6.95 (Table A3).
Cytotoxic, Nonmutagenic Carcinogens
Allyl Isothicyanate. Allyl isothiocyanate is a level D
carcinogen (Table A3). It had one difficult technical prob-
lembecauseitwasreported toreactwithwater(TableAl).
Thetestchemicalwas averycytotoxic to the BALB/c-3T3
cells and had an average LD50 of0.00712 mM (Table Al).
The statistical sensitivities oftransformation assay trials
1 and 2 were 90 and 98/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 13 and 60/110,
respectively (Table A2). The test chemical had an LA
transformation response in the first experiment, and an
SP response in the second experiment. Allyl isothiocya-
nate evaluated as active in the transformation assay, and
its actual and estimated rank t-statistics were 2.86 and
3.39, respectively (Table A3).
Allyl Isovalerate. Allyl isovalerate is a levelA carcino-
gen (Table A3). It had no insurmountable technical prob-
lems (Table Al). The test chemical was moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of4.51 mM (TableAl). The statistical sensitivities of
transformation assay trials 1-4 were 66, 78, 42, and
27/110, respectively; the detection sensitivities for BaP of
trials 1-4 were 81, 58, 35, and 63/110, respectively (Table
A2). The test chemical had an LN transformation
response in the first two experiments, an SN response in
the third experiment, and an LA response in the fourth
experiment. Allyl isovalerate was evaluated as inactive in
the transformation assay, and its actual and estimated
rank t-statistics were both 1.65 (Table A3).
ChlorendicAcid. Chlorendic acid was alevelA carcino-
gen (Table A3). This chemical was reported to bind metal
salts (TableAl); thus, itcouldhave affected the concentra-
tion of metal salts in FBS and culture medium.
The testchemical was moderately cytotoxic chemical with
an average LD50 of 4.07 mM (Table Al). The statistical
sensitivities oftransformation assay trials 1 and 2 were 9
and 57/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 37 and 88/110, respectively
(TableA2). In apreliminarytrial 1 the chemical had an SP
transformation response. In trial 2 the chemical had an
LA transformation response. Chlorendic acid was evalu-
ated as active in the transformation assay. Its actual and
estimated rank t-statistics were both 1.98 (Table A3).
3-Chloro-2-Methylpropene. 3-Chloro-2-methylpropene
was alevelA carcinogen (TableA3). Ithadmanytechnical
problems including its reported reaction (Table Al). The
test chemical was a cytotoxic chemical with an average
LD50 of0.662 mM (Table Al). The statistical sensitivities
oftransformation assay trials 1 and 2 were 9 and 57/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 37 and 88/110, respectively (Table A2). In a
preliminarytrial 1 thechemicalhadan LAtransformation
responses. In trial 2 the chemical had an SP transforma-
tionresponse.3-Chloro-2-methylpropenewasevaluated as
active in the transformation assay, and its actual and
estimated rank t-statistics were both 2.14 (Table A3).
Chlorowax 40. Chlorowax 40 is a level D carcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was moderately cytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 1.43
mM (TableAl). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 12 and 26/110, respectively;
the detection sensitivities forBaP oftrials 1 and 2were 98
and 93/110, respectively (TableA2). The testchemical had
an LA transformation response in the first experiments
and an SN response in the second experiment. Chlorowax
40 was evaluated as inactive in the transformation assay,
anditsactualandestimatedrankt-statisticswere0.46and
0.48, respectively (Table A3)
Chlorowax 500. Chlorowax 500 is a level A carcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was moderately cytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 1.58
mM (TableAl). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 32 and 15/110, respectively;
the detection sensitivities for BaP of trials 1 and 2 were
108 and 21/110, respectively (Table A2). The test chemical
had an SN transformation response in both experiments.
Chlorowax 500 was evaluated as inactive in the transfor-
mationassay, andits actualandestimatedrankt-statistics
were both 0.06 (Table A3).
Cinnamyl Anthranilate. Cinnamyl anthranilate is a
levelA carcinogen (TableA3). Ithad one difficulttechnical
problem. Itwasreportedtobecomeoxidizedbyair; thus,it
could have reacted with air during the treatment period
(Table Al). The test chemical was very cytotoxic to the
BALB/c-3T3 cells and had an average LD50 of0.0947 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1-3 were 53, 102 and 92/110, respectively; the
detection sensitivities forBaP oftrials 1 and 2were30, 95
and ND/110, respectively (Table A2). The test chemical
had an SN transformation response in all three experi-
ments. Cinnamyl anthranilatewas evaluated as inactivein
383MATTHEWS ET AL.
the transformation assay, and its actual and estimated rank
t-statistics were 0.004 and 0.005, respectively (Table A3).
Diethylstilbestrol. Diethylstilbestrol is a level A car-
cinogen (Table A3) with no technical problems (Table Al).
It was very cytotoxic to the BALB/c-3T3 cells with an
average LD50 of 0.0858 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2 were55
and 31/110, respectively; the detection sensitivities for
BaPoftrials 1 and2 were8and52/110,respectively(Table
A2). In a preliminary trial 1 the chemical had an LA
transformation response. Intrial2thechemicalhad anSP
transformation response. Diethylstilbestrol wasevaluated
as active in the transformation assay. Its actual and
estimated rank t-statistics were both 2.91, respectively
(Table A3).
Dimethylvinyl Chloride. Dimethylvinyl chloride is a
levelA carcinogen (Table A3). It had one serious technical
problembecauseit wasnoted tobeoxidized upon exposure
toair(TableAl). Itwasmoderatelycytotoxic totheBALB/
c-3T3 cells with an average LD50 of4.74 mM (Table Al).
The statistical sensitivities oftransformation assay trials
1 and 2 were 12 and 27/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 98 and 63/110,
respectively (TableA2). In apreliminary trial 1 the chemi-
cal had an LA transformation response. In trial 2 the
chemical had an SP transformation response. Dimethyl-
vinyl chloride was evaluated as active in the transforma-
tion assay. Its actual and estimated rank t-statistics were
both 2.59 (Table A3).
Ethyl Acrylate. Ethyl acrylate is a level A carcinogen
(TableA3). Ithas one difficulttechnicalproblembecauseit
was reported to react with water (Table Al). It was very
cytotoxic totheBALB/c-3T3 cellswith an average LD50of
0.0746mM(TableAl).Thestatistical sensitivities oftrans-
formation assaytrials 1 and 2 were 66 and 74/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were 81 and 35/110, respectively (Table A2). In a prelimi-
nary trial 1 the chemical had an LA transformation
response. Intrial2thechemicalhad anSPtransformation
response. Ethyl acrylate was evaluated as active in the
transformation assay. Its actual and estimated rank t-sta-
tistics were 4.51 and 5.25, respectively (Table A3).
Isophorone. Isophorone is a level D carcinogen (Table
A3)with noinsurmountabletechnicalproblems (TableAl).
It was moderately cytotoxic to the BALB/c-3T3 cells with
an average LD50 of 5.18 mM (Table Al). The statistical
sensitivities of transformation assay trials 1-3 were 106,
74 and 26/110, respectively; the detection sensitivities for
BaP oftrials 1 and 2 were 51, 35 and 93/110, respectively
(TableA2). In apreliminarytrial 1 thechemicalhad an LN
transformation response because the test chemical treat-
ment doses were noncytotoxic to the cells. In trials 2 and 3
the chemical had an SP transformation response. Iso-
phorone was evaluated as active in the transformation
assay. Its actual and estimated rank t-statistics were 2.76
and 2.86, respectively (Table A3).
D-Limonene. D-Limoneneis alevelDcarcinogen (Table
A3). Ithad one difficult technical problem. It wasreported
to become oxidized by air; thus, it could have reacted with
air during the treatment period (Table Al). The test
chemical was cytotoxic to the BALB/c-3T3 cells and had
an average LD50 of 0.988 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1-3 were 70, 12
and 57/110, respectively; the detection sensitivities for
BaP of trials 1-3 were 41, 98 and 88/110, respectively
(Table A2). The test chemical had an LN transformation
response in the first experiments and an SN response in
the second and third experiments. D-Limonenewas evalu-
ated as inactive inthetransformation assay, andits actual
and estimated rank t-statistics were 0.24 and 0.27, respec-
tively (Table A3).
Malonaldehyde, Sodium Salt. Malonaldehyde, sodium
salt, is a level C carcinogen (Table A3). It was had one
serious technical problem because it is very temperature
sensitive (Table 1). The test chemical was moderately
cytotoxictotheBALB/c-3T3 cellswithan average LD50of
3.74 mM (Table Al). The statistical sensitivities of trans-
formation assaytrials 1 and 2were 21 and 54/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were 26 and 44/110, respectively (Table A2). In a prelimi-
nary trial 1 the chemical had an SP transformation
response. In trial 2 the chemical had an LA transforma-
tion response. Malonaldehyde, sodium salt, was evaluated
as active in the transformation assay. Its actual and
estimatedrankt-statisticswere 1.87and 1.87,respectively
(Table A3).
Methapyrilene-HCI. Methapyrilene-HCl is a level C
carcinogen (TableA3). Ithad no insurmountable technical
problems (TableAl). The test chemical was cytotoxic to the
BALB/c-3T3 cells and had an average LD50 of0.812 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1-3 were 60, 91 and 82/110, respectively; the
detection sensitivities for BaP oftrials 1 and 2were27,85
and ND/110, respectively (Table A2). The test chemical had
an SN transformation response in all three experiments.
Methapyrilene-HCL was evaluated as inactive in the
transformation assay, and its actual and estimated rank
t-statistics were 0.14 and 0.17, respectively (Table A3).
2-Mercaptobenzothiazole. 2-Mercaptobenzothiazole is
alevelCcarcinogen(TableA3). Ithad oneserioustechnical
problem. It was reported to react with water; thus, its
activity in the transformation assay could have been
unavoidably affected by its exposure to an aqueous
environmentduringthe48-hrtreatmentperiod(TableAl).
The test chemical was cytotoxic to the BALB/c-3T3 cells
and had an average LD50 of 0.130 mM (Table Al). The
statistical sensitivities of transformation assay trials 1-3
were 3,17 and 51/110, respectively, the detection sen-
sitivities for BaP of trials 1-3 were 110, 6 and 50/110,
respectively (Table A2). The test chemical had a LN
transformation response in the first experiment, because
the positive control did not induce significant transforma-
tion in this experiment. In the second and third experi-
mentsthetestchemicalhad LAtransformation responses.
2-Mercaptobenzothiazole was evaluated as having had
equivocal activity in the transformation assay, and its
actual and estimated rank t-statistics were both 1.23
(Table A3).
Nitrilotriacetic Acid, nTisodium Salt. Nitrilotriacetic
acid, trisodium salt, is a level A carcinogen (Table A3).
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Because this chemicalwasreported tobindsmetal salts, it
couldhave affectedtheconcentration ofmetalsaltsinFBS
and culture medium (Table Al). It was moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of5.98mM (TableAl).The statistical sensitivities of
transformation assay trials 1 and 2 were 80 and 33/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were 89and 14/110, respectively (TableA2). Intrials
1 and 2 the chemical had an SP transformation response.
Nitrilotriacetic acid, trisodium salt, was evaluated as
active in the transformation assay. Its actual and esti-
mated rank t-statisticswere both 5.86, respectively (Table
A3).
Polybrominated Biphenyl Mixture. Polybrominated
biphenyl mixture is a level A carcinogen (Table A3). This
test chemical was insoluble in culture medium at aportion
of the treatment doses that were used to induce both
cytotoxic and transforming activity (Table Al). It was
cytotoxic totheBALB/c-3T3 cellswith anaverage LD50of
0.291 mM (TableAl). The statlstical sensitivities oftrans-
formation assaytrials 1 and 2were 81 and39/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were22 and68/110, respectively (TableA2). Intrials 1 and
2 the chemical had an SP transformation responses for
both type III and type I-III focus transformation
responses. However,thistestchemicalwasveryunusualin
that it induced proportionally a much higher response for
thetype I and IIfoci,thanforthetype IIIfoci(refertothe
Discussion). Polybrominated biphenyl mixture was evalu-
ated as active in the transformation assay. Its actual and
estimated rank t-statistics were both 1.93 forthe type III
focus response, and 5.81 for the type I and II focus
response (Table A3).
Reserpine. Reserpine is alevelA carcinogen (TableA3).
It had one difficult technical problem. It was reported to
become oxidizedbyair; thus, itcould havereactedwith air
duringthe treatmentperiod (TableAl). The testchemical
was very cytotoxic to the BALB/c-3T3 cells and had an
average LD50 of 0.0133 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1-3were25, 16
and 92/110, respectively; the detection sensitivities for BaP
oftrials 1 and2were36and7/110,respectively(TableA2).
The test chemical had an LA transformation response in
thefirstexperimentand anSNresponseinthesecond and
third experiments. Reserpine was evaluated as inactive in
the transformation assay, and its actual and estimated
rank t-statistics were both 0.24, respectively (Table A3).
71is(2-ethylhexyl)phosphate. Tris(2-ethylhexyl)phos-
phate is a level D carcinogen (Table A3). It had no insur-
mountable technical problems (Table Al). The test
chemicalwascytotoxic totheBALB/c3T3 cells andhad an
average LD50 of 0.338 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2were 57
and 59/110, respectively, the detection sensitivities for
BaP of trials 1 and 2 were 88 and 17/110, respectively
(Table A2). The test chemical had an SN transformation
response in both experiments. Tris(2-ethylhexyl)-
phosphate was evaluated asinactive inthetransformation
assay, and its actual and estimated rank t-statistics were
both 0.00 (Table A31
4-Vinylcyclohexene. 4-Vinylcyclohexene is a level D
carcinogen (Table A3). It had one difficult technical prob-
lem. Itwas reported to become oxidized upon exposure to
air; thus, it could have reacted with air during the treat-
mentperiod (TableAl). The testchemicalwas moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of3.88 mM (TableAl). The statistical sensitivities of
transformation assay trials 1 and 2 were 32 and 38/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 108 and 16/110, respectively (Table A2). The
test chemical had an SN transformation response in both
experiments. Vinylcyclohexane was evaluated as inactive
in the transformation assay, and its actual and estimated
rank t-statistics were both 0.00 (Table A3).
Cytotoxic, Nonmutagenic Noncarcinogens
Anilazine. Anilazine is a level F noncarcinogen (Table
A3). It had no insurmountable technical problems (Table
1). The test chemical was a very cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of0.0475 (Table Al).
The statistical sensitivities oftransformation assay trials
1 and 2 were 68 and 67/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 40 and 78/110,
respectively (Table A2). In trials 1 and 2 the test chemical
had LA transformation responses. Aniline was evaluated
as having equivocal activity in the transformation assay,
anditsactualandestimatedrankt-statisticswere 1.82and
2.09, respectively (Table A3).
L-Ascorbic Acid. L-Ascorbic acid is a level F noncar-
cinogen (TableA3). Ithadtwo difficulttechnicalproblems.
It was reported to become oxidized upon exposure to air;
thus, it could have reacted with air during the treatment
period. Inaddition,itwasnotedtobindmetalsalts;thus,it
could have combined with metal salts in FBS and EMEM
medium (TableAl). The test chemical was cytotoxic to the
BALB/c-3T3 cells and had an average LD50 of0.363 mM
(Table Al). The statistical sensitivities of transformation
assaytrials 1 and 2were 50 and 101/110, respectively; the
detection sensitivitiesforBaPoftrials 1 and2were59and
104/110, respectively (Table A2). In trials 1 and 2 the test
chemical had SN transformation responses. L-Ascorbic
acidwasevaluated asinactiveinthetransformation assay,
anditsactualandestimatedrankt-statisticswere0.32and
0.46, respectively (Table A3).
Bisphenol A. Bisphenol A is a level E noncarcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of0.147 mM (Table
Al). The statistical sensitivities of transformation assay
trials 1-4 were 53, 16, 99 and 105/110, respectively; the
detection sensitivities for BaP oftrials 1-4 were 30, 7, 37
and39/110, respectively (TableA2). The testchemical had
an SN transformation response in all four experiments.
Bisphenol Awas evaluated as inactive in the transforma-
tion assay, and its actual and estimated rank t-statistics
were both 0.79 (Table A3).
Carbromal. Carbromalis alevelFnoncarcinogen(Table
A3). Ithad one diffiecult technicalproblem. Itwasreported
to become oxidized by air; thus, it could have reactedwith
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air during the treatment period (Table Al). The test
chemical was moderately cytotoxic to the BALB/c-3T3
cells and had an average LD50 of3.60 mM (TableAl). The
statistical sensitivities of transformation assay trials 1
and 2 were 14 and 23/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 72 and 11/110,
respectively (Table A2). The test chemical had an SN
transformation response in the first experiment, and an
SP response in the second experiment. Although the test
chemical had disparate transformation responses in two
experiments, the mean t-statistics of the two responses
were not significantly differentfrom one another. Carbro-
mal was evaluated as weakly active in the transformation
assay, and its actual and estimated rank t-statistics were
both 2.26 (Table A3).
Chlorpheniramine-Maleate. Chlorpheniramine male-
ate is a level F noncarcinogen (Table A3). It had no insur-
mountable technical problems (Table Al). The test
chemical was cytotoxic to the BALB/c-3T3 cells and had
an average LD50 of 0.287 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2were47
and 67/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 43 and 78/110, respectively
(Table A2). The test chemical had an SN transformation
responseinthefirstexperiment, andanSPresponseinthe
second experiment. Although the test chemical had dispa-
rate transformation responses, themeant-statistics ofthe
two responses were not significantly different from one
another. Chlorpheniramine-maleate was evaluated as
weakly active in the transformation assay, and its actual
and estimated rankt-statisticswere 1.18 and 1.26, respec-
tively (Table A3).
C. L AcidRed 14. C. I. Acid red 14 is a level F noncar-
cinogen (Table A3). It had no insurmountable technical
problems (Table Al). The test chemical was moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50of3.38mM (TableAl). The statistical sensitivities of
transformation assay trials 1 and 2 were 40 and 35/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were 54and57/110,respectively(TableA2). Intrials
1 and 2 the test chemical had SP transformation
responses. C. I. Acid red 14 was evaluated as active in the
transformation assay, and its actual and estimated rank
t-statistics were 60th 2.15 (Table A3).
C. L Acid Yellow 73. C. I. Acid yellow 73 is a level F(I)
noncarcinogen which has been reclassified as an
incomplete bioassay study (Table A3). It had no insur-
mountable technical problems (Table Al). The test chemi-
cal was moderately cytotoxic to the BALB/c-3T3 cells and
had anaverageLD50of4.65mM(TableAl).Thestatistical
sensitivities oftransformation assaytrials 1 and2were 17
and 71/110, respectively; the detection sensitivities for
BaPoftrials 1 and2were6and23/110,respectively(Table
A2). Intrials 1 and2thetestchemicalhadSNtransforma-
tion responses. C. I. Acid yellow 73 was evaluated as
inactive in the transformation assay, and its actual and
estimated rank t-statistics were both 0.03 (Table A3).
Ephedrine Sulfate. Ephedrine sulfate is a level F non-
carcinogen (TableA3). Ithad noinsurmountable technical
problems (Table Al). The test chemical was moderately
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of1.53 mM (TableAl). The statistical sensitivities of
transformation assay trials 1-3 were 24, 17 and 51/110,
respectively; the detection sensitivities for BaP of trials
1-3were 10,6 and50/110,respectively(TableA2). The test
chemical had an LN transformation response in the firsl
experiment because the test chemical did not have signifi-
cant cytotoxic activity. The test chemical had an SN
response in the second and third experiments. Ephedrine
sulfate evaluated as inactive in the transformation assay,
and its actual and estimated rank t-statistics were both
0.16 (Table A3).
Erythromycin Stearate. Erythromycin stearate is a
level F noncarcinogen (Table A3). It had no insurmount-
able technical problems (Table Al). The test chemical was
verycytotoxictotheBALB/c-3T3 cellsand had anaverage
LD50 of0.0746 mM (TableAl). The statistical sensitivities
oftransformation assaytrials 1 and 2were 24 and 51/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were 10 and50/110, respectively(TableA2).The test
chemical had an SN transformation response in both the
first and second experiments. Erythromycin stearate was
evaluated as inactive in the transformation assay, and its
actual and estimated rank t-statistics were both 0.08
(Table A3).
Ethoxylated Dodecyl Alcohol. Ethoxylated dodecyl
alcohol is a level F(I) noncarcinogen which has been
reclassified as an incomplete study (Table A3). It had no
insurmountable technical problems (Tlable Al). The test
chemical was very cytotoxic to the BALB/c-3T3 cells and
had an average LD50 of 0.0172 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 1 and 15/110, respectively; the detection sen-
sitivities for BaP of trials 1 and 2 were 3 and 21/110,
respectively (Table A2). The test chemical had an SN
transformation response in both the first and second
experiments. Ethoxylated dodecyl alcohol was evaluated
as inactive in the transformation assay, and its actual and
estimated rank t-statistics were both 0.29 (Table A3).
Ethylenediamine Tetraacetic Acid, 11risodium Salt.
Ethylenediamine tetraacetic acid, trisodium salt, is alevel
F noncarcinogen (Table A3). It had one difficult technical
problem. Itwas reported to bind with certain metal salts;
thus, it could have reacted with metal salts in FBS and
EMEM medium (TableAl). The test chemicalwas moder-
ately cytotoxic to the BALB/c-3T3 cells and had an aver-
age LD50 of 1.89 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and 2were80
and 67/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 89 and 78/110, respectively
(Table A2). The test chemical had an LA transformation
response in the first experiment, and an SN response in
the second experiment. Ethylenediamine tetraacetic acid,
trisodium salt, was evaluated as inactive in the transfor-
mationassay, anditsactualandestimatedrankt-statistics
were 1.41 and 2.01, respectively (Table A3).
Eugenol. Eugenolis alevelEnoncarcinogen (TableA3).
It had one difficult technical problem. It was reported to
become oxidized upon exposure to air; thus, it could have
reacted with air during the treatment period (Table Al).
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The test chemical was cytotoxic to the BALB/c-3T3 cells
and had an average LD50 of 0.875 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 32 and 18/110, respectively; the detection
sensitivities forBaP oftrials 1 and 2were 108 and 31/110,
respectively (Table A2). The test chemical had an LN
transformation response in the first experiment, because
the test chemical did not induce significant cytotoxic
activity. Inthe secondexperimentthetestchemical had an
SN transformation response. Since the test chemical had
an LN transformation response in the first experiment, it
had to be tested in two additional trials. Therefore,
eugenol was evaluated as having had an indeterminate
activity in the transformation assay, and its actual and
estimated rank t-statistics were both 1.07 (Table A3).
Geranyl Acetate. Geranyl acetate is a level F noncar-
cinogen (Table A3). It had no insurmountable technical
problems (Table Al). The test chemical was cytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 0.302
mM (TableAl). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 44 and 41/110, respectively;
the detection sensitivities forBaP oftrials 1 and2were 65
and 83/110, respectively (TableA2). The testchemicalhad
an SN transformation response in the first and second
experiments. Geranyl acetate was evaluated as inactive in
the transformation assay, and its actual and estimated
rank t-statistics were 0.35 and 0.37, respectively (Table
A3).
4-Hexylresorcinol. 4-Hexylresorcinol is a level E non-
carcinogen (TableA3). Ithad noinsurmountable technical
problems (Table Al). The test chemical was cytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 0.103
mM (TableAl). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 13 and 67/110, respectively;
the detection sensitivities forBaPoftrials 1 and 2were 66
and 78/110, respectively (TableA2). The testchemical had
an SN transformation response in the first experiment,
and an LA response in the second experiment. 4-Hex-
ylresorcinol was evaluated as inactive in the transforma-
tion assay, and its actual and estimated rank t-statistics
were 0.46 and 0.47, respectively (Table A3).
D,L-Menthol. D,L-Menthol is a level F noncarcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was moderately cytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 4.63
mM (TableAl). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 46 and 89/110, respectively;
the detection sensitivities forBaPoftrials 1 and 2were80
and 87/110, respectively (TableA2). The test chemical had
an SN transformation response in the first experiment
and second experiments. D,L-Menthol was evaluated as
inactive in the transformation assay, and its actual and
estimatedrankt-statisticswere0.16 and0.22,respectively
(Table A3).
Methoxychlor. Methoxychlor is alevelFnoncarcinogen
(Table A3). It had no insurmountable technical problems
(Table Al). The test chemical was very cytotoxic to the
BALB/c-3T3 cells and had an average LD50 of0.0978 mM
(Table Al). The statistical sensitivities of transformation
assay trials 1 and 2 were 58 and 51/110, respectively; the
detection sensitivities forBaPoftrials 1 and2were55and
50/110, respectively (Table A2). The test chemical had an
SN transformation response in the first experiment, and
an LA response in the second experiment. Methoxychlor
was evaluated as inactiveinthe transformation assay, and
its actual and estimated rank t-statistics were both 1.08
(Table A3).
Methyldopa Sesquihydrate. Methyldopa sesquihy-
drate is a level E noncarcinogen (Table A3). It had no
insurmountable technical problems (Table Al). The test
chemical was very cytotoxic to the BALB/c-3T3 cells and
had an average LD50 of 0.0810 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 21 and 56/110, respectively, the detection
sensitivities forBaP oftrials 1 and2were 26 and 109/110,
respectively (Table A2). The test chemical had an LA
transformation response in the first experiment, and an
SN response in the second experiment. Methyldopa ses-
quihydratewasevaluatedasinactiveinthetransformation
assay, and its actual and estimated rank t-statistics were
both 1.21, respectively (Table A3).
Methylphenidate-HCI. Methylphenidate is a level I
noncarcinogen because it has not been evaluated in a
complete rodent bioassay study (Table A3). It had no
insurmountable technical problems (Table Al). The test
chemical was moderately cytotoxic to the BALB/c-3T3
cells and had an average LD50 of5.63 mM (TableAl). The
statistical sensitivities of transformation assay trials 1
and 2 were 64 and 86/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 84 and 74/110,
respectively (Table A2). In trials 1 and 2 the test chemical
had SN transformation responses. C. I. Acid red 14 was
evaluated as inactive in the transformation assay, and its
actual and estimated rank t-statistics were 1.05 and 1.47,
respectively (Table A3).
Oxytetracycline-HCI. Oxytetracycline is a levelE non-
carcinogen (Table A3). It had one difficult technical prob-
lem. It was reported to hydrolyze in water; thus, it could
have reacted with water during the treatment period
(Table Al). The test chemical was cytotoxic to the BALB/
c-3T3 cells and had an average LD50 of 0.523 mM (Table
Al). The statistical sensitivities of transformation assay
trials 1-3were80,22 and5/110,respectively; thedetection
sensitivities for BaP oftrials 1-3 were 89, 53 and 46/110,
respectively (Table A2). The test chemical had an SN
transformation responseinallthreeexperiments.Thetest
chemical was tested in the third experiment, because the
its cytotoxic activityinthefirstexperimentwas excessive.
Oxytetracycline-HCI was evaluated as inactive in the
transformation assay, and its actual and estimated rank
t-statistics were both 0.00, respectively (Table A3).
Phenol. Phenol is alevelFnoncarcinogen (TableA3). It
had two difficult technical problems. It was reported to
become oxidized byair; thus, itcould havereactedwith air
during the treatment period. In addition, it was reported
to react with sulfate groups on chemicals; thus, it could
have reacted with biochemicals in culture medium, aswell
as biochemicals in the target cells (Table Al). The test
chemical was moderately cytotoxic to the BALB/c-3T3
cells and had an average LD50 of3.29 mM (TableAl). The
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statistical sensitivities of transformation assay trials 1
and 2 were 12 and 15/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 26 and 21/110,
respectively (Table A2). The test chemical had an SP
transformation response in the first and second experi-
ments. Phenol was evaluated as active in the transforma-
tion assay, and its actual and estimated rank t-statistics
were both 7.60 (Table A3).
Phenylephrine-HCI. Phenylephrine-HCl is a level F
noncaranogen (Table A3). It had one difficult technical
problem. Itwasreportedtobecomeoxidized byair;thus,it
could have reacted with air during the treatment period
(Table Al). The test chemical was moderately cytotoxic to
theBALB/c3T3 cells andhad anaverage LD50of3.52mM
(Table Al). The statistical sensitivities of transformation
assay trials 1 and 2 were 80 and 29/110, respectively; the
detection sensitivitiesforBaPoftrials 1 and2were89and
97/110, respectively(TableA2).Thetestchemicalhad an SN
transformation response in the first and second experi-
ments.Phenylephrine-HClwasevaluatedasinactiveinthe
transformation assay, and its actual and estimated rank
t-statistics were 0.31 and 0.42, respectively (Table A3).
Propyl Gallate. Propyl gallate is a level E noncar-
cinogen (Table A3). It had one difficult technical problem.
It was reported to react with iron; thus, it could have
reactedwith theiron in FBS (TableAl). The testchemical
was very cytotoxic to the BALB/c-3T3 cells and had an
average LD50 of 0.0631 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2were 94
and 102/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 91 and 95/110, respectively
(Table A2). The test chemical had an SP transformation
response in the first experiment, and an LA response in
the second experiment. Propyl gallate was evaluated as
active in the transformation assay. Because the statistical
sensitivity and detection sensitivityforBaP in both ofthe
experiments were significantly low, and the testchemicals
actual and estimated rank t-statistics were very different
(i.e., 1.70 and 2.95, respectively (Table A3).
Rotenone. Rotenone is a level E noncarcinogen (Table
A3). Ithad onedifficulttechnicalproblem. Itwasreported
to become oxidized by air; thus, it could have reacted with
air during the treatment period (Table Al). The test
chemical was very cytotoxic to the BALB/c-3T3 cells and
had an average LD50 of 0.000464 mM (Table Al). The
statistical sensitivities of transformation assay trials 1
and 2 were 21 and 31/110, respectively, the detection
sensitivities for BaP oftrials 1 and 2 were 26 and 52/110,
respectively (Table A2). The test chemical had an SN
transformation response in the first and second experi-
ments. Rotenonewasevaluated as inactiveinthetransfor-
mationassay, anditsactualandestimatedrankt-statistics
were both 0.26 (Table A3).
Sodium Diethyldithiocarbamate. Sodium diethyldi-
thiocarbamateis alevelFnoncarcinogen(TableA3). Ithad
noinsurmountable technicalproblems (TableAl). Thetest
chemical was very cytotoxic to the BALB/c-3T3 cells and
had an average LD50 of 0.000142 mM (Table Al). The
statisticalsensilivitiesoftransformation assaytrials 1 and
2 were 69 and 31/110, respectively; the detection sen-
sitivities for BaP of trials 1 and 2 were 12 and 52/110,
respectively (Table A2). The test chemical had an SP
transformation response in the first and second experi-
ments. Sodium diethyldithiocarbamate was evaluated as
active in the transforrnation assay, and its actual and
estimated rank t-statistics were both 2.94 (Table A3).
Stannous Chloride. Stannous chloride is alevel E non-
carcinogen (Table A3). It had two difficult technical prob-
lems. It was reported to react with both alcohols and
amines; thus, itcould have reacted with biochemicalswith
this groups in both FBS and EMEM medium (Table Al).
The test chemical was very cytotoxic to the BALB/c-3T3
cells and had an average LD50 of 0.0285 mM (Table Al).
The statistical sensitivities oftransformation assaytrials
1 and 2 were 77 and 37/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 67 and 20/110,
respectively (Table A2). The test chemical had an SN
transformation response in the first and second experi-
ments. Stannous chloride was evaluated as inactive in the
transformation assay, and its actual and estimated rank
t-statistics were both 0.78 (Table A3).
Tetracycline-HCI. Tetracycline-HCl is alevelFnoncar-
cinogen (Table A3). It had one difficult technical problem,
becauseitwasreported tobecome oxidized upon exposure
to air; thus, it could have reacted with air during the
treatmentperiod (TableAl).Thetestchemicalwasmoder-
ately cytotoxic to the BALB/c-3T3 cells and had an aver-
age LD50 of 3.24 mM (Table Al). The statistical
sensitivities oftransformation assaytrials 1 and2were24
and 51/110, respectively, the detection sensitivities for
BaP of trials 1 and 2 were 10 and 50/110, respectively
(Table A2). The test chemical had an SN transformation
response in the first experiment and second experiments.
Tetracycline-HCl was evaluated as inactive in the trans-
formation assay, and its actual and estimated rank t-sta-
tistics were both 0.021 (Table A3).
Tetrakis(hydroxymethyl)phosphonium Chloride.
Tetrakis(hydrosymethyl)-phosphonium chloride is a level
F noncarcinogen (Table A3). It had no insurmountable
technical problems (TableAl). The test chemicalwasvery
cytotoxic to the BALB/c-3T3 cells and had an average
LD50of0.00825mM(TableAl).Theslatisticalsensitivities
oftransformation assay trials 1-3 were 70, 15 and 59/110,
respectively; the detection sensitivities for BaP of trials
1-3 were 41, 21 and 17/110, respectively (Table A2). The
test chemical had an SN transformation response in the
firstexperiment, and an SPresponsein the secondexperi-
ment. Because the mean t-statistics of the test chemical
transformation responses in the first two experiments
were significantly different from one another, the test
chemicalhadtobetestedinathirdtrial. Thetestchemical
had a SN transformation response in the third experi-
ment. Tetrakis(hydroxymethyl)phosphonium chloridewas
evaluated as havinghad equivocal activityin the transfor-
mationassay,anditsactualandestimatedrankt-statistics
were both 1.27 (Table A3).
Tetrakis(hydroxymethyl)phosphonium Sulfate.
Tetrakis(hydroxymethyl)phosphonium sulfate is a level F
noncarcinogen (Table A3). It had no insurmountable tech-
nical problems (Table Al). The test chemical was very
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cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of 0.00438 mM (Table Al). The statistical sen-
sitivities of transformation assay trials 1 and 2 were 70
and 44/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 41 and 65/110, respectively
(Table A2). The test chemical had an SN transformation
response in the first and second experiments. Tetrakis-
(hydroxymethyl)phosphonium sulfate evaluated as inac-
tive in the transformation assay, and its actual and
estimated rank t-statistics were both 0.083 (Table A3).
Triphenyltin Hydroxide. Triphenyltin hydroxide is a
level F noncarcinogen (Table A3). It had no insurmount-
able technical problems (Table Al). The test chemical was
verycytotoxictotheBALB/c-3T3 cellsandhadanaverage
LD50 of 0.000134 mM (Table Al). The statistical sen-
sitivities of transformation assay trials 1 and 2 were 82
and 43/110, respectively; the detection sensitivities for
BaPoftrials 1 and2were 18and9/110,respectively(Table
A2).Thetestchemicalhad anSNtransformation response
in the first experiment, and an SP response in the second
experiment. Sincethemeant-statisticsofthetestchemical
transformation responses in the first two experiments
were significantly different from one another, it had to be
tested in a third experiment. Therefore, triphenyltin
hydroxide was evaluated as having had an indeterminate
activity in the transformation assay, and its actual and
estimated rank t-statistics were both 1.64 (Table A3).
Xylenes, (mixed). Xylenes (mixed) is a level F noncar-
cinogen (Table A3). It had no insurmountable technical
problems (Table Al). The test chemical was moderately
cytotoxic tothe BALB/c-3T3 cells and had an average LD50
of3.20 mM (Table Al). The statistical sensitivities oftrans-
formation assay trials 1 and 2 were 70 and 73/110, respec-
tively; the detection sensitivities for BaP of trials 1 and 2
were 41 and49/110, respectively (TableA2). The testchemi-
cal had an SN transformation response in the first and
second experiments. Xylenes (mixed) was evaluated as inac-
tiveinthetransformationassay,anditsactualandestimated
rank t-statistics were 0.47 and 0.50, respectively (Table A3).
Noncytotoxic, Mutagenic Carcinogens
DC Red No. 9. DC Red no. 9 is a level B carcinogen
(Table A6). It had no insurmountable technical problems;
howeverithadasolubilitylimitinculturemediumofabout
500 ,ug/ml. This improved to 2250 pLg/ml when the
medium was supplemented with the solvent vehicle plu-
ronic F68 (Table A4). The test chemical was noncytotoxic
to the BALB/c-3T3 cells and had an average LD50 of3.82
mM and 6.52 mM, either with or without using pluronic
F68 (TableA4). The statistical sensitivities oftransforma-
tion assaytrials 1-3were 30, 91 and 107/110, respectively;
the detection sensitivities for BaP oftrials 1-3 were 4, 85
and 106/110, respectively (Table A5). The test chemical
had an SP transformation response in two experiments,
and an LA response in one experiment. Significant test
chemicaltransformingactivitywasdetected atdosesboth
above and belowits solubilitylimitin culture medium. DC
Red No. 9 was evaluated as active in the transformation
assay, and its actual and estimated rank t-statistics were
4.33 and 5.50, respectively (Table A6).
Diethanolnitrosamine. Diethanolnitrosamine is a
level I carcinogen (Table A6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an aver-
age LD50 of 61.1 mM (Table A4). The test chemical was
only evaluated in one trial due to the limited availability
during this investigation. The statistical sensitivity of
transformation assay trial 1 was 52/110; the detection
sensitivity for BaP of trial 1 was 79/110, respectively
(Table A5). The test chemical had an SP transformation
response in the only experiment conducted for this test
chemical. Diethanolnitrosamine was evaluated as active
in the transformation assay, and its actual and esti-
mated rank t-statistics were 4.01 and 4.87, respectively
(Table A6).
Diethylnitrosamine. Diethylnitrosamine is a level A
carcinogen (TableA6). Ithad noinsurmountable technical
problems (TableA4).Thetestchemicalwasnoncytotoxicto
the BALB/c-3T3 cells and had an average LD50 of 46.0
mM (TableA4). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 4 and 27/110, respectively;
the detection sensitivities for BaP oftrials 1 and 2 were 1
and63/110, respectively(TableA5). The testchemical had
an SP transformation response in the two consecutive
experiments. Diethylnitrosamine was evaluated as active
in the transformation assay, and its actual and estimated
rank t-statistics were both 4.69 (Table A6).
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Table A4. Cytotoxic responses of54 noncytotoxic chemicals.
Cytotoxic Responsesb
Test Chemicala Physicochemical Properties (mi1 1 imolar LD50)
Co-culture
Name CAS No. M.W. 1 2 3 Assay
21 Carcinogens
Group I. Very Non-Cytotoxic Chemicals
3-amino-1,2,4-triazole 61-82-5
cyclamate, sodium salt 139-05-9
dimethyl hydrogen phosphite 868-85-9
dimethyl methyl phosphonate 756-79-6
dimethylnitrosamine 62-75-9
methyl carbamate (uncoded) 598-55-0
(coded) "
saccharin, sodium salt 81-07-2
Group II. Non-Cytotoxic Chenica7s
2432-99-7
5160-02-1
1163-19-5
103-23-1
117-81-7
55-18-5
597-25-1
11
96-45-7
680-31-9
108-78-1
150-68-5
57-30-7
26471-62-5
11-aminoundecanoic acid
D & C red no. 9
decabromodiphenyloxide
di(2-ethylhexyl)adipate
di(2-ethylhexyl)phthalate
diethanolnitrosamine
diethyinitrosamine
dimethylmorpholino- (uncoded)
phosphoramidate (coded)
ethylene thiourea
hexamethylphosphoramide
melamine
monuron
phenobarbital, sodium salt
2,4- & 2,6-toluene diiso-
thiocyanate
Group I. Very Non-Cytotoxic Chemicals
D-mannitol 69-65-8
3-sulfolene 77-79-2
witch hazel 68916-39-2
84.08
201.22
110.05
124.08
74.08
75.07
11
205.2
201.35
444.49
959.22
370.57
390.54
102.14
195.18
I,
102.16
179.2
126.12
198.65
254.22
174.16
S
S
L
L
L
S
S
S
S
S
L
L
L
L
L
S
L
S
S
S
L
C
C
C
C
C
C
a, ach, m, o
a, b, m, n, o
ac, b, o, v, w
ai, alk, b, o, oh, v
ai, b, o, v
C
FC a, b, o
FC o, Sp
FC i, o, sp
FC o, Sp, v
FC a, b, n, o, v
C a, l, v
C l, o, r, v
C a, ai, v
FC o,
C v
FC a, o, Sp
C a, b, sp
FC a, ai, o
FC am, b, l, ts, v, w
109.
132.
130. (260 mOsM)
172.
256.
225.
195.
76.5 (153 mOsM)
19.4
3.82 (6.52)
>6.26
98.4
21.4
61.1
46.0
17.1
24.4
91.4
64.4
39.6
5.54
6.11
7.93
26 Non-Carcinogens
182.18
118.15
46.07
S C
S C
L C
ts
o, v
>329.
117.
540.
Group II. Non-Cytotoxic Chemici
aldicarb
ampicillin trihydrate
o-anthranilic acid
benzoin
benzyl alcohol
caprolactam
2-chloroethanol
(2-chloroethyl)trimethyl-
anmnonium chloride
C. I. acid orange 10
dimethyl terephthalate
diphenylhydantoin
FD & C yellow No. 6
methyl methacrylate
molybdenum trioxide
4-nitroanthranilic acid
penicillin VK+
phthalamide
phthalic anhydride
roxarsone
sodium(2-ethylhexyl) alcohol
sulfate
sulfisoxazole
tetrahydrofuran
titanium dioxide
aIs
116-06-3
7177-48-2
118-92-3
119-53-9
100-51-6
105-60-2
107-07-3
999-81-5
1936-15-8
120-61-6
57-41-0
2783-94-0
80-62-6
1313-27-5
619-17-0
132-98-9
88-96-0
85-44-9
121-19-7
126-92-1
127-69-5
109-99-9
13463-67-7
190.27
403.50
137.14
212.25
108.13
113.16
80.52
158.07
452.38
194.19
252.27
452.37
100.12
144.
182.15
388.51
164.18
148.12
-260.
232.28
267.32
72.11
79.90
S FC a, b, ts
S FC ts
S FC ai, l, ts
S FC Sp,
L FC a, ach, ai, ts
s c ai, b, ch, o, ts
L C b, o, ts, w
S C m,so
S FC
S FC
S FC
S FC
L DFC
S FC
S FC
S C
S FC
S FC
S FC
L C
a, ai, b, o, sp, ts, w
b, o, Sp
ail, am, b, l, ra, ts
a&b, ts
a, ach, b, o
a, sp
a, am, b, o, ra, ts, w,
a, l, o, ts
S FC ai, l
L FC a, ai, b, o, ts
S FC m, Sp
10.7
23.8
72.9
14.8
17.9
71.8
81.0
62.0
26.5
>15.4
5.02
67.7
10.8
9.38
8.58
17.8
73.1
13.2
43.8
12.5
18.7
90.3
12.1
(Continued on nextpage)
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Table A4. Continued.
Cytotoxic Responsesb
Test Chemicala Physicochemical Properties (mil imolar LD50)
Co-culture
Name CAS No. M.W. 1 2 3 Assay
7 Model Very Non-Cytotoxic Chemicals
Group I. Non-Cytotoxic Chemicals
acetone 67-64-1 58.08 L C a, l, o, oc, ts 257.
dimethyl sulfoxide 67-68-5 78.13 L C a, ach, am, r, o 507.
ethanol 64-17-5 46.07 L C a, ach, o, am 429.
glycerol 56-81-5 92.09 L C - 401.
sodium chloride 7647-14-5 58.44 S C - 144.
sucrose 57-50-1 342.30 S C a 240.
urea 57-13-6 60.07 S C - 254.
Abbreviations: CAS No., Chemical Abstract Service registry number; LD50, lethal dose for 50% ofthe cells; M.W., molecularweight.
Abbreviations for Test Chemical Physicochemical Properties: Physicochemical considered in this study included: [1] physical state (S = solid, L =
liquid); [2] solventvehicle (D = dimethylsulfoxide, C = culturemedium, F = pluronic F68,A = acetone, E = ethanol) and [3] technicalproblems. The
technicalproblemsincluded testchemicals thatwere a = reactswithacids; ac = reactswith acid chlorides andacid anhydrides; ai = reactswithair, al
= reactswith alcohols; alk = alkylatingagentandreactswithlabilehydrogen;b = reactswithbases;bc = reactswithbiochemicals (amino,hydroxyl,
and carboxyl groups); hc = reactswithhalogenated chemicals; k = reactswith alphaketo acids; ls = light sensitive; m = binds metals; mel = reacts
with hexachloro- and trichloromelamine; met = reactswith metals (aluminum, iron, magnesium, potassium, sodium, tin or zinc); mh = metal halides;
msc = reactswithmiscellaneous organicchemicals (i.e.alpha-aminoethanol, chlorosulfonic acid, ethyleneimine,linseed oil,maleic anhydride, oleum, or
K-tert-butyloxide); o = reacts with oxidizing agents; p = reacts with plastics; pi = polymerization initiators; r = reacts with reducing agents; ru =
reacts with rubber; sp = solubility problem in culture medium; te = reacts with thiocyanates; ts = temperature sensitive; vts = very temperature
sensitive; v = volatile at 37,C; and w = reacts with water [refer to MATERIALS and METHODS].
aTestChemical: TablesAl andA3 contain 168 chemicals alongwith theirindividualCASregistrynumberand molecularweight. The chemicalswere
divided into groups ofchemicals thatcorrespond to thegroupsofchemicalsthatwere comparedin differenttextTables 1-12. Thus, the chemicalswere
divided into twogroups, including 114cytotoxic testchemicals (LD50 < 5.0mM)presented inTableAl, and 53 noncytotoxic chemicals (LD50 >5.0mM
presentedin TableA4.The 114cytotoxicchemicals inTableAl were subdividedintogroupsof43mutageniccarcinogens, 21 mutagenicnoncarcinogens,
20nonmutagenic carcinogens, and30non-mutagenicnoncarcinogens. The 53noncytotoxic testchemicals inTableA4were subdivided into groups of21
carcinogens, 26 noncarcinogens and 7 model very noncytotoxic chemicals. In addition, all of the cytotoxic test chemicals were separated into three
groups, including: Group I, moderately cytotoxic test chemicals [LD50 1-5mM]; Group II, cytotoxic chemicals [LD50 0.1-1.0 mM]; and Group III, very
cytotoxicchemicals [LD50<0.1 mM]. Inaddition,thistablepresentsimportantphysicochemicalpropertiesthatinfluencedtheprocedureusedintesting
the chemicals.
bCytotoxic Response: The co-culture clonal sulvival assaydesign used to detectthe cytotoxic response ofthe test chemical is described in Materials
andMethods.Thecytotoxicresponsesofchemicalsinindividualexperiments aresummarizedintermsofthemillimolar(mM)LD50treatmentdosethat
resulted in 50% survival ofthe chemically-treated cells relativeto the survival ofuntreated or solvent control treated cell cultures. The LD50 cytotoxic
response ofeach chemical in Tables Al and A4 is an average oftwo or more experiments with the chemical. The molecularweight ofeach chemical is
providedinorderthattreatmentdosescouldbeconvertedfrommMto ,ug/ml. Forexample,baseduponthemolecularweightof84.08,theLD50detected
for the first chemical in Table A4, 3-amino-1,2,4-triazole, was 109 mM or 9165 ,ug/ml.
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Tble A5. nfansformation responses of54 noncytotoxic chemicals.
Chemicala Transformation Responseb
Spontaneousc Benzo(a)pyrened Test Chemical"
Name Exp. No. Foci/Vessel: Rank Order Call: Rank Order Call: Mean t-statistic
Active Chemicals (false positives)
dimethyl hydrogen phosphite 1 (84)
2 (104)
dimethyl methyl phosphonate 1 (84)
2 (102)
Active Chemical s
3-amino-1,2,4-triazole 1 (69)
2 (99)
11-aminoundecanoic acid 1 (17)
2 (24)
3 (32)
4 (67)
cyclamate, sodium salt 1 (71)
2 (107)
D & C red No. 9 1 (43)
2 (54)
3 (67)
diethanotnitrosamine 1 (86)
2 (NA)
diethylnitrosamine 1 (79)
2 (102)
dimethylmorpholinophos- 1 (86)
phoramidate (uncoded) 2 (106)
dimethylmorpholinophos- 1 (86)
phoramidate (coded) 2 (108)
dimethyLnitrosamine 1 (31)
2 (100)
hexamethytphosphoramide 1 (78)
2 (98)
metamine 1 (43)
2 (58)
Active Chemicals
methyl carbamate
Continuec
methyl carbamate (315183-S)
phenobarbital, sodium salt
saccharin, sodium salt
1 (42)
2 (66)
3 (80)
1 (83)
2 (99)
1 (59)
2 (109)
1 (75)
2 (101)
21 Carcinogens
.511 44
.878 26
.511 44
.697 27
.288 85
.586 33
.327 83
.308 89
1.99 19
.085 107**
1.06 24
2.95 5***
1.05 30
.265 91
.085 107***
.464 52
5.12 4**
.697 27
.464 52
1.30 28
.464 52
1.17 20
.930 42
.268 73
3.28 9*
.618 59
1.05 30
.189 97
21 Carcinogens Continued
.861 55
.056 108**
3.02 10*
.351 71
.586 33
.297 75
2.55 6*
.882 21
.260 62
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
NA
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
65
93**
65
63
102***
14**
70
87***
34
106***
10**
46
4**
85
106***
79*
1 *
63
79*
15**
79*
19**
25*
49
37
17**
4**
94*
SP 8***
SP 99***
SP 5***
SP 23**
SP 14**
SP 76
SP 92***
SP 26*
SP 48
SP
SP
LA
SP
SP
SP
LN
LN
SP
SP
SP
SP
SP
LA
SP
SP
NA
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
SP
LA
6.02
5.93
2.17
3.63
3.54
8.08
1.10
.000
1.86
2.37
2.76
5.24
8.46
1.10
3.42
4.01
5.91
3.88
3.70
2.68
4.44
4.02
3.64
5.66
2.62
1.53
2.21
1.99
392
SP 7.80
LA 1.53
SP 5.08
SP 2.38
SP 4.81
LA 2.01
SP 3.52
SP 4.95
SP 10.3
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Tible A5. Continueds
Chemicala Transformation Responseb
Spontaneousc Benzo(a)pyrened Test Chemical"
Name Exp. No. Foci/Vessel: Rank Order Call: Rank Order Call: Mean t-statistic
2,4- & 2,6-toluene
diisothiocyanate
Weakly Active Chemical s
ethylene thiourea
1 (76)
2 (106)
1 (59)
2 (65)
1.79 12*
1.30 28
.297 75
.244 95
SP 98***
SP 15***
SP 76
SP 61
.....................................................................................................
Inactive Chemicals
di(2-ethylhexyl)adipate 1 (88) .406 57 SP 88*** SN
di(2-ethylhexyl)phthalate
monuron
Inactive Chemical with an
decabromodiphenyloxide
2 (108)
1 (36)
2 (100)
1 (20)
2 (28)
Indeterminate
1 (75)
2 (101)
1.17
.424
.268
.368
.818
Activity
.882
.260
20
74
73
81
39
21
62
SP 19**
SP 35
SP 49
SP 22***
SP 68
SP 26*
SP 48
SP 2.61
SP 3.54
LN 1.57
SP 2.17
.000
SN .000
SN .000
SN .000
LA 1.57
SN .453
LN .150
LN .430
26 Non-Carcinogens
Active Chemicals
benzyl alcohol
2-chloroethanol
(2-chloroethyl)trimethyl-
anwmonium chloride
FD & C yellow No. 6
penicillin VK+
3-sulfolene
Weakly Active Chemicals
methyl methacrylate
4-nitroanthranilic acid
1 (81)
2 (110)
1 (78)
2 (100)
1 (30)
2 (45)
1 (34)
2 (65)
3 (103)
1 (80)
2 (101)
1 (33)
2 (44)
1 (79)
2 (106)
1 (34)
2 (103)
7.36
.609
3.28
.268
.787
.732
2.51
.244
.874
3.02
.260
1.04
1.52
5.12
1.30
2.51
.874
2***
38
9*
73
SP 2***
SP 16***
SP 37
SP 49
40
35
7*
95
22
10*
62
49
23
4**
28
7*
22
SP 54
SP 57
SP 56
SP 61
SP 53
SP 5***
SP 48
SP 24**
SP 11***
SP 1***
SP 15***
SP 56
SP 53
LA 2.11
SP 1.79
SP 3.78
SP 2.66
SP 1.90
LA 1.68
SP 8.18
SP 4.85
SP 9.90
SP 6.26
SP 5.76
SP 3.84
LA 3.00
SP 4.34
SN 1,19
SN .015
SP 2.16
...........................................................................................................
Chemical with an Equivocal Activity
ampicillin trihydrate 1 (83) .351 71 SP 23*** LA 1.04
2 (105) .581 29 SP 97*** LA 1.52
(Continued on nextpage)
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Ilble A5. Continued.
Chemicala Transformation Responseb
Spontaneousc Benzo(a)pyrened Test Chemical
e
Name Exp. No. Foci/Vessel: Rank Order Call: RankOrder Call: Mean t-statistic
Inactive Chemicals
benzoin 1 (4) 1.51
2 (10) .053
caprolactam 1 (5) .035
2 (10) .053
C. I. acid orange 10 1 (64) .291
2 (103) .874
diphenyLhydantoin 1 (56) .260
2 (65) .244
moLybdenum trioxide 1 (47) .579
2 (56) .260
phthalic anhydride 1 (39) .427
2 (107) 2.95
tetrahydrofuran 1 (82) 8.01
2 (106) 1.30
Inactive Chemical with an Indeterminate Activity
titanium dioxide 1 (38) .496
2 (109) 2.55
Active Chemicals (false positive)
D-mannitol 1 (18) .663
2 (45) .732
3 (110) .609
witch hazeL 1 (81) 7.36
2 (110) .609
Chemicals with an Indeterminate Activity
aldicarb 1 (32) 1.99
2 (99) .586
o-anthranilic acid 1 (15) .186
2 (22) .893
dimethyl terephthaLate 1 (103) .874
2 (107) 2.95
phthalamide 1 (35) 1.97
2 (110) .609
roxarsone 1 (80) 3.02
2 (109) 2.55
sodium(2-ethyLhexyl) 1 (82) 8.01
aLcohol suLfate 2 (108) 1.17
sulfisoxazole 1 (19) .357
2 (26) .907
3 (NA)
50
109**
1 10***
109**
92
22
84
95
61
84
82
1 *
28
82
6*
46
35
38
2***
38
19
33
100
36
22
5***
14
38
10*
27
1***
6*
77
37
SP 59
SP 103***
SP 107***
SP 103***
SP 71
SP 53
SP 105***
SP 61
SP 47
SP 105***
SP 18***
SP 46
SP 3***
SP 15***
SP 12***
SP 92***
SP 80*
SP 57
SP 16***
SP 2***
SP 16***
SP 34
SP 14***
SP 42
SP 28*
SP 53
SP 46
SP 72
SP 16***
SP 5***
SP 92***
SP 3***
SP 19***
SP 67
SP 20***
SN .000
SN 1.48
SN 1.37
SN 1.08
SN .825
SN .435
SN .00
SN .00
LA .830
SN .347
LA 1.60
SN .000
SN .393
LA 1.36
SN .UOC
SN .000
LN .728
LA 1.23
SP 4.69
LA 1.61
LA 2.17
SN .267
SP 3.17
SN 1.47
SP 2.99
SP 1.71
LA 1.86
LN .000
LA 2.02
SP 2.94
SN .000
SN .180
SP 3.42
LN .690
LA 1.26
(Continued on nextpage)
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Table A5. Continued.
Chemicala Transformation Responseb
Spontaneousc Benzo(a)pyrened Test Chemicale
Name Exp. No. Foci/Vessel: Rank Order Call: Rank Order Call Mean t-statistic
7Model_Very Non-Cytotoxic Chemicals
Active Chemicals (false positives)
acetone 1 (82) 8.01 1*** SP 3*** LA 8.19
2 (102) .697 27 SP 63 SP 3.25
dimethyl sulfoxide 1 (41) .274 90 SP 13*** LA 3.92
2 (100) .268 73 SP 49 SP 2.97
ethanol 1 (81) 7.36 2*** SP 2*** LA 3.03
2 (108) 1.17 20 SP 19*** SP 2.23
glycerol 1 (82) 8.01 1*** SP 3*** SP 2.55
2 (108) 1.17 20 SP 19*** SP 3.69
sodium chloride 1 (80) 3.02 10* SP 5*** SP 12.2
2 (109) 2.55 6* SP 92*** SN .855
3 (Ri) .416 106* NA SP 4.35
sucrose 1 (101) .260 62 SP 48 SP 10.4
2 (107) 2.95 5** SP 46 SP 2.24
urea 1 (109) 2.55 6* SP 92*** SP 1.81
2 (NA)
General Abbreviations: Exp. No., experiment number; NA, not available.
Abbreviations for the Transformation Responses: SP, sufficient positive; LA, limited activity; SN, sufficient negative; LN, limited negative.
aTestChemical: The54noncytotoxic chemicalsinTableA5areidenticaltothoseinTableA4,andtheyaresubdividedintogroupsof21 carcinogens, 26
noncarcinogens and 7 model very noncytotoxic chemicals.
bTransformation Response: This table presents a summary ofthe spontaneous, BaP, and testchemical transformation responses detected in two or
more experiments per test chemical. The assay design and procedures used in the standard transformation assay are described in the Materials and
Methods. The transforming activities ofindividual chemical treatment doses (i.e. focus data), as well as the individual transformation responses (i.e.
type III foci/vessel), areprovided indetailintheAppendices B-H.Appendices B,C, D, E, F,GandH containtheactivitiesofthe43cytotoxic,mutagenic
carcinogens; 21 cytotoxic, mutagenic noncarcinogens; 20 cytotoxic, non-mutagenic carcinogens; 30 cytotoxic, nonmutagenic, noncarcinogens; 21
noncytotoxic carcinogens; 26 noncytotoxic noncarcinogens; and 7 very noncytotoxic model test chemicals.
cSpontaneous Transformation Response: Themethodused tocaIculate the spontaneous transformation response, aswell as the positive control and
test chemical responses, is explained in the Materials and Methods. The transformation responses are expressed as type III foci/vessel and were
calculated using a loglo mathematical transformation procedure. The arithmetic value for foci/vessel in this table is the antilog of the log1o mean
transformation response minus one.
The procedure for rank ordering the spontaneous responses from 110 experiments is based upon the different statistical sensitivities of
transformation experirnents with different spontaneous responses is explained in the Statistical Sensitivity versus Spontaneous Transformation
Response section oftheMaterials andMethods. Experimentswithhigh spontaneousresponses had ahigh statistical sensitivity andhaverelativelylow
rank-order numbers. For example, diethylnitrosamine had a high spontaneous response of 5.12 foci/vessel in exp. 79, which had a high statistical
sensitivityandrankordernumber4/110. Conversely, experimentswith alowstatistical sensitivityandhavehighrank-ordernumbers. Forexample, 11-
aminoundecanoic acid had alowspontaneous responseof.085foci/vesselinexp.67,whichhadalowstatistical sensitivitywithahighrankordernumber
107/110.
dBenzo(a)pyrene Transformation Response. The method used to call individual transformation experiments is described in detail in Materials and
Methods. The method used torank orderthe BaPtransformation responses from the 110 experiments is basedupon statistical comparison ofthe BaP
transformation at the two treatment doses detected in an individual experiment with the median historical activity of the assay. This procedure is
described in the Detection Sensitivity versus Benzo(a)pyrene Transformation Response section ofthe Materials and Methods. The rational for rank-
ordering the experiments is analogous to that described for the spontaneous transformation responses (refer to footnote c above).
eTest Chemical Transformation Response: The method used to call individual experiments is described in detail in Materials and Methods, and the
abbreviations for the calls are provided in footnote d above. The significance ofthe transformation responses ofindividual chemical treatment doses
were calculated using SAS statistical software (22). The mean t-statistic represents the average ofthe t-statistics ofthe four test chemical treatment
doses in the experiment. The t-statistics for individual chemical treatment doses which were used to calculate the mean t-statistic are provided in
Appendices B-H.
*Significant spontaneous or BaP transformation response, 0.01 < p < 0.05.
**Significant spontaneous or BaP transformation response, 0.001 < p < 0.01.
'Significant spontaneous or BaP transformation response, p < 0.001.
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Table A6. Rank-ordered potency ofthe transformation responses of54 noncytotoxic chemicals compared to rodent bioassay activities.
Rodent Bioassayb Transformation Responsec
Test Chemicala Level of Activity Rank t-statistic
Name High Low None Actual Estimatedd
6 Mutagenic Carcinogens
Total Active Chemicals [100.X]
Active Chemicals
D & C red no. 9 B 4.33 5.50
diethanolnitrosamine I 4.01 4.87
diethyLnitrosamine A 4.69 4.69
dimethylnitrosamine A 4.45 4.45
phenobarbital, sodium salt A 2.77 3.14
2,4- & 2,6-toluene diisothiocyanate A 3.01 3.01
15 Non-Mutagenic Carcinogens
Total Active Chemicals [73.3%]
Active Chemicals (false positive)
dimethyl hydrogen phosphite B 5.97 6.19
dimethyl methyl phosphonate D 2.90 2.90
Active Chemicals
saccharin, sodium salt A 7.99 7.99
3-amino-1,2,4-triazole A 6.14 6.53
methyl carbamate (Average) C 4.12 4.12
(uncoded) (4.48) (4.48)
(coded) (3.76) (3.76)
cyclamate, sodium salt A 4.09 4.09
dimethyl morpholino- (average) C 3.71 3.71
phosphoramidate (uncoded) (3.19) (3.19)
(coded) (4.23) (4.23)
11-aminoundecanoic acid B 2.11 2.55
melamine D 2.10 2.15
hexamethylphosphoramide C 2.08 2.08
Weakly Active Chemical
ethylene thiourea A 2.84 3.96
.------...------------.-----------------------------------------------------------------------
Total Inactive Chemicals [26.7%]
Inactive Chemicals
monuron B 1.01 1.01
di(2-ethylhexyl)adipate C .00 .00
di(2-ethylhexyl)phthalate A .00 .00
Inactive Chemical (Indeterminate Activity)
decabromodiphenyloxide C .29 .29
3 Mutagenic Non-Carcinogens
Total Active Chemicals [100.%]
Active Chemicals
2-chloroethanol F 3.22 3.22
Weak7l Active Chemicals
methyl methacrylate F 2.54 2.54
4-nitroanthranilic acid F 1.09 1.09
(Continued on nextpage)
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¶bble A6. Continuedt
Rodent Bioassayb Transformation Responsec
Test Chemicala Level of Activity Rank t-statistic
Name High Low None Actual Estimatedd
23 Non-Mutagenic Non-Carcinogens
Total Active Chemicals [23.8%]
Active Chemicals
FD & C yellow No. 6 F 7.65 7.65
penicillin VK+ F 5.96 5.96
benzyl alcohol F 1.95 1.95
(2-chloroethyl)trimethylammonium Cl F 1.74 1.74
3-sulfolene F 3.24 3.24
...................................................................................................
Total Inactive Chemicals [76.2%]
Chemical with Equivocal Activity
ampicillin trihydrate E 1.32 1.32
Inactive Chemicals
caprolactam F 1.20 2.34
phthalic anhydride F .80 .80
benzoin E .74 1.08
C. I. acid orange 10 F .63 .68
diphenylhydantoin I .00 .00
molybdenum trioxide I .64 .86
tetrahydrofuran I .72 .72
Inactive Chemical (Indeterminate Activity)
titanium dioxide F .00 .00
23 Non-Mutagenic Non-Carcinogens Continued
Total Inactive Chemicals [23.8X] Continued
Chemicals with Indeterminate Activity
aldicarb F 1.93 1.93
o-anthranilic acid F 2.19 2.19
dimethyl terephthalate E 1.79 1.79
phthalamide F 1.01 .64
roxarsone E 1.67 1.67
sodium(2-ethylhexyl)alcohol sulfate F(I) 2.04 2.04
sulfisoxazole F 1.26 1.26
Active Chemicals (false positives)
D-mannitol F 3.00 1.99
witch hazel F 1.89 1.89
7 Model Very Non-Cytotoxic Chemicals
Total Active Chemicals [100X]
False Positive Active Chemicals
sodium chloride I 6.53 6.53
sucrose I 5.73 5.73
acetone I 4.49 4.49
dimethyl sulfoxide I 3.38 3.45
glycerol I 3.09 3,09
ethanol I 2.50 2.50
urea I 1.81 1.81
(Continued on nextpage)
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Thble A6. Continued.
aTest Chemical: The 54 noncytotoxic chemicals in TableA6 areidenical to thosein TableA4, and they are subdivided into groups of21 carcinogens, 26
noncarcinogens and 7 model very noncytotoxic chemicals.
i'Rodent Bioassay Level ofActivity: The relative carcinogenic activity of chemicals in rodent bioassay has been described in terms ofthe chemical's
level of effect (1,.). The highest level A corresponds to chemicals that cause cancer in both mice and rats at one or more sites, and level B refers to
chemicals that cause cancer atmultiple sites in one species ofrodent. Level C includeschemicals carcinogenic atone site inboth sexes ofone species, and
D includes chemicals carcinogenic at one site in only one sex ofa single species. Level E includes chemicals that only equivocal evidence ofcarcinogenic
activity. Finally, level F includes both noncarcinogens and chemicals that had inadequate carcinogenicity studies.
'Transformation Response Rank t-statistic: The method used to calculate the significance oftest chemical transformation responses employed SAS
statistical software (22) and is described in detail in Materials and Methods. The correct t-statistics of each treatment dose ofthe test chemical in a
single experiment are presented in the Appendices B-H, and these t-statistics were averaged to determine the mean t-statistic ofthe test chemical for
the experiment (refer to Table A2). The mean t-statistics for two or experiments for each chemical was weighted according to the number oftreatment
doses evaluated and averaged to determine the actual rankt-statisticpresented in this table. Forexample, the actual rankt-statistic ofD&C ried no. 9in
experiments43,54 and 67is equal to 4.33 [i.e., 10.9 + 10.5 + 7.16 + 5.26 (exp.43) + 2.96 + 1.39 + .04 + .00 (Exp. 54) + 5.47 + 3.37 + 3.07 + 1.78 (exp.
67); Appendix F].
d'Estimated Rank t-statistic: The estimated riank t-statistic is used to estimate both the historical behavior ofthe test chemical in the transformation
assay, as well aspredictingthe future behavior or the chemical. It is calculated bycorrectingthe actual rank t-statistic. The datapresented in Table A5
showed that individual experiments had very different rank-ordered sensitivities to detect chemical-induced transformation. Therefore, the estimated
rank t-statistic modified the actual rank t-statistic to correct for differences in the sensitivities of individual experiments. The method uses the rank
ordered sensitivity of individual experiments to detect spontaneous and BaP-induced transformation, and an example calculation is provided below.
The most active mutagenic carcinogen. D&C red no. 9, had statistical sensitivities forspontaneous transformationresponses of30, 91 and 107/110for
experiments43,54 and 67, respectively, and detection sensitivities forBaP of4,85 and 106/110 forthe same experiments. The average rankorderofthe
three experiments was 70.5 (i.e., 30 + 91 + 107 + 4 + 85 + 106/110 = 78.5). For a total of 110 experiments, the median experiment has an automatic
average rank order of 55.0 (i.e. 110/2 = 55.0). Therefore, the correction factor for the experimental sensitivity to detect chemical-induced
transformation was 70.5/55.0 or 1.28.
Thus, these two experiments had a combined statistical sensitivity and detection sensitivity that was above the median of 55.0. The actual rank
t-statistic was multiplied by the corirection factor to obtain the estimated rank t-statistic (i.e., 5.50). Ajustification for this correction factoi has been
reported (18), and it is explained in the Materials and Methods.
ePercentage (%) of Active Chemicals: Active chemicals included chemicals with active and weakly active transformation responses. In contrast,
inactive chemicals included chemicals with equivocal and inactive transformation responses. Chemicals with an indeterminate activity have to be
retested in anaddlitional experiment in order to determine theiractivityin the standard transformation assay. Therefore, chemicalswithindeterminate
transformation responses were omitted fromthecomputation ofthepercentage (%) ofthe total chemicalsthatwereeither activeor inactive in the assay.
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Dimethylnitrosamine. Dimethylnitrosamine is a level
A carcinogen (Table A6). It had one difficult technical
problem. It was reported to be oxidized upon exposure to
air, and it was exposed to air during the standard treat-
ment period (Table A4). The test chemical was non-
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of256 mM (Table A4). The statistical sensitivities
of transformation assay trials 1 and 2 were 42 and
73/110, respectively; the detection sensitivities for BaP
oftrials 1 and 2 were 25 and 49/110, respectively (Table
A5). The test chemical had an SP transformation
response in the two consecutive experiments. Dimethyl-
nitrosamine was evaluated as active in the transforma-
tion assay, and its actual and estimated rank t-statistics
were both 4.45 (Table A6).
Phenobarbital, Sodium Salt. Phenobarbital, sodium
salt, is a levelA carcinogen (Table A6). It had one difficult
technical problem. It was reported to be oxidized by air,
and it was exposed to air during the standard treatment
period (Table A4). The test chemical was noncytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 6.11
mM (TableA4). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 75 and 6/110, respectively;
the detection sensitivities forBaPoftrials 1 and 2were 76
and 92/110, respectively (TableA5). The testchemical had
an SP transformation response in the two consecutive
experiments. Phenobarbital was evaluated as active in the
transformation assay, and its actual and estimated rank
t-statistics were 2.77 and 3.14, respectively (Table A6).
2,4- and 2,6-Tbluene Diisothiocyanate. 2,4- and 2,6-
Toluenediisothiocyanate is alevelAcarcinogen (TableA6).
It had three difficult technical problems. It was reported
to react with strong bases such as NaOH, and stock
solutions were acidic and had to be neutralized before
testing. It was also reported to react with water, and
treatments were performed in an aqueous environment.
Finally, it was noted to react with amines; thus, it could
have reacted with the amine portion of biochemicals in
culture medium, aswell as inthe targetBALB/c-3T3 cells
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 7.93 mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 12 and 28/110, respectively; the
detection sensitivitiesforBaPoftrials 1 and2were98and
15/110, respectively (Table A5). The test chemical had an
SPtransformation responseinthetwoconsecutive experi-
ments. 2,4 and2,6-Toluene diisothiocyanate was evaluated
as active in the transformation assay, and its actual and
estimated rank t-statistics were both 3.01 (Table A6).
Noncytotoxic, Nonmutagenic Carcinogens
3-Amino-1,2,4-Triazole. 3-Amino-1,2,4-triazole is a
levelA carcinogen (TableA6). Ithad onedifficult technical
problem. Itwasreportedtobindmetals; thus,itcouldhave
bound metals contained in FBS and EMEM medium
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 109 mM
(Table A4). The statistical sensitivities oftransformation
assay trials 1 and 2 were 85 and 33/110, respectively; the
detection sensitivities for BaP of trials 1 and 2 were 102
and 14/110, respectively (TableA5). The testchemical had
an SP transformation response in the two consecutive
experiments. 3-Amino-1,2,4-triazole was evaluated as
active in the transformation assay, and its actual and
estimatedrankt-statisticswere6.14and6.53,respectively
(Table A6).
Il-Aminoundecanoic Acid. 11-Aminoundecanoic acid
is a level B carcinogen (Table A6). It had no insurmount-
abletechnicalproblems;however,ithadalimitedsolubility
of 1500 ,ug/ml in culture medium supplemented with
pluronic F68 (Table A4). The test chemical was non-
cytotoxic to the BALB/c-3T3 cells and had an average
LD50of19.4mM (TableA4). The statistical sensitivities of
transformation assay trials 1-4 were 83, 89,19 and
107/110,respectively; thedetectionsensitivitiesforBaPof
trials 1-4 were 70, 87, 34 and 106/110, respectively (Table
A5). The test chemical had a LN transformation response
in the first two experiments because it was not tested at
cytotoxic treatmentdoses. In contrast, ithad an SPtrans-
formation response in the last two experiments. Signifi-
canttransformingactivitywas onlydetected attreatment
doses that were slightly above the solubility limit of the
testchemicalinculturemedium.11-Aminoundecanoic acid
was evaluated as active in the transformation assay, and
its actual and estimated rank t-statistics were 2.11 and
2.55, respectively (Table A6).
Cyclamate, Sodium Salt. Cyclamate, sodium salt, is a
levelA carcinogen (TableA6). Ithad one difficult technical
problem. It was reported to bind potassium salts; thus, it
could have bound the potassium in culture medium (Table
A4). The test chemical was noncytotoxic to the BALB/
c-3T3cellsandhad anaverageLD50of132mM(TableA4).
The statistical sensitivities oftransformation assay trials
1 and 2 were 24 and 5/110, respectively, the detection
sensitivities for BaP oftrials 1 and 2 were 10 and 46/110,
respectively (Table A5). The test chemical had an SP
transformation response in the two consecutive experi-
ments. Cyclamate was evaluated as active in the transfor-
mationassay, anditsactualandestimatedrankt-statistics
were both 4.09 (Table A6).
Decabromodiphenyloaxide. Decabromodiphenyloxide is
alevel Ccarcinogen (TableA6). It had one difficult techni-
cal problem. It had a limited solubility in culture medium
of 250 ,ug/ml (Table A4). The test chemical was non-
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 of6.26 mM (TableA4). Thus, the testchemical LD50
was about24-fold higherthanits solubilitylimitin culture
medium. The statistical sensitivities of transformation
assay trials 1 and 2 were 21 and 62/110, respectively; the
detectionsensitivities forBaPoftrials 1 and2were26and
48/110, respectively (Table A5). The test chemical had an
LN transformation response in the two consecutive
experiments. It was tested at treatment doses that far
exceeded its solubility limit in culture medium, but these
doses were not cytotoxic to the target cells. Taken
together, decabromodiphenyloxide was evaluated as both
inactive and indeterminate in the transformation assay,
and its actual and estimated rank t-statistics were both
0.29 (Table A6).
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Di(2-ethylhexyl)adipate. Di(2-ethylhexyl)adipate is a
level Ccarcinogen (TableA6). Ithad one difficult technical
problem. Its solubility limit in culture medium supple-
mentedwith pluronic F68was only 1000 nl/ml (TableA4).
The test chemical was noncytotoxic to the BALB/c-3T3
cells and had an average LD50 of 98.4 mM (Table A4).
Thus,this LD50farexceededthe solubilitylimitofthetest
chemical. The statistical sensitivities of transformation
assay trials 1 and 2 were 57 and 20/110 respectively; the
detectionsensitivitiesforBaPoftrials 1 and2were88and
19/110, respectively (Table A5). The test chemical had an
SN transformation response in the two consecutive
experiments. The test chemical was tested using treat-
ment doses that were both above and below its solubility
limit. Di(2-ethylhexyl)adipate was evaluated as inactive in
the transformation assay, and its actual and estimated
rank t-statistics were both 0.00 (Table A6).
Di(2-ethylhexyl)phthalate. Di(2-elhylhexyl)phthalate
is a level A carcinogen (Table A6). It had no insurmount-
able technical problems, and its solubility limit in culture
medium supplemented with pluronic F68was 12000 nl/ml
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 21.4 mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 74 and 73/110, respectively; the
detection sensitivities forBaPoftrials 1 and2were35and
49/110, respectively (Table A5). The test chemical had an
SN transformation response in the two consecutive
experiments. Di(2-ethylhexyl)phthalate was evaluated as
active in the transformation assay, and its actual and
estimated rank t-statistics were both 0.00 (Table A6).
Dimethyl Hydrogen Phosphite. Dimethyl hydrogen
phosphite is a level B carcinogen (Table A6). It had two
difficult technical problems. It was a very acidic test
chemical, and stock solutions had to be neutralized with
NaOH. Unfortunately, the test chemical was reported to
reactwith strongbases andwithwater; thus, itcouldhave
been altered during the treatment period (Table A4). The
test chemical was noncytotoxic to the BALB/c-3T3 cells
and had an average LD50 of 130 mM (Table A4). Since it
required an equal molar concentration of NaOH to neu-
tralize the test chemical, this LD50 was actually equal to
260 mOsM. The statistical sensitivities oftransformation
assay trials 1 and 2 were 44 and 26/110, respectively; the
detection sensitivities forBaPoftrials 1 and2were65and
93/110, respectively (Table A5). The test chemical had an
SPtransformation responseinthetwoconsecutive experi-
ments; however,'significant transforming activity was
detected at treatment doses that exceeded the upper dose
limit ofthe assay of 100 mOsM. Taken together, dimethyl
hydrogen phosphite was evaluated as active and a false
positive in the transformation assay. Its actual and esti-
mated rank t-statistics were 5.97 and 6.19, respectively
(Table A6).
Dimethyl Methyl Phosphonate. Dimethyl methyl
phosphonate is alevelD carcinogen (TableA6). Ithad two
difficult technical problems. It was reported to reactwith
air, and itwas exposed to air duringthe treatmentperiod.
In addition, it was noted to be an alkylating agent and
reacted with basic nitrogen compounds. Thus, this test
chemical could have reacted not onlywith biochemicals in
culture medium, but also with biochemicals in the target
cells (TableA4). The test chemicalwas noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 172 mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 44 and 27/110, respectively; the
detection sensitivities forBaPoftrials 1 and2were65and
63/110, respectively (Table A5). The test chemical had an
LA transformation response in the first experiment, and
an SP transformation response in the second experiment.
Significant transforming activity for this test chemical
was detected using treatment doses that exceeded the
upperdoselimitofthe assayof100 mOsM. Taken together,
dimethyl methyl phosphonate was evaluated as active and
afalsepositiveinthe transformation assay. Its actual and
estimated rank t-statistics were both 2.90 (Table A6).
Dimethylmorpholinophosphoramidate. Dimethyl-
morpholinophosphoramidate is one of five chemicals that
was tested as a coded and as a uncoded test chemical in
thisinvestigation. Itis alevelC carcinogen (TableA6), and
it had no insurmountable technical problems (Table A4).
The test chemical was noncytotoxic to the BALB/c-3T3
cells, and the uncoded and coded test chemicals had an
averageLD50 of17.1 and24.4mM,respectively(TableA4).
For the uncoded test chemical the statistical sensitivities
oftransformation assaytrials 1 and2were 52 and28/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 79 and 15/110, respectively (TableA5). Forthe
codedtestchemicalthe statistical sensitivities oftransfor-
mation assay trials 1 and 2 were 52 and 20/110; the
detection sensitivities forBaPoftrials 1 and2were 79and
19/110, respectively. Both the uncoded and coded test
chemical had an SP transformation response in the two
consecutive experiments. Dimethylmorpholinophosphor-
amidate was evaluated as active in the transformation
assay. The actual and estimated rank t-statistics for the
uncoded test chemical were both 3.19; the actual and
estimated rank t-statistics for the coded test chemical
were both 4.23 (Table A6). Taken together, the coded and
uncoded test chemicals had virtually identical cytotoxic
andtransforming activities inthe BALB/c-3T3 cell trans-
formation assay.
Ethylene Thiourea. Ethylene thiourea is a level A
carcinogen (TableA6). Ithad no insurmountable technical
problems(TableA4).Thetestchemicalwasnoncytotoxicto
the BALB/c-3T3 cells and had an average LD50 of91.4mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 75 and 95/110, respectively; the
detectionsensitivities forBaPoftrials 1 and2were76and
61/110, respectively (Table A5). The test chemical had an
LN transformation response in the first experiment and
an SP transformation response in the second experiment.
Ethylene thiourea was evaluated as weakly active in the
transformation assay, and its actual and estimated rank
t-statistics were 2.84 and 3.96, respectively (Table A6).
Hexamethylphosphoramide. Hexamethylphosphor-
amide is a level C carcinogen (Table A6). It had no insur-
mountable technical problems (Table A4). The test
chemical was noncytotoxic to the BALB/c-3T3 cells and
had an average LD50 of64.4 mM CTableA4). The statisti-
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calsensitivities oftransformation assaytrials 1 and2were
9 and 59/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 37 and 17/110, respectively
(Table A5). The test chemical had an SP transformation
responseinthetwoconsecutive experiments. Hexamethyl-
phosphoramidewasevaluated as activeinthetransforma-
tion assay, and its actual and estimated rank t-statistics
were both 2.08 (Table A6).
Melamine. Melamineis alevelD carcinogen (TableA6).
Ithad onedifficulttechnicalproblem,becauseitssolubility
limit in culture medium supplemented with pluronic F68
was about 1000 ,ug/ml (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of39.6 mM (TableA4). Thus, this LD50 farexceeded
the solubilitylimit ofthe test chemical in culture medium.
The statistical sensitivities oftransformation assay trials
1 and 2 were 30 and 97/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 4 and 94/110,
respectively (Table A5). The test chemical had an SP
transformation response in the first experiment, and an
LA transformation response in the second experiment.
Melamine was evaluated as active in the transformation
assay, and its actual and estimated rank t-statistics were
2.10 and 2.15, respectively (Table A6).
Methyl Carbamate. Methyl carbamate is one of five
chemicalsthatwastested as acoded andas auncodedtest
chemical in this investigation. It is a level C carcinogen
(Table A6). It had no insurmountable technical problems
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells, and theuncoded and coded test chemi-
cals had an average LD50 of225 and 195mM, respectively
(Table A4). For the uncoded test chemical the statistical
sensitivities of transformation assay trials 1-3 were 55,
108and 10/110,respectively; thedetectionsensitivities for
BaP oftrials 1-3 were 8, 99 and 5/110, respectively (Table
A5). Forthecodedtestchemicalthestatistical sensitivities
oftransformation assaytrials 1 and 2were 71 and33/110;
the detection sensitivities forBaPoftrials 1 and 2were23
and 14/110, respectively. The uncoded test chemical had
two SP and a LA transformation responses in three
experiments. The coded testchemical had an SPtransfor-
mation response in the two consecutive experiments.
Methyl carbamate was evaluated as active in the transfor-
mation assay. The actual and estimated rank t-statistics
for the uncoded test chemical were both 4.48; the actual
and estimated rankt-statistics forthecoded testchemical
were 3.76 (Table A6). Taken together, the coded and
uncoded test chemicals had virtually identical cytotoxic
and transformation responses in the BALB/c-3T3 cell
transformation assay.
Monuron. Monuronis alevelBcarcinogen (TableA6). It
had one difficult technical problem. It had a limited sol-
ubilityin culture medium supplementedwithpluronic F68
of about 25 Fg/ml (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of5.54 mM (TableA4). Thus, this LD50 farexceeded
the solubility limit ofthe test chemical in culture medium.
The statistical sensitivities oftransformation assay trials
1 and 2 were 81 and 39/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 22 and 68/110,
respectively (Table2). The test chemical had an LAtrans-
formation response in the first experiment and an SN
transformation response in the second experiment.
Monuron was evaluated as inactive in the transformation
assay, and its actual and estimated rank t-statistics were
both 1.01 (Table A6).
Saccharin, Sodium Salt. Saccharin, sodium salt, is a
level A caranogen (Table A6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50of76.5mMand 153mOsM(TableA4).The statistical
sensitivities oftransformation assaylrials 1 and2were21
and 62/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 26 and 48/110, respectively
(Table A5). The test chemical had an SP transformation
response in the two consecutive experiments. Significant
transforming activity was detected at treatment doses
that were below the upper dose limit of the assay of 100
mOsM. Saccharin was evaluated as active in the transfor-
mationassay, andits actualandestimatedrankt-statistics
were both 7.99 (Table A6).
Noncytotoxic, Mutagenic Noncarcinogens
2-Chloroethanol. 2-Chloroethanol is a level Fnoncarci-
nogen (TableA6). It had one difficulttechnical problem. It
was reported to react with water; thus, it may have been
altered by the aqueous environment during the treatment
period (Table A4). The test chemical was noncytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 81.0
mM (TableA4). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 9 and 73/110, respectively;
the detection sensitivities forBaP oftrials 1 and2were37
and 49/110, respectively (TableA5). The test chemical had
an SP transformation response in the both the first and
second experiments. 2-Chloroethanol was evaluated as
active in the transformation assay, and its actual and
estimated rank t-statistics were both 3.22 (Table A6).
MethylMethacrylate. Methylmethacrylateis alevelF
noncarcinogen (Table A6). It had two difficult technical
problems. It was reported to react with air; thus, it may
havebeen altered byexposure to airduringthe treatment
period. In addition, it was noted to react with amines;
therefore,itmayhavereactedwithaminesonbiochemicals
in culture medium and in the target BALB/c-3T3 cells
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 10.8 mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 4 and 28/110, respectively; the
detection sensitivities for BaP oftrials 1 and 2 were 1 and
15/110, respectively (Table A5). The test chemical had an
SPtransformationresponseinthefirstexperimentand an
SN transformation response in the second experiment.
Since the mean t-statistics of the two transformation
responses were not significantly different from one
another, the testchemical did nothave to be evaluated in a
third trial. Methyl methacrylate was evaluated as having
been weakly active in the transformation assay, and its
actual and estimated rank t-statistics were both 2.54
(Table A6).
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4-Nitroanthranilic Acid. 4-Nitroanthranilic acid is a
level F noncarcinogen (Table A6). It had no insurmount-
able technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of8.58 mM (TableA4). The statistical sensitivities of
transformation assay trials 1 and 2 were 7 and 22/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were56and53/110,respectively(TableA5).Thetest
chemical had an SN transformation response in the first
experiment and an SP transformation response in the
second experiment. Because the mean t-statistics of the
two transformation responses were not significantly dif-
ferent from one another, the test chemical was not evalu-
atedin athird trial. 4-Nitroanthranilic acidwas evaluated
as havingbeenweakly active in the transformation assay,
and its actual and estimated rank t-statistics were both
1.09 (Table A6).
Noncytotoxic, Nonmutagenic
Noncarcinogens
Aldicarb. AldicarbisalevelFnoncarcinogen (TableA6).
It had no insurmountable technical problems (Table A4).
The test chemical was noncytotoxic to the BALB/c-3T3
cells and had an average LD50 of10.7 mM (TableA4). The
statistical sensitivities of transformation assay trials 1
and 2 were 19 and 33/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 34 and 14/110,
respectively (Table A5). The test chemical had an SN
transformation response in the first experiment, and an
SP response in the second experiment. Since the mean
t-statistics of the transformation responses in the two
experimentsweresignificantlydifferentfromoneanother,
thetestchemicalhas tobeevaluatedin athirdtrial. Inthe
absence ofthe data from a third trial, aldicarb was evalu-
ated as having an indeterminate activity in the transfor-
mation assay. Its actual and estimated rank t-statistics
were both 1.93 (Table A6).
Ampicillin 7hihydrate. Ampicillin trihydrate is a level
E noncarcinogen (Table A6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50of23.8mM (TableA4). The statistical sensitivities of
transformation assay trials 1 and 2 were 71 and 29/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2were23and97/110,respectively(TableA5). Thetest
chemical had an LA transformation response in the both
the first and second experiments. Ampicillin trihydrate
was evaluated as having anequivocal activityin the trans-
formationassay, anditsactualandestimatedrankt-statis-
tics were both 1.32 (Table A6).
o-AnthranilicAcid. o-Anthranilic acid is a level F non-
carcinogen (Table A6). It had one difficult technical prob-
lem. Itwasreportedtobecomeoxidizedbyair; thus,itmay
have been alteredby exposure to air duringthe treatment
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 72.9 mM
(Table A4). The statistical sensitivities of transformation
assaytrials 1 and 2were 100 and36/110, respectively; the
detection sensitivities forBaPoftrials 1 and2were42 and
28/110, respectively (Table A5). The test chemical had an
SN transformation response in the first experiment and
an SP transformation response in the second experiment.
Since the mean t-statistics of the two transformation
responses were significantly different from one another,
thetestchemicalhastobeevaluatedinathirdtrial. Inthe
absence of data from a third trial, o-anthranilic acid was
evaluated ashavinganindeterminateactivityinthetrans-
formation assay. Its actual and estimated rank t-statistics
were both 2.19 (Table A6).
Benzoin. Benzoin is a level E noncaranogen (TableA6).
It had one difficult technical problem. The solubility limit
ofthistestchemicalinculturemedium supplementedwith
pluronic F68 was about 500 ,ug/ml (Table A4). The test
chemical was noncytotoxic to the BALB/c-3T3 cells and
hadanaverage LD50of14.8mM(TableA4). Thus,thistest
chemical had a LD50 that far exceeded its solubility in
culture medium. The statistical sensitivities of transfor-
mation assay trials 1 and 2 were 50 and 109/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were 59 and 103/110, respectively (Table A5). The test
chemical had an SN transformation response in the both
the first and second experiments. The test chemical was
tested at treatment doses that far exceeded its solubility
limitinculturemedium. Benzoinwasevaluated asinactive
in the transformation assay, and its actual and estimated
rank t-statistics were 0.74 and 1.08, respectively (Table
A6).
Benzyl Alcohol. Benzyl alcohol is a level F noncar-
cinogen (Table A6). It had one difficult technical problem.
Itwasreportedtobecomeoxidizedbyair; thus,itmayhave
been altered by exposure to air during the treatment
period (Table A4. The test chemical was noncytotoxic to
theBALB/c-3T3cellsandhadanaverage LD50of17.9mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 2 and 38/110, respectively; the
detection sensitivities for BaP oftrials 1 and 2were 2 and
16/110, respectively (Table A5). The test chemical had an
LA transformation response in the first experiment and
an SP transformation response in the second experiment.
Benyl alcohol was evaluated as active in the transforma-
tion assay, and its actual and estimated rank t-statistics
were both 1.95 (Table A6).
Caprolactam. Caprolactam is a level F noncarcinogen
(Table A6). It had no insurmountable technical problems
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 71.8 mM
(Table A4). The statistical sensitivities of transformation
assaytrials 1 and2were 110and 109/110,respectively; the
detection sensitivities for BaP of trials 1 and 2 were 107
and 103/110, respectively (Table A5). Thus, both of these
experiments had an unusually low statistical sensitivity
anddetectionsensitivityforBaR The testchemicalhad an
SN transformation response in the both the first and
second experiments. Caprolactam was evaluated as inac-
tive in the transformation assay, and its actual and esti-
mated rank t-statistics were 1.20 and 2.34, respectively
(Table A6).
(2-Chloroethyl)trimethylammonium Chloride. (2-
Chloroethyl)trimethylammonium chlorideis alevel F non-
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carcinogen (Table A6). Ithad noinsurmountable technical
problems (TableA4).Thetestchemicalwasnoncytotoxicto
the BALB/c-3T3 cells and had an average LD50 of 62.0
mM (TableA4). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 40 and 35/110, respectively;
the detection sensitivities for BaP oftrials 1 and2were 54
and 57/110, respectively (TableA5). The testchemical had
anSPtransformationresponse inthefirstexperimentand
an LAtransformation response in the second experiment.
(2-Chloroethyl)trimethylammonium chloride was evalu-
ated as active in the transformation assay, and its actual
and estimated rank t-statistics were both 1.74 (Table A6).
C. I. Acid Orange 10. C. I. Acid orange 10 is a level F
noncarcinogen (Table A6). It had no insurmountable tech-
nical problems (Table A4). The test chemical was non-
cytotoxic to the BALB/c-3T3 cells and had an average
LD50of26.5 mM (TableA4). The statistical sensitivities of
transformation assay trials 1 and 2 were 92 and 22/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were 71 and53/110,respectively(TableA5).Thetest
chemical had an SN transformation response in the both
thefirst and second experiments. C. I.Acid orange 10was
evaluated as inactive in the transformation assay, and its
actual and estimated rank t-statistics were 0.63 and 0.68,
respectively (Table A6)
Dimethyl Terephthalate. Dimethyl terephthalate is a
levelE noncarcinogen (TableA6). It two difficult technical
problems. It was reported to be very temperature sensi-
tive and react with water. Because the test chemical was
insoluble in water, it had to be sonicated and warmed at
37°C for 30 minutes or more to become a fine particulate
suspension in culture medium supplementedwithpluronic
F68. Its solubilityin culture mediumwas about 125 pLg/ml
(Table A4). Thus, it is possible that the test chemical was
alteredduringtheproceduretosolubilizethetestchemical
as well as the treatment period. The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of15.4 mM (TableA4).The statistical sensitivities of
transformation assay trials 1 and 2 were 22 and 5/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were53and46/110, respectively(TableA5).Thetest
chemical had an SP transformation response in the first
experiment and an LA transformation response in the
second experiment. The test chemical was tested at doses
that far exceeded its solubility in culture medium. Taken
together, dimethyl terephthalate was evaluated as having
an indeterminate activity in the transformation assay,
becauseitneedstoberetested attreatmentdosescloserto
its solubilitylimitinculturemedium. Furthermore, itmust
beevaluatedusingaprocedurelesslikelytoalteritwhileit
is being solubilized for testing. Its actual and estimated
rank t-statistics were both 1.79 (Table A6).
Diphenylhydantoin. Diphenylhydantoin is a level I
chemical, because its testing in rodent bioassay is incom-
plete (TableA6). Ithad no insurmountable technical prob-
lems (TableA4). Thetestchemicalwas noncytotoxic tothe
BALB/c-3T3 cells and had an average LD50 of 5.02 mM
(Table A4). The solubility limit of this test chemical was
about 500 ,ug/ml in culture medium supplemented with
pluronic F68. The statistical sensitivities of transforma-
tion assay trials 1 and 2 were 84 and 95/110, respectively;
the detection sensitivities for BaP of trials 1 and 2 were
105 and 61/110, respectively (TableA5). The test chemical
had an SN transformation response in two consecutive
experiments, and it was tested at treatment doses above
its solubility limit. Diphenylhydantoin was evaluated as
inactive in the transformation assay, and its actual and
estimated rank t-statistics were both 0.00 (Table A6).
FDandC YellowNo. 6. FD and CYellowno. 6is alevel
F noncarcinogen (Table A6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of67.7mM (TableA4). The statistical sensitivities of
transformation assay trials 1-3 were 7, 95 and 22/110,
respectively; the detection sensitivities for BaP of trials
1-3 were 56, 61 and 53/110, respectively (Table A5). The
testchemicalhad anSPtransformationresponseintheall
three experiments. FD and C Yellow No. 6 was evaluated
as active in the transformation assay, and its actual and
estimated rank t-statistics were both 7.65 (Table A6).
D-Mannitol. D-Mannitol is a level F noncarcinogen
(Table A6). It had no insurmountable technical problems
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 estimated to
be over 324 mM (Table A4). The statistical sensitivities of
transformation assay trials 1-3 were 46, 35 and 38/110,
respectively; the detection sensitivities for BaP of trials
1-3were 80, 57 and 16/110, respectively(TableA5). The test
chemical had an LN transformation response in the first
experiment, anLAresponseinthe secondexperiment, and
an SP response in the third experiments. In all three
experiments significant transforming activity was only
detected at treatment doses that exceeded the upper dose
limit ofthe assay of 100 mOsM. Taken together, D-man-
nitol was evaluated as active and a false positive in the
transformation assay, and its actual and estimated rank
t-statistics were 3.00 and 1.99, respectively (Table A6).
Molybdenum Riaoxide. Molybdenumtrioxideis alevelI
noncarcinogen (Table A6). It had one difficult technical
problem. It was reported to form polymeric compounds
whenitwasexposedtoacidsandbases. Sincestocksofthe
test chemical were acidic and had to be neutralized with
NaOH in order to tested, it is possible that the test
chemical was altered during preparation of the dosing
solutions (TableA4).Thetestchemicalwasnoncytotoxic to
the BALB/c-3T3 cells and had an average LD50 of 9.38
mM (TableA4). The statistical sensitivities oftransforma-
tion assay trials 1 and 2 were 61 and 84/110, respectively;
the detection sensitivities forBaPoftrials 1 and 2were47
and 105/110, respectively (Table A5). The test chemical
had an LA transforrnation response in the first experi-
ment and an SN transformation response in the second
experiment. Molybdenum trioxide was evaluated as inac-
tive in the transformation assay, and ils actual and esti-
mated rank t-statistics were 0.64 and 0.86, respectively
(Table A6).
Penicillin VK+. Penicillin VK+ is a level F noncar-
cinogen (Table A6). It had no insurmountable technical
problems (TableA4).Thetestchemicalwasnoncytotoxicto
theBALB/c-3T3cellsandhad anaverageLD50 of17.8mM
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(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 10 and 62/110, respectively, the
detection sensitivities forBaP oftrials 1 and 2were 5 and
48/110, respectively (Table A5). The test chemical had an
SP transformation response in two consecutive experi-
ments. Penicillin VK+ was evaluated as active in the
transforrnation assay, and its actual and estimated rank
t-statistics were both 5.96 (Table A6).
Phthalamide. Phthalamide is a level F noncarcinogen
(Table A6). It had no insurmountable technical problems
(Table A4). The lest chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 73.1 mM
(Table A4). This LD50 was far above the solubility limit of
the testchemical of1000 ,ug/mlinculturemedium supple-
mented with pluronic F68. The statistical sensitivities of
transformation assay trials 1 and 2 were 14 and 38/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were 72and 16/110, respectively(TableA5).Thetest
chemical had an LN transformation response in the first
experiment and an LA transformation response in the
second experiment. Phthalamide was evaluated as having
anindeterminate activityinthetransformation assay, and
its actual and estimated rank t-statistics were 1.01 and
0.64, respectively (Table A6).
Phthalic Anhydride. Phthalic anhydride is a level F
noncarcinogen (Table A6). It had three difficult technical
problems. Itwas reported to reactwith water and strong
bases. Because thetestchemical stock solutions werevery
acidic, they had to be neutralized with NaOH; thus, the
test chemical may have been altered during the prepara-
tion ofdosing solutions. In addition, the test chemicalwas
notedtoreactwith amine groups,thusitmayhavereacted
with amine groups on biochemicals in culture medium, as
well asbiochemicals inthetargetcells (TableA4). Thetest
chemical was noncytotoxic to the BALB/c-3T3 cells and
hadanaverageLD50of13.2mM(TableA4).Thestatlstical
sensitivities oftransformation assaytrials 1 and2were82
and 5/110, respectively; the detection sensitivities forBaP
of trials 1 and 2 were 18 and 46/110, respectively (Table
A5).ThetestchemicalhadanLAtransformation response
in the first experiment and an SN transformation
response in the second experiment. Phthalic anhydride
was evaluated as inactive in thetransformation assay, and
its actual and estimated rank t-statistics were both 0.80
(Table A6).
Roaxarsone. Roxarsoneis alevelEnoncarcinogen (Tlable
A6). It had no insurmountable technical problems (Table
A4). The test chemical was noncytotoxic to the BALB/
c-3I3 cells andhad anaverage LD50of43.8mM(TableA4).
The statistical sensitivities oftransformation assaytrials
1 and 2 were 10 and 27/110, respectively; the detection
sensitivities for BaP oftrials 1 and 2 were 5 and 92/110,
respectively (Table A5). The test chemical had an SP
transformation response in the first experiment and an
SN transformation response in the second experiment.
Since the mean t-statistics ofthe two test chemical trans-
formation responses were significantly different from one
another, it has to be evaluated in a third trial. In the
absence ofdatafromathirdtrial,roxarsonewasevaluated
as having an indeterminate activity in the transformation
assay, and its actual and estimated rank t-statistics were
both 1.67 (Table A6).
Sodium(2-ethylhexyl) Alcohol Sulfate. Sodium(2-
ethylhexyl) alcohol sulfate is a level F(I) noncarcinogen
(Table A6). It had no insurmountable technical problems
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 12.5 mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 1 and 6/110, respectively; the
detection sensitivities forBaP oftrials 1 and 2were 3 and
19/110, respectively (Table A5). The test chemical had an
SN transformation response in the first experiment and
an SP transformation response in the second experiment.
Since the mean t-statistics ofthe two test chemical trans-
formation responses were significantly different from one
another,thechemicalhastobeevaluatedinathirdtrial. In
the absence of data from a third experiment, sodium(2-
ethylhexyl alcohol sulfate was evaluated as having an
indeterminute activityinthetransformationassay,andits
actual and estimated rank t-statistics were both 2.04
(Table A6).
Sulfisoaazole. Sulfisoxazole is a level F noncarcinogen
(Table A6). It had one difficult technical problem. It was
reported to become oxidized upon exposure to air; thus, it
may have been altered by exposure to air during the
treatment period (Table A4). The test chemical was non-
cytotoxic to the BALB/c-3T3 cells and had an average
LD50 estimated to be 18.7 mM (Table A4). The statistical
sensitivities oftransformation assay trials 1 and 2 were 1
and 6/110, respectively; the detection sensitivities forBaP
oftrials 1 and2were3and 19/110,respectively(TableA5).
The test chemical had an LN transformation response in
thefirstexperimentand an SPtransformationresponsein
the second experiment. Since the LN transformation
response did not qualify as one ofthe two required trials,
the test chemical has to be tested in a third experiment.
Taken together, sulfisoxazole was evaluated as having an
indeterminate activityinthetransformationassay, andits
actual and estimated rank t-statistics were both 1.26
(Table A6).
3-Sulfolene. 3-Sulfolene is a level F noncarcinogen
(Table A6). It had no insurmountable technical problems
(Table A4). The test chemical was noncytotoxic to the
BALB/c-3T3 cells and had an average LD50 of 117 mM
(Table A4). The statistical sensitivities of transformation
assay trials 1 and 2 were 49 and 23/110, respectively; the
detection sensitivitiesforBaPoftrials 1 and2were24and
11/110, respectively (Table A5). The test chemical had an
SP transformation response in two consecutive experi-
ments. 3-Sulfolene was evaluated as having been weakly
active in the transformation assay, and its actual and
estimated rank t-statistics were both 3.24 (Table A6).
Tetrahydrofuran. Tetrahydrofuranis alevelIchemical
because its testinginrodentbioassay is incomplete (Table
A6). It had one difficult technical problem because it was
reported to reactwithwater (TableA4). The test chemical
was noncytotoxic to the BALB/c-3T3 cells and had an
average LD50 of 90.3 mM (Table A4). The statistical sen-
sitivities oftransformation assaytrials 1 and 2were 1 and
28/110, respectively; the detection sensitivities for BaP of
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trials 1 and 2 were 3 and 15/110, respectively (Table A5).
The test chemical had an SN transformation response in
two consecutive experiments. Tetrahydrofuran was evalu-
ated asinactivein thetransformation assay, andits actual
and estimated rank t-statistics were both 0.72 (Table A6).
TitaniumDioxide. TitaniumdioxideisalevelFnoncar-
cinogen (Table A6). It had one difficult technical problem.
It was reported to be reduced by metals such as calcium,
magnesium, potassium and sodium; thus, it could have
been altered by these metals in culture medium. In addi-
tion, this test chemical was very insoluble in culture
medium supplemented with pluronic F68, and had a sol-
ubility limit of about 125 ,ug/ml (Table A4). The test
chemical was noncytotoxic to the BALB/c-3T3 cells and
had an average LD50 of 12.1 mM (Table A4). Thus, this
LD50, farexceeded the solubilitylimitofthe testchemical
inculture medium. The statistical sensitivities oftransfor-
mation assay trials 1 and 2 were 82 and 6/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were 12 and 92/110, respectively (Table A5). The test
chemical had an LN transformation response in two con-
secutiveexperiments, anditwastested attreatmentdoses
thatfarexceeded its solubilitylimit. Titanium dioxide was
evaluated as an inactive with an indeterminate activity in
the transfonnation assay. Its actual and estimated rank
t-statistics were both 0.00 (Table A6).
Witch Hazel. Witch hazelis amixture ofchemicals that
include 15% v/v ethanol, 85% v/v water and some inert
ingredients. It has been shown to be a level F noncar-
cinogen (Table A6). It had no insurmountable technical
problems(TableA4).Thetestchemicalwasnoncytotoxicto
theBALB/c-3T3 cells andhad an average LD50estimated
to be 540 mOsM (Table A4). The statistical sensitivities of
transformation assay trials 1 and 2 were 2 and 38/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 2 and 16/110, respectively (TableA5). The test
chemical had an LA transformation response in two con-
secutive experiments. This test chemical only induced
significant transforming activity at treatment doses that
exceeded the upper dose limit ofthe assay of 100 mOsM.
Taken together, witch hazel was evaluated as having an
equivocal activity and a false positive in the transforma-
tion assay. Its actual and estimated rank t-statistics were
both 1.95 (Table A6).
Very Noncytotoxic Chemicals
Acetone. Acetone has not been evaluated in rodent
bioassay, therefore, its level ofcarcinogenicityis classified
as a level I chemical (Table A6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of about 257 mOsM (Table A4). The statistical sen-
sitivities oftransformation assaytrials 1 and 2were 1 and
27/110, respectively; the detection sensitivities for BaP of
trials 1 and 2 were 3 and 63/110, respectively (Table A5).
The test chemical had an LA transformation response in
the first experiment, and an SP response in the second
experiment. This test chemical induced significant trans-
forming activity only at treatment doses above the upper
dose limit of the assay of 100 mOsM. Taken together,
acetone was evaluated as active and a false positive in the
transfonnation assay. Its actual and estimated rank t-sta-
tistics were both 4.49 (Table A6).
Dimethyl Sulfoxide. Dimethyl sulfoxide has not been
evaluatedinrodentbioassay;therefore,itslevelofcarcino-
genicityisclassified as alevelIchemical (TableA6). Ithad
noinsurmountable technicalproblems (TableA4). Thetest
chemical was noncytotoxic to the BALB/c-3T3 cells and
had an average LD50 of507mM (TableA4).Thestatistical
sensitivities oftransformation assaytrials 1 and2were90
and 73/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 13 and 49/110, respectively
(Table A5). The test chemical had an LA transformation
responseinthefirstexperiment,andanSPresponseinthe
second experiment. This test chemical induced significant
transforming activity only at treatment doses above the
upper dose limit of the assay of 100 mOsM. Taken
together, dimethyl sulfoxidewas evaluated as active and a
false positive in the transformation assay. Its actual and
estimatedrankt-statisticswere3.38and3.45,respectively
(Table A6).
Ethanol. Ethanol has not been evaluated in rodent
bioassay; therefore, itslevel ofcarcinogenicityis classified
as a level I chemical (TableA6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALBtc-3T3 cells and had an average
LD50 of429 mM (Table A4). The statistical sensitivities of
transformation assay trials 1 and 2 were 2 and 20/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 2 anid 19/110, respectively (TableA5). The test
chemical had an LA transformation response in the first
experiment, and anSPresponseinthe secondexperiment.
This test chemical induced significant transforming
activityonlyattreatmentdosesabovetheupperdoselimit
of the assay of 100 mOsM. Taken together, ethanol was
evaluated as active and afalse positive in the transforma-
tion assay. Its actual and estimated rank t-statistics were
both 2.50 (Table A6).
Glycerol. Glycerol has not been evaluated in rodent
bioassay; therefore, itslevelofcarcinogenicityisclassified
as a level I chemical (Table A6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of401 mM (Table A4). The statistical sensitivities of
transformation assay trials 1 and 2 were 1 and 20/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 3 and 19/110, respectively (TableA5). The test
chemical had an SP transformation response in both the
first and second experiments. This test chemical induced
significant transforming activity only at treatment doses
above the upper dose limit of the assay of 100 mOsM.
Taken together, glycerol was evaluated as active and a
false positive in the transformation assay. Its actual and
estimated rank t-statistics were both 3.09 (Table A6).
Sodium Chloride. Sodium chloride has not been evalu-
ated in rodent bioassay; therefore, its level of carcino-
genicityis classified as alevelIchemical (TableA6). Ithad
noinsurmountable technicalproblems (TableA4).Thetest
chemical was noncytotoxic to the BALB/c-3T3 cells
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and had an average LD50 of about 144 mM (288 mOsM)
(Table A4). The statistical sensitivities of transformation
assay trials 1-3 were 10, 6 and 106/110, respectively; the
detection sensitivities for BaP oftrials 1 and 2 were 5, 92
and ND/110, respectively (Table A5). The test chemical
had an SP transformation response in the first and third
experiments, and an SN response in the second experi-
ment. There was no apparent explanation for the absence
of test chemical transforming activity in the second
experiment. This test chemical induced significant trans-
forming activity only at treatment doses above the upper
dose limit of the assay of 100 mOsM. Taken together,
sodium chloride was evaluated as active and a false posi-
tive in the transformation assay. Its actual and estimated
rank t-statistics were both 6.53 (Table A6).
Sucrose. Sucrose has not been evaluated in rodent
bioassay, therefore, its level ofcarcinogenicity is classified
as a level I chemical (Table A6). It had no insurmountable
technical problems (Table A4). The test chemical was
noncytotoxic to the BALB/c-3T3 cells and had an average
LD50 of240 mM (Table A4). The statistical sensitivities of
transformation assay trials 1 and 2 were 62 and 5/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were48and46/110,respectively(TableA5). Thetest
chemical had an SP transformation response in both the
first and second experiments. This test chemical induced
significant transforming activity only at treatment doses
above the upper dose limit of the assay of 100 mOsM.
Takentogether, sucrosewasevaluatedasactiveandafalse
positive in the transformation assay. Its actual and esti-
mated rank t-statistics were both 5.73 (Table A6).
Urea. Urea has not been evaluated in rodent bioassay;
therefore, its level ofcarcinogenicityis classified as alevel
I chemical (Table A6). It had no insurmountable technical
problems(TableA4).Thetestchemicalwasnoncytotoxicto
the BALB/c-3T3 cells and had an average LD50 of about
254 mM (TableA4). The statistical sensitivity oftransfon-
nation assaytrial 1 was6/110; the detection sensitivityfor
BaPoftrial 1was92/110(TableA5).Thetestchemicalhad
an SP transformation response in the first experiment.
This test chemical induced significant transforming
activityonlyattreatmentdoses abovetheupperdoselimit
of the assay of 100 mOsM. Taken together, urea was
evaluated as active and afalse positive in the transforma-
tion assay. Its actual and estimated rank t-statistics were
both 1.81 (Table A6).
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Appendix B.
Summary ofthe transformation responses of43 cytotoxic, mutagenic carcinogens.
Treatment Cytotoxic Transforming Transformation
Condition'a Activity ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
2-Acetylaminofluorene [2MF, M.W. =223.3]
Trial 1 [17]
B(a)P .000791 .000 52.9
B(a)P .000250 3.54 79.1
94 (20)
86 (20)
4.43 ***
3.91 ***
+ 13.5
+ 11.6
2AAF
2AAF
2AAF
2AAF
NC-1
.358
.179
.0900
.0450
Control
Trial 2 [24]
B(a)P .000791
B(a)P .000250
2AAF
2AAF
2AAF
2AAF
NC-1
.358
.179
.0900
.0450
Control
.442
3.54
19.5
66.8
100.
47.4
55.6
102.
113.
100.
.000 18.7
5.66 70.0
.000
7.55
23.3
59.7
100.
34.8
47.1
83.3
108.
100.
36 (20)
62 (20)
30 (20)
14 (20)
18 (40)
83 (20)
86 (20)
21 (20)
31 (20)
18 (20)
2 (20)
18 (40)
1.54 ***
2.34 ***
1.25 ***
.473
.327
3.65 ***
3.73 ***
.781*
1.18 ***
.686*
.072
.308
+ 5.56
+ 5.81
+ 4.39
+ .85
Control
Mean t = 4.73
+ 10.7
+ 10.7
+ 2.19
+ 4.06
+ 2.08
.00 (-1.01)
Control
Mean t = 2.08
Acrylonitrile [ACRL, M.W. = 53.06. Density = 0.806 g/ml]
Trial 1 [86]
B(a)P .000791
B(a)P .000250
64 (18)
42 (18)
4 (15,18)
79 (18)
13 (18)
8 (18)
47 (72)
69 (18)
44 (18)
32 (17)
0 (15,18)
11 (18)
57 (18)
10 (18)
62 (71)
3.32***
2.02***
.203
3.90***
.503
.297
.464
3.54***
2.14***
1 .52***
.000
.479
2.57***
.423
.579
+ 9.07
+ 5.74
+ 0.84
+ 12.5
+ 2.28
+ 1.31
Control
Mean t = 5.36
+ 8.31
+ 5.20
+ 3.32
.00
.00
+ 6.43
.00
Control
Mean t = 2.14
(-7.93)
(- .41)
(- .90
2-Amino-4-nitrophenol [847910-S, M.W. = 154.13]
Trial 1 [63]
B(a)P .000791
B(a)P .000250
141 (20)
93 (20)
2 (12)
2 (9)
8 (13)
33 (18)
84 (39)
6.13***
3.20*
.122
.167
.696
1.63
1.92
+ 6.33
+ 2.02
.00 (-7.26)
.00 (-6.04)
.00 (-3.61)
.00 (- .85)
Control
Mean t = .00
(Continued on nextpage)
18.7 63.0
47.9 87.6
.000
1.17
49.0
84.4
100.
.000
71.7
83.9
94.0
100.
ACRL
ACRL
ACRL
ACRL
NC-1
Trial 2
B(a)P
B(a)P
B(a)P
ACRL
ACRL
ACRL
ACRL
NC-1
.608
.304
.152
.0760
Control
[92]
.00250
.000791
.000250
.608
.456
.304
.152
ControL
.394 45.3
18.2 72.2
19.4 78.2
.000
.000
.396
28.5
100.
.000
.000
39.3
80.5
100.
4.00 80.5
24.8 93.1
847910-S
847910-S
847910-S
847910-S
NC-1
2.00
1.00
.500
.250
Control
.000
.000
9.45
57.5
100.
.201
78.5
90.6
93.4
100.
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 2 [91]
B(a)P .000791 28.9 73.6 60 (20) 2.00*** + 7.77
B(a)P .000250 58.1 89.9 14 (20) .503 + 2.63
847910-S 1.67 .000 .000 0 (0,20) .000 .00 (-3.67)
847910-S 1.25 .000 .000 0 (0,20) .000 .00 (-7.36)
847910-S .833 2.36 .000 0 (0,20) .000 .00 (-4.20)
847910-S .417 54.2 92.5 7 (20) .256 .00 (-1.48)
NC-1A+1B Control 100. 100. 31 (75) .322 Control
Mean t= .00
2-Amino-5-Nitrophenol [738717-S, M.W. =154.13]
Trial 1 [62]
B(a)P .000791 5.24 72.5 188 (20) 8.32* + 2.50
B(a)P .000250 18.6 85.1 105 (18) 5.59 NS .00 (- .62)
738717-S 2.00 .000 32.1 13 (20) .473 .00 (- 13.6)
738717-S .632 1.43 26.2 5 (19) .182 .00 (- 17.0)
738717-S .200 10.5 78.6 30 (20) 1.26 .00 (- 9.93)
738717-S .0632 46.2 95.0 96 (20) 4.31 .00 ( - 2.54)
NC-1 Control 100. 100. 261 (40) 6.02 Control
Mean t = .00
Trial 2 [83]
B(a)P .000791 2.86 73.0 141 (20) 6.14*** + 13.5
B(a)P .000250 13.8 78.9 64 (20) 2.93*** + 9.12
738717-S 2.00 .000 20.1 10 (19) .419 + .41
738717-S .632 3.33 42.7 15 (16) .738 + 1.89
738717-S .200 23.3 71.7 5 (14) .281 .00 (- .39)
738717-S .0632 31.9 85.1 6 (15) .294 .00 (- .32)
NC-1A+1B Control 100. 100. 48 (80) .351 Control
Mean t = .575
Trial 3 [93]
B(a)P .000791 2.65 46.7 138 (20) 6.48*** + 16.8
B(a)P .000250 7.96 79.9 115 (20) 4.80*** + 12.0
738717-S 1.33 .000 7.92 38 (20) 1.44*** + 3.66
738717-S .667 .000 11.2 50 (20) 2.28*** + 8.22
738717-S .333 5.31 16.6 43 (20) 1.73*** + 4.66
738717-S .167 8.85 31.7 36 (20) 1.47*** + 5.10
NC-1A+1B Control 100. 100. 43 (79) .416 Control
Mean t= 5.41
Trial 4 [103]
B(a)P .000791 8.60 76.9 95 (20) 4.59*** + 13.7
B(a)P .000250 23.6 91.5 75 (20) 2.86*** + 5.37
738717-S 1.67 .000 30.3 90 (20) 4.24*** + 11.3
738717-S .833 6.45 38.3 115 (20) 4.97*** + 9.09
738717-S .417 24.5 32.7 140 (20) 6.79*** + 18.4
738717-S .208 38.3 41.5 122 (20) 5.02*** + 8.57
NC-1A+1B Control 100. 100. 89 (79) .874 Control
Mean t = 11.8
5-Azacytidine [5AZA, M.W. = 244.2]
Trial 1 [6]
B(a)P .000791 1.71 26.9 141 (20) 6.80*** + 21.9
B(a)P .000250 13.7 74.0 69 (20) 3.14*** + 18.5
(Continued on nextpage)
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Appendix B. Continued
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic . .~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
5AZA
5AZA
5AZA
5AZA
NC-1
.0164
.0123
.00615
.00308
Control
.000
.000
4.79
15.4
100.
Trial 2 [11]
B(a)P .000791
B(a)P .000250
5AZA
5AZA
5AZA
5AZA
NC-1
.0061
.0031
.0015
.0008
Control
11.1
18.2
41.0
ND
100.
1.37 34.4
7.22 36.0
.000
4.12
20.9
27.8
100.
25.8
73.1
71.0
77.4
100.
62 (20)
70 (20)
134 (20)
316 (20)
24 (74)
128 (20)
37 (20)
182 (20)
248 (20)
52 (20)
11 (20)
21 (40)
e.59***
2.92***
6.16***
15.3***
.431
4.94***
1.62***
8.10***
12.0***
1.77**
.423
.301
+ 8.36
+ 9.11
+ 15.3
+ 33.9
Control
Mean t = 14.5
+ 10.5
+ 5.38
+ 14.7
+ 16.5
+ 4.21
+ .70
Control
Mean t = 9.03
Benzidine-2HC1 [BENZD, M.W. = 257.18]
Trial 1 [43]
B(a)P .000791
B(a)P .000250
1.00 53.0
4.80 77.5
382 (20)
270 (20)
18.9***
13.0***
+ 26.3
+ 19.0
BENZD
BENZD
BENZD
BENZD
NC-1
.194
.146
.0972
.0486
Control
Trial 2 [52]
B(a)P .000791
B(a)P .000250
.000
.000
2.38
42.9
100.
3.94
26.3
62.1
70.9
100.
4.05 39.1
11.1 73.8
42 (18)
64 (17)
82 (20)
40 (18)
44 (35)
150 (20)
126 (20)
2.00**
3.57***
3.74***
1.85*
1.05
6.63***
5.61***
+ 2.71
+ 6.41
+ 6.79
+ 2.26
Control
Mean t = 4.54
+ 9.35
+ 8.18
37 (20)
49 (20)
46 (20)
36 (20)
55 (38)
+ 1.73
+ 3.04
+ 2.43
+ 1.66
Control
Mean t = 2.22
2-Biphenylamine [2BPA, M.W. =169.22]
Trial 1 [33]
B(a)P .000791
B(a)P .000250
214 (20)
130 (20)
2-BPA
2-BPA
2-BPA
2-BPA
NC-1
.591
.433
.296
.148
Control
Trial 2 [52]
B(a)P .000791
B(a)P .000250
2BPA
2BPA
2BPA
2BPA
NC-1
.296
.222
.148
.074
Control
.000
3.05
4.58
40.1
100.
7.46
28.5
53.8
106.
100.
4.04 39.8
11.1 75.4
8.08
36.0
59.6
83.8
100.
59.0
80.3
84.9
95.9
100.
12 (18)
49 (20)
77 (20)
44 (19)
54 (37)
150 (20)
126 (20)
33 (20)
63 (20)
66 (20)
93 (20)
55 (38)
.562
2.26***
3.33***
1.91*
1.04
6.63***
5.61***
1 .43
2.85***
3.06***
3.21 ***
1.09
.00 (- 1.97)
+ 3.66
+ 4.74
+ 2.10
Control
Mean t = 2.63
+ 9.35
+ 8.18
+ 1.03
+ 4.40
+ 5.54
+ 4.20
Control
Mean t = 3.79
(Continued on nextpage)
BENZD*
BENZD*
BENZD*
BENZD*
NC-1
.1944
.1458
.0972
.0486
Controt
96.3
98.3
98.7
99.7
100.
94.0
96.3
103.
110.
100.
1.66
2.20**
1.95*
1.63
1.09
3.44 2.40
5.73 51.4
10.0***
5.86***
+ 13.6
+ 7.74
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Response Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mn S.A CC.A. III (N) III t-statistic
4-Biphenylamine [4BPA, M.W. =169.22]
Trial 1 [35]
B(a)P .000791 4.51 66.1 103 (20) 4.91*** + 6.41
B(a)P .000250 12.3 87.5 133 (20) 6.01*** + 6.34
4BPA .591 .000 23.7 15 (18) .671 .00 (- 4.00)
4BPA .443 7.79 70.3 54 (20) 2.51 + 1.47
4BPA .295 18.9 86.7 92 (20) 4.05*** + 3.81
4BPA .148 40.6 111. 61 (20) 2.63 + 1.36
NC-1 Control 100. 100. 94 (40) 1.97 ControL
Mean t = 2.21
Trial 2 [53]
B(a)P .000791 4.78 58.9 182 (20) 8.30*** + 7.68
B(a)P .000250 7.97 76.8 195 (20) 8.74*** + 7.74
4BPA .473 3.59 67.1 96 (20) 4.25** + 2.70
4BPA .355 14.7 72.3 99 (20) 4.59** + 3.39
4BPA .236 42.2 80.0 100 (20) 4.53** + 3.25
4BPA .118 74.9 91.0 68 (20) 3.10 + .70
NC-1 Control 100. 100. 128 (20) 2.78 Control
Mean t = 2.51
3-(Chloromethyl)pyridine [3CMP, M.W. = 164.04]
Trial 1 [14]
B(a)P .000791 1.75 36.1 177 (20) 6.73*** + 13.3
B(a)P .000250 5.26 74.7 61 (20) 2.45*** + 7.12
3CMP .0732 .000 52.9 10 (20) .374 + 1.22
3CMP .0488 8.33 89.5 3 (20) .110 .00 (- 1.02
3CMP .0244 55.7 101. 15 (20) .611** + 2.76
3CMP .0122 74.1 102. 25 (20) .542 + 1.42
NC-1 Control 100. 100. 12 (20) .213 Control
Mean t = 1.35
Trial 2 [22]
B(a)P .000791 1.86 53.4 187 (20) 8.86*** + 16.0
B(a)P .000250 6.52 81.4 116 (20) 5.25*** + 9.33
3CMP .0488 12.4 99.7 52 (20) 2.07** + 3.43
3CMP .0244 59.6 94.3 68 (20) 2.59*** + 4.41
3CMP .0122 68.6 84.7 37 (20) 1.65* + 2.65
3CMP .00610 89.8 88.9 31 (20) 1.07 + .60
NC-1 Control 100. 100. 45 (40) .893 Control
Mean t = 2.77
4-Chloro-o-Phenylenediamine [4CPD, NM.W. = 142.59]
Trial 1 [13]
B(a)P .000791 .823 30.6 95 (20) 4.38*** + 14.2
B(a)P .000250 2.06 75.4 66 (20) 3.14*** + 15.7
4CPD .0245 4.12 85.1 23 (20) .871** + 3.37
4CPD .0123 25.6 97.9 6 (20) .214 + .11
4CPD .00614 63.3 100. 1 (20) .035 .00 (- 2.39)
4CPD .00307 88.5 99.4 2 (20) .056 .00 (- 1.55)
NC-1 Control 100. 100. 11 (40) .201 Control
Mean t = .870
Trial 2 [20]
B(a)P .000791 .000 39.4 268 (20) 13.0*** + 26.3
B(a)P .000250 2.34 77.3 69 (20) 4.00*** + 9.22
(Continued on nextpage)
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
4CPD
4CPD
4CPD
4CPD
NC-1
.0351
.0245
.0140
.00701
Control
3.91
5.47
4.69
21.1
100.
Trial 3 [101]
B(a)P .000791
B(a)P .000250
4CPD
4CPD
4CPD
4CPD
NC-1
.0526
.0394
.0263
.0131
Control
58.2
82.4
96.6
112.
100.
ND 64.8
ND 83.6
25.6
27.0
43.3
76.8
100.
59 (20)
28 (20)
9 (20)
4 (20)
21 (40)
108
48
35.7
47.1
76.4
90.9
100.
107
55
38
18
27
2.61***
1.03**
.308
.132
.368
4.63***
2.11***
5.19***
2.37***
1.59***
.652*
.260
4-Chloro-o-Toluidine-HC1 [M.W. = 178.07]
+ 8.16
+ 2.89
.00 (- .37)
.00 (- 1.71)
Control
Mean t = 2.76
+ 12.7
+ 9.73
+ 19.4
+ 8.26
+ 5.83
+ 2.19
Control
Mean t = 8.92
Trial 1 [81]
B(a)P .000791
B(a)P .000250
10.2 63.9
28.0 67.8
4CT .842
4CT .632
4CT .421
4CT .211
NC-1 Control
Trial 2 [92]
B(a)P .00250
B(a)P .000791
B(a)P .000250
.000 .516
7.34 92.3
28.3 102.
55.9 106.
100. 100.
.394 45.3
18.2 72.2
19.4 78.2
88 (16,18)
349 (18)
209 (18)
150 (18)
583 (72)
69 (18)
44 (18)
32 (17)
4.05
19.2***
11.4***
8.04
7.36
3.54***
2.14***
1.52**
.00 (- 2.44)
+ 14.6
+ 5.93
+ 1.00
Control
Mean t = 7.18
+ 8.31
+ 5.20
+ 3.32
4CT
4CT
4CT
4CT
NC-1
.786
.590
.393
.197
Control
6.73
11.9
61.4
108.
100.
33.3
81.0
95.8
95.5
100.
35 (17,18)
47 (18)
31 (18)
30 (18)
62 (71)
1.59**
2.28***
1.52***
1.56***
.597
5-Chloro-o-Toluidine [M.W = 141.61]
Trial 1 [81]
B(a)P .000791
B(a)P .000250
5CT 2.26
5CT 1.69
5CT 1.13
5CT .565
NC-1 Control
Trial 2 [92]
B(a)P .00250
B(a)P .000791
B(a)P .000250
10.2 63.9
28.0 67.8
.000
14.3
38.5
72.7
100.
378 (18)
280 (18)
.344
62.8
93.3
106.
100.
.394 45.3
18.2 72.2
19.4 78.2
12 (9,18)
221 (18)
288 (18)
158 (18)
583 (72)
69 (18)
44 (18)
32 (17)
20.8***
15.3***
1.03
11.4***
15.4***
7.88
7.36
3.54***
2.14***
1.52**
+ 3.39
+ 5.54
+ 3.56
+ 5.28
Control
Mean t = 4.44
+ 15.5
+ 10.5
.00 (- 7.06)
+ 3.71
+ 6.51
+ .54
Control
Mean t = 3.57
+ 8.31
+ 5.20
+ 3.32
+ .58
+ 5.43
+ 7.67
+ 3.03
Control
Mean t = 5.38
(Continued on nextpage)
378 (18)
280 (18)
20.8***
15.3***
+ 15.5
+ 10.5
5CT
5CT
5CT
5CT
NC-1
2.26
1.69
1.13
.565
Control
1.19
7.92
22.2
49.9
100.
19.9
49.5
92.8
87.2
100.
19 (17,18)
48 (17)
78 (17)
53 (18)
62 (71)
.682
2.36***
3.75***
1.80**
.597
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
C. I. Acid Orange 3 [038399-S, M.W. = 453.51]
Trial 1 [70]
B(a)P .000791 1.24 48.9 11 (3) 3.38*** + 4.23
B(a)P .000250 11.8 81.0 19 (5) 3.62*** + 5.73
038399-S .222 .000 .000 0 (0,20) .000 ND
038399-S .111 .000 38.9 34 (16) 1.69*** + 4.44
038399-S .0555 1.86 90.7 13 (18) .562 + .20
038399-S .0278 61.5 97.4 5 (15) .260 .00 (-1.62)
NC-1A+1B Control 100. 100. 36 (54) .526 Control
Mean t = 1.55
Trial 2 [87]
B(a)P .000791 25.1 77.0 59 (20) 2.26*** + 5.84
B(a)P .000250 42.2 80.2 34 (20) 1.45*** + 5.24
038399-S .178 .000 .000 0 (0,20) .000 ND
038399-S .1334 .000 35.9 44 (20) 1.81*** + 6.11
038399-S .0890 .000 67.0 37 (20) 1.54*** + 5.45
038399-S .0445 13.8 109. 14 (20) .534 + 1.13
NC-1 Control 100. 100. 43 (80) .346 Control
Mean t = 4.23
C. I. Basic Red 9-HC1 [CIBR9, M.W. = 323.83]
Trial 1 [48]
B(a)P .000791 2.28 47.9 148 (20) 7.06*** + 16.5
B(a)P .000250 10.1 90.8 63 (20) 2.68*** + 6.53
CIBR9 .00679 .000 .000 4 (20) .149 .00 (- 2.98)
CIBR9 .00509 .000 .252 5 (20) .189 .00 (- 2.53)
CIBR9 .00340 2.61 29.0 5 (20) .189 .00 (- 2.53)
CIBR9 .00170 32.6 67.3 23 (20) .861 + 1.41
NC-1 Control 100. 100. 29 (40) .537 Control
Mean t = 353
Trial 2 [66]
B(a)P .000791 2.33 52.0 90 (20) 3.92*** + 14.1
B(a)P .000250 6.08 98.4 24 (20) .795** + 3.69
CIBR9 .00617 .000 .188 2 (18,20) .080 + .39
CIBR9 .00309 44.9 29.7 4 (20) .149 + 1.19
CIBR9 .00154 62.8 97.8 1 (20) .035 .00 (- .40)
CIBR9 .00077 74.3 109. 3 (19) .116 + .91
NC-1 Control 100. 100. 3 (38) .056 Control
Mean t = .700
Trial 3 [DRI4]
B(a)P .000791 ND ND ND ND
B(a)P .000250 ND ND ND ND
CIBR9 .00463 ND 10.6 5 (20) .189 .00 (- 2.51)
CIBR9 .00309 ND 79.5 12 (20) .443 .00 (- .94)
CIBR9 .00154 ND 103. 8 (20) .301 .00 (- 1.73)
NC-1 Control ND 100. 18 (20) .668 ControL
Mean t =.000
C. I. Basic Red 9-HCG [947733-S, m.w. = 323.83]
Trial 1 [73]
B(a)P .000791 2.21 71.9 61 (19) 2.60*** + 8.09
B(a)P .000250 7.18 88.8 48 (20) 1.58*** + 4.37
(Continuedon nextpage)
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc. , nM S.A CC.A. III (N) III t-statistic
947733-S .00375 .000 3.3 12 (20) .338 + .39
947733-S .00250 .000 33.6 7 (20) .238 .00 (- .25)
947733-S .00125 30.4 88.6 3 (20) .110 .00 (- 1.24)
947733-S .000625 43.6 96.9 7 (20) .203 .00 (- .50)
NC-1A+1B Control 100. 100. 45 (79) .274 Control
Mean t = .098
Trial 2 [95]
B(a)P .000791 16.0 ND 152 (20) 7.35*** + 9.48
B(a)P .000250 33.3 ND 115 (20) 5.27*** + 3.82
947733-S .00281 .000 ND 18 (20) .620 .00 (- 6.44)
947733-S .00211 .000 ND 38 (19) 1.82 .00 (- 2.39)
947733-S .00140 15.1 ND 26 (20) 1.07 .00 (- 4.70)
947733-S .000700 65.2 ND 37 (19) 1.69 .00 (- 2.68)
NC-1A+1B Control 100. ND 263 (77) 2.84 ControL
Mean t = .000
C. I. Disperse Blue 1 [933178-S, M.W. = 268.3]
Trial 1 [73]
B(a)P .000791 2.21 71.9 61 (19) 2.60*** + 8.09
B(a)P .000250 7.18 88.8 48 (20) 1.58*** + 4.37
933178-S 3.70 .000 17.1 20 (20) .572 + 1.66
933178-S 1.17 4.42 59.3 18 (20) .787** + 2.93
933178-S .370 33.1 72.3 36 (20) 1.56*** + 5.85
933178-S .117 68.0 100. 22 (20) .955*** + 3.67
NC-1A+1B Control 100. 100. 45 (79) .274 ControL
Mean t = 3.53
Trial 2 [97]
B(a)P .000791 4.74 78.0 118 (20) 5.02*** + 12.5
B(a)P .000250 17.4 104. 52 (20) 2.26*** + 7.26
933178-S 1.48 3.16 27.9 6 (18) .260 .00 (- 1.01)
933178-S .741 9.49 32.6 9 (20) .282 .00 (- .86)
933178-S .370 13.4 45.2 13 (18) .513 + .55
933178-S .185 20.2 41.9 14 (18) .608 + 1.07
NC-1A+1B ControL 100. 100. 47 (80) .414 Controt
Mean t =.405
Trial 3 [107]
B(a)P .000791 5.81 47.3 131 (20) 6.09*** + 5.74
B(a)P .000250 21.2 75.8 122 (20) 5.53*** + 4.05
933178-S 1.85 19.1 6.98 11 (20) .443 .00 (- 7.86)
933178-S .926 22.2 16.5 22 (20) .792 .00 (- 6.00)
933178-S .463 36.6 23.8 5 (20) .189 .00 (-12.9)
933178-S .231 44.1 28.2 6 (19) .226 .00 (- 9.38)
NC-1A+1B Control 100. 100. 274 (80) 2.95 Control
Mean t =.000
C. I. Disperse Blue 1 [933178-S, M.W. = 268.3]
Trial 1 [73]
B(a)P .000791 2.21 71.9 132 (19) 6.38*** + 13.1
B(a)P .000250 7.18 88.8 90 (20) 3.20*** + 5.92
933178-S 3.70 .000 17.1 104 (20) 3.91 *** + 7.00
933178-S 1.17 4.42 59.3 86 (20) 3.97 * + 10.4
933178-S .370 33.1 72.3 122 (20) 5.49 * + 11.8
933178-S .117 68.0 100. 77 (20) 3.25 *** + 6.22
NC-1A+1B Control 100. 100. 99 (79) .608 Control
Mean t = 8.86
(Continued on nextpage)
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Conditionfa Activityb Activity' Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 2 [97]
B(a)P .000791 4.74 78.0 248 (20) 9.95*** + 11.3
B(a)P .000250 17.4 104. 126 (20) 5.14*** + 7.49
933178-S 1.48 3.16 27.9 46 (18) 2.05 * + 2.51
933178-S .741 9.49 32.6 51 (20) 2.05 * + 2.64
933178-S .370 13.4 45.2 67 (18) 3.51 *** + 7.80
933178-S .185 20.2 41.9 78 (18) 3.45 * + 5.03
NC-1A+1B Control 100. 100. 118 (80) 1.07 Control
Mean t = 4.50
Trial 3 [107]
B(a)P .000791 5.81 47.3 402 (20) 19.5 * + 8.11
B(a)P .000250 21.2 75.8 330 (20) 16.0 *** + 6.00
933178-S 1.85 19.1 6.98 594 (20) 27.8 *** + 15.3
933178-S .926 22.2 16.5 650 (20) 32.0 *** + 16.2
933178-S .463 36.6 23.8 160 (20) 7.07 .00 (- 1.63)
933178-S .231 44.1 28.2 143 (19) 7.31 .00 (- 3.00)
NC-1A+1B Control 100. 100. 929 (80) 9.56 Control
Mean t = 7.88
C. I. Disperse Yellow 3 [DY3, M.W. = 269.31]
Trial 1 [71]
B(a)P .000791 4.48 50.7 251 (20) 11.0*** + 12.1
B(a)P .000250 18.1 68.7 77 (20) 3.50*** + 7.12
DY3 1.423 .000 41.8 19 (20) .772 .00 (- 1.030
DY3 .450 .000 92.4 12 (20) .423 .00 (- 2.53)
DY3 .142 .000 89.3 15 (17) .340 .00 (- 2.60)
DY3 .045 14.3 104. 3 (20) .094 .00 (- 6.70)
NC-1 Control 100. 100. 110 (75) 1.06 Control
Mean t = .000
Trial 2 [91]
B(a)P .000791 28.9 73.6 60 2.00*** + 5.11
B(a)P .000250 58.1 89.9 14 .503 + 1.31
DY3 1.577 21.7 79.3 8 .301 .00 (- .17)
DY3 .788 29.2 87.4 11 .402 + .62
DY3 .394 41.4 89.1 1 .035 .00 (- 4.52)
DY3 .197 66.7 93.4 2 .072 .00 (- 3.31)
NC-1 Control 100. 100. 31 .322 Control
Mean t = .155
Cytembena [CYTB, M.W. = 307.09]
Trial 1 [70]
B(a)P .00079 1.24 48.9 11 (3) 3.38*** + 4.23
B(a)P .00025 11.8 81.0 19 (5) 3.62*** + 5.73
CYTB .325 .000 .000 0 (9,16) .000 .00 (- 7.39)
CYTB .243 .000 2.25 7 (15) .356 .00 (- .98)
CYTB .162 4.97 29.9 88 (18) 4.48*** + 11.2
CYTB .081 19.9 89.7 42 (20) 1.11 + 1.83
NC-1 Control 100. 100. 36 (54) .526 Control
Trial 2 [83]
Mean t = 4.34
B(a)P .00079 2.86 73.0 141 (20) 6.14*** + 13.5
B(a)P .00025 13.8 78.9 64 (20) 2.93*** + 9.12
CYTB .243 .000 8.74 21 (16) .979** + 2.76
CYTB .183 .000 39.1 92 (19) 4.35*** + 11.2
CYTB .122 5.71 73.3 119 (20) 5.18*** + 12.1
CYTB .061 20.5 94.1 20 (20) .808* + 2.41
NC-1 Control 100. 100. 48 (80) .351 Control
Mean t = 7.12
(Continued on nextpage)
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., M S.A CC.A. III (N) III t-statistic
C. I. Solvent Yellow 14 [CISY14, M.W. = 248.30]
212 (20)
41 (19)
13 (19)
16 (19)
16 (19)
12 (19)
7 (36)
48 (20)
39 (20)
16 (20)
26 (20)
28 (20)
21 (20)
5 (39)
100 (15)
84 (15)
15 (15)
21 (15)
19 (14)
20 (29)
110 (12)
82 (12)
10.0***
1.80***
.535*
.739***
.713***
.480*
.135
2.07***
.969**
.634***
.927***
1.09***
.888***
.085
5.28***
5.27***
.838
1.12*
1.16*
.411
8.86***
6.31***
+ 26.6
+ 7.07
+ 2.69
+ 4.72
+ 4.33
+ 2.34
Control
Mean t = 3.52
+ 8.71
+ 3.32
+ 3.79
+ 4.18
+ 5.23
+ 5.34
Control
Mean t = 4.64
+ 8.30
+ 11.4
+ 1.63
+ 2.36
+ 2.50
Control
Mean t = 2.16
+ 20.5
+ 10.7
CISY14 .242
CISY14 .161
CISY14 .0805
CISY14 .0403
NC-1** Control
@Trial was conducted
1.71
5.15
11.2
22.3
100.
10.6
14.7
35.7
58.1
100.
in 100lnn culture dishes.
6 (12)
12 (12)
25 (12)
19 (12)
6 (24)
.348 + .98
.861*** + 3.68
1.73*** + 4.82
1.32*** + 4.23
.189 Control
Mean t = 3.43
1,3-Dibromo-3-Chloropropane [DBCP. M.W. = 236.35, Density = 2.093 g/ml]
Trial 1 [23]
B(a)P .000791 .000 61.0 157 (18) 6.71***
B(a)P .000250 4.84 100. 57 (18) 3.04***
DBCP
DBCP
DBCP
DBCP
NC-1
.213
.159
.106
.0531
Control
Trial 2 [27]
B(a)P .000791
B(a)P .000250
DBCP
DBCP
DBCP
DBCP
NC-1
.531
.398
.266
.133
Control
.000
2.42
6.06
39.4
100.
98.2
85.6
93.1
95.4
100.
4.04 33.7
13.0 47.4
.000
1.24
9.94
35.7
100.
36.9
67.0
81.1
70.2
100.
14 (18)
19 (18)
16 (18)
20 (18)
23 (27)
170 (18)
73 (18)
163 (18)
111 (18)
36 (18)
17 (18)
31 (36)
.572
.937
.698
.590
.661
8.90***
3.18***
8.21***
5.51***
1 .64***
.765
.555
.00 (-
+ 1.17
+ .16
.00 (-
Control
Mean t = .333
+ 14.8
+ 5.71
.37)
.26)
+ 12.0
+ 9.35
+ 3.26
+ .83
Control
Mean t = 6.36
(Continued on nextpage)
1.52 48.4
3.41 56.9
6.06
13.6
19.7
20.1
100.
70.4
66.5
66.2
75.8
100.
5.87 34.4
20.8 63.9
Trial 1
B(a)P
B(a)P
CIs
CIs
CIs
CIs
NC-1
Trial 2
B(a)P
B(a)P
CISY14
CISY14
CISY14
CISY14
NC-1*
Trial 3
B(a)P
B(a)P
CISY14
CISY14
CISY14
NC-1
Trial 4
B(a)P
B(a)P
[7]
.000791
.000250
.242
.121
.0605
.0303
Control
[67]
.000791
.000250
.242
.161
.0805
.0403
Control
[IP17]
.000791
.000250
.201
.101
.0503
Control
[IP18]
.000791
.000250
34.9
52.5
52.8
56.5
100.
73.9
80.7
79.5
83.4
100.
.000 ND
3.1 ND
.000
.5
.5
100.
ND
ND
ND
ND
1.33 3.77
2.67 22.1
+ 9.25
+ 8.07
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activity' Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 3 [102]
B(a)P .000791
B(a)P .000250
DBCP
DBCP
DBCP
DBCP
NC-1
.708
.531
.354
.177
Control
9.64 69.9
19.3 93.1
.000
.000
1.68
13.4
100.
1.33
7.73
34.7
70.1
100.
99 (18)
45 (18)
9 (18)
51 (18)
109 (18)
47 (18)
64 (72)
4.65***
2.22***
.392
2.27***
5.09***
2. 14***
.697
+ 9.48
+ 5.22
.00 (- 1.65)
+ 4.97
+ 9.56
+ 4.77
Control
Mean t = 4.83
2,6-Dichloro-p-Phenylenediamine [26DCPD, M.W. = 177.]
Trial 1 [32]
B(a)P .000791
B(a)P .000250
26DCPD
26DCPD
26DCPD
26DCPD
NC-1
1.130
.847
.565
.282
Control
.000
1 .87
4.12
41.6
100.
Trial 2 [54]
B(a)P .000791
B(a)P .000250
26DCPD
26DCPD
26DCPD
26DCPD
NC-1
1.13
.847
.565
.282
Control
39.5
62.7
76.0
86.3
100.
1.47 17.6
.490 61.1
.000
2.94
4.41
34.9
100.
35.8
55.7
90.5
89.5
100.
68 (20)
86 (20)
101 (20)
38 (20)
91 (38)
105 (20)
100 (20)
17 (20)
21 (20)
11 (20)
1 1 (20)
15 (40)
2.96
4.07***
4.05**
1.55
1.99
4.75***
4.52***
.677*
.845**
.443
.423
.265
+ 1.91
+ 4.63
+ 3.41
+ .00 (- 1.08)
ControL
Mean t = 2.50
+ 13.8
+ 13.5
+ 2.51
+ 3.27
+ 1.25
+ 1.08
Control
Mean t = 2.03
1,3-Dichloropropene [13DCP, M.W. = 110.98, Density = 1.217 g/ml]
Trial 1 [79]
B(a)P .000791
B(a)P .000250
13DCP
13DCP
13DCP
13DCP
NC-1
.308
.231
.154
.0770
ControL
Trial 2 [94]
B(a)P .000791
B(a)P .000250
.000
.000
.413
40.1
100.
59.0
91.8
96.6
108.
100.
.000 75.7
17.4 114.
263 (18)
194 (18)
93 (18)
80 (18)
430 (72)
122 (18)
81 (18)
13.9***
9.08***
4.74
4.01
5.12
5.92***
3.88***
+ 8.91
+ 3.53
.00 (- .48)
.00 (- 1.49)
Control
Mean t = 3.11
+ 6.26
+ 4.08
13DCP
13DCP
13DCP
13DCP
NC-1
.330
.247
.165
.0824
Control
Trial 3 [104]
B(a)P .000791
B(a)P .000250
.000 .000
.000 63.2
.000 132.
.000 155.
100. 100.
25.0 64.5
50.6 89.6
11 (11,18)
33 (18)
37 (18)
21 (18)
150 (71)
62 (18)
63 (18)
.753
1.41
1.47
.634
1.52
2.79***
2.47***
.00 (-
.00 (-
.00 (-
.00 (-
Control
Mean t = .000
+ 4.87
+ 4.10
(Continued on nextpage)
10.1 51.7
6.37 77.4
197 (19)
115 (20)
10.1***
5.46***
+ 12.6
+ 6.94
22.7 79.6
39.3 94.2
279 (13)
241 (18)
20.8***
12.9***
+ 13.9
+ 9.34
1.80)
.26)
.12)
2.58)
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Condi_ti_on' Activityb Activityc Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
16 (14,18)
51 (17)
26 (18)
17 (18)
83 (71)
.669
2.36***
1.27
.655
.878
.00 (-
+ 3.84
+ 1.41
.00 (-
Control
Mean t = 1.75
Diglycidyl Resorcinol Ether [DIG, M.W. = 222.26, Density = 1.21 g/ml]
175 (18)
101 (18)
9. 16***
5.42***
+ 21.9
+ 18.5
DIG
DIG
DIG
DIG
NC-1
.00953
.00626
.00408
.00218
Control
Trial 2 [12]
B(a)P@ .000791
B(a)P .000250
DIG
DIG
DIG
DIG
NC-1
.00544
.00408
.00272
.00136
Control
2.02
3.63
5.24
17.7
100.
.000
.588
19.4
80.0
100.
90.7 99.0
77.6 114.
.000
.000
.000
41.1
100.
2.20
18.9
70.4
104.
100.
0 (2,18)
31 (7, 18)
230 (18)
71 (18)
18 (74)
61 (19)
81 (17)
63 (17)
46 (11)
17 (14)
9 (18)
8 (40)
.000
1.51
11 .8***
3.49***
.348
2.90***
3.94***
3.45***
3.45***
.842*
.392*
.160
.00 (- 7.42
+ 1.25
+ 20.1
+ 10.3
Control
Mean t = 15.2
+ 13.1
+ 10.5
+ 15.0
+ 6.71
+ 2.79
+ 2.14
Control
Mean t = 6.66
Dichlorvos [DCV, M.W. = 220.98, Density = 1.415 g/ml]
Trial
B(a)P
B(a)P
DCV
DCV
DCV
DCV
NC-1
Trial 2
B(a)P
B(a)P
DCV
DCV
DCV
DCV
NC-1
Trial 3
B(a)P
B(a)P
1 [68]
.000791
.000250
.181
.0905
.0452
.0226
Control
[98]
.000791
.000250
.181
.136
.0905
.0452
Control
[DRI5]
.000791
.000250
3.60 51.9
4.50 77.2
.000
16.7
50.0
73.9
100.
.000
83.2
101.
101.
100.
8.38 79.6
29.3 91.3
.000
.000
9.42
67.0
100.
.000
.186
52.1
83.5
100.
91 (18)
37 (18)
4 (13,18)
11 (18)
2 (18)
4 (18)
11 (36)
132 (18)
75 (18)
0 (1,18)
7 (16,18)
9 (18)
9 (18)
39 (45)
4.63***
1.73***
.211
.433
.080
.167
.226
6.82***
3.38***
.000
.330
.370
.326
.618
+ 3.24
+ 15.0
.00 (-
+ 1.38
.00 (-
.00 (-
Control
Mean t = .460
+ 11.8
+ 6.81
.00 (-
.00 (-
.00 (-
.00 (-
Control
Mean t = .000
.1 1 )
1.43)
.53)
.92)
1.38)
1.21)
1.43)
NA NA
NA NA
DCV .136
DCV .0905
DCV .0452
NC-1 Control
NA 16.6
NA 79.0
NA 98.3
NA 100.
187 (18)
47 (18)
6 (18)
46 (18)
9.84**
2.20
.29
1.27
+ 8.82
+ 1.71
.00 (- 2.88)
Control
Mean t = 3.51
13DCP
13DCP
13DCP
13DCP
NC-1
.384
.288
.192
.0960
Control
.000
.000
.000
20.6
100.
23.1
98.2
96.4
86.4
100.
Trial
B(a)P
B(a)P
1 [6]
.000791
.000250
.73)
.88)
1.71 30.6
13.7 85.9
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activity' Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Dichlorvos [676384-L, M.W. = 220.98, Density = 1.415 g/ml]
Trial 1 [78]
B(a)P .000791
B(a)P .000250
8.09 60.6
14.9 84.2
116 (18)
184 (18)
6.11***
9.84***
+ 4.93
+ 9.74
676384-L
676384-L
676384-L
676384- L
NC-1
.182
.136
.0910
.0450
Control
Trial 2 [90]
B(a)P .000791
B(a)P .000250
676384- L
676384-L
676384-L
676384- L
NC-1
.159
.119
.080
.040
Control
.000
.426
8.94
37.4
100.
2.49
26.6
72.2
88.4
100.
28.5 76.0
51.8 95.8
.000
.000
52.5
107.
100.
1.95
24.7
83.6
114.
100.
17
96
97
41
296
(6,18)
(18)
(18)
(18)
(72)
157 (18)
110 (18)
27 (14,17)
103 (18)
104 (18)
85 (18)
219 (71)
1.98
4.47
4.83*
2.01
3.28
7.60***
4.91***
1.51
4.85***
4.10**
2.91
1.95
.00 (- 1.40)
.00 (- 1.57)
+ 2.09
.00 (- 2.36)
Control
Mean t = .697
+ 5.89
+ 3.71
.00 (- .78)
+ 3.76
+ 2.82
+ 1.41
Control
Mean t = 2.66
2,4-Dinitrotoluene [24DNT, M.W. = 182.14]
Trial 1 [46]
B(a)P .00791
B(a)P .00250
24DNT
24DNT
24DNT
24DNT
NC-1
2.333
1.167
.583
.292
Control
Trial 2 [55]
B(a)P .000791
B(a)P .000250
24DNT
24DNT
24DNT
24DNT
NC-1
1 .333
1 .000
.667
.333
Control
Trail 3 [DRI2]
MNNG .00850
24DNT
24DNT
24DNT
NC-1
1.373
.686
.343
Control
5.52 35.7
22.4 81.1
.000
11.0
56.6
79.7
100.
.000
55.1
85.8
93.3
100.
2.26 23.9
4.07 62.4
.452
3.17
22.7
57.0
100.
13.3
39.6
69.8
84.7
100.
60.8 NA
23.0
41.6
79.0
100.
NA
NA
NA
100.
127 (20)
75 (20)
0 (5,20)
38 (20)
20 (20)
7 (20)
24 (40)
133 (20)
48 (20)
8 (20)
1 (20)
4 (20)
0 (20)
7 (40)
242 (20)
2 (20)
6 (20)
12 (20)
13 (20)
6.14***
3.32***
.000
1.61***
.527
.275
.384
5.49***
1.88***
.301
.035
.149
.000
.129
11.7 ***
.072
.196
.357
.503
+ 12.4
+ 8.63
.00 (- 4.15)
+ 4.70
+ .66
.00 (- .67)
Control
Mean t = 1.57
+ 15.2
+ 7.12
+ 1.68
.00 (- 1.59)
+ .23
.00 (- 1.87)
Control
Mean t = .478
+ 19.0
.00 (-3.10)
.00 (-1.76)
.00 (- .68)
Control
Mean t = 0.00
Epichlorohydrin [EPCH, M.W. = 92.53, Density = 1.181 g/ml]
Trial 1 [68]
B(a)P .000791
B(a)P .000250
(Continued on nextpage)
3.60 51.9
4.50 77.2
91 (18)
37 (18)
4.63**
1 73***
+ 3.24
+ 15.0
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Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Condi_tion' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t--,;tatistic
EPCH
EPCH
EPCH
EPCH
NC-1
.670
.447
.223
.112
Control
Trial 2 [DRI5]
B(a)P .000791
B(a)P .000250
EPCH .383
EPCH .255
EPCH .128
NC-1 Control
.000
.000
.450
33.8
100.
.000
.531
73.6
105.
100.
0 (0,17)
0 (3,18)
39 (18)
8 (18)
11 (36)
.000
.000
1.57***
.260
.226
ND
+ .00 (- 3.60)
+ 4.51
+ .24
Control
Mean t = 2.38
ND ND
ND ND
ND ND
ND ND
ND ND
ND 100.
98 (18)
115 (18)
27 (18)
46 (18)
4.58**
6.02**
1.27
1.27
+ 4.20
+ 6.22
.00 (-
Control
Mean t = 3.47
.01 )
1,2-Epoxybutane [835701-L, M.W. = 72.11, Density = 0.8297 g/ml]
Trial 1 [79]
B(a)P .000791
B(a)P .000250
835701 -L
835701 -L
835701 -L
835701 -L
NC- 1A+1B
22.9
17.1
11.4
5.71
Control
Trial 2 [104]
B(a)P .000791
B(a)P .000250
.000
.000
.000
.000
100.
.000
.000
.000
.000
100.
25.0 64.5
50.6 89.6
0 (0,18)
0 (0,18)
0 (0,18)
0 (0,18)
430 (62)
62 (18)
63 (18)
.000
.000
.000
.000
5.12
2.79***
2.47***
NA
NA
NA
NA
Control
Mean t = ND
+ 4.87
+ 4.10
.000 .000
.000 28.1
5.06 92.3
37.3 108.
100. 100.
0 (0,18)
57 (18)
66 (18)
15 (5)
83 (71)
.000
2.48***
3.31***
1.61
.878
NA
+ 4.16
+ 6.07
+ .69
Control
Mean t = 3.64
Trial 3 [108]
B(a)P .000791
B(a)P .000250
835701 -L
835701 -L
835701 -L
835701 -L
NC- lA+1B
2.86
2.14
1.43
.714
Control
1,2-Epoxypropane
Trial 1 [72]
B(a)P .000791
B(a)P .000250
12EP
12EP
12EP
12EP
NC-1
1.38
1.03
.689
.344
Control
15.5 31.3
30.0 65.7
.000
.000
7.42
82.5
100.
139 (18)
72 (13)
2.52
30.8
92.0
98.7
100.
10 (11)
60 (16)
18 (4)
20 (18)
108 (70)
7.38***
4.77***
.603
3.55***
3.82**
.777
1.17
+ 13.9
+ 5.96
.00 (- 1.71
+ 7.18
+ 2.83
.00 (- 1.38)
Control
Mean t = 2.50
[12EP, M.W. = 58.08. Density = NA g/ml]
2.75 56.8
6.61 82.1
.000
.000
21.5
51.8
100.
85 (18)
84 (18)
90.9
78.5
63.1
97.4
100.
34 (18)
37 (18)
23 (18)
16 (18)
29 (72)
4.1 1***
3.04***
1 .62***
1.61***
.994**
.603
.289
+ 12.7
+ 6.20
+ 6.64
+ 4.81
+ 3.17
+ 1.53
Control
Mean t = 4.04
(Continued on nextpage)
22.7 79.6
39.3 94.2
279 (18)
241 (18)
20.8***
12.9***
+ 13.9
+ 9.34
835701 -L
835701 -L
835701 -L
835701 -L
NC- 1A+lB
4.29
2.14
1.07
.536
Control
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 2 [88]
B(a)P .000791
B(a)P .000250
12EP
12EP
12EP
12EP
NC-1
1.38
1.03
.689
.344
Control
15.8 73.9
35.4 82.6
.000
5.92
28.4
83.6
100.
54 (15)
24 (15)
74.0
82.2
87.4
93.8
100.
39 (18)
60 (17)
29 (14)
7 (6)
37 (67)
3.36***
1.50***
1 .90***
2.73***
1.81***
1 .04*
.406
+ 9.58
+ 4.90
+ 6.22
+ 6.05
+ 5.41
+ 2.04
Control
Mean t = 4.93
Ethylene Dibromide [EDB, M.W. = 187.88, Density = 2.177 g/ml]
Trial 1 [74]
B(a)P .000791
B(a)P .000250
EDB .852
EDB .639
EDB .426
EDB .213
NC-1 Control
Trial 2 [92]
B(a)P .00250
B(a)P .000791
B(a)P .000250
EDB .958
EDB .719
EDB .479
EDB .240
NC-1 Control
.000
35.9
62.3
105.
100.
48.5
97.2
104.
93.8
100.
.394 45.3
18.2 72.2
19.4 78.2
.396
2.77
28.1
72.8
100.
137 (18)
89 (18)
50 (18)
59 (18)
65 (71)
69 (18)
44 (18)
32 (17)
54.1
80.5
94.6
89.5
100.
33 (16)
38 (18)
26 (18)
16 (18)
62 (71)
7.33***
3.86***
2.46***
1.51
.657
3.54***
2. 14***
1.52**
1 .68***
1 .90***
1 .20*
.698
.597
+ 18.7
+ 7.81
+ 5.66
+ 1.93
Control
Mean t = 8.53
+ 8.31
+ 5.20
+ 3.32
+ 3.68
+ 4.71
+ 2.45
+ .47
Control
U^-%- 4- _ f 013
HC Blue 1 [HCB1, M.W. = 256.31]
Trial 1 [15]
B(a)P .000791
B(a)P .000250
.851 12.4
3.83 56.7
209 (20)
72 (20)
8.95***
3.40***
+ 15.8
+ 14.9
HCB1
HCB1
HCB1
HCB1
NC-1
2.35
1.76
1.18
.588
Control
1.28
2.55
16.2
87.7
100.
Trial 2 [21]
B(a)P .000791
B(a)P .000250
HCB1
HCB1
HCB1
HCB1
NC-1
2.45
1.75
1.05
.526
Control
Trial 3 [DRI2]
MNNG .00850
HCB1 2.45
HCB1 1.23
HCB1 .613
NC-1 Control
32.5
83.7
101.
121.
100.
.441 46.1
1.32 75.8
.000
.000
1.32
54.6
100.
11 (17)
11 (20)
9 (19)
11 (19)
10 (39)
133 (18)
63 (19)
.000
39.8
97.9
103.
100.
60.8 NA
49.8
51.9
92.0
100.
NA
NA
NA
100.
6 (7,19)
17 (18)
4 (17)
15 (18)
19 (40)
242 (20)
26 (20)
51 (19)
46 (19)
13 (20)
.488
.423
.291
.397
.186
6.92***
3.1 1***
.524
.671
.177
.576
.347
11.7***
1.07*
2.08***
1.65**
.503
+ 2.13
+ 1.86
+ .71
+ 1.35
Control
Mean t = 1.51
+ 15.8
+ 10.5
+ .72
+ 1.65
.00 (- 1.22)
+ 1.25
Control
Mean t = .725
+ 19.0
+ 2.18
+ 4.12
+ 2.98
Control
Mean t = 3.09
(Continued on nextpage)
3.00 69.2
9.58 78.4
43 (18)
27 (18)
2.02***
1 .29*
+ 4.51
+ 2.49
420TRANSFORMATION RESPONSES OF 168 CHEMICALS
Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Condition' Activityb ActivityC Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Iodinated Glycerol [513502-L, M.W. = 258.07, Density = 1.797 g/ml]
Trial 1 [74]
B(a)P .000791 3.00 69.2 43 (17) 2.02***
B(a)P .000250 9.58 78.4 27 (17) 1.29*
+ 4.51
+ 2.49
513502-L
513502-L
513502-L
513502-L
NC-1
2.69
2.02
1.35
.673
Control
Trial 2 [106]
B(a)P .000791
B(a)P .000250
513502-L 2.69
513502-L 2.02
513502-L 1.35
513502-L .673
NC-1 Control
.000
.000
.000
10.2
100.
.000
50.6
86.4
102.
100.
24.8 56.9
40.7 77.9
.000
.000
.000
16.8
100.
9 (13,18)
89 (18)
99 (17,18)
37 (18)
65 (71)
134 (18)
91 (18)
1.31
24.7
68.5
95.4
100.
6 (8,18)
24 (18)
42 (18)
42 (18)
74 (43)
.498
4.22***
4.29***
1.68***
.657
6.88***
4.53***
.622
.923
2.13
2.11
1.30
.00 (- .67)
+ 8.41
+ 6.11
+ 3.61
Control
Mean t = 6.04
+ 8.00
+ 5.56
.00 (- 1.58)
.00 (- 1.06)
+ 1.99
+ 1.95
Control
Mean t = 1.31
Melphalan [MELP, M.W. = 305.23]
Trial 1 [80]
B(a)P .000791
B(a)P .000250
16.9 65.2
35.6 87.2
261 (20)
185 (20)
12.9***
8.53***
+ 13.0
+ 7.65
MELP
MELP
MELP
MELP
NC-1
.00721
.00361
.00180
.00090
Control
Trial 2 [96]
B(a)P .000791
B(a)P .000250
MELP
MELP
MELP
MELP
NC-1
.00262
.00197
.00131
.000655
Control
.890
2.67
8.01
46.3
100.
3.40
6.16
30.3
75.9
100.
11.0 43.5
38.9 75.4
5.11
14.9
32.6
76.6
100.
0
0
48
113
317
(0,12)
(0,20)
(20)
(20)
(80)
86 (20)
62 (20)
6.66
26.2
47.0
104.
100.
13 (20)
37 (20)
62 (20)
43 (20)
62 (70)
.000
.000
1.72
5.10**
3.02
4.03***
2.88***
.443
1.70***
2.92***
1 .92***
.660
NA
NA
.00 (- 2.44
+ 2.73
Control
Mean t = 1.37
+ 9.40
+ 7.12
.00 (- 1.11)
+ 5.21
+ 9.30
+ 4.71
Control
Mean t = 4.81
N-Methyl-o-Acrylamide [027516-S, M.W. = 101.11]
Trial 1 [70]
B(a)P .000791
B(a)P .000250
1.24 48.9
11.8 81.0
11 (3)
19 (5)
3.38***
3.62***
+ 4.23
+ 5.73
027516-S 5.00
027516-S 2.50
027516-S 1.25
027516-S .625
NC-1A+1B Control
Trial 2 [85]
B(a)P .000791
B(a)P .000250
.000
.000
.000
15.5
100.
.000
2.89
85.2
107.
100.
18.8 55.6
28.7 91.8
0 (0,19)
7 (12,14)
27 (16)
12 (16)
36 (54)
133 (20)
66 (19)
.000
.381
1 .27**
.542
.526
3.43***
2. 10***
NA
.00 (- .72)
+ 2.97
+ .08
Control
Mean t = 1.53
+ 5.10
+ 4.56
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., iM S.A CC.A. III (N) III t-statistic
027516-S 2.00
027516-S 1.50
027516-S 1.00
027516-S .500
NC-1 Control
.000
.000
10.4
34.7
100.
20.2
69.8
100.
101.
100.
76 (19)
32 (20)
9 (20)
18 (20)
38 (80)
3.41***
1.17***
.327
.445
.313
+ 10.5
+ 4.28
+ .10
+ .65
Control
Mean t = 3.88
4,4-Methylenedianiline [44MD, M.W. = 271.21]
Trial 1 [40]
B(a)P .000791
B(a)P .000250
1.06 39.7
8.48 79.2
182 (19)
101 (18)
8.71***
4.86***
44MD
44MD
44MD
44MD
NC-1
2.21
1.66
1.11
.554
Control
Trial 2 [55]
B(a)P .000791
B(a)P .000250
.000
.000
.353
16.3
100.
.000
30.9
76.0
96.5
100.
2.26 23.9
4.07 62.4
5 (11,20)
18 (20)
36 (20)
25 (20)
28 (40)
133 (20)
48 (20)
.287
.668
1.60***
1.08*
.533
5.49***
1.88***
.00 (- 1.14)
+ .65
+ 4.54
+ 2.51
Control
Mean t = 1.93
+ 15.2
+ 7.12
44MD
44MD
44MD
44MD
NC-1
1.85
1.38
.923
.461
Control
.000
.000
2.71
29.0
100.
45.1
73.3
65.9
82.4
100.
4 (20)
26 (20)
12 (20)
4 (20)
7 (40)
.132
1 .1 1***
.330
.149
.129
N-Methyl -N'-Nitro-N-Nitrosoguanidine [MNNG, M.W.
= 147.1]
Trial 1 [93]
B(a)P .000791
B(a)P .000250
MNNG
MNNG
MNNG
MNNG
NC-1
.0204
.0153
.0102
.00510
Control
Trial 2 [IP2]
B(a)P .000791
B(a)P .000250
2.65 46.7
7.96 79.9
.000
.000
8.85
21.2
100.
1.58
14.2
46.7
90.2
100.
138 (20)
115 (20)
19 (20)
102 (19)
169 (20)
80 (19)
43 (79)
6.48***
4.80***
.634
4.54***
8.01***
3.83***
.416
+ .04
+ 5.74
+ 1.26
+ .23
Control
Mean t = 1.82
+ 16.8
+ 12.0
+ 1.02
+ 9.02
+ 18.8
+ 11.7
Control
Mean t = 10.1
ND ND
ND ND
MNNG .0170
MNNG .00850
MNNG .00425
NC-1 Control
30.0
81.0
79.6
100.
ND
ND
ND
ND
228 (20)
219 (20)
101 (20)
71 (40)
10 .9***
6.51***
3.47***
1.13
2-Naphthylamine [2NAP, M.W. = 143.18]
Trial 1 [13]
B(a)P .000791
B(a)P .000250
2NAP
2NAP
2NAP
2NAP
NC-1
1.40
.698
.348
.175
Control
.823 30.6
2.06 75.4
.000
4.12
14.0
51.9
100.
34.8
73.1
99.2
95.7
100.
95 (20)
66 (20)
9 (20)
21 (20)
25 (20)
14 (18)
11 (40)
4.38***
3.14***
.347
.850***
1 .05***
.608**
.201
+ 13.2
+ 5.64
+ 3.72
Control
Mean t = 7.52
+ 14.2
+ 15.7
+ 1.20
+ 4.14
+ 5.21
+ 2.75
Control
Mean t = 3.33
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 2 [26]
B(a)P .000791
B(a)P .000250
.382 13.5
1.15 56.2
204 (20)
144 (20)
9.88***
6.58***
+ 17.8
+ 10.5
2NAP
2NAP
2NAP
2NAP
NC-1
1.05
.698
.348
.175
Control
.763
11.1
46.6
71.0
100.
101.
93.4
94.5
97.8
100.
112 (20)
49 (20)
42 (20)
38 (20)
46 (40)
4.57***
2.09***
1 .86**
1.50
.907
Nitrofurantoin [291535-S, M.W. = 238.16]
Trial 1 [61]
B(a)P .000791
B(a)P .000250
291535-S
291535-S
291535-S
291535-S
NC-1
.167
.125
.0833
.0417
Control
.377 32.6
9.81 69.9
.000
6.04
48.3
100.
100.
Trial 2 [93]
B(a)P .000791
B(a)P .000250
7.90
48.4
93.8
98.5
100.
2.65 46.7
7.96 79.9
94 (20)
43 (20)
9 (20)
10 (15)
3 (20)
4 (20)
12 (40)
138 (20)
115 (20)
4.28***
1 .92***
.327
.557*
.110
.149
.222
6.48***
4.80***
+ 7.41
+ 3.55
+ 3.08
+ 1.92
Control
Mean t = 3.99
+ 14.3
+ 8.76
+ .83
+ 2.28
.00 (- 1.13)
.00 (- .71)
Control
Mean t = .778
+ 16.8
+ 12.0
291535-S .167
291535-S .125
291535-S .0833
201535-S .0417
NC-1 Controt
.000 .000
.000 3.17
21.2 44.3
97.3 105.
100. 100.
3 (20)
31 (20)
59 (20)
15 (20)
43 (79)
.110
1 .17**
2.59**
.578
.416
Nitrofurazone [196993-S, M.W. = 198.14]
Trial 1 [71]
B(a)P .000791
B(a)P .000250
196993-S 1.00
196993-S .750
196993-S .500
196993-S .250
NC-1 Control
Trial 2 [77]
B(a)P .000791
B(a)P .000250
4.48 50.7
18.1 68.7
.000
.000
.000
.000
100.
251 (20)
77 (20)
.000
.000
.000
.000
100.
5.66 69.5
16.5 78.7
0 (0,19)
0 (0,20)
0 (0,19)
6 (20)
110 (75)
179 (20)
114 (19)
11 .0***
3.50***
.000
.000
.000
.196
1.06
8.33***
5.53***
.00 (- 3.34)
+ 2.99
+ 8.73
+ 1.03
Control
Mean t = 4.25
+ 12.1
+ 7.12
NA
NA
NA
.00 (- 4.94)
Controt
Mean t = .000
+ 13.6
+ 10.0
196993-S
196993-S
196993-S
196993-S
NC-1
.100
.0750
.0500
.0250
Control
Trial 3 [87]
B(a)P .000791
B(a)P .000250
196993-S .0750
196993-S .0563
196993-S .0375
196993-S .0188
NC-1 Control
.000
.000
.000
2.83
100.
1.47
8.25
39.8
92.1
100.
25.1 77.0
42.2 80.2
.000
1.09
3.27
45.1
100.
16.6
35.0
72.1
90.0
100.
18 (20)
44 (20)
77 (20)
55 (20)
94 (78)
59 (20)
34 (20)
57 (20)
64 (20)
29 (20)
10 (20)
43 (80)
.737
1.77**
3.13***
2.38***
.972
2.26***
1.45***
2.33***
2.69***
1.14***
.374
.346
.00 (- 1.07)
+ 2.72
+ 5.85
+ 4.46
Control
Mean t = 3.26
+ 5.84
+ 5.24
+ 7.56
+ 8.33
+ 3.89
+ .18
Controt
Mean t = 4.99
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activity' Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
4,4-Oxydianiline [oxY, M.W. = 200.24]
Trial 1 [1]
B(a)P .000791 9.75 56.3 171 (20) 8.16*** + 12.1
B(a)P .000250 15.5 91.0 114 (20) 5.18*** + 6.68
OXY .674 .000 10.4 17 (20) .644 .00 (- 2.68)
OXY .549 .000 32.6 36 (20) 1.41 .00 (- .06)
OXY .370 1.08 73.6 51 (20) 2.34* + 2.31
OXY .165 26.0 117. 70 (20) 3.28*** + 4.92
NC-1 Control 100. 100. 73 (40) 1.44 Control
Mean t = 1.81
Trial 2 [8]
B(a)P .000791 1.45 5.83 244 (19) 10.7*** + 8.19
B(a)P .000250 4.35 52.4 254 (20) 11.8*** + 11.2
OXY .499 .000 .000 32 (20) 1.25 .00 (- 2.24)
OXY .375 .000 .000 68 (20) 2.93 + 1.38
OXY .250 2.90 25.2 134 (20) 5.88** + 5.12
OXY .125 22.2 89.3 163 (20) 7.70*** + 8.36
NC-1 Control 100. 100. 110 (40) 2.19 Control
Mean t = 3.72
2-Nitro-p-Phenylenediamine [2NPD, M.W. = 153.16]
Trial 1 [15]
B(a)P .000791 .851 12.4 209 (20) 8.95*** + 15.8
B(a)P .000250 3.83 56.7 72 (20) 3.40*** + 14.9
2NPD 6.53 .426 .000 0 (8,20) .000 .00 (- 3.31)
2NPD 3.27 .851 9.64 22 (19) .965** + 4.84
2NPD 1.63 2.31 11.6 27 (20) .977** + 3.55
2NPD .816 4.26 54.0 50 (20) 2.16*** + 8.23
NC-1 Control 100. 100. 10 (39) .186 Control
Mean t = 4.21
Trial 2 [21]
B(a)P .000791 .441 46.1 133 (18) 6.92*** + 15.8
B(a)P .000250 1.32 75.8 63 (19) 3.11*** + 10.5
2NPD 1.63 .000 21.4 21 (20) .726 + 1.92
2NPD .816 .000 63.9 16 (19) .652 + 1.69
2NPD .408 17.2 90.8 17 (20) .551 + 1.09
2NPD .204 45.8 97.4 12 (20) .473 + .80
NC-1 Control 100. 100. 19 (40) .347 Control
Mean t = 1.38
Trial 3 [96]
B(a)P .000791 11.0 43.5 86 (20) 4.03*** + 9.40
B(a)P .000250 38.9 75.4 62 (20) 2.88*** + 7.12
2NPD 1.63 3.54 61.7 35 (19) 1.57** + 3.39
2NPD 1.22 7.47 62.1 29 (18) 1.17 + 1.93
2NPD .816 19.3 60.4 46 (19) 2.28*** + 7.57
2NPD .408 64.8 82.5 43 (19) 1.98*** + 4.64
NC-1 Control 100. 100. 62 (70) .660 Control
Mean t = 4.38
Quinoline [QUIN, M.W. = 129.16, Density= 1.095 g/ml]
Trial 1 [16]
B(a)P .000791 .881 47.5 139 (17) 7.96*** + 17.5
B(a)P .000250 4.85 76.6 58 (17) 2.77*** + 7.77
(Continued on nextpage)
424TRANSFORMATION RESPONSES OF 168 CHEMICALS
Appendix B. Continued.
Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
QUIN 1.70
QUIN 1.10
QUIN .551
QUIN .276
NC-1 Control
Trial 2 [27]
B(a)P .000791
B(a)P .000250
QUIN 2.54
QUIN 1.70
QUIN .848
QUIN .424
NC-1 Control
Trial 3 [31]
B(a)P .000791
B(a)P .000250
QUIN 6.32
QUIN 4.24
QUIN 3.18
QUIN 2.12
NC-1 Control
8.81 94.3
27.8 96.8
53.3 94.6
99.1 109.
100. 100.
4.04 33.7
13.0 47.4
17.4 77.4
23.6 95.2
52.8 81.1
91.3 44.2
100. 100.
1.87 69.1
5.14 99.9
.000 .485
.467 29.1
9.35 64.0
12.6 93.1
100. 100.
6 (18)
7 (18)
2 (18)
4 (18)
17 (36)
170 (18)
73 (18)
16 (18)
18 (18)
14 (18)
5 (18)
31 (36)
136 (15)
126 (18)
2 (4,18)
39 (17)
33 (18)
28 (18)
43 (36)
.260
.289
.080
.148
.344
8.90***
3. 18***
.737
.765
.537
.193
.555
8.63***
6.06***
.316
1 .80*
1 .59*
1.36
.930
.00 (- .570
.00 (- .36)
.00 (- 2.51 )
.00 (- 1.40)
Control
Mean t = .000
+ 14.8
+ 5.71
+ .73
+ .81
.00 (- .07)
.00 (- 2.12)
Control
Mean t = .385
+ 11.1
+ 8.51
.00 (- 1.330
+ 2.29
+ 2.05
+ 1.44
Control
Mean t = 1.93
Trial 4 [104]
B(a)P .000791
B(a)P .000250
QUIN
QUIN
QUIN
QUIN
NC-1 Control
.000 22.5
21.8 72.8
46.5 101.
65.8 96.2
100. 100.
21 (14,18)
51 (18)
66 (18)
32 (18)
83 (71)
.950
2.37***
3.22***
1.47
.878
Selenium Sulfide [SESU, M.W. = 111.02]
Trial 1 [7]
B(a)P .000791
B(a)P .000250
1.52 48.4
3.41 56.9
212 (19)
41 (20)
10.0***
1 .80***
+ .22
+ 4.11
+ 5.83
+ 1.94
Control
Mean t = 3.96
+ 26.6
+ 7.07
SESU .180
SESU .108
SESU .0721
SESU .0360
NC-1 ControL
Trial 2 [11]
B(a)P .000791
B(a)P .000250
.758 21.3
14.4 48.7
22.0 45.6
57.2 76.2
100. 100.
1.37 34.4
7.22 36.0
26 (19)
18 (18)
13 (20)
11 (19)
7 (36)
128 (20)
37 (20)
1.06***
.793**
.503*
.471**
.135
4.94**
1.62**
+ 4.34
+ 3.69
+ 2.56
+ 2.78
Control
Mean t = 3.34
+ 10.5
+ 5.38
SESU .180
SESU .108
SESU .0721
SESU .0360
NC-1 Control
Trial 3 [97]
B(a)P .000791
B(a)P .000250
6.19 49.5
14.4 103.
25.1 125.
32.6 151.
100. 100.
4.74 78.0
17.4 104.
7 (18,20)
16 (20)
6 (20)
15 (20)
21 (40)
118 (20)
52 (20)
.309
.410
.214
.322
.301
5.02***
2.26***
+ .06
+ .56
.00 (- .56)
+ .11
Control
Mean t = .223
+ 12.5
+ 7.26
(Continued on nextpage)
25.0 64.5
50.6 89.6
62 (18)
63 (18)
2.79***
2.47***
+ 4.87
+ 4.10
425MATTHEWS ET AL.
Appendtx B. Continuedc
Treatent Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Coac., mM S.A CC.A. III (N) III t-statistic
SESU .225
SESU .169
SESU .113
SESU .0563
NC-1 Control
79.8 84.6
92.5 85.4
111. 84.6
113. 92.0
100. 100.
22 (16)
22 (19)
18 (18)
44 (19)
47 (80)
.956*
1 .03**
.765
.916
.414
+ 2.45
+ 3.17
+ 1.81
+ 1.51
Control
Mean t = 2.24
o-Toluidine [OTOL, M.W. = 107.16, Density = 1.008 g/ml]
Trial 1 [16]
B(a)P .000791
B(a)P .000250
.881 47.5
4.85 76.6
139 (17)
58 (17)
7.96***
2.77***
OTOL 4.70
OTOL 3.06
OTOL 1.41
OTOL .705
NC-1 Control
Trial 2 [25]
B(a)P .000791
B(a)P .000250
OTOL 9.41
OTOL 7.05
OTOL 4.70
OTOL 2.35
NC-1 Control
1.32 88.3
5.73 90.5
26.4 100.
44.1 109.
100. 100.
NA 21.4
NA 73.4
NA 6.77
NA 12.5
NA 26.6
NA 25.0
NA 100.
22 (18)
11 (18)
10 (18)
6 (18)
17 (36)
192 (18)
59 (18)
25 (17,18)
30 (18)
39 (18)
57 (18)
5 (36)
.950**
.409
.414
.212
.344
9.74***
2.55***
1 .25**
1 .47***
2.01***
2.80***
.101
+ 2.81
+ .37
+ .42
.00 (- .87)
ControL
Mean t = .900
+ 19.9
+ 7.52
+ 5.90
+ 7.50
+ 12.6
+ 11.1
Control
Mean t = 9.28
Trial 3 [98]
B(a)P .000791
B(a)P .000250
OTOL 4.70
OTOL 3.53
OTOL 2.35
OTOL 1.18
NC-1 Control
6.28 80.4
7.33 79.4
12.6 81.1
23.0 86.8
100. 100.
33 (18)
60 (18)
60 (18)
38 (18)
39 (45)
1 .62***
2.78***
2.38***
1 .63**
.618
+ 3.48
+ 5.73
+ 4.87
+ 3.17
Control
Mean t = 4.31
Ziram [ZIRAM, M.W. = 305.81]
Trial 1 [77]
B(a)P .000791
B(a)P .000250
ZIRAM .000164
ZIRAM .0000818
ZIRAM .0000409
ZIRAM .0000204
NC-1 Control
Trial 2 [99]
B(a)P .000791
B(a)P .000250
ZIRAM .000114
ZIRAM .0000572
ZIRAM .0000286
ZIRAM .0000143
NC-1 Control
.000 1.65
.000 3.30
4.72 27.8
12.7 74.8
100. 100.
28.9 73.6
58.1 89.9
.000 2.12
12.0 8.91
56.4 78.5
91.3 101.
100. 100.
22 (19)
36 (19)
34 (18)
26 (16)
94 (78)
60 (20)
14 (20)
40 (20)
54 (20)
8 (20)
27 (20)
31 (75)
.825
1 .62*
1.58*
1.06
.972
2.00***
.503
1 .62***
2.54***
.301
.303
.322
.00 (- .63)
+ 2.33
+ 2.12
+ .24
Control
Mean t = 1.17
+ 5.11
+ 1.31
+ 5.21
+ 11.2
.00 (- .17)
.00 (- .08)
Control
Mean t = 4.10
(Continued on nextpage)
+ 17.5
+ 7.77
8.38 79.6
29.3 91.3
132 (18)
75 (18)
6.82***
3.38***
+ 11.8
+ 6.81
5.66 69.5
16.5 78.7
179 (20)
114 (19)
8.33***
5.53***
+ 13.6
+ 10.0
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Appendix B. Continued.
Abbreviations: BaP, benzo(a)pyrene; CCA, co-culture clonal survival assay; Conc, concentration; mM, millimole; M.W., molecularweight; N,
number ofculture vessels, NC, negative control; ND; not determined; %RCE, percent relative cloning efficiency; S.A, standard clonal survival
assay.
aTreatment condition: The experimental design for the transformation assay is described in detail in the Materials and Methods. The
concentration ofthe positive control and test chemical treatment are presented in mM, but they can be converted to ,ug/ml using the molecular
weight that is provided with each chemical. The solvent vehicles used for the individual test chemicals were listed in Appendix Tables Al and A3,
and the concentrations ofthe solvent vehicles are presented in the Materials and Methods.
bCytotoxic activity: The experimental design for the standard survival assay (SA) and the co-culture clonal survival assay (CCA) were described
in the Materials and Methods. The test chemical cytotoxic response was expressed as % RCE and was calculated as described in theMaterials and
Methods.
cThe criteria used to evaluate the transformed foci ofBALB/c-3T3 cells is described in the Materials and Methods. The number oftype III foci
> 2-mm in diameter per culturevessel scored are recorded in this table.
dTransformation response: The transformation responses are expressed as type III foci/vessel and were calculated using alog1o,mathematical
transformation procedure (refer to Materials and Methods). The arithmetic value or foci/vessel represents the antilog ofthe log1o mean
transformation responseminus one.
eSignificance: The significance oftest chemical transformation responses was calculated by a computer using the SAS statistical. software (22),
and the method is described in detail in Materials and Methods. The correct t-statistic according to the F-test is presented in this table. The
t-statistics ofeach treatment dose ofthe test chemical in a single experimentwere averaged to determine the mean t-statistic ofthe test chemical
for the experiment (refer to Appendix Tables A2 and A5). The mean t-statistics for two or experiments for each chemical was weighted to the
number oftreatment doses evaluated and averaged to determine the rank t-statistic which was used to rank-order the test chemical
transformation responses in Appendix Tables A3 and A6. Arbitrarily, transformation responses with negative (-) t-statistics were given avalue of
zero (0).
*Significant BaP ortest chemical transformation response, 0.01 < p < 0.05.
**Significant BaP or test chemical transformation response, 0.001 < p < 0.01.
***Significant or BaP or test chemical transformation response, p < 0.001.
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Summary ofthe transformation responses of21 cytotoxic, mutagenic noncarcinogens.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc.t, mM S.A CC.A. III (N) III t-statistic
4-Acetylaminofluorene [4AAF, M.W. = 223.29]
Trial 1 [12]
B(a)P* .000791 90.7 99.0 61 (19)
B(a)P .000250 77.6 114. 81 (17)
2.90 ***
3.94 ***
+ 13.1
+ 10.5
4AAF
4AAF
4AAF
4AAF
NC-1
1.79
1.31
.896
.448
Control
47.3
63.5
77.1
71.9
100.
123.
129.
129.
128.
100.
11 (18)
5 (19)
5 (17)
5 (18)
8 (40)
.432
.200
.206
.212
.160
*NOTE: B(a)P was accidentally not dosed in the standard and the co-culture
Trial
B(a)P
B(a)P
4AAF
4AAF
4AAF
4AAF
NC-1
2 [17]
.000791
.000250
1.79
.896
.448
.224
Control
.000 52.9
3.54 79.1
55.8
55.2
51.8
65.9
100.
93.0
99.0
104.
106.
100.
94 (20)
86 (20)
29 (20)
30 (20)
5 (20)
23 (20)
18 (40)
4.43***
3.91***
.997*
.724
.189
.821*
.327
4' - (Chloroacetyl )acetanilide [4CM, M.W. = 211.66]
Trial
B(a)P
B(a)P
1 [37]
.000791
.000250
1.60 46.0
6.80 77.2
101 (20)
113 (20)
4.59***
5.38***
+ 1.92
+ .61
+ .61
+ .71
Control
Mean t = .963
clonal survival assays.
+ 13.5
+ 11.6
+ 2.62
+ 1.44
.00 (-1.07)
+ 2.50
Control
Mean t = 1.64
+ 9.94
+ 13.5
4CM
4CAA
4CAA
4CM
NC-1
Trial
B(a)P
B(a)P
4CM
4CAA
4CAA
4CM
NC-1
.00378
.00283
.00189
.00094
Control
2 [95]
.000791
.000250
.00472
.00354
.00236
.00118
Control
.000
.000
1.60
58.0
100.
57.1
74.9
90.9
86.2
100.
16.0 ND
33.3 ND
.000
.000
.000
46.1
100.
ND
ND
ND
ND
ND
55 (20)
21 (20)
21 (20)
22 (20)
32 (39)
152 (20)
115 (20)
127
24
27
70
263
(15)
(8)
(14)
(18)
(77)
2.37***
.702
.839
.787
.631
7.35***
5.27***.
6.71***
2.60
1.82
3.56
2.84
2-(Chloromethyl )pyridine-HC1 [2CMP, M.W. = 164.04]
Trial 1
B(a)P
B(a)P
[14]
.000791
.000250
2CMP .152
2CMP .107
2CMP .0533
2CMP .0267
NC-1 Control
Trial 2 [22]
B(a)P .000791
B(a)P .000250
1.75 36.1
5.26 74.7
.000
4.82
36.4
93.0
100.
8.89
73.0
103.
108.
100.
1.86 53.4
6.52 81.4
177 (20)
61 (20)
23 (20)
12 (19)
18 (20)
15 (20)
12 (40)
187 (20)
116 (20)
6.73***
2.45***
.938***
.526*
.550
.452
.213
8.86***
5.25***
+ 5.49
+ .31
+ .92
+ .66
Control
Mean t = 1.85
+ 9.48
+ 3.82
+ 4.54
.00 (- .33)
.00 (-3.13)
+ 1.29
Control
Mean t = 1.46
+ 13.3
+ 7.12
+ 4.28
+ 2.21
+ 1.66
+ 1.29
Control
Mean t = 2.36
+ 16.0
+ 9.33
(Continued on nextpage)
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Appendix C. Continued.
Treatment Cytotoxic Transforming Transformation
Condi_ti_ona Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
2CMP .213 .000 99.7 63 (20) 2.94*** + 6.03
2CMP .152 39.1 105. 54 (20) 2.14*** + 3.59
2CMP .0914 72.0 107. 35 (20) 1.33 + 1.45
2CMP .0457 84.5 94.0 23 (20) .877 .00 (- .06)
NC-1 Control 100. 100. 45 (40) .893 Control
Mean t = 2.77
3-Chloro-p-Toluidine [3CT, M.W. = 141.60]
Trial 1 [81]
B(a)P .000791 10.2 63.9 378 (18) 20.8*** + 15.5
B(a)P .000250 28.0 67.8 280 (18) 15.3*** + 10.5
3CT 1.41 .000 42.2 215 (18) 11.2*** + 3.55
3CT 1.06 7.34 91.4 225 (18) 11.9*** + 4.13
3CT .706 13.6 94.3 211 (18) 10.3* + 2.70
3CT .353 50.3 107. 105 (18) 5.45 .00 (-2.45)
NC-1 Control 100. 100. 583 (72) 7.36 Control
Mean t = 2.60
Trial 2 [92]
B(a)P .00250 .394 45.3 69 (18) 3.54*** + 8.31
B(a)P .000791 18.2 72.2 44 (18) 2.14*** + 5.20
B(a)P .000250 19.4 78.2 32 (17) 1.52** + 3.32
3CT 1.55 11.9 92.3 37 (18) 1.78*** + 4.29
3CT 1.17 44.8 87.4 49 (18) 2.44*** + 5.95
3CT .777 45.5 89.3 33 (18) 1.50** + 3.40
3CT .388 75.2 94.8 22 (18) 1.07* + 2.05
NC-1 Control 100. 100. 62 (71) .597 Control
Mean t = 3.92
Coumaphos [COU, M.W. = 362.78]
Trial 1 [30]
B(a)P .000791 1.32 60.3 158 (20) 7.23*** + 12.3
B(a)P .000250 2.63 101. 98 (19) 4.24*** + 8.08
COU .276 .000 .510 2 (18,20) .080 .00(-4.29)
COU .138 5.70 4.08 8 (20) .301 .00(-2.61)
COU .0689 18.4 54.0 17 (20) .751 .00(- .17)
COU .0345 31.6 94.8 13 (20) .459 .00(-1.56)
NC-1 ControL 100. 100. 40 (40) .787 ControL
Mean t = .000
Trial 2 [95]
B(a)P .000791 16.0 ND 152 (20) 7.35*** + 9.48
B(a)P .000250 33.3 ND 115 (20) 5.27*** + 3.82
COU .221 66.5 ND 125 (18) 6.11*** + 4.54
COU .110 77.1 ND 93 (18) 4.89*** + 4.37
COU .0551 81.1 ND 71 (12) 5.47** + 3.25
COU .0276 86.0 ND 88 (17) 4.68** + 2.83
NC-1 ControL 100. 100. 263 (77) 2.84 ControL
Mean t = 3.75
Trial 3 [99]
B(a)P .000791 18.9 68.4 160 (20) 6.67*** + 12.4
B(a)P .000250 32.1 85.0 94 (20) 3.59*** + 7.95
COU .331 44.2 56.9 83 (20) 3.20*** + 7.18
COU .165 50.2 62.0 100 (20) 4.53*** + 10.3
COU .0827 52.5 91.0 89 (20) 3.83*** + 8.84
COU .0413 60.4 87.9 39 (20) 1.64*** + 4.06
NC-1 ControL 100. 100. 65 (80) .586 Control
Mean t = 7.60
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Appendix C. Continued.
Treatment Cytotoxic Transforming Transformation
Condition'a Activityb Activity' Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., m4 S.A CC.A. III (N) III t-statistic
Dimnethoate [CYGON, M.W. = 229.27, Density = 1.277 g/ml]
Trial 1 [41]
B(a)P .000791
B(a)P .000250
1.29 33.6
6.45 78.2
189 (18)
123 (18)
10.2*
6.37***
+
+
CYGON .668
CYGON .334
CYGON .167
CYGON .0835
NC-i Control
Trial 2 [94]
B(a)P .000791
B(a)P .000250
CYGON .835
CYGON .627
CYGON .418
CYGON .209
NC-i Control
1.29 50.1
14.8 78.2
85.8 89.2
91.3 103.
100. 100.
.000 75.7
17.4 114.
2.05 55.9
2.05 53.5
14.4 64.6
40.0 123.
100. 100.
16 (18)
16 (18)
8 (18)
6 (18)
13 (36)
122 (18)
81 (18)
117 (18)
129 (18)
69 (18)
30 (18)
150 (71)
.655*
.698*
.309
.260
.274
5.92***
3.88***
6.33***
6.26***
3.39***
.935
1.52
Controt
Mean t =
2.4-Dimnethoxyaniline-HC1 [DMAN, M.W. = 189.66]
Trial 1 [34]
B(a)P .000791
B(a)P .000250
DMAN 1.32
DMAN .923
DMAN .527
DMAN .264
NC-i ControL
Trial 2 [87]
B(a)P .000791
B(a)P .000250
6.91 58.7
19.3 84.5
.000 55.6
.000 78.9
.000 86.5
9.09 69.5
100. 100.
25.1 77.0
42.2 80.2
167 (20)
138 (20)
91 (20)
108 (20)
124 (20)
127' (20)
108 (40)
59 (20)
34 (20)
8.23***
6.39***
4.20***
5.18*
5.76***
5.8**
2.51
2.26***
1.45***
+ 14.5
+ 7.66
+ 4.09
+ 6.27
+ 6.81
+ 6.63
Controt
Mean t = 5.95
+ 5.84
+ 5.24
DMAN 1.58
DMAN 1.19
DMAN .791
DMAN .395
NC-i Control
Trial 3 [97]
B(a)P .000791
BOW) .000250
DMAN 1.48
DMAN 1.11
DMAN .738
DMAN .369
NC-i Control
.000 2.69
.000 58.7
.000 77.3
44.7 88.3
100. 100.
4.74 78.0
17.4 104.
.000 .000
.000 10.9
.000 60.2
9.48 93.9
100. 100.
1 (18,20)
18 (20)
17 (20)
13 (20)
43 (80)
118 (20)
52 (20)
3 (16,20)
7 (20)
16 (20)
15 (17)
47 (80)
.039
.662
.601
.460
.346
5.02***
2.26***
.139
.238
.644
.711
.414
.00(-4.02)
+ 1.79
+ 1.46
+ .70
Controt
Mean t = 1.32
+ 12.5
+ 7.26
.00(-2.50)
.00(-1 .19)
+ 1.32
+ 1.56
Control
Mean t = .960
HG Blue 2 [HCB2, M.W. = 285.34]
Trial 1 [5]
B(a)P .000791
B(a)P .000250
7.76 9.41
12.5 12.5
(Continued on ne-xt page)
84 (19)
57 (20)
3.97***
2.58***
+ 15.5
+ 12.5
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Appendix C. Continued.
Treatment Cytotoxic Transforming Transformation
Condi_ti_on' Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
HCB2 7.01
HCB2 5.84
HCB2 4.21
HCB2 3.50
NC-1 Control
Trial 2 [10]
B(a)P .000791
B(a)P .000250
HCB2 4.21
HCB2 3.50
HCB2 2.80
HCB2 2.10
NC-1 Control
.000 .000
.000 14.1
.431 11.8
.000 127.
100. 100.
1.89 30.6
8.49 91.7
.000 94.4
.000 168.
.000 135.
.000 214.
100. 100.
0 (0,20)
0 (0,20)
2 (8,20)
11 (20)
2 (40)
105 (20)
34 (20)
12 (20)
3 (20)
7 (20)
5 (19)
3 (40)
.000
.000
.072
.423
.035
4.79***
1.37***
.264
.110
.256
.182
.053
ND
ND
+ .65
+ 3.30
Control
Mean t = 3.30
+ 18.3
+ 6.23
+ 1.42
+ .90
+ 2.02
+ 1.38
Control
Mean t = 1.43
HC Red 3 [HCR3, M.W. = 197.22]
Trial 1 [40]
B(a)P .000791
B(a)P .000250
HCR3 6.09
HCR3 3.04
HCR3 1.52
HCR3 .761
NC-1 Control
Trial 2 [57]
B(a)P .000791
B(a)P .000250
HCR3 6.09
HCR3 3.04
HCR3 1.52
HCR3 .761
NC-1 Control
.000 34.3
.353 35.1
11.0 72.1
78.8 91.1
100. 100.
3.55 30.1
5.32 69.9
.000 9.42
28.0 88.0
80.5 88.8
81.6 84.0
100. 100.
25 (19)
27 (19)
44 (20)
25 (20)
28 (40)
162 (20)
37 (20)
29 (20)
31 (20)
14 (20)
10 (17)
15 (40)
1.16**
1.07*
1.29*
1 .11**
.533
7.55***
1.63***
1.18***
1.22***
.534
.395
.278
+ 2.86
+ 2.19
+ 2.24
+ 2.71
Control
Mean t = 2.50
+ 18.7
+ 6.91
+ 4.69
+ 3.99
+ 1.66
+ .74
Control
Mean t = 2.77
HC Red 3 [HCR3, 260886-S. M.W. = 197.22]
Trial 1 [61]
B(a)P .000791
B(a)P .000250
.377 32.6
9.81 69.9
260886-S 6.00
260886-S 3.00
260886-S 1.50
260886-S .750
NC-1 Control
Trial 2 [99]
B(a)P .000791
B(a)P .000250
.000 46.1
2.26 67.1
13.6 86.4
44.9 86.4
100. 100.
18.9 68.4
32.1 85.0
11 (18)
12 (20)
17 (20)
7 (19)
12 (40)
160 (20)
94 (20)
.503*
.494*
.568
.272
.222
6.67***
3.59***
+ 2.07
+ 2.08
+ 1.89
+ .41
Control
Mean t = 1.61
+ 12.4
+ 7.95
260886-S 7.89 3.40 38.5
260886-S 3.95 9.43 38.7
260886-S 1.97 17.7 74.9
260886-S .986 67.2 81.8
NC-1 Control 100. 100.
135 (20)
81 (20)
94 (20)
89 (20)
65 (80)
5.94***
3.38***
4.07***
4.01***
.586
+ 11.7
+ 7.92
+ 9.28
+ 9.41
Control
Mean t = 9.58
(Continued on nextpage)
1.06 39.7
8.48 79.2
182 (19)
101 (18)
8.71***
4.86***
+ 14.9
+ 9.93
95 (20)
43 (20)
4.28***
1.92***
+ 14.3
+ 8.76
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Appendix C. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed _Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
8-Hydroxyquinoline [8HYQ, M.W. = 145.16]
Trial 1 [3]
B(a)P .000791
B(a)P .000250
10.7 47.1
13.4 81.6
8HYD .00379
8HYD .00331
8HYD .00276
8HYD .00186
NC-1 Control
Trial 2 [9]
B(a)P .000791
B(a)P .000250
.000 2.30
.000 13.8
.000 19.5
.000 46.0
100. 100.
3.14 3.83
8.52 87.2
6 (19,20)
21 (20)
20 (20)
14 (20)
17 (40)
108 (20)
47 (20)
.245
.787*
.850**
.547
.285
4.93***
1.92***
.00(- .30)
+ 2.61
+ 3.19
+ 1.59
Control
Mean t = 2.46
+ 16.2
+ 7.04
8HYD .00344
8HYD .00276
8HYD .00207
8HYD .00138
NC-1 Control
Trial 3 [28]
B(a)P .000791
B(a)P .000250
8HYD .00413
8HYD .00276
8HYD .00207
8HYD .00138
NC-1 Control
.000 1.03
.000 3.08
.000 41.0
2.24 89.2
100. 100.
2.84 28.6
6.74 68.0
.000 48.9
.000 66.0
5.32 70.0
84.8 75.2
100. 100.
4 (20)
3 (20)
4 (20)
17 (20)
8 (40)
189 (20)
62 (20)
22 (20)
21 (20)
25 (20)
19 (20)
41 (40)
.149
.110
.149
.270
.149
9.02***
2.78***
.937
.756
.341
.726
.818
.00
.00(- .46)
.00
+ .68
Control
Mean t = .170
+ 16.9
+ 5.73
+ .51
.00(- .25)
.00(-1.72)
.00(- .39)
Control
Mean t = .128
Malaoxon [MALX, M.W. = 314.32; Density = NA g/ml]
Trial 1 [16]
B(a)P .000791
B(a)P .000250
MALX 2.36
MALX 1.57
MALX .786
MALX .393
NC-1 Control
Trial 2 [25]
B(a)P .000791
B(a)P .000250
MALX .589
MALX .393
MALX .255
MALX .118
NC-1 Control
.000 .000
.000 .000
.000 .000
.000 78.8
100. 100.
ND 21.4
ND 73.4
ND 9.90
ND 61.9
ND 84.4
ND 85.9
ND 100.
0 (0,18)
0 (0,18)
0 (0,18)
44 (18)
17 (36)
192 (18)
59 (18)
0 (0,18)
87 (18)
29 (18)
9 (18)
5 (36)
.000
.000
.000
1.81***
.344
9.74***
2.55***
.000
4.64***
1. 15***
.309
.101
ND
ND
ND
+ 4.17
Control
Mean t = 4.17
+ 19.9
+ 7.52
ND
+ 22.7
+ 4.24
+ 1.43
Control
Mean t = 9.46
1-Naphthylamine [lNAP, M.W. = 143.18]
Trial 1 [13]
B(a)P .000791
B(a)P .000250
(Continued on nextpage)
127 (20)
39 (20)
5.84***
1.61***
+ 14.8
+ 5.63
.881 47.5
4.85 76.6
139 (17)
58 (17)
7.96***
2.77***
+ 17.5
+ 7.77
.823 30.6
2.06 75.4
95 (20)
66 (20)
4.38***
3. 14***
+ 14.2
+ 15.7
432TRANSFORMATION RESPONSES OF 168 CHEMICALS
Appendix C. Continued.
Treatment Cytotoxic Transforming Transformation
Condition' Activityb ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc.,mM S.A CC.A. III (N) III t-statistic
1NAP .210
1NAP .140
1NAP .0698
1NAP .0349
NC-1 Control
Trial 2 [19]
B(a)P .000791
B(a)P .000250
1NAP .279
1NAP .140
1NAP .0698
1NAP .0349
NC-1 Control
.823 84.3
4.94 82.0
14.4 96.3
50.6 113.
100. 100.
.000 62.5
1.67 89.0
5.83 62.9
15.4 72.8
25.0 86.2
52.5 97.6
100. 100.
22 (20)
21 (20)
16 (20)
6 (20)
11 (40)
99 (20)
100 (20)
26 (19)
28 (20)
32 (20)
24 (20)
18 (38)
.775**
.899***
.634**
.214
.201
4.61***
4.02***
1.14***
1 .09***
1 .00*
.888*
.357
+ 2.85
+ 4.65
+ 3.02
+ .11
Control
Mean t = 2.66
+ 13.4
+ 10.6
+ 3.80
+ 3.46
+ 2.35
+ 2.28
Control
Mean t = 2.97
N- (1-Naphthyl )ethylenediamine-2HC1
Trial 1 [38]
B(a)P .000791
B(a)P .000250
2.10 28.4
9.44 74.7
[NED, M.W. = 259.18]
174 (20)
162 (20)
NED .193
NED .145
NED .0965
NED .0482
NC-1 Control
Trial 2 [87]
B(a)P .000791
B(a)P .000250
NED .193
NED .145
NED .0965
NED .0482
NC-1 Control
.000 .000
.000 64.4
33.9 78.5
71.7 75.5
100. 100.
25.1 77.0
42.2 80.2
.000 .000
.000 39.9
22.2 72.4
105. 71.6
100. 100.
4 (12,19)
9 (19)
16 (20)
31 (20)
27 (40)
59 (20)
34 (20)
0 (1,20)
19 (19)
11 (19)
23 (19)
43 (80)
.230
.368
.494
1.21**
.496
2.26***
1.45***
.000
.826*
.419
1 .09***
.346
.00(-1.33)
.00(- .73)
.00)- .01
+ 2.87
Control
Mean t = .957
+ 5.84
+ 5.24
.00(- .64)
+ 2.60
+ .45
+ 3.89
Control
Mean t = 2.31
1-Nitronaphthalene [lNNAP, M.W. = 173.17]
Trial 1 [33]
B(a)P .000791
B(a)P .000250
3.44 2.40
5.73 51.4
1NNAP .866
1NNAP .577
1NNAP .289
1NNAP .144
NC-1 Control
Trial 2 [87]
B(a)P .000791
B(a)P .000250
.000 .000
1.53 10.7
29.4 93.2
49.6 98.0
100. 100.
25.1 77.0
42.2 80.2
1 (3,20)
20 (19)
10 (20)
9 (20)
54 (37)
59 (20)
34 (20)
.260
.727
.394
.327
1.04
2.26***
1.45***
.00(-1 .32)
.00(- .98)
.00(-2.85)
.00( -2.79)
Controtl
Mean t = .000
+ 5.84
+ 5.24
1NNAP .577
1NNAP .433
1NNAP .289
1NNAP .144
NC-1 Control
16.4
25.8
33.8
59.6
100.
54.5
68.7
73.6
75.8
100.
20 (19)
24 (16)
17 (14)
11 (14)
43 (80)
.826*
1 .11**
.950*
.641
.346
+ 2.54
+ 3.37
+ 2.72
+ 1.50
Controtl
Mean t = 2.53
(Continued on nextpage)
7.75***
8.17***
+ 15.6
+ 18.0
214 (20)
130 (20)
10.0***
5.86***
+ 13.6
+ 7.74
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Appendix C. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
9rug Conc., mM S.A CC.A. III (N) III t-statistic
4-Nitro-o-Phenylenediamine [4NPD, M.W. = 153.14]
Trial 1 [14]
B(a)P .000791
B(a)P .000250
1.75 36.1
5.26 74.7
177 (20)
61 (20)
6.73***
2.45***
+ 13.3
+ 7.12
4NPD .490
4NPD .245
4NPD .123
4NPD .0306
NC-1 Control
Trial 2 [18]
B(a)P .000791
B(a)P .000250
4NPD .261
4NPD .131
4NPD .0653
4NPD .0326
NC-1 Control
1.32 46.8
3.95 52.2
7.46 70.9
22.8 102.
100. 100.
2.24 45.8
8.52 78.5
.000 81.1
.448 88.6
8.97 86.1
23.8 90.2
100. 100.
23 (20)
22 (20)
41 (20)
13 (20)
12 (40)
125 (20)
86 (20)
25 (20)
34 (20)
14 (17)
17 (19)
33 (40)
.955***
.860***
1.58***
.481
.213
5.91***
3.36***
1.10*
1.32*
.671
.777
.663
+ 4.48
+ 3.85
+ 5.14
+ 1.86
Control
Mean t = 3.83
+ 13.0
+ 7.28
+ 1.99
+ 2.46
+ .04
+ .57
Control
Mean t = 1.27
3-Nitropropionic Acid [3NPA, M.W. = 119.08]
Trial 1 [39]
B(a)P .000791
B(a)P .000250
3NPA 3.36
3NPA 1.68
3NPA .840
3NPA .420
NC-1 Control
Trial 2 [85]
B(a)P .000791
B(a)P .000250
3NPA 2.52
3NPA 1.68
3NPA .840
3NPA .420
NC-1 Control
1.07 23.6
3.56 64.5
.000 1.24
.000 15.7
8.19 52.9
30.6 78.5
100. 100.
18.8 55.6
28.7 91.8
2.00 21.7
4.00 47.6
14.0 86.6
43.5 105.
100. 100.
172 (20)
145 (20)
21 (20)
52 (20)
60 (20)
19 (20)
27 (40)
133 (20)
66 (19)
74 (20)
77 (20)
50 (20)
13 (20)
38 (80)
8.04***
6.84***
.699
2.41***
2.43***
.737
.427
3.43***
2.10***
2.82***
3.16***
1.65***
.503
.313
+ 14.5
+ 15.8
+ 1.20
+ 6.95
+ 6.01
+ 1.43
Control
Mean t = 3.90
+ 5.10
+ 4.56
+ 6.63
+ 9.87
+ 4.15
+ 1.24
Control
Mean t = 5.47
p-Phenylenediamine-2HC1 [PD, M.W. = 181.07]
Trial 1 [37]
B(a)P .000791
B(a)P .000250
PD .110
PD .0552
PD .0276
PD .0138
NC-1 Control
Trial 2 [89]
B(a)P .000791
B(a)P .000250
1.60 47.6
6.80 79.7
.000 4.51
.000 56.9
35.6 86.0
98.4 100.
100. 100.
8.13 69.0
31.9 89.1
101 (20)
113 (20)
18 (20)
72 (20)
44 (20)
35 (19)
32 (39)
119 (20)
63 (20)
4.59***
5.38***
.702
3.31***
1.96***
1.21*
.631
4.77***
2.33***
+ 9.94
+ 13.5
+ .33
+ 8.06
+ 4.84
+ 2.01
Control
Mean t = 3.81
+ 10.3
+ 5.84
(Continued on nextpage)
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Appendix C. Continued
Treatment Cytotoxic Transforming Transfonmation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc.,, mM S.A CC.A. III (N) III t-statistic
PD .0828
PD .0552
PD .0276
PD .0138
NC-1 Control
.000 65.6
2.61 75.4
64.2 84.4
99.6 96.6
100. 100.
45 (20)
49 (18)
16 (20)
10 (20)
57 (79)
1 .80***
1.71**
.668
.347
.492
+ 4.88
+ 3.29
+ .91
.00(- .82)
Control
Mean t = 2.27
N-Phenyl-2-Naphthylamide [130668-S, M.W. = 219.30]
Trial 1 [61]
B(a)P .000791
B(a)P .000250
.377 32.6
9.81 69.9
94 (20)
43 (20)
4.28***
1 .92***
+ 14.3
+ 8.76
130688-S .227
130688-S .170
130688-S .114
130688-S .0568
NC-1 Control
Trial 2 [87]
B(a)P .000791
B(a)P .000250
130688-S .227
130688-S .170
130688-S .114
130688-S .0568
NC-1 Control
.000 49.4
.000 47.9
6.42 65.0
50.9 87.7
100. 100.
25.1 77.2
42.2 80.2
1.64 75.6
8.18 86.3
54.5 97.6
74.9 100.
100. 100.
28 (20)
29 (20)
26 (20)
16 (20)
12 (40)
59 (20)
34 (20)
36 (20)
24 (20)
29 (20)
20 (20)
43 (80)
1 .31***
1. 14***
1 .08***
.634**
.222
2.26***
1.45***
1 .50***
.903**
1 .21***
.787*
.346
2,3,5,6.-Tetrachloro-4-Nitroanisole [TC4NA, M.W. = 290.91]
Trial 1 [29]
B(a)P .000791
B(a)P .000250
1.15 57.0
2.29 78.5
122 (20)
142 (20)
5.79***
6. 19***
+ 7.14
+ 4.27
+ 4.95
+ 2.81
Control
Mean t = 4.79
+ 5.84
+ 5.24
+ 5.28
+ 2.89
+ 4.24
+ 2.43
Control
Mean t = 3.71
+ 13.1
+ 10.3
TCNA .155
TCNA .103
TCNA .052
TCNA .025
NC-1 Control
Trial 2 [93]
B(a)P .000791
B(a)P .000250
TCNA .0859
TCNA .0645
TCNA .0430
TCNA .0215
NC-1 Control
.000 .000
.000 .000
.000 34.3
12.6 76.2
100. 100.
2.65 46.7
7.96 79.9
.000 .000
.000 .000
.845 7.12
8.85 82.3
100. 100.
0 (3,20)
1 (15,20)
33 (20)
26 (20)
36 (40)
138 (20)
115 (20)
0 (0,19)
0 (3,20)
38 (18)
10 (20)
43 (79)
.000
.047
1.50**
1.03
.606
6.48***
4.80***
.000
.000
1 .48**
.394
.416
Tetraethylthiuram Disulfide [TETD, M.W. = 296.54]
.00(-5.58)
.00(-4.42)
+ 3.32
+ 1.61
Control
Mean t = 2.47
+ 16.8
+ 12.0
NA
.00(-7.56)
+ 3.40
.00( -.16)
Control
Mean t = 1.70
Trial 1 [80]
B(a)P .000791
B(a)P .000250
16.9 65.2
35.6 87.2
TETD .000202
TETD .000101
TETD .0000506
TETD .0000253
NC-1 Control
.000 1.62
.000 6.00
11.6 77.5
87.5 104.
100. 100.
141 (20)
159 (20)
107 (20)
67 (20)
317 (80)
6.79***
7.77***
4.82*
2.62
3.02
+ 6.86
+ 9.12
+ 2.43
.00(- .67)
Control
itcean t - 4.60
(Continued on nextpage)
261 (20)
185 (20)
12.9***
8.53***
+ 13.0
+ 7.65
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb ActivityC Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 2 [93]
B(a)P .000791 2.65 46.7 138 (20) 6.48*** + 16.8
B(a)P .000250 7.96 79.9 115 (20) 4.80*** + 12.0
TETD .000169 .000 .000 0 (0,20) .000 ND
TETD .0000843 1.77 .792 26 (20) .999** + 3.13
TETD .0000422 31.0 79.2 34 (20) 1.44*** + 5.12
TETD .0000211 46.0 108. 13 (20) .494 + .51
NC-1 Control 100. 100. 43 (79) .416 Control
Mean t = 2.92
2,6-Toluenediamine-2HCl [26TD, M.W. = 195.11]
Trial 1 [29]
B(a)P .000791 1.15 57.0 122 (20) 5.79*** + 13.1
B(a)P .000250 2.29 78.5 142 (20) 6.19*** + 10.3
T26D 8.20 .000 3.29 24 (19) .825 + .82
T26D 6.15 .000 14.2 31 (20) 1.31* + 2.63
T26D 4.10 1.53 43.5 40 (20) 1.54** + 3.06
T26D 2.05 31.7 92.7 94 (20) 4.35*** + 9.05
NC-1 Control 100. 100. 36 (40) .606 ControL
Mean t = 3.89
Trial 2 [44]
B(a)P .000791 5.07 25.9 335 (20) 15.8*** + 16.3
B(a)P .000250 14.2 67.2 137 (20) 6.15*** + 7.33
T26D 4.00 5.41 30.4 91 (20) 4.23*** + 5.29
T26D 2.00 45.6 55.6 172 (20) 7.76*** + 8.77
T26D 1.00 79.1 64.0 180 (20) 8.42*** + 11.3
T26D .500 91.2 88.4 218 (19) 11.1*** + 14.7
NC-1 Control 100. 100. 77 (40) 1.52 Control
Mean t = 10.0
Abbreviations: BaP, benzo(a)pyrene; CC.A., co-culture clonal survival assay; Conc, concentration; mM, millimole; M.W., molecular weight; N,
number ofculture vessels, NC, negative control; ND; not determined; %RCE, percent relative cloning efficiency; S.A., standard clonal survival
assay.
`Treatment condition: The experimental design for the transformation assay is described in detail in the Materials and Methods. The
concentration of the positive control and test chemical treatment are presented in mM, but they can be converted to ,ug/ml using the molecular
weight that is provided with each chemical. The solvent vehicles used for the individual test chemicals were listed in Appendix Tables Al and A3,
and the concentrations of the solvent vehicles are presented in the Materials and Methods.
bCytotoxic activity: The experimental design for the standard survival assay (SA) and the co-culture clonal survival assay (CCA) were described
in the Materials and Methods. The test chemical cytotoxic response was expressed as % RCE and was calculated as described in the Materials and
Methods.
cThe criteria used to evaluate the transformed foci ofBALB/c-3T3 cells is described in the Materials and Methods. The number oftype III foci
> 2-mm in diameter per culture vessel scored are recorded in this table.
dTransformation response: The transformation responses are expressed as type III foci/vessel and were calculated using alog1o mathematical
transformation procedure (refer to Materials and Methods). The arithmetic value or foci/vessel represents the antilog ofthe log1o mean
transformation response minus one.
eSignificance: The significance of test chemical transformation responses was calculated by a computer using the SAS statistical software (22),
and the method is described in detail in Materials and Methods. The correct t-statistic according to the F-test is presented in this table. The
t-statistics ofeach treatment dose ofthe test chemical in a single experiment were averaged to determine the mean t-statistic ofthe test chemical
for the experiment (refer to Appendix Tables A2 and A5). The mean t-statistics for two or experiments for each chemical was weighted to the
number of treatment doses evaluated and averaged to determine the rank t-statistic which was used to rank-order the test chemical
transformation responses in Appendix Tables A3 and A6. Arbitrarily, transformation responses with negative (-) t-statistics were given a value of
zero (0).
*Significant BaP or test chemical transformation response, 0.01 < p < 0.05.
**Significant BaP or test chemical transformation response, 0.001 < p < 0.01.
***Significant or BaP or test chemical transformation response, p <. 0.001.
436TRANSFORMATION RESPONSES OF 168 CHEMICALS
Appendix D.
Summary ofthe transformation responses of20 cytotoxic, nonmutagenic carcinogens.
Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Allyl Isothiocyanate [ALITC, M.W. = 99.16, Density = 1.0165 g/ml]
Trial 1 [41]
B(a)P .000791
B(a)P .000250
ALITC
ALITC
ALITC
ALITC
NC-1
Trial 2
B(a)P
B(a)P
ALITC
ALITC
ALITC
ALITC
NC-1
.0133
.00666
.00333
.00166
Control
[98]
.000791
.000250
.0133
.00666
.00333
.00166
Control
1.29 33.6
6.45 78.2
.000
12.9
22.6
63.9
100.
189 (18)
123 (18)
47.5
69.1
76.4
91.0
100.
3.60 51.9
4.50 77.2
.901
2.70
18.5
73.9
100.
.177
3.89
43.5
94.0
100.
9 (18)
11 (18)
29 (18)
7 (18)
13 (36)
91 (18)
37 (18)
8 (16)
22 (17)
46 (18)
10 (18)
1 1 (36)
10.2***
6.37***
.339
.503
1.30***
.309
.274
4.63***
1 .73***
.414
1 .09***
2.25***
.424
.226
+ 23.1
+ 17.1
+ .44
+ 1.57
+ 4.21
+ .27
Control
Mean t = 1.62
+ 3.24
+ 15.0
+ 1.38
+ 4.71
+ 8.86
+ 1.40
Control
Mean t = 4.09
Chlorendic Acid [954870-S, M.W. = 388.83]
Trial 1 [63]
B(a)P .000791
B(a)P .000250
4.00 80.5
24.8 93.1
141 (20)
93 (20)
6. 13***
3.20*
954870-S
954870-S
954870-S
954870-S
NC-1
4.00
2.00
1.00
.500
Control
Trial 2 [83]
B(a)P .000791
B(a)P .000250
32.7
37.8
46.1
94.9
100.
30.5
38.0
71.3
96.6
100.
2.86 73.0
13.8 78.9
45 (18)
55 (20)
107 (18)
63 (20)
84 (39)
141 (20)
64 (20)
1.78
2.34
4.68***
2.76*
1.92
6. 14***
2.93***
.00 (-
+ 1.08
+ 4.70
+ 2.05
Control
Mean t = 1.96
+ 13.5
+ 9.12
.473
2.27***
.347
.214
.351
+ .73
+ 7.30
.00 (- .02)
.00 (- .93)
Control
Mean t = 2.01
Allyl Isovalerate [ALIV, M.W. = 142.22, Density = 0.882 g/ml]
Trial 1 [23]
B(a)P .000791
B(a)P .000250
ALIV
ALIV
ALIV
ALIV
NC-1
.744
.372
.186
.0930
Control
.000 61.0
4.84 100.
6.67
58.8
89.1
90.9
100.
98.5
108.
105.
87.7
100.
157 (18)
57 (18)
8 (18)
9 (18)
13 (18)
16 (18)
23 (27)
6.71***
3.04***
.361
.370
.562
.737
.661
+ 9.25
+ 8.07
.00(-1.52)
.00(-1.40)
.00(- .43)
+ .32
Control
Mean t = .080
+ 6.87
+ 2.02
.29)
954870-S
954870-S
954870-S
954870-S
NC-1A+1B
3.85
1.92
.962
.481
Control
27.6
52.4
70.5
98.1
100.
37.5
56.3
89.2
94.3
100.
12 (20)
54 (20)
9 (20)
6 (20)
48 (80)
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., nM S.A CC.A. III (N) III t-statistic
+ 14.8
+ 5.71
.00(-1 .41)
.00(- .18)
.00(- .43)
+ .22
Control
Mean t = .055
+ 11.1
+ 8.51
ND
.00( -2.50)
+ 1.18
.00(- .35)
Control
Mean t = .591
+ 9.48
+ 5.22
.00(- .33)
+ 4.83
+ 1.64
+ .59
Control
Mean t = 2.35
Chlorinated Paraffins C23 43% Chlorine [Chlorowax 40, 499546-L, M.W.avg. = 560, Density = ND]
Trial 1 [76]
B(a)P .000791
B(a)P .000250
499546-L ND
495546-L ND
495546-L ND
499546-L ND
NC-1 Control
Trial 2 [104]
B(a)P .000791
B(a)P .000250
499546-L ND
499546-L ND
499546-L ND
499546-L ND
NC-1 Control
5.91
23.3
74.9
90.0
82.4
87.7
100.
25.0
50.6
111.
113.
111.
110.
100.
63.1
97.0
78.9
75.9
83.6
84.8
100.
64.5
89.6
98.2
99.7
100.
101.
100.
87 (18)
54 (18)
43 (18)
35 (18)
67 (18)
18 (12)
152 (71)
62 (18)
63 (18)
17 (18)
10 (17)
21 (18)
14 (18)
83 (71)
Chlorinated Paraffins C12 60% Chlorine [Chlorowax 500c,
Trial 1 [74]
B(a)P .000791
B(a)P .000250
164848-L
164848-L
164848-L
164848-L
NC-1
2.89
1.93
.964
.482
Control
3.00 69.2
9.58 78.4
.000
.000
.000
24.6
100.
.000
.000
68.3
98.6
100.
43 (18)
27 (18)
0 (0,18)
0 (0,18)
16 (18)
11 (18)
65 (71)
4.41***
2.72*
2.06
1.67
3.02**
1.26
1.79
+ 5.23
+ 2.26
+ .72
.00(- .33)
+ 2.68
.00(-1 .36)
Control
Mean t = .850
2.79*** + 4.87
2.47*** + 4.10
.650 .00(- .90)
.386 .00(-2.12)
.961 + .31
.562 .00(-1.31)
.878 Control
Mean t = .078
164848-L, M.W.avg.= 415, Density= ND]
2.02***
1 .29*
.000
.000
.737
.456
.657
+ 4.51
+ 2.49
ND
ND
+ .37
.00(-1 .00)
Control
Mean t = .185
(Continued on nextpage)
Trial
B(a)P
B(a)P
ALIV
ALIV
ALIV
ALIV
NC-1
Trial
B(a)P
B(a)P
ALIV
ALIV
ALIV
ALIV
NC-1
Trial
B(a)P
B(a)P
ALIV
ALIV
ALIV
ALIV
NC-1
2 [27]
.000791
.000250
1.40
.930
.465
.233
Control
3 [31]
.000791
.000250
5.58
4.34
3.10
1.86
ControL
4 [102]
.000791
.000250
5.89
4.42
2.95
1.47
Control
4.04
13.0
17.7
35.1
62.7
88.2
100.
1.87
5.14
.000
.000
.000
.000
100.
9.64
19.3
.000
.000
.419
7.55
100.
33.7
47.4
61.5
45.6
75.6
52.4
100.
69.1
99.9
.000
53.3
94.3
109.
100.
69.9
93.1
13.6
83.2
79.2
91.5
100.
170 (18)
73 (18)
7 (18)
12 (18)
11 (18)
14 (18)
31 (36)
136 (15)
126 (18)
0 (0,18)
1 (4,18)
28 (17)
19 (18)
43 (36)
99 (18)
45 (18)
3 (4,18)
41 (18)
26 (18)
19 (18)
64 (72)
8.90***
3.18***
.260
.513
.456
.608
.555
8.63***
6.06***
.000
.189
1.30
.834
.930
4.65***
2.22***
.565
2.05***
1.10
.828
.697
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Appendix D. Continued.
Treatment Cytotoxic Transforing Transfomtiom
Corditionfla Activib ActivityY' Respoased Significance
RCE (%) FocusData Foec/Vessel
Type Vessels Focus Type
Drug Conc., o S.A CC.A. III (N) III t-statistic
Trial 2 [90]
B(a)P .000791 28.5 76.0
B(a)P .000250 51.8 95.8
164848-L 1.93 6.61 58.4
164848-L 1.45 41.4 64.5
164848-L .964 29.2 78.7
164848-L .482 94.6 107.
NC-1 ControL 100. 100.
157 (18)
111 (18)
15 (18)
20 (18)
27 (18)
15 (18)
219 (71)
7.60***
4.91*
.618
.628
1.07
.661
1.95
3-Chloro-2-Methylpropene [3C2MP, M.W. = 99.55, Density = 0.928 g/ml]
+ 5.89
+ 3.71
.00(-3.32)
.00(-3.17)
.00(-1.89)
.00(-4.16)
Control
Mean t = .000
Trial 1 [29]
B(a)P .000791
B(a)P .000250
8.09 60.6
14.9 84.2
3C2MP .883
3C2MP .442
3C2MP .221
3C2MP .110
NC-1 Control
Trial 2 [31]
B(a)P .000791
B(a)P .000250
3C2MP 1.104
3C2MP .828
3C2MP .552
3C2MP .276
NC-1 Control
.000 60.3
12.8 97.0
56.2 97.6
57.4 95.1
100. 100.
15.8 73.9
35.5 82.6
.000 42.3
.000 57.5
1.18 81.2
55.8 102.
100. 100.
162 (18)
102 (18)
60 (18)
54 (18)
296 (72)
54 (15)
24 (15)
24 (17,18)
36 (18)
23 (18)
16 (18)
37 (67)
8.23***
4.21
2.53
2.72
3.28
3.36***
1 .50***
.928*
1.75***
.805
.582
.406
Cinnamyl Anthranilate [CIN. M.W. = 253.32]
Trial 1 [2]
B(a)P .000791
B(a)P .000250
1.02 36.4
3.41 68.7
187 (20)
110 (20)
8.89***
4.52***
+ 5.22
+ 1.25
.00 (- 1.23)
.00 (- .95)
Control
Mean t = 1.62
+ 9.58
+ 4.90
+ 2.23
+ 5.87
+ 1.58
+ .95
Control
Mean t = 2.66
+ 15.5
+ 8.43
CIN .115
CIN .105
CIN .0829
CIN .0651
NC-1 Control
Trial 2 [9]
B(a)P .000791
B(a)P .000250
CIN .118
CIN .0987
CIN .0790
CIN .0592
NC-1 Control
.000 17.2
3.07 17.9
58.0 83.8
61.1 99.0
100. 100.
3.14 38.3
8.52 87.2
2.69 22.5
20.6 51.3
48.0 107.
53.4 93.3
100. 100.
5 (20)
37 (20)
16 (20)
5 (20)
34 (20)
108 (20)
47 (20)
2 (16,20)
2 (20)
2 (20)
1 (20)
8 (40)
.172
.656
.668
.189
.660
4.93***
1.92***
.091
.076
.056
.035
.149
Trial 3 [DRI3]
B(a)P .000791
B(a)P .000250
.00( -2.97)
.00(- .01)
+ .04
.00(-2.90)
Control
Mean = .010
+ 16.2
+ 7.04
.00(- .65)
.00(- .90)
.00(-1 .13)
.00(-1 .85)
Control
Mean t = .000
CIN .142
CIN .095
CIN .0475
NC-1 Control
ND .000
ND 37.3
ND 109.
ND 100.
0 (17)
8 (18)
8 (20)
5 (9)
.000
.318
.275
.424
ND
.00(- .45)
.00(- .66)
Control
Mean t = .000
(Continued on nextpage)
116 (18)
184 (18)
6.1 1***
9.84***
+ 4.93
+ 9.74
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Diethylsti1bestrol [DES,
Trial
B(a)P
B(a)P
1 [42]
.000791
.000250
M.W. = 268.]
2.41 35.7
5.72 65.4
280 (20)
161 (19)
13.7***
7.44***
+ 20.2
+ 9.55
1.81
62.0
54.5
75.6
100.
13.5
65.1
64.4
77.5
100.
11.0 43.5
38.9 75.4
31.4
51.5
54.2
59.3
100.
31 (19,20)
15 (20)
11 (20)
154 (19)
52 (40)
86 (20)
62 (20)
74.6
86.5
83.4
79.0
100.
37 (20)
44 (20)
37 (20)
32 (20)
62 (70)
1.19
.578
.443
6.79***
.861
4.03***
2.88***
1.62***
1.89***
1.52**
1.19*
.660
+ .97
.00 (- 1.10)
.00 (- 1.76)
+ 8.84
Control
Mean t = 2.22
+ 9.40
+ 7.12
+ 3.69
+ 4.44
+ 3.30
+ 2.07
Control
Mean t = 3.38
Dimethylvinyl Chloride [309712-L, M.W. = 90.55, Density = ND g/ml]
1 [76]
.000791
.000250
4.00
2.00
1.00
.500
Control
7.78
5.83
3.89
1.94
Control
5.91 63.1
23.3 97.0
.000
.000
15.4
58.8
100.
.000
.000
.000
13.4
100.
87 (18)
54 (18)
41.2
84.4
87.1
94.3
100.
69.9
93.1
116 (15,18)
59 (18)
38 (18)
41 (18)
152 (71)
99 (18)
45 (18)
19 (7,18)
84 (18)
31 (18)
17 (18)
64 (72)
27.5
77.1
96.5
93.3
100.
4.41***
2.72*
5.56**
2.63
1.69
1.62
1.79
4.65***
2.22***
2.26***
4.04***
1.27*
.834
.697
+ 5.23
+ 2.26
+ 3.88
+ 1.91
.00 (-
.00 (-
Control
Mean t = 1.45
+ 9.48
+ 5.22
+ 3.47
+ 8.63
+ 2.21
+ .65
Control
Mean t = 3.74
.24)
.43)
Ethyl Acrylate [ETAC, M.W. = 100.12, Density = ND g/ml]
6.71***
3.04***
1.00
3.03***
.864
.289
.661
7.27***
4.37***
+ 9.25
+ 8.07
.00 (- 4.75)
+ 6.71
+ .77
.00 (- 1.90)
Control
Mean t = 2.49
+ 21.8
+ 10.8
(Continued on nextpage)
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DES
DES
DES
DES
NC-1
Trial
B(a)P
B(a)P
DES
DES
DES
DES
NC-1
.0894
.0671
.0447
.0112
Control
2 [96]
.000791
.000250
.112
.0838
.0559
.0279
Control
Trial
B(a)P
B(a)P
309712-L
309712-L
309712-L
309712-L
NC-1
Trial 2 1
B(a)P
B(a)P
309712-L
309712-L
309712-L
309712-L
NC-1
[102]
.000791
.000250
.000 61.0
4.84 100.
Trial 1
B(a)P
B(a)P
ETAC
ETAC
ETAC
ETAC
NC-1
Trial
B(a)P
B(a)P
[23]
.000791
.000250
.1199
.0799
.0400
.0200
Control
2 [36]
.000791
.000250
157 (18)
57 (18)
.000
.000
4.85
37.0
100.
.000
21.8
84.9
97.9
100.
1 (1,18)
59 (18)
20 (18)
7 (18)
23 (27)
73 (9)
88 (18)
2.98 40.1
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Appendix D. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activity' Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessel s Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
ETAC .1199 1.28 55.8 45 (18) 1.87*** + 4.96
ETAC .0899 8.09 79.8 53 (18) 2.68*** + 8.05
ETAC .0599 27.7 94.8 50 (18) 2.20** + 5.02
ETAC .0300 63.4 99.3 43 (18) 2.08*** + 6.04
NC-1 Control 100. 100. 20 (36) .424 Control
Mean t = 6.02
Isophorone [ISPH, M.W. = 138.21, Density = 0.9229 g/ml]
Trial 1 [25]
B(a)P .000791 ND 21.4 192 (18) 9.74*** + 19.9
B(a)P .000250 ND 73.4 59 (18) 2.55*** + 7.52
ISPH 1.34 ND 92.2 7 (18) .268 .00 (- 1.35)
ISPH 1.00 ND 89.6 3 (18) .122 + .27
ISPH .668 ND 102. 3 (18) .122 + .27
ISPH .334 ND 102. 3 (18) .122 + .27
NC-1 Control ND 100. 5 (36) .101 Control
Mean t = .203
Trial 2 [36]
B(a)P .000791 2.98 40.1 73 (9) 7.27*** + 21.8
B(a)P .000250 7.66 78.1 88 (18) 4.37*** + 10.8
ISPH 4.01 .000 31.5 33 (18) 1.65** + 5.29
ISPH 2.00 .851 92.9 17 (18) .754 + 1.66
ISPH 1.00 21.3 98.6 20 (18) .950* + 2.60
ISPH .501 76.6 108. 28 (18) 1.38** + 4.29
NC-1 Control 100. 100. 20 (36) .424 Control
Mean t = 3.46
Trial 3 [104]
B(a)P .000791 25.0 64.5 62 (18) 2.79*** + 4.87
B(a)P .000250 50.6 89.6 63 (18) 2.47*** + 4.10
ISPH 5.34 6.75 80.2 34 (18) 1.68* + 2.61
ISPH 4.01 16.8 103. 30 (18) 1.53** + 2.85
ISPH 2.67 31.6 104. 36 (18) 1.66* + 2.45
ISPH 1.34 45.9 97.6 21 (18) .963 + .32
NC-1 Control 100. 100. 83 (71) .878 Control
Mean t = 2.06
D-Limonene [036267-L, M.W. = 136.24, Density = 0.8411 g/ml]
Trial 1 [72]
B(a)P .000791 2.75 56.8 85 (18) 4.11*** + 12.7
B(a)P .000250 6.61 82.1 84 (18) 3.04*** + 6.20
036267-L .224 .000 90.7 7 (18) .248 .00(- .30)
036267-L .179 .000 101. 9 (18) .392 + .75
036267-L .134 .000 94.4 17 (18) .619 + 1.54
036267-L .089 .000 96.2 15 (18) .572 + 1.80
NC-1 Control 100. 100. 29 (72) .289 Control
Mean t = 1.02
Trial 2 [76]
B(a)P .000791 5.91 63.1 87 (18) 4.41*** + 5.23
B(a)P .000250 23.3 97.0 54 (18) 2.72* + 2.26
036267-L 1.57 .000 .893 1 (17,18) .042 .00(-13.6)
036267-L 1.18 18.4 33.8 15 (18) .557 .00(- 4.30)
036267-L .786 49.6 104. 60 (17) 1.95 + .27
036267-L .393 82.4 100. 30 (18) 1.39 + 1.15
NC-1 Control 100. 100. 152 (71) 1.79 Control
Mean t = .473
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 3 [88]
B(a)P .000791
B(a)P .000250
036267-L
036267-L
036267-L
036267-L
NC-1
1.43
1.07
.714
.357
Control
15.8 73.9
35.5 82.6
.000
9.07
88.0
103.
100.
.167
10.7
85.7
90.1
100.
54 (15)
24 (15)
0 (6,16)
4 (14)
10 (18)
9 (18)
37 (67)
3.36***
1.50***
.000
.194
.392
.392
.406
+ 9.58
+ 4.90
.00(-6.49)
.00(-1.32)
.00(- .09)
.00(- .09)
Control
Mean t = .000
Malonaldehyde, Sodium Salt [605428-S, M.W. = 94.05]
Trial 1 [75]
B(a)P .000791
B(a)P .000250
7.10 66.5
28.4 85.4
605428-S
605428-S
605428-S
605428-S
NC-1
5.00
3.75
2.50
1.25
Control
Trial 2 [97]
B(a)P .000791
B(a)P .000250
605428-S
605428-S
605428-S
605428-S
NC-1
5.00
3.75
2.50
1.25
Control
.000
2.92
15.9
59.3
100.
14.2
66.5
80.9
93.1
100.
4.74 78.0
17.4 104.
.000
.000
9.49
44.3
100.
14.2
44.1
89.2
89.0
100.
34 (20)
19 (20)
61 (20)
38 (19)
89 (78)
118 (20)
52 (20)
18 (19)
9 (20)
26 (20)
18 (20)
47 (80)
1.18
.777
2.65***
1.79*
.882
5.02***
2.26***
.751
.320
1.04**
.652
.414
+ 1.08
.00 (- .68)
+ 5.06
+ 2.61
Control
Mean t = 1.92
+ 12.5
+ 7.26
+ 1.81
.00 ( - .62)
+ 3.08
+ 1.32
Control
Mean t = 1.55
2-Mercaptobenzothiazole [481989-S, M.W. = 167.25]
Trial 1 [62]
B(a)P .000791
B(a)P .000250
481989-S
481989-S
481989-S
481989-S
NC-1
.294
.221
.147
.074
Control
Trial 2 [77]
B(a)P .000791
B(a)P .000250
5.24 72.5
18.6 85.1
.000
.476
16.1
49.0
100.
1.91
11.0
70.1
84.5
100.
5.66 69.5
16.5 78.7
188 (20)
105 (18)
15 (20)
48 (20)
56 (17)
60 (20)
261 (40)
179 (20)
114 (19)
8.32*
5.59
.543
1.84
2.90
2.42
6.02
8.33***
6.03***
+ 2.50
.00 (- .62)
.00 (-12.8)
.00 (- 5.85)
.00 (- 5.06)
.00 (- 5.59)
Control
Mean t = .00
+ 13.6
+ 10.0
481989-S
481989-S
481989-S
481989-S
NC-1A+1B
.265
.199
.132
.066
Control
Trial 3 [89]
B(a)P .000791
B(a)P .000250
.000
ND
7.55
11.8
100.
.275
ND
19.3
82.0
100.
8.13 69.0
31.9 89.1
2 (6)
7 (10)
11 (2)
12 (6)
94 (78)
119 (20)
63 (20)
.260
.490
5.33**
1.70
.97
4.77***
2.33***
.00 (- 2.24)
.00 (- 1.74)
+ 3.41
+ 1.52
Control
Mean t = 1.23
+ 10.3
+ 5.84
149 (20)
67 (20)
6.35***
3.10***
+ 10.9
+ 6.56
(Continued on nextpage)
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Appendix D. Continued.
Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc.,, mM S.A CC.A. III (N) III t-statistic
.771
19.9
57.6
84.3
100.
22 (20)
41 (20)
7 (14)
6 (12)
57 (79)
.762
1 .45***
.385
.414
.492
+ 1.26
+ 3.63
.00 (- .52)
.00 (- .35)
Control
Mean t = 1.22
Methapyri 1 ene-HCG
Trial
B(a)P
B(a)P
1 [40]
.000791
.000250
MEPY 1.43
MEPY .955
MEPY .477
MEPY .239
NC-1 Control
Trial 2 [54]
B(a)P .000791
B(a)P .000250
MEPY 1.15
MEPY .859
MEPY .573
MEPY .286
NC-1 Control
Trial 3 [DRI4]
B(a)P .000791
B(a)P .000250
MEPY 1.28
MEPY .853
MEPY .426
NC-1 Control
[MEPY, M.W. = 297.88]
1.06 39.7
8.48 79.2
.000
.707
21.9
68.9
100.
4.87
53.1
88.7
95.2
100.
1.47 17.6
.490 61.1
.000
3.92
20.6
33.8
100.
.000
18.6
81.1
81.4
100.
ND
ND 13.2
ND 83.2
ND 100.
ND 100.
182 (19)
101 (18)
4 (17,20)
14 (20)
7 (20)
6 (19)
28 (40)
105 (20)
100 (20)
3 (17,20)
7 (20)
1 1 (20)
3 (20)
15 (40)
NO
0 (20)
8 (20)
5 (20)
18 (20)
8.71***
4.86***
.177
.468
.256
.208
.533
4.75***
4.52***
.130
.231
.443
.110
.265
ND
.04
.32
.19
.67
+ 14.9
+ 9.93
.00(-2.22)
.00(- .34)
.00(-1 .72)
.00(-2.00)
Control
Mean t = .000
+ 13.8
+ 13.5
.00(-1. 10)
.26(- .26)
+ 1.25
.00(-1 .39)
Control
Mean t = .417
ND ND
.00(-3.94)
.00(-1 .68)
.00(-2.51)
Control
Mean t = .000
Nitrilotriacetic Acid, Trisodium Salt [NTTA, M.W. = 257.1]
Trial
B(a)P
B(a)P
1 [73]
.000791
.000250
2.21 71.9
7.18 88.8
61 (19)
48 (20)
NTTA 7.78
NTTA 5.83
NTTA 3.89
NTTA 1.94
NC-1 Control
Trial 2 [99]
B(a)P .000791
B(a)P .000250
NTTA
NTTA
NTTA
NTTA
NC-1
7.00
5.25
3.50
1.75
Control
.000
.000
14.4
44.8
100.
.836
12.7
87.1
92.5
100.
18.9 68.4
32.1 85.0
7.92
23.8
61.9
76.6
100.
65.0
89.3
108.
103.
100.
3 (15,20)
24 (20)
28 (20)
10 (20)
45 (79)
160 (20)
94 (20)
125 (20)
148 (20)
64 (20)
49 (20)
65 (80)
.127
.807*
1.03***
.414
.274
6.67***
3.59***
5.58***
6.87***
2.37***
1.78***
.586
.00 (- .95)
+ 2.76
+ 3.72
+ .91
Control
Mean t = 2.46
+ 12.4
+ 7.95
+ 11.5
+ 13.3
+ 4.55
+ 4.30
ControL
Mean t = 8.41
(Continued on nextpage)
481989-S
481989-S
481989-S
481989-S
NC- 1A+1B
.212
.159
.106
.0530
Control
.581
23.8
33.1
47.3
100.
2.60***
1.58***
+ 8.09
+ 4.37
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Appendix D. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessel s Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Polybrominated Biphenyl Mixture
Trial
B(a)P
B(a)P
PBB
PBB
PBB
PBB
NC-1
Trial
B(a)P
B(a)P
PBB
PBB
PBB
PBB
NC-1
1 [20]
.000791
.000250
.398
.199
.100
.050
ControL
2 [28]
.000791
.000250
.398
.199
.100
.0500
Control
.000 39.4
2.34 77.3
13.3
33.6
35.9
53.2
100.
75.3
92.4
92.4
94.9
100.
2.84 28.6
6.74 68.0
14.2
67.8
84.0
86.9
100.
47.4
44.3
58.2
67.0
100.
[PBB, M.W. = 628.]
268 (20)
99 (20)
29 (19)
23 (18)
18 (20)
11 (20)
21 (40)
189 (20)
62 (20)
41 (20)
33 (20)
19 (20)
27 (20)
41 (40)
13.0***
4.00***
1.25***
1 .07**
.668
.394
.368
9.02***
2.78***
1.77**
1.37*
.737
1.15
.818
+ 26.3
+ 9.22
+ 3.85
+ 3.30
+ 1.55
+ .16
Control
Mean t = 2.22
+ 16.9
+ 5.73
+ 3.24
+ 2.00
.00 (-
+ 1.31
Control
Mean t = 1.64
Reserpine [RES, M.W. = 608.70]
9.75 56.3
15.5 91.0
.000
2.53
22.4
94.2
100.
.000
.000
57.6
105.
100.
1.45 5.83
4.35 52.4
171 (20)
114 (20)
0 (4,20)
0 (16,20)
9 (20)
51 (20)
73 (40)
244 (19)
254 (20)
8.16***
5.18***
.000
.000
.301
2.36**
1.44
10.7***
11.8***
+ 12.1
+ 6.68
.00(-10.2)
.00(-10.2)
.00(- 4.41)
+ 2.37
Control
Mean t = 1.38
+ 8.19
+ 11.2
RES .0164
RES .0123
RES .0082
RES .0041
NC-1 Control
Trial 3 [DRI3]
B(a)P .000791
B(a)P .000250
RES .0148
RES .00986
RES .00493
NC-1 Control
28.0
68.1
94.2
90.3
100.
.000
91.3
202.
221.
100.
17 (20)
37 (20)
39 (20)
52 (20)
110 (40)
.677
1.60
1.54
2.03
2.19
.00(-4.29)
.00(-1 .36)
.00(-1 .46)
.00(- .32)
Control
Mean t = .000
ND ND
ND ND
ND 54.5
ND 101.
ND 106.
ND 100.
5 (15)
32 (16)
11 (13)
5 (9)
.277
1.31*
.682
.424
.00(- .61)
+ 1.80
+ .86
Control
Mean t = .887
Tris(2-ethylhexyl)phosphate [T2EHP, M.W. = 434.65, Density = 0.925 g/ml]
Trial 1 [88]
B(a)P .000791
B(a)P .000250
15.8 73.9
35.5 82.6
.35)
Trial
B(a)P
B(a)P
RES
RES
RES
RES
NC-1
Trial
B(a)P
B(a)P
1 [1]
.000791
.000250
.0230
.0197
.0156
.0099
Control
2 [8]
.000791
.000250
54 (15)
24 (15)
3.36***
1.50***
+ 9.58
+ 4.90
(Continued on nextpage)
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Appendix D. Continued.
Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
.920
.460
.230
.115
Control
2 [98]
.000791
.000250
.575
.431
.287
.144
Control
.000
.000
.000
.000
100.
.000
27.4
74.9
84.7
100.
8.38 79.6
29.3 91.3
.000
7.33
9.42
6.28
100.
36.5
69.0
73.8
67.3
100.
0 (2,18)
7 (18)
2 (18)
6 (18)
37 (67)
21 (18)
17 (18)
10 (17,18)
7 (18)
11 (18)
13 (18)
39 (45)
.000
.260
.080
.260
.406
6.82***
3.38***
.453
.268
.479
.572
.618
.00(-6.49)
.00(- .97)
.00(-2.50)
.00(-1 .00)
Control
Mean t = .000
+ 11.8
+ 6.81
.00(- .76)
.00(-1 .79)
.00(- .65)
.00(- .21)
Control
Mean t = .000
4-Vinylcyclohexene [195579-L. M.W. = 108.20, Density = NA]
Trial 1 [74]
B(a)P .000791
B(a)P .000250
3.00 69.2
9.58 78.4
43 (18)
27 (18)
2.02***
1.29*
+ 4.51
+ 2.49
195579-L
195579- L
195579-L
195579-L
NC-1
5.23
4.18
3.14
2.09
Control
Trial 2 [110]
B(a)P .000791
B(a)P .000250
.000
22.8
28.7
60.5
100.
2.53
93.1
98.6
107.
100.
11.6 61.1
26.7 88.0
1 (4,18)
3 (12,18)
9 (18)
11 (18)
65 (71)
116 (18)
75 (18)
.189
.208
.348
.456
.657
5.78***
3.89***
.00(-1.31)
.00(-2.02)
.00(-1 .70)
.00(-1 .00)
Control
Mean t
= .000
+ 10.7
+ 8.52
195579-L 5.82
195579-L 4.36
195579-L 2.91
195579-L 1.45
NC-1 Control
.000
8.04
.322
83.6
100.
.000
.712
4.24
87.7
100.
0 (1,18)
0 (3,18)
4 (15,17)
14 (18)
65 (75)
.000
.000
.157
.598
.609
.00(-7.87)
.00(-7.87)
.00(-2.19)
.00(- .05)
Control
Mean t = .000
Abbreviations: B(a)P, benzo(a)pyrene; CC.A., co-culture clonal survival assay; Conc., concentration; mM, millimole; M.W., molecular weight; N,
number ofculture vessels, NC, negative control; ND, not determined; %RCE, percent relative cloning efficiency; S.A., standard clonal survival
assay.
aTreatment condition: The experimental design for the transformation assay is described in detail in the Materials and Methods. The
concentration ofthe positive control and test chemical treatment are presented in mM, but they can be converted to p,g/ml using the molecular
weight that is provided with each chemical. The solvent vehicles used for the individual test chemicals were listed in Appendix Tables Al and A3,
and the concentrations ofthe solvent vehicles are presented in the Materials and Methods.
bCytotoxic activity: The experimental design for the standard survival assay (SA) and the co-culture clonal survival assay (CCA) were described
in the Materials and Methods. The test chemical cytotoxic response was expressed as & RCE and was calculated as described in the Materials and
Methods.
cThe criteria used to evaluate the transformed foci ofBALB/c-3T3 cells is described in the Materials and Methods. The number oftype III foci
> 2-mm in diameter per culture vessel scored are recorded in this table.
dTTransformation response: The transformation responses are expressed as type III foci/vessel and were calculated using a log1o mathematical
transformation procedure (refer to Materials and Methods). The arithmetic value or foci/vessel represents the antilog ofthe loglo mean
transformation response minus one.
eSignificance: The significance of test chemical transformation responses was calculated by a computer using the SAS statistical software (22),
and the method is described in detail in Materials and Methods. The correct t-statistic according to the F-test is presented in this table. The
t-statistics ofeach treatment dose ofthe test chemical in a single experiment were averaged to determine the mean t-statistic of the test chemical
for the experiment (refer to Appendix Tables A2 and A5). The mean t-statistics for two or experiments for each chemical was weighted to the
number of treatment doses evaluated and averaged to determine the rank t-statistic which was used to rank-order the test chemical
transformation responses in Appendix Tables A3 and A6. Arbitrarily, transformation responses with negative (-) t-statistics were given a value of
zero (0).
*Significant BaP or test chemical transformation response, 0.01 < p < 0.05.
**Significant BaP or test chemical transformation response, 0.001 < p < 0.01.
***Significant or BaP or test chemical transformation response, p < 0.001.
T2EHP
T2EHP
T2EHP
T2EHP
NC-1
Trial
B(a)P
B(a)P
T2EHP
T2EHP
T2EHP
T2EHP
NC-1
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Appendix E.
Summary ofthe transformation responses of30 cytotoxic, nonmutagenic noncarcinogens
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Anilazitle [ANIL, M.W. = 275.53]
Trial 1 [29]
B(a)P .000791
B(a)P .000250
ANIL .0581
ANIL .0436
ANIL .0290
ANIL .0145
NC-1 Control
Trial 2 [85]
B(a)P .000791
B(a)P .000250
ANIL .0581
ANIL .0436
ANIL .0290
ANIL .0145
NC-1 Control
5.34 7.59
34.0 71.1
73.7 87.3
93.9 105.
100. 100.
18.8 55.6
28.7 91.5
3.19 20.4
51.1 64.7
46.7 96.7
50.3 107.
100. 100.
9 (20)
43 (20)
19 (20)
13 (20)
36 (40)
133 (20)
66 (19)
4 (11,20)
46 (20)
13 (20)
14 (20)
38 (80)
.347
1.81***
.721
.503
.606
3.43***
2.10***
.110
2.00***
.365
.394
.313
.00(-1.31)
+ 3.86
+ .48
.00(- .48)
Control
Mean t = 1.09
+ 5.10
+ 4.56
.00(- .59)
+ 7.57
+ .34
+ .52
Control
Mean t = 2.81
L-Ascorbic Acid [ASC, M.W. = 176.14]
Trial 1 [4]
B(a)P .000791
B(a)P .000250
ASC .341
ASC .298
ASC .256
ASC .199
NC-1 Control
Trial 2 [11]
B(a)P .000791
B(a)P .000250
ASC .568
ASC .426
ASC .284
ASC .142
NC-1 Control
62.0 53.5
75.2 58.1
89.7 56.2
100. 84.8
100. 100.
1.37 34.4
7.22 36.0
9.97 73.1
23.4 86.0
63.2 90.3
78.0 64.5
100. 100.
34 (20)
68 (20)
43 (20)
30 (20)
118 (40)
128 (20)
37 (20)
18 (20)
6 (20)
5 (20)
9 (20)
21 (40)
1.34
2.24
1.08
1.02
1.51
4.94***
1.62***
.525
.231
.189
.347
.301
.00(- .33)
+ 1.20
.00(- .82)
.00(-1.03)
Control
Mean t = .300
+ 10.5
+ 5.38
+ 1.11
.00(- .45)
.00(- .86)
+ .28
Control
Mean t = .348
Bisphenol A [BIS, M.W. = 228.29]
Trial 1 [2]
B(a)P .000791
B(a)P .000250
1.02 36.4
3.41 68.7
187 (20)
110 (20)
8.89***
4.52***
+ 15.5
+ 8.43
BIS .215
BIS .193
BIS .167
BIS .127
NC-1 Control
Trial 2 [8]
B(a)P .000791
B(a)P .000250
2.39 56.4
11.3 73.5
46.4 95.5
61.1 118.
100. 100.
1.45 5.83
4.35 52.4
8 (20)
12 (19)
18 (20)
16 (20)
34 (40)
244 (19)
254 (20)
.282
.449
.712
.573
.660
10.7***
11 .8***
.00( -2. 11)
.00(-1 .04)
+ .24
.00(- .41)
Control
Mean t = .060
+ 8.19
+ 11.2
(Continued on nextpage)
1.15 57.0
2.29 78.5
122 (20)
142 (20)
5.79***
6.19***
+ 13.1
+ 10.3
15.7 74.7
24.0 82.9
184 (20)
116 (20)
8.81***
4.38***
+ 9.38
+ 3.62
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Appendix E. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
BIS .263
BIS .219
BIS .175
BIS .131
NC-1 Control
Trial 3 [IP17]
B(a)P .000791
B(a)P .000250
BIS .197
BIS .131
BIS .0657
NC-1 Control
Trial
B(a)P
B(a)P
BIS
BIS
BIS
BIS
*NC-1
4 [IP18]
.000791
.000250
.210
.158
.105
.0526
Control
*Trial No. 6 was
Exp. IP18).
.000
7.25
22.2
43.9
100.
.000
.000
1.94
27.2
100.
.000 NA
3.1 NA
8.3
34.8
76.0
100.
NA
NA
NA
NA
1.3 3.7
2.6 22.1
.000
3.0
20.6
69.5
100.
1 (15)
13 (18)
55 (20)
89 (19)
110 (40)
100 (15)
84 (15)
4 (15)
15 (15)
8 (15)
20 (29)
82 (11)
110 (12)
2.7
19.5
52.3
81.3
100.
1 (12)
10 (12)
11 (12)
17 (12)
6 (24)
.047
.572
2.15
4.31**
2.19
5.28***
5.28***
.18
.72
.42
.41
6.31***
8.85***
.059
.55
.658
1 .01*
.189
.00(-10.8)
.00(- 4.58)
.00(- .08
+ 3.45
Control
Mean t = 1.15
+ 8.30
+ 11.4
.00(-1.15)
+ 1.14
+ .04
Control
Mean t = .393
+ 20.5
+ 10.7
.00(-1.18)
+ 1.48
+ 1.92
+ 2.75
Control
Mean t = 1.54
conducted in 100 nmn dishes using 20000 BALB/c-3T3 Cells (refer to
Carbromal [CARB, M.W. = 237.10]
Trial 1 [35]
B(a)P .000791
B(a)P .000250
4.51 66.1
12.3 87.5
CARB
CARB
CARB
CARB
NC-1
5.06
3.80
2.53
1.27
Control
Trial 2 [44]
B(a)P .000791
B(a)P .000250
2.05
7.79
30.7
59.0
100.
12.5
72.1
115.
111.
100.
5.07 25.9
14.2 67.2
12 (11,20)
67 (20)
36 (20)
37 (20)
94 (40)
335 (20)
137 (20)
.782
2.96*
1.41
1.68
1.97
15.8***
6.15***
.00(-2.76)
+ 2.02
.00(-1.41)
.00(- .79)
Control
Mean t = .673
+ 16.3
+ 7.33
7.00***
3.80**
2.60*
1.97
1.52
+ 8.03
+ 4.39
+ 2.26
+ 1.09
Control
Mean t = 3.00
Chlorpheni ramine-Maleate [005004-S, M.W. = 390.87]
Trial 1 [70]
B(a)P .000791
B(a)P .000250
1.24 48.9
11.8 81.0
(Continued on nextpage)
103 (20)
133 (20)
4.91***
6.01***
+ 6.41
+ 6.34
CARB
CARB
CARB
CARB
NC- 1
4.00
2.00
1.00
.500
Control
9.80
35.1
89.2
98.3
100.
22.0
85.2
84.4
91.3
100.
156
83
68
47
77
(20)
(19)
(20)
(20)
(40)
11 (3)
19 (5)
3.38***
3.62***
+ 4.23
+ 5.73
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Appendix E. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
005004-S .513
005004-S .385
005004-S .256
005004-S .128
NC-1 Control
Trial 2 [85]
B(a)P .000791
B(a)P .000250
.000
.000
.000
8.07
100.
.000
4.50
74.3
105.
100.
18.8 55.6
28.7 91.8
0 (0,8)
1 (4,11)
2 (9)
10 (17)
36 (54)
133 (20)
66 (19)
.000
.119
.167
.503
.526
3.43***
2.10***
NA
.00(-1.15)
.00(-1.83)
.00(- .13)
ControL
Mean t = .000
+ 5.10
+ 4.56
.231
.807**
.737*
.374
.313
.00(- .55)
+ 2.91
+ 2.56
.43
Control
Mean t = 1.97
C. I. Acid Red 14 [CIAR14, M.W. = 502.44]
7.23***
4.25***
+ 12.3
+ 8.08
CIAR14 3.98
CIAR14 2.98
CIAR14 1.99
CIAR14 1.00
NC-1 Control
Trial 2 [45]
B(a)P .000791
B(a)P .000250
CIAR14 4.00
CIAR14 2.00
CIAR14 1.00
CIAR14 .500
NC-1 Control
3.95
21.5
32.9
72.4
100.
32.6
48.4
51.7
78.5
100.
8.74 42.5
28.2 86.4
13.9
89.3
102.
100.
100.
87.9
103.
99.2
103.
100.
44 (20)
35 (20)
38 (20)
22 (20)
40 (40)
186 (20)
77 (20)
26 (20)
48 (19)
35 (20)
15 (20)
54 (59)
1.54*
1.61**
1.59**
.966
.787
8.98***
3.42***
.848*
2.30***
1.48***
.547
.732
+ 2.33
+ 3.17
+ 2.75
+ .78
Control
Mean t = 2.26
+ 20.9
+ 8.88
+ 2.15
+ 8.11
+ 4.80
+ 1.32
Control
Mean t = 4.09
C. I. Acid Yellow 73 [CIAY73. M.W. = 376.]
5.66 69.5
16.5 78.7
2.83
.000
9.91
54.2
100.
11.9
18.7
66.0
86.4
100.
2.86 73.0
13.8 78.9
179 (20)
114 (19)
13 (16)
14 (16)
7 (20)
17 (20)
94 (78)
141 (20)
64 (20)
8.33*** + 13.6
5.53*** + 10.0
.664
.645
.221
.702
.972
.00(-1.31)
.00(-1.36)
.00(-4.09)
.00(-1 .25)
Control
Mean t = .000
6.14*** + 13.5
2.93*** + 9.12
.00(-1.01)
+ .26
.00(- .64)
.00(- .81)
Control
Mean t = .065
(Continued on nextpage)
005004-S
005004-S
005004-S
005004-S
NC-1
.410
.308
.205
.103
Control
.000
.000
1.20
63.1
100.
.000
34.1
91.8
103.
100.
3 (10,20)
20 (20)
18 (20)
10 (20)
38 (80)
Trial
B(a)P
B(a)P
1 [30]
.000791
.000250
1.32 60.3
2.63 101.
158 (20)
98 (19)
Trial 1
B(a)P
B(a)P
CIAY73
CIAY73
CIAY73
CIAY73
NC-1
Trial 2
B(a)P
B(a)P
[77]
.000791
.000250
7.98
5.98
3.99
1.99
Control
[83]
.000791
.000250
CIAY73
CIAY73
CIAY73
CIAY73
NC-i1
7.98
5.98
3.99
1.99
Control
.000
2.38
4.29
34.8
100.
13.1
23.9
35.7
78.4
100.
3 (13)
10 (13)
4 (12)
6 (20)
48 (80)
.173
.406
.230
.231
.351
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Ephedrine Sulfate [213387-S, M.W. = 428.54]
Trial 1 [71]
B(a)P .000791
B(a)P .000250
213387-S .279
213387-S .209
213387-S .140
213387-S .0700
NC-1 Control
Trial 2 [77]
B(a)P .000791
B(a)P .000250
213387-S
213387-S
213387-S
213387-S
NC-1
2.79
2.09
1.40
.698
Control
Trial 3 [89]
B(a)P .000791
B(a)P .000250
4.48 50.7
18.1 68.7
73.9
75.7
80.6
93.1
100.
80.9
79.4
87.8
83.2
100.
5.66 69.5
16.5 78.7
.000
.000
.943
30.2
100.
.367
10.6
83.6
97.6
100.
8.13 69.0
31.9 89.1
251 (20)
77 (20)
18 (20)
16 (20)
37 (15)
24 (13)
110 (75)
179 (20)
114 (19)
0 (7,20)
4 (19)
28 (20)
19 (19)
94 (78)
119 (20)
63 (20)
11 .0***
3.50***
.712
.611
1.96*
1.51
1.06
8.33***
5.53***
.000
.157
.880
.760
.972
4.77***
2.33***
+ 12.1
+ 7.12
.00(-1 .26)
.00(-1 .67)
+ 2.14
+ 1.10
ControL
Mean t = .810
+ 13.6
+ 10.0
.00(-12.5)
.00(- 6.21)
.00(- .37)
.00(- .92)
Control
Mean t = .000
+ 10.3
+ 5.84
.000
.270
.704
.480
.492
.00(-7.01)
.00(-1.12)
+ .96
.00(- .06)
Control
Mean t = .320
Erythromycin Stearate [302486-S, M.W. = 1018.59]
Trial 1 [71]
B(a)P .000791
B(a)P .000250
4.48 50.7
18.1 68.7
302486-S
302486-S
302486-S
302486-S
NC-1
.118
.0882
.0588
.0294
Control
Trial 2 [89]
B(a)P .000791
B(a)P .000250
.000
.000
1.79
25.1
100.
13.4
39.1
75.1
98.9
100.
6
7
9
10
110
8.13 69.0
31.9 89.1
(16)
(20)
(20)
(16)
(75)
119 (20)
63 (20)
.242
.275
.366
.461
1.06
4.77***
2.33***
.00(-3.18)
.00(-4.65)
.00(-3.89)
.00(-2.13)
Control
Mean t = .000
+ 10.3
+ 5.84
302486-S .118
302486-S .0882
302486-S .0588
302486-S .0294
NC-1 Control
.000
.000
2.61
49.3
100.
12.0
27.0
75.4
83.7
100.
5 (20)
7 (20)
11 (20)
17 (20)
57 (79)
.172
.275
.402
.620
.492
.00(-2.55)
.00(-1.31)
.00( -50)
+ .65
Controt
Mean t = .163
Ethoxylated Dodecyl Alcohol [EDA. M.W. = -1200., Density = 0.999 g/ml]
Trial 1 [82]
B(a)P .000791
B(a)P .000250
46.8 47.2
56.3 51.6
(Continued on nextpage)
213387-S
213387-S
213387-S
213387-S
NC-1
2.09
1.74
1.40
.698
Control
42.5 ?
102.
107.
100.
.2 ?
2.3 ?
13.3
91.9
100.
0 (5,20)
8 (15)
23 (19)
12 (19)
57 (79)
251 (20)
77 (20)
11 .0***
3.50***
+ 12.1
+ 7.12
371 (18)
288 (18)
19.4***
15.5***
+ 7.45
+ 7.97
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
EDA .0417
EDA .0132
EDA .00417
EDA .00132
NC-1 Control
Trial 2 [90]
B(a)P .000791
B(a)P .000255
.000
.867
26.9
63.3
100.
.000
67.8
101.
91.8
100.
0
125
110
82
649
28.5 76.0
51.8 95.8
(0,18)
(18)
(18)
(18)
(72)
157 (18)
111 (18)
.000
6.42
5.77
4.40
8.01
7.60***
4.91***
NA
.00(-1 .74)
.00(-2.59)
.00(-6.45)
Control
Mean t = .000
+ 5.89
+ 3.71
1 (12,18)
11 (18)
68 (18)
51 (18)
219 (71)
.059
.414
2.85
2.12
1.95
.00(-9.90)
.00(-4.07)
+ 1.44
+ .31
Control
Mean t = .583
Ethylenediamine Tetraacetic Acid, Trisodium Salt [EDTA, M.W. = 358.22]
61 (19)
48 (20)
2.60***
1 .58***
+ 8.09
+ 4.37
EDTA 2.72
EDTA 1.81
EDTA 1.36
EDTA .907
NC-1 Control
Trial 2 [85]
B(a)Ph .000791
B(a)P .000250
.000
5.00
45.3
80.1
100.
3.13
60.0
79.4
98.8
100.
12.8 55.6
22.4 91.8
5 (20)
34 (20)
14 (20)
19 (20)
45 (79)
133 (20)
66 (19)
.172
1 .26**
.525
.542
.274
3.43***
2. 10***
.00(- .45)
+ 4.49
+ 1.50
+ 1.48
Control
Mean t = 2.49
+ 5.10
+ 4.56
B(a)P .000791
B(a)P .000250
EDTA
EDTA
EDTA
EDTA
NC-1
2.79
2.33
1.67
.837
Control
18.8 55.9
28.7 79.4
.000
1.20
37.5
94.6
100.
.000
2.33
49.1
89.7
100.
2 (15,20)
1 1 (20)
15 (20)
7 (20)
38 (80)
.072
.423
.578
.272
.313
.00(-2.26)
+ .75
+ 1.68
.00(- .29)
Control
Mean t = .810
Eugenol [EUG, M.W. = 164.20, Density = 1.064 g/ml]
Trial
B(a)P
B(a)P
1 [74]
.00079
.000250
? 69.2
9.58 78.4
43 (18)
27 (18)
2.02***
1 .29*
EUG .649
EUG .325
EUG .162
EUG .0812
NC-1 Control
Trial 2 [94]
B(a)P .000791
B(a)P .000250
.000
11.4
39.5
66.5
100.
96.3
110.
99.1
107.
100.
.000 75.7
17.4 114.
43 (18)
30 (18)
23 (18)
17 (18)
65 (71)
122 (18)
81 (18)
1 . 99***
1.00
1.03
.765
.657
5.92***
3.88***
+ 4.45
+ 1.07
+ 1.51
+ .49
Control
Mean t = 1.88
+ 6.26
+ 4.08
(Continued on nextpage)
EDA
EDA
EDA
EDA
NC-1
.0250
.0188
.0125
.00625
Control
.000
8.70
8.35
15.7
100.
.000
12.5
62.1
94.3
100.
Trial
B(a)P
B(a)P
1 [73]
.000791
.000250
2.21 71.9
7.18 88.8
+ 4.51
+ 2.49
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
.000
1.52
.586
.624
1.52
.00(-1.44)
.00(- .01)
.00(-2.72)
.00(-2.73)
Control
Mean t = .000
Geranyl Acetate [GEAC, M.W. = 196.32, Density = 0.907 - 0.918 g/ml]
1 [84]
.000791
.000250
.560
.280
.140
.0700
Control
2 [92]
.00250
.000791
.000250
.509
.382
.255
.127
ControL
49.8 57.9
ND 71.7
.733
53.5
84.2
114.
100.
.394
18.2
19.4
1.19
14.7
61.4
89.5
100.
1.68
50.9
60.6
101.
100.
45.3
72.2
78.2
.000
19.9
66.2
98.1
100.
71 (18)
57 (18)
1 (16,18)
10 (18)
18 (18)
9 (18)
50 (72)
69 (18)
44 (18)
32 (17)
0 (0,18)
9 (9,18)
14 (18)
7 (18)
62 (71)
3.27***
2.44***
.039
.446
.834
.339
.511
3.54***
2.14***
1.52**
.000
.714
.634
.260
.597
+ 6.82
+ 6.14
.00(-5.25)
.00(- .36)
+ 1.59
.00(- .98)
Control
Mean t = .530
+ 8.31
+ 5.20
+ 3.32
NA
+ .39
+ .18
.00(-1.86)
Control
Mean t = .090
4-Hexylresorcinol [012776-S, M.W. = 194.27]
4.00 80.5
24.8 93.1
4.7
14.5
49.1
76.3
100.
2.21
51.0
82.7
103.
100.
12.8 55.9
28.7 79.4
2.00
25.1
48.3
70.3
100.
.000
44.0
80.2
95.2
100.
141 (20)
93 (20)
2 (18)
3 (9)
16 (10)
26 (15)
84 (39)
133 (20)
66 (19)
2 (19)
26 (20)
12 (20)
7 (20)
38 (80)
6.13***
3.20*
.080
.220
1.35
1.57
1.92
3.43***
2.10***
.076
.927*
.374
.172
.313
+ 6.87
+ 2.02
.00(-11.5)
.00(- 5.54)
.00(- 1.36)
.00(- 1.00)
Control
Mean t = .000
+ 5.10
+ 4.56
.00(-2.85)
+ 3.28
+ .40
.00(-1 .04)
Control
Mean t = .920
D,L-Menthol [MENT, M.W. = 156.27]
Trial
B(a)P
B(a)P
1 [18]
.000791
.000250
2.24 45.8
8.52 78.5
EUG
EUG
EUG
EUG
NC-1
1.62
.812
.406
.203
Control
.000
.000
5.13
5.13
100.
.000
59.8
121.
137.
100.
0
32
22
15
150
(1,18)
(15)
(18)
(18)
(71)
Trial
B(a)P
B(a)P
GEAC
GEAC
GEAC
GEAC
NC-1
Trial
B(a)P
B(a)P
B(a)P
GEAC
GEAC
GEAC
GEAC
NC-1
Trial
B(a)P
B(a)P
012776-S
012776-S
012776-S
012776-S
NC-1
Trial
B(a)P
B(a)P
012776-S
012776-S
012776-S
012776-S
NC-1
1 [63]
.000791
.000250
.158
.118
.079
.039
Control
2 [85]
.000791
.000250
.147
.111
.074
.037
Control
125 (20)
86 (20)
5.91***
3.36***
+ 13.0
+ 7.28
(Continued on nextpage)
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Conditiona Activityb Activity' Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
7 (10,20)
3 (4,19)
14 (20)
58 (20)
33 (40)
83- (20)
86 (20)
2 (15,20)
4 (20)
6 (20)
10 (20)
18 (40)
.578
.414
.525
.925
.663
3.65***
3.73***
.097
.132
.231
.347
.308
.00(- .34)
.00(- .67)
.00(- .71
+ .69
Control
Mean t = .215
+ 10.7
+ 10.7
.00(-1 .92)
.00(-1.35)
.00(- .56)
+ .25
Control
Mean t = .083
Methoxychlor [METH, M.W. = 345.66]
1 [37]
.000791
.000250
.231
.174
.116
.058
Control
2 [89]
.000791
.000250
.145
.108
.072
.036
Control
1.60 46.0
6.80 77.2
.000
.000
.000
72.8
100.
.000
.000
2.48
78.3
100.
8.13 69.0
31.9 89.1
.000
31.1
63.6
90.3
100.
16.8
60.9
84.4
85.0
100.
101 (20)
113 (20)
0 (0,20)
0 (5,20)
7 (19)
24 (20)
32 (39)
119 (20)
63 (20)
3 (14)
21 (19)
30 (20)
15 (18)
57 (79)
4.59***
5.38***
.000
.000
.272
.966
.631
4.77***
2.33***
.160
.809
1.30***
.502
.492
+ 9.94
+ 13.5
ND
.00(-6.46)
.00(-2.01)
+ 1.41
Control
Mean t = .705
+ 10.3
+ 5.84
.00(-1 .79)
+ 1.45
+ 3.54
+ .05
Control
Mean t = 1.26
Methyldopa Sesquihydrate [973697-S, M.W. = 238.24]
Trial
B(a)P
B(a)P
1 [75]
.000791
.000250
973697-S .119
973697-S .0595
973697-S .0298
973697-S .0149
NC-1 Control
Trial 2 [91]
B(a)P .000791
B(a)P .000250
7.10 66.5
28.4 85.4
.000
55.5
92.3
100.
100.
45.8
71.3
71.0
72.2
100.
28.9 73.6
58.1 89.9
149 (20)
67 (20)
51 (20)
39 (20)
32 (20)
17 (20)
89 (78)
60 (20)
14 (20)
6.35***
3.10***
2.09***
1.37
1.18
.677
.882
2.00***
.503
+ 10.9
+ 6.56
+ 3.85
+ 1.71
+ 1.11
.00(- .93)
Control
Mean t = 1.67
+ 5.11
+ 1.31
973697-S .167
973697-S .125
973697-S .083
973697-S .042
NC-1 Control
.000
.000
.000
93.5
100.
.849
16.1
84.4
93.1
100.
5 (10,20)
17 (18,20)
5 (20)
3 (20)
31 (75)
.155
.596
.172
.110
.322
+ .08
+ 1.80
.00(-1 .34)
.00(-2.04)
Control
Mean t = .600
(Continued on nextpage)
.000
.000
42.2
69.5
100.
.000
39.8
102.
110.
100.
MENT
MENT
MENT
MENT
NC-1
Trial
B(a)P
B(a)P
MENT
MENT
MENT
MENT
NC-1
6.40
3.20
1.60
.800
Control
2 [24]
.000791
.000250
4.80
3.20
1.60
.800
Control
.000 18.7
5.66 70.0
.629
50.3
64.8
72.3
100.
.000
85.6
91.7
98.7
100.
Trial
B(a)P
B(a)P
METH
METH
METH
METH
NC-1
Trial
B(a)P
B(a)P
METH
METH
METH
METH
NC-1
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RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc.,mM S.A CC.A. III (N) III t-statistic
Methylphenidate [MEPH, M.W. = 269.80]
1 [48]
.00791
.00250
8.36
6.27
4.18
2.09
Control
[57]
.000791
.000250
8.00
6.00
4.18
2.09
Control
2.28 47.9
10.1 90.8
.000
3.91
57.2
82.6
100.
5.80
73.6
103.
102.
100.
3.55 30.1
5.32 69.9
.000
12.4
68.4
95.0
100.
20.3
71.4
81.8
78.6
100.
148 (20)
63 (20)
23 (20)
25 (20)
18 (19)
9 (20)
29 (40)
162 (20)
37 (20)
14 (20)
12 (20)
3 (20)
8 (20)
15 (40)
7.06***
2.68***
.927
1.08*
.777
.327
.537
7.55***
1.63***
.525
.473
.094
.301
.278
+ 16.5
+ 6.53
+ 1.72
+ 2.40
+ 1.12
.00(-1.19)
Control
Mean t = 1.31
+ 18.7
+ 6.91
+ 1.60
+ 1.35
.00(-1.66)
+ .17
Control
Mean t = .780
Oxytetracycline-HC1 [925728-S, M.W. = 496.90]
2.21 71.9
7.18 88.8
61 (19)
48 (20)
2.60***
1 .58***
+ 8.09
+ 4.37
925728-S
925728-S
925728-S
925728-S
NC-1
Trial
B(a)P
B(a)P
1.80
.900
.450
.225
Control
2 [103]
.000791
.000250
925728-S .640
925728-S .320
925728-S .160
925728-S .0800
NC-1 Control
Trial 3 [107]
B(a)P .000791
B(a)P .000250
.000
.000
.000
.000
100.
.000
.000
.000
20.7
100.
8.60 76.9
23.6 91.5
.000
31.4
77.8
81.7
100.
20.7
86.2
81.4
95.5
100.
5.81 47.3
21.2 75.8
0 (2,19)
0 (19,20)
1 (20)
1 (20)
45 (79)
95 (20)
75 (20)
38 (20)
19 (19)
19 (20)
11 (19)
89 (79)
131 (20)
122 (20)
.000
.000
.035
.035
.274
4.59***
2.86***
.623
.777
.634
.389
.874
6.09***
5.53***
.00(-4.49)
.00(-4-49)
.00(-3.24)
.00(-3.24)
Control
Mean t = .000
+ 13.7
+ 5.37
.00(- .75)
.00(- .41 )
.00(-1 .05)
.00(-2.31 )
Control
Mean t = .000
+ 5.74
+ 4.05
925728-S .690
925728-S .518
925728-S .345
925728-S .173
NC-1 Control
1.37
22.2
44.4
88.2
100.
19.0
68.5
86.0
97.0
100.
10 (20)
10 (19)
16 (20)
23 (20)
274 (80)
.347
.397
.619
.899
2.95
.00( -8.60)
.00(-8.19)
.00(-7.09)
.00(-5.68)
Control
Mean t = .000
Phenol [PHENOL, M.W. = 94.11]
Trial 1
B(a)P
B(a)P
[76]
.000791
.000250
5.91 63.1
23.3 97.0
87 (18)
54 (18)
4.41***
2.72*
+ 5.23
+ 2.26
Trial
B(a)P
B(a)P
MEPH
MEPH
MEPH
MEPH
NC-1
Trial 2
B(a)P
B(a)P
MEPH
MEPH
MEPH
MEPH
NC-1
Trial
B(a)P
B(a)P
1 [73]
.000791
.000250
(Continued on nextpage)
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RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
PHENOL
PHENOL
PHENOL
PHENOL
NC-1
Trial 2
B(a)P
B(a)P
PHENOL
PHENOL
PHENOL
PHENOL
NC-1
4.25
2.13
1.06
.53
Control
[90]
.000791
.000250
4.25
3.19
2.13
1.06
Control
.000
4.60
25.9
59.1
100.
65.0
82.9
92.4
102.
100.
28.5 76.0
51.8 95.8
7.65
13.6
17.7
61.2
100.
42.5
48.6
67.9
90.9
100.
239
152
89
97
152
(18)
(18)
(18)
(18)
(71)
157 (18)
111 (18)
159
114
55
49
219
(18)
(18)
(18)
(18)
(71)
13.0***
8.01***
4.61***
3.84***
1.79
7.60***
4.91***
8.17***
5.95***
2.74
2.33
1.95
+ 20.3
+ 12.3
+ 5.54
+ 3.90
Control
Mean t = 10.5
+ 5.89
+ 3.71
+ 8.78
+ 7.15
+ 1.80
+ .67
Control
Mean t = 4.60
Phenylephrine-HC1 [571483-S, M.W. = 203.67]
Trial 1 [73]
B(a)P .000791
B(a)P .000250
2.21 71.9
7.18 88.8
61 (19)
48 (20)
2.60***
1.58***
+ 8.09
+ 4.37
571483-S
571483-S
571483-S
571483-S
NC-1
7.00
5.25
3.50
1.75
Control
Trial 2 [105]
B(a)P .000791
B(a)P .000250
571483-S
571483-S
571483-S
571483-S
NC-1
6.00
4.50
3.00
1.50
Control
.000
.000
.552
88.4
100.
.209
2.09
38.6
99.2
100.
5.67 63.1
18.2 86.5
.000
.000
9.67
81.7
100.
.792
10.6
89.2
98.7
100.
0 (3,20)
0 (19,20)
8 (20)
10 (20)
45 (79)
59 (20)
40 (19)
0 (10,19)
6 (20)
20 (20)
14 (18)
58 (77)
.000
.000
.275
.394
.274
2.43***
1.93***
.000
.172
.715
.598
.581
.00(-4.49)
.00(-4.49)
.00
+ .77
ControL
Mean t = .385
+ 6.70
+ 5.54
.00(-8.86)
.00(-2.68)
+ .69
+ .09
Controt
Mean t = .260
Propyl Gallate [PRGA, M.W. = 212.22]
Trial 1 [3]
B(a)P .000791
B(a)P .000250
10.7 47.1
13.4 81.6
PRGA
PRGA
PRGA
PRGA
NC-1
.087
.075
.059
.038
Control
.000
.000
.000
.000
100.
Trial 2 [9]
B(a)P .000791
B(a)P .000250
PRGA
PRGA
PRGA
PRGA
NC-1
.094
.071
.047
.024
ControL
32.2
37.9
42.5
72.4
100.
3.14 38.3
8.52 87.2
.000
.000
1 .35
74.4
100.
44.1
66.7
83.1
84.1
100.
33 (19)
27 (20)
17 (20)
14 (20)
17 (40)
108 (20)
47 (20)
25 (20)
7 (20)
3 (20)
0 (20)
8 (40)
1 . 04*
.977**
.658*
.556
.285
4.93***
1 .92***
.800**
.238
.110
.000
.149
+ 2.60
+ 3.31
+ 2.24
+ 1.65
Control
Mean t = 2.42
+ 16.2
+ 7.04
+ 2.98
+ .85
.00(- .46)
.00(-3.12)
Control
Mean t = .958
(Continued on nextpage)
127 (20)
39 (20)
5.84***
1.61***
+ 14.8
+ 5.63
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activity' Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Rotenone [959444-S, M.W. = 394.43]
Trial 1 [75]
B(a)P .000791
B(a)P .000250
7.10 66.5
28.4 85.4
959444-S .00513
959444-S .00162
959444-S .000513
959444-S .000162
NC-1 Controt
Trial 2 [96]
B(a)P .000791
B(a)P .000250
.000 13.7
.000 49.2
2.92 45.4
5.43 85.2
100. 100.
11.0 43.5
38.9 75.5
1 (19,20)
0 (10,20)
2 (19)
9 (20)
89 (78)
86 (20)
62 (20)
.037
.000
.060
.289
.882
4.03***
2.88***
.00(- 8.85)
.00(-11.2)
.00(- 7.10)
.00(- 3.09)
Control
Mean t = .000
+ 9.40
+ 7.12
959444-S .00256 .786 23.5
959444-S .000810 2.36 51.9
959444-S .000256 21.6 54.6
959444-S .0000810 46.8 86.5
NC-1 ControL 100. 100.
0 (1,20)
0 (11,20)
18 (20)
19 (20)
62 (70)
.000
.000
.813
.677
.660
.00(-1 .02)
.00(-8.55)
+ .94
+ .08
Control
Mean t = .510
Sodium Diethyldithiocarbamate [SDEDTC, M.W. = 171.27]
Trial 1 [38]
B(a)P .000791
B(a)P .000250
2.10 28.4
9.44 74.7
174 (20)
162 (20)
7.75***
8.17***
+ 15.6
+ 18.0
SDEDTC .000467
SDEDTC .000234
SDEDTC .000117
SDECTC .0000584
NC-1 Control
Trial 2 [96]
B(a)P .000791
B(a)P .000250
SDEDTC .000350
SDECTC .000263
SDEDTC .000175
SDEDTC .0000876
NC-1 Control
.000 4.39
17.1 12.9
87.4 71.4
96.5 84.3
100. 100.
11.0 43.5
38.9 75.4
.786 4.88
7.07 11.1
23.6 48.8
97.4 100.
100. 100.
31 (20)
42 (19)
39 (19)
19 (19)
27 (40)
86 (20)
62 (20)
41 (20)
46 (20)
27 (20)
13 (20)
62 (70)
1.18**
1.91***
1.63**
.815
.496
4.03***
2.88***
1.75***
1.98***
1.00
.49
.660
+ 2.74
+ 5.18
+ 4.06
+ 1.50
Control
Mean t = 3.37
+ 9.40
+ 7.12
+ 3.99
+ 4.64
+ 1.45
.00(- .86)
ControL
Mean t = 2.52
Stannous Chloride [STCL, M.W. = 189.60]
Trial 1 [19]
B(a)P .000791
B(a)P .000250
STCL .0633
STCL .0422
STCL .0211
STCL .0105
NC-1 Control
Trial 2 [26]
B(a)P .000791
B(a)P .000250
.000 9.19
7.08 29.6
47.9 72.4
75.0 93.0
100. 100.
.382 13.5
1.15 56.2
11 (20)
9 (20)
10 (20)
11 (20)
18 (38)
204 (20)
144 (20)
.402
.327
.266
.423
.357
9.88***
6.58***
+ .28
.00(- .20)
.00(- .58)
+ .42
Control
Mean t = .175
+ 17.8
+ 10.5
(Continued on nextpage)
149 (20)
67 (20)
6.35***
3.10***
+ 10.9
+ 6.56
.000 62.5
1.67 89.0
99 (20)
100 (20)
4.61***
4.02***
+ 13.4
+ 10.6
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Treatment Cytotoxic Transforming Transformation
Condition'a Activity Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
3.82
26.3
58.8
78.2
100.
33.6
69.7
56.9
68.2
100.
28 (20)
35 (20)
39 (20)
25 (20)
46 (40)
1.18
1.45
1 .61*
1.04
.907
+ .99
+ 1.77
+ 2.27
+ .48
Control
Mean t = 1.38
Tetracycline-HCG [186206-S, M.W. = 480.94]
4.48 50.7
18.1 68.7
251 (20)
77 (20)
11 .0***
3.50***
+ 12.1
+ 7.12
186206-S .542
186206-S .406
186206-S .271
186206-S .135
NC-1 Control
Trial 2 [89]
B(a)P .000791
B(a)P .000250
.000
3.58
27.3
43.5
100.
.000
1.27
18.5
61.1
100.
8.13 69.0
31.9 89.1
3 (20)
3 (20)
25 (20)
20 (16)
110 (75)
119 (20)
63 (20)
.110
.110
.988
1.03
1.06
4.77***
2.33***
.00(-6.87)
.00(-6.87)
.00(- .23)
.00(- .09)
Control
Mean t = .000
+ 10.3
+ 5.84
186206-S .458
186206-S .394
186206-S .229
186206-S .115
NC-1 Control
9.29
56.3
87.4
89.1
100.
52.4
58.2
77.1
94.3
100.
9 (18)
9 (19)
3 (19)
19 (19)
57 (79)
Tetrakis(hydroxymethyl )phosphonium Chloride
Trial
B(a)P
B(a)P
120152
120152
120152
120152
NC-1
Trial
B(a)P
B(a)P
1 [72]
.000791
.000250
!-L .0263
!-L .0132
!-L .00658
'-L .00329
Control
2 [90]
.000791
.000250
2.75 56.8
6.61 82.1
.000
.000
17.1
40.8
100.
3.76
14.5
53.1
91.2
100.
28.5 76.0
51.8 95.8
.348
.389
.116
.526
.492
.00(- .78)
.00(- .58)
.00(-3.52)
+ .17
Control
Mean t = .043
[120152-L, M.W. = 190.58, Density = 1.322 g/ml]
85 (18)
84 (18)
11 (18)
4 (18)
3 (18)
5 (18)
29 (72)
157 (18)
111 (18)
4.1 1***
3.04***
.456
.148
.122
.212
.289
7.60***
4.91***
+ 12.7
+ 6.20
+ 1.15
.00( -1. 16)
.00(-1 .42)
.00(- .61 )
Control
Mean t = .288
+ 5.89
+ 3.71
120152-L .0132
120152-L .00987
120152-L .00658
120152-L .00329
NC-1 Control
Trial 3 [98]
B(a)P .000791
B(a)P .000250
120152-L .0132
120152-L .00987
120152-L .00658
120152-L .00329
NC-1 Control
.348
2.43
12.2
50.4
100.
4.89
18.6
38.1
78.7
100.
8.38 79.6
29.3 91.3
.000
2.10
5.24
17.8
100.
17.8
26.3
44.2
71.2
100.
101 (18)
122 (18)
106 (18)
66 (18)
219 (71)
132 (18)
75 (18)
12 (18)
10 (18)
6 (18)
5 (18)
39 (45)
4.93***
5.70***
5.22***
2.12
1 .95
6.82***
3.38***
.489
.414
.240
.212
.618
+ 3.88
+ 4.52
+ 5.42
+ .29
Control
Mean t = 3.53
+ 11.8
+ 6.81
.00(- .59)
.00(- .98)
.00(-1 .99)
.00(-2.68)
Control
Mean t = .000
(Continued on nextpage)
STCL
STCL
STCL
STCL
NC-1
.0527
.0264
.0132
.00659
Control
Trial 1
B(a)P
B(a)P
[71]
.000791
.000250
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Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessel s Focus Type
Drug Conc.,mM S.A CC.A. III (N) III t-statistic
Tetrakis(hydroxymethyl )phosphonium Sulfate [003374-L, M.W. = 404.32, Density = NA g/ml]
Trial 1 [72]
B(a)P .000791
B(a)P .000250
2.75 56.8
6.61 82.1
85 (18)
84 (18)
4.11***
3.04***
+ 12.7
+ 6.20
003374-L
003374-L
003374-L
003374-L
NC-1
.01098
.00732
.00366
.00183
Control
Trial 2 [84]
B(a)P .000791
B(a)P .000250
.000
.000
12.1
51.8
100.
1.25
1.75
35.3
68.9
100.
49.8 57.9
NA 71.7
10 (18)
6 (18)
4 (18)
1 (18)
29 (72)
71 (18)
57 (18)
.361
.220
.148
.039
.289
3.27***
2.44***
+ .50
.00(- .53)
.00(-1.16)
.00(-3.59)
Control
Mean t = .125
+ 6.82
+ 6.14
.000
.044
.413
.240
.511
.00(-7.45)
.00(-5.25)
.00(- .52)
.00(-1.66)
Control
Mean t = .000
Triphenyltin Hydroxide [TPH, M.W. = 367.03]
Trial 1 [39]
B(a)P .000791
B(a)P .000250
8.04***
6.84***
.193
.955
.533*
.526
.427
6.48***
4.80***
.260
.072
1.58**
.999**
.416
+ 14.5
+ 15.8
+ .50
+ .51
+ 2.30
.00(-1.36)
Control
Mean t = .828
+ 16.8
+ 12.0
.00(- .49)
.00(-3.35)
+ 3.33
+ 3.21
Control
Mean t = 3.27
Xylenes, (Mixed) [109591-L, M.W. = 106.17, Density = NA g/ml]
Trial 1 [72]
B(a)P .000791
B(a)P .000250
4.1 1***
3.04***
109591 -L
109591 -L
109591 -L
109591 -L
NC-1
4.77
3.18
2.39
1.59
Control
Trial 2 [100]
B(a)P .000791
B(a)P .000250
.000
.000
20.9
53.4
100.
.000
53.8
44.3
99.7
100.
89.7 77.9
81.0 93.8
0 (0,18)
0 (1,18)
3 (10,18)
5 (18)
29 (72)
65 (18)
62 (18)
.000
.000
.231
.193
.289
3.30***
2.85***
NA
.00( - .65)
.00(- .35)
.00(- .76)
Control
Mean t = .000
+ 11.7
+ 7.75
(Continued on nextpage)
003374-L
003374-L
003374-L
003374-L
NC-1
.01098
.00732
.00366
.00183
Control
.000
.000
1.47
11.7
100.
.635
.212
2.96
51.0
100.
0 (2,18)
1 (16,18)
13 (18)
6 (18)
50 (72)
1.07 23.6
3.56 64.5
172 (20)
145 (20)
.000
26.0
67.6
86.8
100.
35.1
78.5
88.4
98.3
100.
TPTH
TPTH
TPTH
TPTH
NC-1
Trial
B(a)P
B(a)P
TPTH
TPTH
TPTH
TPTH
NC-1
.000272
.000136
.0000681
.0000341
Control
2 [93]
.000791
.000250
.000327
.000163
.0000817
.0000409
Control
2.65 46.7
7.96 79.9
5 (18)
24 (20)
16 (20)
13 (19)
27 (40)
138 (20)
115 (20)
1 (3,18)
1 (10,20)
45 (18)
25 (20)
43 (79)
.000
.000
.000
34.5
100.
17.4
9.50
73.6
86.3
100.
2.75 56.8
6.61 82.1
85 (18)
84 (18)
+ 12.7
+ 6.20
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
109591-L 9.09 .000 .000 0 (2,18) .000 .00(-5.11)
109591-L 6.82 29.9 54.1 1 (8,18) .091 .00(-1.06)
109591-L 4.55 30.3 71.8 9 (18) .348 + .57
109591-L 2.27 57.0 92.1 12 (18) .464 + 1.32
NC-1 Cont-rol 100. 100. 28 (72) .268 ControL
Mean t = .945
Abbreviations: B(a)P, benzo(a)pyrene; CC.A., co-culture clonal survival assay; Conc., concentration; mM, millimole; M.W., molecular weight; N,
number ofculture vessels, NC, negative control; ND, not determined; %RCE, percent relative cloning efficiency; S.A, standard clonal survival
assay.
aTreatment Condition: The experimental design for the transformation assay is described in detail in the Materials and Methods. The
concentration ofthe positive control and test chemical treatment are presented in mM, but they can be converted to ,ug/ml using the molecular
weight that is provided with each chemical. The solvent vehicles used for the individual test chemicals were listed in Appendix Tables Al and A3,
and the concentrations ofthe solvent vehicles are presented in the Materials and Methods.
bCytotoxic activity: The experimental design for the standard survival assay (SA) and the co-culture clonal survival assay (CCA) were described
in the Materials and Methods. The test chemical cytotoxic response was expressed as & RCE and was calculated as described in the Materials and
Methods.
cThe criteria used to evaluate the transformed foci ofBALB/c-3T3 cells is described in the Materials and Methods. The number oftype III foci
> 2-mm in diameter per culture vessel scored are recorded in this table.
dTransformation response: The transformation responses are expressed as type III foci/vessel and were calculated using a log1o mathematical
transformation procedure (refer to Materials and Methods). The arithmetic value or foci/vessel represents the antilog ofthe log1o mean
transformation response minus one.
eSignificance: The significance oftest chemical transformation responses was calculated by a computer using the SAS statistical software (22),
and the method is described in detail in Materials and Methods. The correct t-statistic according to the F-test is presented in this table. The
t-statistics ofeach treatment dose ofthe test chemical in a single experiment were averaged to determine the mean t-statistic ofthe test chemical
for the experiment (refer to Appendix Tables A2 and A5). The mean t-statistics for two or experiments for each chemical was weighted to the
number oftreatment doses evaluated and averaged to determine the rank t-statistic which was used to rank-order the test chemical
transformation responses in Appendix Tables A3 and A6. Arbitrarily, transformation responses with negative (-) t-statistics were given a value of
zero (0).
*Significant BaP or test chemical transformation response, 0.01 < p < 0.05.
**Significant BaP or test chemical transformation response, 0.001 < p < 0.01.
***Significant or BaP or test chemical transformation response, p < 0.001.
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Appendix E
Summary ofthe transformation responses of 12 noncytotoxic carcinogens.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
3-Amino-1,2,4-Triazole [AMT, M.W. = 84.08]
Trial 1 [69]
B(a)P .000791 1.72 50.1 63 (20) 2.67*** + 9.34
B(a)P .000250 11.3 68.1 33 (20) 1.17** + 3.53
AMT 200. .000 .000 1 (9,20) .080 .00(-1.42)
AMT 100. 3.44 57.7 21 (20) .798* + 2.53
AMT 50.0 53.3 94.2 33 (20) 1.30*** + 4.24
AMT 25.0 88.7 75.3 27 (19) 1.14*** + 3.86
NC-1 Control 100. 100. 15 (40) .288 Control
Mean t = 3.54
Trial 2 [99]
B(a)P .000791 18.9 68.4 160 (20) 6.67*** + 12.4
B(a)P .000250 32.1 85.0 94 (20) 3.59*** + 7.95
AMT 107. 4.91 31.0 50 (20) 2.20*** + 5.77
AMT 80.3 39.6 56.9 123 (20) 5.57*** + 11.6
AMT 53.5 87.5 87.3 104 (20) 4.39*** + 9.35
AMT 26.8 96.6 106. 53 (20) 2.20*** + 5.60
NC-1 Control 100. 100. 65 (80) .586 Control
Mean t = 8.08
Cyclamate, Sodium Salt [CYC. M.W. = 201.22]
Trial 1 [71]
B(a)P .000791 4.48 50.7 251 (20) 11.0*** + 12.1
B(a)P .000250 18.1 68.9 77 (20) 3.50*** + 7.12
CYC 29.8 42.3 84.4 74 (18) 3.10*** + 4.21
CYC 22.4 57.4 78.9 54 (18) 2.39** + 3.12
CYC 14.9 67.6 76.3 55 (19) 2.40** + 3.32
CYC 7.45 78.4 77.3 28 (20) 1.18 + .38
NC-1 Control 100. 100. 110 (75) 1.06 Control
Mean t = 2.76
Trial 2 [107]
B(a)P .000791 5.81 47.3 131 (20) 6.09*** + 5.74
B(a)P .000250 21.2 75.8 122 (20) 5.53*** + 4.05
CYC 149. 8.55 31.4 61 (20) 2.57 .00(- .78)
CYC 112. 25.0 77.1 159 (19) 7.99*** + 9.43
CYC 74.6 67.4 87.8 151 (20) 7.21*** + 8.24
CYC 37.3 92.3 85.6 142 (20) 5.69*** + 4.00
NA-1 Control 100. 100. 274 (80) 2.95 Control
Mean t = 5.42
11-Aminoundecanoic Acid [11AMI, M.W. = 201.35]
Trial 1 [17]
B(a)P .000791 .000 52.9 94 (20) 4.43*** + 13.5
B(a)P .000250 3.54 79.1 86 (20) 3.91*** + 11.6
11AMI .497 .000 100. 15 (20) .578 + 1.49
11AMI .248 .000 102. 11 (20) .374 + .30
11AMI .124 9.29 104. 17 (20) .606 + 1.54
11AMI .0621 57.1 106. 12 (20) .494 + 1.08
NC-1 Control 100. 100. 18 (40) .327 Control
Mean t = 1.10
Trial 2 [24]
t3(a)P .000791 .000 18.7 83 (20) 3.65*** + 10.7
B(a)P .000250 5.66 70.0 86 (20) 3.73*** + 10.7
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
.000
.000
.000
.000
100.
105.
104.
106.
104.
100.
10.1 51.7
6.37 77.4
.000
.000
.000
.000
100.
26.2
75.3
78.1
74.2
100.
5.87 34.4
20.8 63.9
.000
.000
.000
.000
100.
72.0
90.7
86.8
87.6
100.
4 (20)
3 (20)
7 (20)
3 (20)
18 (40)
197 (19)
115 (20)
100 (20)
87 (20)
42 (20)
53 (20)
91 (38)
48 (20)
39 (20)
17 (20)
10 (20)
10 (18)
9 (20)
5 (39)
.132
.110
.275
.072
.308
10.1***
5.46***
4.52***
3.77***
1.56
1.79
1.99
2.07***
.969**
.644***
.354*
.392*
.301
.085
.00(-1 .35)
.00(-1 .88)
.00(- .24)
.00(-1 .87)
Control
Mean t = .000
+ 12.6
+ 6.94
+ 4.31
+ 3.11
.00(- .97)
.00(- .41)
Control
Mean t = 1.86
+ 8.71
+ 3.32
+ 3.52
+ 2.08
+ 2.16
+ 1.71
Control
Mean t = 2.37
Decabromodiphenyloxide [917884-S, M.W. = 959.22]
Trial 1 [75]
B(a)P .000791
B(a)P .000250
7.10 66.5
28.4 85.4
917884-S
917884-S
917884-S
917884-S
NC-1
4.00
2.00
1.00
.500
Control
Trial 2 [101]
B(a)P .000791
B(a)P .000250
83.9
94.8
101.
92.7
100.
80.9
91.0
82.8
99.4
100.
ND 64.8
ND 83.6
22 (20)
22 (20)
24 (20)
30 (20)
89 (78)
108 (20)
48 (20)
.818
.882
.882
1.04
.882
4.63***
2.1 1***
.00(- .27)
.00
.00
+ .60
Control
Mean t = .150
+ 12.7
+ 9.73
.245
.238
.473
.189
.260
.00( -
.00( -
+ 1.72
.00( -
Control
Mean t = .430
DC Red No. 9 [DCR9, M.W. = 444.49]
Tri al 1 [43]
B(a)P .000791
B(a)P .000250
DCR9
DCR9
DCR9
DCR9
NC-1
4.50
2.50
1.12
.562
Control
1.02 53.0
4.75 77.5
30.0
71.1
93.9
98.3
100.
80.5
85.8
96.7
107.
100.
382 (20)
270 (20)
145 (20)
108 (20)
95 (20)
75 (20)
44 (35)
18.9***
13.0***
6.75***
5.12***
4.22***
3. 16***
1.05
+ 26.3
+ 19.0
+ 10.9
+ 10.5
+ 7.16
+ 5.26
Control
Mean t = 8.46
(Continued on nextpage)
11AMI
11AMI
11AMI
11AMI
NC-1
Trial
B(a)P
B(a)P
11AMI
11AMI
11AMI
11AMI
NC-1
Trial
B(a)P
B(a)P
11AMI
11AMI
11AMI
11AMI
NC-1
.993
.745
.497
.248
Control
3 [32]
.000791
.000250
19.87
9.93
4.97
2.48
Control
4 [67]
.000791
.000250
20.0
10.0
5.00
2.50
ControL
149 (20)
67 (20)
6.35***
3.10***
+ 10.9
+ 6.56
917884-S
917884-S
917884-S
917884-S
NC-1
4.17
2.08
1.04
.521
Control
ND
ND
ND
ND
100.
106.
108.
108.
110.
100.
6 (19)
7 (20)
12 (20)
5 (20)
27 (78)
.14)
.19)
.68)
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessel s Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 2
B(a)P
B(a)P
[54]
.000791
.000250
1.47 17.6
.490 61.1
105 (20)
100 (20)
4.75***
4.52***
+ 13.8
+ 13.5
2.02
1.01
.526
.253
Control
3 [67]
.000791
.000250
4.05
2.02
1.01
.506
Control
67.6
111.
112.
102.
100.
65.9
81.8
98.3
99.3
100.
5.87 34.4
20.8 63.9
80.8
91.4
93.3
106.
100.
47.8
59.3
65.4
74.1
100.
19 (18)
12 (19)
9 (20)
6 (20)
15 (40)
48 (20)
39 (20)
47 (20)
27 (20)
13 (20)
9 (20)
5 (39)
.817**
.480
.270
.214
.265
2.07***
.969**
1 .65***
.835**
.503**
.308
.085
+ 2.96
+ 1.39
+ .04
.00(- .41)
Control
Mean t = 1.10
+ 8.71
+ 3.32
+ 5.47
+ 3.37
+ 3.07
+ 1.78
Control
Mean t = 3.42
Di (2 -Ethylhexyl )adipate [DEHA, M.W. = 370.57, Density = 0.928 g/ml]
Trial 1 [88]
B(a)P .000791
B(a)P .000250
15.8 73.9
35.5 82.6
54 (15)
24 (15)
3.36***
1 .50***
+ 9.58
+ 4.90
DEHA
DEHA
DEHA
DEHA
NC-1
Trial 2
B(a)P
B(a)P
DEHA
DEHA
DEHA
DEHA
NC-1
85.3
27.0
8.53
2.70
Control
[108]
.000791
.000250
85.3
27.0
8.53
2.70
Control
2.76
3.53
11.4
17.0
100.
57.0
71.2
94.9
102.
100.
15.5 31.3
30.0 65.7
15.8
22.6
42.3
60.0
100.
57.3
83.6
78.0
92.0
100.
6 (18)
3 (18)
8 (18)
6 (18)
37 (67)
139 (18)
72 (18)
5 (18)
3 (18)
12 (18)
7 (18)
108 (70)
.181
.122
.339
.240
.406
7.38***
4.77***
.212
.122
.587
.289
1.17
Di(2-Ethylhexyl)phthalate [DEHP, M.W. = 390.54, Density = 0.981 g/ml]
Trial 1 [36]
B(a)P .000791 2.98 40.1 73 (9) 7.27***
B(a)P .000250 7.66 78.1 88 (18) 4.37***
.00(-1 .53)
.00(-2.11)
.00(- .43)
.00(-1 .13)
Control
Mean t = .000
+ 13.9
+ 5.96
.00(-5.88)
.00(-7.33)
.00(-3.07)
.00(-3.84)
Control
Mean t = .000
+ 21.8
+ 10.8
DEHP
DEHP
DEHP
DEHP
NC-1
30.1
15.1
7.54
3.77
Control
Trial 2 [100]
B(a)P .000791
B(a)P .000250
2.13
6.81
20.9
28.9
100.
31.5
70.3
92.3
94.4
100.
89.7 77.9
81.0 93.8
0 (10,18)
1 (9,18)
2 (16,18)
7 (18)
20 (36)
65 (18)
62 (18)
.000
.080
.071
.289
.424
3.30***
2.85***
.00(-5.07)
.00(-1 .90)
.00( -2.49)
.00(- .85)
Control
Mean t = .000
+ 11.7
+ 7.75
(Continued on nextpage)
DCR9
DCR9
DCR9
DCR9
NC-1
Trial
B(a)P
B(a)P
DCR9
DCR9
DCR9
DCR9
NC-1
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Appendix F. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
.000
3.22
22.1
47.4
100.
64.3
74.7
69.0
87.0
100.
3 (17)
0 (18)
2 (18)
4 (18)
20 (72)
.130
.000
.080
.148
.268
.00(-1. 14)
.00(-5.11)
.00(-1 .66)
.00(- .99)
Control
Mean = .000
Dimethyl Hydrogen Phosphite [DMHP, M.W. = 110.05, Density = ND g/ml]]
Trial 1 [84]
B(a)P .000791
B(a)P .000250
49.8 57.9
ND 71.7
200.
150.
100.
50.0
Control
2 [104]
.000791
.000250
164.
123.
81.8
40.9
Control
.000
1.47
5.13
22.7
100.
.000
7.36
66.9
90.4
100.
25.0 64.5
50.6 89.6
.000
6.96
16.8
63.3
100.
16.6
65.7
71.0
94.1
100.
0 (3,18)
7 (18)
141 (18)
33 (18)
50 (72)
62 (18)
63 (18)
30 (18)
111 (18)
89 (18)
32 (18)
83 (71)
.000
.248
7.00***
1 .60***
.511
2.79***
2.47***
1.18
5.76***
4.67***
1.50*
.878
.00(-7.45)
.00(-1 .56)
+ 13.6
+ 4.47
Control
Mean t = 6.02
+ 4.87
+ 4.10
+ 1.01
+ 9.55
+ 11.1
+ 2.06
Control
Mean t = 5.93
Diethylnitrosamine [DEN, M.W. = 102.14, Density = ND g/ml]
[79]
.000791
.000250
22.7 79.6
39.3 94.2
279 (13)
241 (18)
20.8***
12.9***
+ 13.9
+ 9.34
138.
104.
69.2
34.6
Control
2 [102]
.000791
.000250
73.8
55.3
36.9
18.4
Control
.000
.000
.826
2.48
100.
.000
.000
4.05
78.8
100.
0
0
153
207
430
9.64 69.9
19.3 93.1
.000
.000
.000
1.26
100.
.000
1.87
45.9
57.3
100.
(0,18)
(0, 18)
(18)
(18)
(72)
99 (18)
45 (18)
2 (1,18)
61 (18)
40 (18)
44 (18)
64 (72)
.000
.000
8. 12***
11 .1***
5.12
4.65***
2.22***
.063
2.46**
1 .77***
1 .91***
.697
ND
ND
+ 4.11
+ 7.71
ControL
Mean t = 5.91
+ 9.48
+ 5.22
+ 1.20
+ 3.78
+ 3.77
+ 4.10
Control
Mean t = 3.88
Dimethylnitrosamine [DMN, M.W. - 74.08, Density = 1.01 g/ml]
Trial 1 [31]
B(a)P .000791
B(a)P .000250
(Continued on nextpage)
DEHP
DEHP
DEHP
DEHP
NC-1
37.7
18.8
9.42
4.71
Control
71 (18)
57 (18)
3.27***
2.44***
DMHP
DMHP
DMHP
DMHP
NC-1
Trial
B(a)P
B(a)P
DMHP
DMHP
DMHP
DMHP
NC-1
+ 6.82
+ 6.14
Trial 1
B(a)P
B(a)P
DEN
DEN
DEN
DEN
NC-1
Trial
B(a)P
B(a)P
DEN
DEN
DEN
DEN
NC-1
1.87 69.1
5.14 99.9
136 (15)
126 (18)
8.63***
6.06***
+ 11.1
+ 8.51
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Appendix F. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
DMN
DMN
DMN
DMN
NC-1
489.
367.
244.
122.
Control
Trial 2 [100]
B(a)P .000791
B(a)P .000250
.000
.000
.000
10.7
100.
.000
34.2
88.0
113.
100.
89.7 77.9
81.0 93.8
1 (18)
31 (18)
42 (17)
123 (18)
43 (36)
65 (18)
62 (18)
.059
1.49
1.98**
4.76**
.930
3.30***
2.85***
.00(-5.78)
+ 1.78
+ 2.72
+ 6.42
Control
Mean t = 3.64
+ 11.7
+ 7.75
.000
.139
1.54***
1.49***
.268
NA
.00(-1.03
+ 4.82
+ 6.50
Control
Mean t = 5.66
Dimethyl Methyl Phosphonate [267599-L, M.W. = 124.08, Density = 1.145 g/ml]
Trial 1 [84]
B(a)P .000791
B(a)P .000250
267599-L
267599-L
267599-L
267599-L
NC-1
175.
131.
87.5
43.8
Control
Trial 2 [102]
B(a)P .000791
B(a)P .000250
267599-L
267599-L
267599-L
267599-L
NC-1
183.
137.
91.7
45.8
Control
49.8 57.9
ND 71.7
.000
2.93
11.7
60.1
100.
17.6
77.7
88.3
101.
100.
9.64 69.9
19.3 93.1
.419
1.33
11.3
55.8
100.
27.5
70.9
82.1
82.9
100.
71 (18)
57 (18)
14 (17)
32 (18)
20 (18)
27 (18)
50 (72)
99 (18)
45 (18)
57 (18)
52 (18)
20 (17)
27 (18)
64 (72)
3.27***
2.44***
.604
1.32**
.876
1.25**
.511
4.65***
2.22***
2.80***
2.36***
.947
1.11
.697
+ 6.82
+ 6.14
+ .47
+ 3.26
+ 1.72
+ 3.21
Control
Mean t = 2.17
+ 9.48
+ 5.22
+ 6.57
+ 5.23
+ 1.07
+ 1.65
Control
Mean t = 3.63
Dimethylmorphol inophosphorami date [945355-L, M.W. = 195.18, Density = NA g/ml]
Trial 1 [86]
B(a)P .000791
B(a)P .000250
18.7 63.3
47.9 87.6
945355-L
945355-L
945355-L
945355-L
NC-1
ND .000
ND .000
ND 5.45
ND 27.2
Control 100.
Trial 2 [108]
B(a)P .000791
B(a)P .000250
945355-L
945355-L
945355-L
945355-L
NC-1
ND
ND
ND
ND
Control
38.5
82.4
77.7
77.7
100.
15.5 31.3
30.0 65.7
.000
.000
.000
1.24
100.
61.2
73.5
86.7
97.3
100.
75 (18)
43 (18)
24 (18)
12 (18)
47 (72)
139 (18)
72 (13)
31 (16)
33 (11)
58 (12)
29 (9)
108 (70)
3.48***
2.12***
1.11**
.441
.464
7.38***
4.77***
1.66
2.63**
4.62***
2. 70**
1.17
+ 8.69
+ 6.15
+ 2.90
.00(- .12)
Control
Mean t = 4.44
+ 13.9
+ 5.96
+ 1.36
+ 2.96
+ 8.96
+ 2.78
Control
Mean t = 4.02
(Continued on nextpage)
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DMN
DMN
DMN
DMN
NC-1
367.
244.
122.
61.1
Control
.000
.000
.000
18.9
100.
.000
.000
83.9
88.7
100.
0 (0,18)
3 (16,18)
35 (18)
30 (18)
29 (72)
64 (18)
42 (18)
3.32***
2.02***
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+ 5.74MATTHEWS ETAL.
Appendix F. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Dimethylmorpholinophosphoramidate [DMMP, M.W. = 195.16, Density = ND g/ml]
Trial 1 [86]
B(a)P .000791
B(a)P .000250
18.7 63.3
47.9 87.6
.000
4.09
12.1
49.8
100.
50.7
74.0
83.0
82.6
100.
27.0 56.9
44.3 77.9
.000
.000
.000
7.65
100.
47.3
61.3
89.1
91.2
100.
64 (18)
29 (18)
28 (18)
14 (18)
47 (72)
134 (18)
91 (18)
47 (18)
66 (18)
57 (18)
41 (18)
74 (43)
2.99***
1.31**
1 .06*
.650
.464
6.88***
4.53***
2.30*
3. 13***
2.86**
1.95
1.30
+ 7.70
+ 3.56
+ 2.54
+ .98
Control
Mean t = 3.70
+ 8.00
+ 5.56
+ 2.28
+ 3.56
+ 3.35
+ 1.54
Control
Mean t = 2.68
Diethanolnitrosamine [DETN, M.W. = 134.14, Density = ND g/ml]
Trial 1 [86]
B(a)P .000791
B(a)P .000250
DETN
DETN
DETN
DETN
NC-1
59.6
44.7
29.8
14.9
Control
18.7 63.3
47.9 87.6
.000
1.17
26.1
49.8
100.
64 (18)
42 (18)
66.6
75.2
87.0
90.5
100.
38 (18)
24 (18)
21 (18)
25 (18)
47 (72)
3.32***
2.02***
1 .83***
1 .24***
1 .04**
1 . 18**
.464
+ 9.07
+ 5.74
+ 5.39
+ 3.61
+ 2.75
+ 3.22
Control
Mean t = 4.01
Ethylene Thiourea [ETU, M.W. = 102.16]
Trial 1 [59]
B(a)P .00079
B(a)P .00025
1.3 36.5
7.4 74.5
165 (20)
33 (19)
7.31***
1 .34***
7.4
47.8
68.4
80.8
100.
80.8
96.1
83.9
104.
100.
6.95 60.7
19.2 90.2
2.65
15.2
45.7
106.
100.
.000
57.3
62.5
65.1
100.
14 (20)
12 (20)
59 (20)
13 (20)
15 (40)
85 (18)
43 (20)
.533
.473
1.21*
.459
.297
4.38***
1 .80***
12 (11,20)
19 (20)
10 (20)
17 (20)
14 (40)
.829**
.772**
.394
.61 1*
.244
+ 1.62
+ 1.27
+ 2.41
+ .99
Control
Mean t = 1.57
+ 13.9
+ 6.94
+ 2.72
+ 3.18
+ 1.10
+ 2.22
Control
Mean t = 2.17
464
64 (18)
42 (18)
3.32***
2.02***
DMMP
DMMP
DMMP
DMMP
NC-1
Trial 2
B(a)P
B(a)P
DMMP
DMMP
DMMP
DMMP
NC-1
+ 9.07
+ 5.74
16.4
8.21
4.10
2.05
Control
[106]
.00079
.00025
23.1
17.3
11.5
5.77
Control
ETU
ETU
ETU
ETU
NC-1
Trial 2
B(a)P
B(a)P
ETU
ETU
ETU
ETU
NC-1
+ 17.9
+ 4.28
157.
117.
78.3
39.1
Control
[65]
.000791
.000250
157.
78.3
39.1
3.91
Control
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Appendix F. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mN S.A CC.A. III (N) III t-statistic
Hexamethylphosphoramide [HMPA, M.W. - 179.2, Density = NA g/ml]
Trial 1 [78]
B(a)P .000791 8.09 60.6 116 (18) 6.11*** + 4*93
B(a)P .000250 14.9 84.2 184 (18) 9.84*** + 9.74
HMPA 78.1 .426 34.0 92 (18) 4.02 + 1.01
HMPA 58.6 .426 76.5 167 (18) 8.50*** + 5.42
HMPA 39.1 8.09 77.6 103 (18) 5.44*** + 4.05
HMPA 19.5 48.9 94.8 64 (18) 3.13 .00(- .23)
NC-1 Control 100. 100. 296 (72) 3.28 Control
Mean t = 2.62
Trial 2 [98]
B(a)P .000791 8.38 79.6 132 (18) 6.82*** + 11.8
B(a)P .000250 29.3 91.3 75 (18) 3.38*** + 6.81
HMPA 83.7 1.05 26.0 10 (18) .401 .00(-1.03)
HMPA 62.8 5.24 62.2 34 (18) 1.43** + 2.67
HMPA 41.9 6.28 83.5 19 (18) .805 + .75
HMPA 20.9 36.6 93.0 31 (18) 1.40** + 2.71
NC-1 Control 100. 100. 39 (45) .618 Control
Mean t = 1.53
Melamine [MELM, M.W. = 126.12]
Trial 1 [43]
B(a)P .000791 1.02 53.0 382 (20) 18.9*** + 26.3
B(a)P .000250 4.75 77.5 270 (20) 13.0*** + 19.0
MELM 31.7 8.50 45.5 55 (19) 2.32** + 3.23
MELM 15.9 35.0 73.1 64 (20) 2.56*** + 4.03
MELM 7.93 63.6 75.3 51 (20) 1.61 + 1.56
MELM 3.96 95.6 80.1 17 (20) .69 .00(-1.48)
NC-1 Control 100. 100. 44 (35) 1.05 Control
Mean t
= 1.82
Trial 2 [58]
B(a)P .000791 3.92 34.3 128 (20) 6.17*** + 22.5
B(a)P .000250 14.7 60.6 71 (20) 1.83*** + 4.78
MELM 32.0 14.0 68.9 26 (20) 1.12*** + 5.97
MELM 16.0 25.2 70.7 10 (20) .414 + 1.97
MELM 8.00 87.9 80.7 4 (19) .157 .00(- .33)
MELM 4.00 93.1 80.4 4 (20) .149 .00(- .43)
NC-1 Control 100. 100. 10 (40) .189 Control
Mean t = 1.99
Methyl Carbamate [MEC, M.W. = 75.07]
Trial 1 [42]
B(a)P .000791 2.41 35.7 280 (20) 13.7*** + 20.2
B(a)P .000250 5.72 65.4 161 (19) 7.44*** + 9.55
MEC 293. 1.81 6.91 13 (20) .400 .00(-1.67)
MEC 220. 13.6 57.8 114 (20) 4.69*** + 6.73
MEC 147. 62.3 72.3 156 (20) 6.70*** + 9.44
MEC 73.3 84.9 85.8 137 (20) 5.23***
+ 7.23
NC-1 Control 100. 100. 52 (40) .861 Control
Mean t = 5.85
Trial 2 [66]
B(a)P .000791 2.33 48.6 90 (20) 3.92*** + 14.1
B(a)P .000250 6.08 98.4 24 (20) *795*** + 3.69
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Appendix F. Continued.
Treatment Cytotoxic Transforming Transformation
Condition'a Activity ActivityC Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
200.
63.3
20.0
6.32
Control
[80]
.000791
.000250
320.
240.
160.
80.0
Control
5.41
86.1
91.9
105.
100.
80.6
101.
109.
111.
100.
16.9 65.2
35.6 87.2
.000
3.86
52.2
87.8
100.
3.24
60.6
76.3
106.
100.
10 (16)
13 (20)
4 (19)
1 (20)
3 (38)
261 (20)
185 (20)
12
86
179
237
317
.330
.525***
.123
.035
.056
12.9***
8.53***
.473
3.54
8.36***
10.2***
3.02
(20)
(20)
(20)
(20)
(80)
+ 1.59
+ 3.80
+ .72
.00(- .41)
Control
Mean t = 1.53
+ 13.0
+ 7.65
.00(-8.62)
+ .77
+ 7.72
+ 6.75
Control
Mean t = 3.81
Methyl Carbamate [315183-S, M.W. = 75.07]
[83]
.000791
.000250
2.86 73.0
13.9 78.9
141 (20)
64 (20)
6.14***
2.93***
+ 13.5
+ 9.12
315183-S
315183-S
315183-S
315183-S
NC-1
325.
244.
163.
81.3
Control
Trial 2 [99]
B(a)P .000791
B(a)P .000250
.000
2.86
19.5
71.9
100.
.000
34.2
63.5
87.9
100.
18.9 68.4
32.1 85.0
1 (18,20)
8 (20)
23 (20)
48 (19)
48 (80)
160 (20)
94 (20)
.039
.301
.771*
1.65***
.351
6.67***
3.59***
.00(-3.94)
.00(- .33)
+ 2.09
+ 5.02
Control
Mean t = 2.38
+ 12.4
+ 7.95
50 (20)
48 (20)
92 (20)
63 (20)
65 (80)
+ 2.01
+ 4.66
+ 9.12
+ 3.43
Control
Mean t = 4.81
Monuron [MONU, M.W. = 198.65]
Trial 1 [20]
B(a)P .000791
B(a)P .000250
268 (20)
99 (20)
MONU
MONU
MONU
MONU
NC-1
7.95
2.52
.795
.252
Control
Trial 2 [28]
B(a)P .000791
B(a)P .000250
MONU
MONU
MONU
MONU
NC-1
12.1
8.05
4.03
2.01
Control
.000
1.56
7.03
28.1
100.
44.5
79.5
89.7
92.4
100.
2.84 28.6
6.74 68.0
.000
.000
.000
15.6
100.
19.1
45.9
90.2
109.
100.
54 (20)
14 (20)
6 (20)
3 (20)
21 (40)
189 (20)
62 (20)
7 (18,19)
4 (18,20)
21 (20)
32 (20)
41 (40)
2.17***
.385
.214
.110
.368
9.02***
2.78***
.289
.167
.807
1.32
.818
+ 6.19
+ .09
.00(-1.06)
.00(-2.33)
Control
Mean t = 1.57
+ 16.9
+ 5.73
.00(-2.71
.00(-4.33)
.00(- .05)
+ 1.81
Control
Mean t = .453
(Continued on nextpage)
MEC
MEC
MEC
MEC
NC-1
Trial 3
B(a)P
B(a)P
MEC
MEC
MEC
MEC
NC-1
Trial 1
B(a)P
B(a)P
315183-S
315183-S
315183-S
315183-S
NC-1
231.
173.
116.
57.8
Control
7.92
41.9
84.9
103.
100.
39.8
70.9
82.7
104.
100.
1.35
1 .91***
3.99***
2.00**
.586
.000 39.4
2.34 77.3
13.0***
4.00***
+ 26.3
+ 9.22
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Appendix F. Continued.
Treatment Cytotoxic Transforming Transformation
Condition'a Activity ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Phenobarbital, Sodium Salt [PHENB. M.W. = 254.22]
Trial 1 [59]
B(a)P .000791
B(a)P .000250
1.35 36.5
7.41 74.3
165 (20)
33 (19)
7.31***
1.34***
+ 17.9
+ 4.28
PHENB
PHENB
PHENB
PHENB
NC-1
7.87
5.90
3.94
1.97
Control
Trial 2 [109]
B(a)P .000791
B(a)P .000250
21.2
33.0
59.6
100.
100.
23.1
81.7
89.9
100.
100.
51.9 94.3
66.2 108.
12 (20)
11 (20)
14 (20)
22 (20)
15 (40)
99 (20)
81 (20)
.494
.414
.578
.927***
.297
4.69***
3.91***
+ 1.46
+ .86
+ 1.88
+ 3.85
Control
Mean t = 2.01
+ 5.31
+ 4.16
3.37
5.99***
5.25***
3.56*
2.55
+ 1.78
+ 5.76
+ 4.50
+ 2.04
Control
Mean t = 3.52
Saccharin, Sodium Salt [SAC, M.W. = 205.2]
Trial 1 [75]
B(a)P .000791
B(a)P .000250
7.10 66.5
28.4 85.4
SAC
SAC
SAC
SAC
NC-1
136.
102.
68.2
34.1
ControL
Trial 2 [101]
B(a)P .000791
B(a)P .000250
SAC
SAC
SAC
SAC
NC-1
122.
91.4
60.9
30.5
Control
.835
7.93
33.4
82.3
100.
.000
19.2
59.5
73.2
100.
ND 64.8
ND 83.6
.000
28.7
91.3
93.4
100.
12.2
53.2
67.7
108.
100.
2,4- 2,6-Toluene Diisothiocyandte [TDIC,
10 (20)
63 (20)
64 (20)
51 (20)
89 (78)
108 (20)
48 (20)
33
67
149
48
27
(18)
(17)
(17)
(19)
(78)
.394
2.41***
2.88***
2.23***
.882
4.63***
2.11***
1.30**
3.33***
8.32***
2.05***
.260
.00(-2.50
+ 4.55
+ 5.93
+ 4.36
Control
Mean t = 3.71
+ 12.7
+ 9.73
+ 3.74
+ 9.12
+ 21.8
+ 6.43
Control
Mean t = 10.3
M.W. = 174.16, Density = 1.255 g/ml]
1 [76]
.000791
.000250
5.91 63.1
23.3 97.0
TDIC
TDIC
TDIC
TDIC
NC-1
8.76
4.38
1.39
.438
Control
Trial 2 [106]
B(a)P .000791
B(a)P .000250
115.
110.
106.
107.
100.
59.2
64.7
72.6
83.6
100.
2.48 56.9
40.7 77.9
46 (18)
92 (18)
83 (17)
65 (18)
152 (71)
134 (18)
91 (18)
1.39
3.60*
4.53***
3.02**
1.79
6.88***
4.53***
.00(- .68)
+ 2.40
+ 5.32
+ 2.70
Control
Mean t = 2.61
+ 8.00
+ 5.56
(Continued on nextpage)
PHENB
PHENB
PHENB
PHENB
NC-1
3.94
2.95
1.97
.984
Control
69.1
70.1
85.0
86.9
100.
104.
110.
112.
112.
100.
72 (20)
128 (20)
95 (17)
81 (20)
237 (80)
149 (20)
67 (20)
6.35***
3.10***
+ 10.9
+ 6.56
Trial
B(a)P
B(a)P
87 (18)
54 (18)
4.41***
2.72*
+ 5.23
+ 2.26
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Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., M S.A CC.A. III (N) III t-statistic
TDIC 4.02 .000 2.19 6 (14,16) .281 .00(-3.38)
TDIC 3.02 12.8 10.3 12 (18) .513 .00(-2.68)
TDIC 2.01 64.8 47.7 60 (17) 3.17*** + 3.74
TDIC 1.01 100. 92.6 78 (17) 4.33*** + 6.89
NC-1 ControL 100. 100. 74 (43) 1.30 Control
Mean t = 3.54
Abbreviations: B(a)P, benzo(a)pyrene; CC.A, co-culture clonal survival assay; Cone, concentration; mM, millimole; M.W., molecularweight; N,
number ofculture vessels, NC, negative control; ND, not determined; %RCE, percent relative cloning efficiency; S.A, standard clonal survival
assay.
'Treatment Condition: The experimental design for the transformation assay is described in detail in the Materials and Methods. The
concentration ofthe positive control and test chemical treatment are presented in mM, but they can be converted to j±g/ml using the molecular
weight that is provided with each chemical. The solvent vehicles used for the individual test chemicals were listed in Appendix Tables Al and A3,
and the concentrations ofthe solvent vehicles are presented in the Materials and Methods.
bCytotoxic activity: The experimental design for the standard survival assay (SA) and the co-culture clonal survival assay (CCA) were described
in the Materials and Methods. The test chemical cytotoxic response was expressed as & RCE and was calculated as described in the Materials and
Methods.
cThe criteria used to evaluate the transformed foci ofBALB/c-3T3 cells is described in the Materials and Methods. The number oftype III foci
> 2-mm in diameter per culturevessel scored are recorded in this table.
dThansformation response: The transformation responses are expressed as type III foci/vessel and were calculated using alog1o mathematical
transformation procedure (refer to Materials and Methods). The arithmetic value or foci/vessel represents the antilog ofthe log1o mean
transformation responseminus one.
eSignificance: The significance oftest chemical transformation responses was calculated by a computer using the SAS statistical software (22),
and the method is described in detail in Materials and Methods. The correct t-statistic according to the F-test is presented in this table. The
t-statistics ofeach treatment dose ofthe test chemical in a single experiment were averaged to determine the mean t-statistic ofthe test chemical
for the experiment (refer to Appendix Tables A2 and A5). The mean t-statistics for two or experiments for each chemical was weighted to the
number oftreatment doses evaluated and averaged to determine the rank t-statistic which was used to rank-order the test chemical
transformation responses in Appendix Tables A3 and A6. Arbitrarily, transformation responses with negative (-) t-statistics were given a value of
zero (0).
*Significant BaP ortestchemical transformation response, 0.01 < p < 0.05.
'Significant BaP ortestchemical transformation response, 0.001 < p < 0.01.
***Significant or BaP or test chemical transformation response, p < 0.001.
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Appendix G.
Summary ofthe transformation responses of26 noncytotoxic, noncarcinogens.
Treatment Cytotoxi c Transforming Transformation
ConditiOona Activityb Activityc Responsed Significance*
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc. , mM S.A CC.A. III (N) III t-statistic
Aldicarb [ALDC, M.W. = 190.27]
Trial 1 [32]
B(a)P .000791
B(a)P .000250
10.1 51.7
6.37 77.4
ALDC
ALDC
ALDC
ALDC
NC-1
15.8
10.5
5.26
2.63
ControL
Trial 2 [99]
B(a)P .000791
B(a)P .000250
.000
.000
6.37
58.1
100.
.000
38.4
95.0
85.1
100.
18.9 68.4
32.1 85.0
3 (15,20)
52 (19)
29 (19)
35 (19)
91 (38)
160 (20)
94 (20)
.149
2.36
1.41
1.58
1.99
6.67***
3.59***
.00(-8.26)
+ .80
.00(-1 .85)
.00(-1 .00)
Control
Mean t = .267
+ 12.4
+ 7.95
41 (18,20)
43 (19)
30 (20)
27 (20)
65 (80)
1.73***
1.74***
1.23**
1.05*
.586
+ 3.92
+ 4.09
+ 2.69
+ 1.99
Control
Mean t = 3.17
Ampicillin Trihydrate [577642-S, M.W. = 403.50]
Trial 1 [83]
B(a)P .000791
B(a)P .000250
2.86 73.0
13.8 78.9
577642-S
577642-S
577642-S
577642-S
NC-1
65.0
48.8
32.5
16.3
Control
Trial 2 [105]
B(a)P .000791
B(a)P .000250
.000
1.43
72.9
111.
100.
.000
.257
18.3
88.7
100.
5.67 63.1
18.2 86.5
0 (0,14)
3 (15)
9 (17)
25 (26)
48 (80)
59 (20)
40 (19)
.000
.127
.395
.938**
.351
2.43***
1.93***
NA
.00(-1 .82)
+ .25
+ 2.87
Control
Mean t = 1.04
+ 6.70
+ 5.54
.593
.740
2.07**
.950
.581
+ .06
+ .68
+ 3.60
+ 1.75
Control
Mean t = 1.52
o-Anthranilic Acid [ANT, M.W. = 137.14]
Trial 1 [15]
B(a)P .000791
B(a)P .000250
ANT
ANT
ANT
ANT
NC-1
36.5
18.2
9.11
4.56
Control
Tri al 2 [22]
B(a)P .000791
B(a)P .OO250
.851 12.4
3.83 56.7
68.9
78.7
94.0
94.9
100.
95.9
113.
113.
114.
100.
1.86 53.4
6.52 81.4
209 (20)
72 (20)
7 (17)
13 (19)
24 (19)
14 (18)
10 (39)
187 (20)
116 (20)
8.95***
3.40***
.206
.379
.605
.608*
.186
8.86***
5.25***
+ 15.8
+ 14.9
+ .15
+ 1.06
+ 1.78
+ 2.53
Control
Mean t = 1.47
+ 16.0
+ 9.33
(Continued on nextpage)
197 (19)
115 (20)
10.1***
5.46***
+ 12.6
+ 6.94
ALDC
ALDC
ALDC
ALDC
NC-1
14.7
11.0
7.36
3.68
Control
15.5
26.4
47.2
51.7
100.
24.0
97.2
86.6
108.
100.
141 (20)
64 (20)
6.14***
2.93***
+ 13.5
+ 9.12
577642-S
577642-S
577642-S
577642-S
NC-1
52.5
39.4
26.3
13.1
Control
.000
.000
11.7
114.
100.
.000
1.32
13.0
84.0
100.
14 (16)
11 (12)
45 (16)
21 (18)
58 (77)
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Appendix G. Continued.
Treatment Cytotoxi c Transforming Transformation
Conditiona Activityb Activityc Responsed Significancee
RCE (%) Focus Data Foci/Vessel
Type Vessel s Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
ANT 18.2 70.2 95.2 44 (19) 2.06*** + 3.71
ANT 9.11 82.6 106. 52 (20) 2.11** + 3.42
ANT 4.56 90.4 105. 38 (20) 1.60* + 2.33
ANT 2.28 91.0 108. 37 (20) 1.62* + 2.51
NC-1 Control 100. 100. 45 (40) .893 Control
Mean t = 2.99
Benzoin [BENZ, M.W. = 212.25]
Trial 1 [4]
B(a)P .000791 15.7 74.7 184 (20) 8.81*** + 9.38
B(a)P .000250 24.0 82.9 116 (20) 4.38*** + 3.62
BENZ 14.1 .000 54.4 29 (20) .849 .00(-1 .42)
BENZ 9.42 .000 61.8 34 (20) 1.20 .00(- .61)
BENZ 4.71 .000 62.7 18 (20) .711 .00(-1.91)
BENZ 2.36 2.89 75.6 30 (20) 1.12 .00(- .80)
NC-1 Control 100. 100. 118 (40) 1.51 Control
Mean t .000 Trial 2 [10]
B(a)P .000791 1.89 30.6 105 (20) 4.79*** + 18.3
B(a)P .000250 8.49 91.7 34 (20) 1.37*** + 6.23
BENZ 9.42 .000 69.4 3 (19) .116 + .98
BENZ 4.71 .000 76.4 9 (20) .308* + 2.13
BENZ 2.36 .000 100. 5 (20) .189 + 1.62
BENZ 1.18 .000 115. 10 (19) .266 + 1.20
NC-1 Control 100. 100. 3 (40) .053 Control
Mean t = 1.48
Benzyl Alcohol [926895-L, M.W. = 108.13, Density= 1.04013 g/ml]
Trial 1 [81]
B(a)P .000791 10.2 63.9 378 (18) 20.8*** + 15.5
B(a)P .000250 28.0 67.8 280 (18) 15.3*** + 10.5
926895-L 20.0 .000 10.2 59 (18) 2.41 .00(-4.95)
926895-L 15.0 3.15 72.1 167 (18) 8.66 + 1.35
926895-L 10.0 10.8 85.0 243 (18) 13.1*** + 7.10
926895-L 5.00 24.8 101. 136 (18) 6.00 .00(-1.51)
NC-1 Control 100. 100. 583 (72) 7.36 Control
Mean t = 2.11
Trial 2 [110]
B(a)P .000791 11.6 61.1 116 (18) 5.78*** + 10.7
B(a)P .000250 26.7 88.0 75 (18) 3.89*** + 8.52
926895-L 20.0 .000 51.1 14 (18) .572 .00(- .17)
926895-L 15.0 8.04 84.4 29 (18) 1.25* + 2.39
926895-L 10.0 28.6 95.1 40 (18) 1.97*** + 4.60
926895-L 5.00 48.2 101. 15 (18) .645 + .16
NC-1 Control 100. 100. 65 (75) .609 Control
Mean t = 1.79
Caprolactam [CAP, M.W. = 113.16]
Trial 1 [5]
B(a)P .000791 7.76 9.41 84 (19) 3.97*** + 15.5
B(a)P .000250 12.5 12.5 57 (20) 2.58*** + 12.5
(Continued on nextpage)
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Appendix G. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessel s Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
CAP 106. .862 .000 1 (18,20) .039 + .09
CAP 88.4 .862 18.0 2 (20) .072 + .72
CAP 70.7 4.74 58.0 3 (20) .110 + 1.12
CAP 53.0 23.7 95.7 7 (20) .256* + 2.26
NC-1 ControL 100. 100. 2 (40) .035 Cont-ol
Mean t = 1.37
Trial 2 [10]
B(a)P .000791 1.89 30.6 105 (20) 4.79*** + 18.3
B(a)P .000250 8.49 91.7 34 (20) 1.37*** + 6.23
CAP 70.7 .472 38.9 5 (20) .172 + 1.33
CAP 53.0 4.72 190. 3 (20) .110 + .90
CAP 35.3 5.66 108. 1 (20) .035 .00(- .36)
CAP 17.7 28.8 144. 17 (19) .419 + 2.08
NC-1 Control 100. 100. 3 (40) .053 Control
Mean t = 1.80
2-Chloroethanol [2CE, M.W. = 80.52, Density = 1.200 g/ml]
Trial 1 [78]
B(a)P .000791 8.09 60.6 116 (18) 6.11*** + 4.93
B(a)P .000250 14.9 84.2 184 (18) 9.84*** + 9.74
2CE 74.3 .000 67.7 133 (18) 6.98*** + 5.81
2CE 37.2 1.70 79.7 161 (18) 8.36*** + 7.18
2CE 18.6 39.1 99.8 109 (18) 4.99* + 2.13
2CE 9.29 68.5 100. 56 (18) 2.72 .00(- .92)
NC-1 Control 100. 100. 296 (72) 3.28 Control
Mean t = 3.78
Trial 2 [102]
B(a)P .000791 89.7 77.9 65 (18) 3.30*** + 11.7
B(a)P .000250 81.0 93.8 62 (18) 2.85*** + 7.75
2CE 74.3 .000 65.8 35 (18) 1.52*** + 4.76
2CE 37.2 .460 92.8 24 (18) 1.02*** + 3.28
2CE 18.6 37.2 86.4 15 (18) .671* + 2.58
2CE 9.29 70.8 92.6 6 (18) .240 .00(- .22)
NC-1 Control 100. 100. 28 (18) .268 Control
Mean t = 2.66
(2-Chloroethyl )trimethylammonium Chloride [2CETS, M.W. = 158.07]
Trial 1 [30]
B(a)P .000791 1.32 60.3 158 (20) 7.23*** + 12.3
B(a)P .000250 2.63 101. 98 (19) 4.25*** + 8.08
2CETA 75.9 .000 17.8 54 (20) 1.88** + 3.24
2CETA 50.6 .000 62.4 51 (20) 2.18*** + 4.36
2CETA 25.3 10.1 103. 17 (20) .668 .00(- .54)
2CETA 12.7 65.4 101. 18 (20) .677 .00(- .49)
NC-1 ControL 100. 100. 40 (40) .787 Control
Mean t = 1.90
Trial 2 [45]
B(a)P .000791 8.74 42.5 186 (20) 8.98*** + 19.5
B(a)P .000250 28.2 86.4 77 (20) 3.42*** + 7.04
2CETA 50.6 12.9 77.1 25 (20) .988 + 1.03
2CETA 4.00 98.1 114. 37 (20) 1.46* + 2.57
2CETA 2.00 100. 108. 44 (19) 1.53* + 2.55
2CETA 1.00 101. 116. 25 (20) .876 + .57
NC-1 ControL 100. 100. 54 (79) .732 Control
Mean t = 1.68
(Continuedon nextpage)
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Appendix G. Continuedt
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., nM S.A CC.A. III (N) III t-statistic
C. I. Acid Orange 10 [CIA0lO, M.W. = 452.38]
Trial 1 [64]
B(a)P .00079i 6.45 26.6 98 (20) 4.47*** + 12.7
B(a)P .000250 16.9 69.1 32 (20) 1.37*** + 5.13
CIA010 32.0 .000 9.35 6 (20) .231 .00(- .45)
CIA010 16.0 20.2 78.3 4 (20) .149 .00(-1.13)
CIA010 8.00 37.1 103. 13 (20) .473 + 1.10
CIA010 4.00 56.4 81.2 19 (20) .702* + 2.20
NC-1 Control 100. 100. 17 (40) .291 Control
Mean t = .825
Trial 2 [103]
B(a)P .000791 8.60 76.9 95 (20) 4.59*** + 13.7
B(a)P .000250 23.6 91.5 75 (20) 2.86*** + 5.37
CIA010 35.4 .000 .798 18 (20) .751 .00(- .54)
CIA010 17.7 4.73 63.3 19 (20) .726 .00(- .64)
CIA010 8.84 43.0 99.2 15 (20) .588 .00(-1.32)
CIA010 4.42 82.2 104. 37 (20) 1.37 + 1.74
NC-1 Control 100. 100. 89 (79) .874 Control
Mean t= .435
Dimethyl Terephthalate [DMTP, M.W. = 194.19]
Trial 1 [103]
B(a)P .00791 8.60 76.9 95 (20) 4.59*** + 13.7
B(a)P .00250 23.6 91.5 75 (20) 2.86*** + 5.37
DMTP 5.15 18.5 81.1 43 (20) 1.50* + 2.15
DMTP 2.58 24.5 83.2 45 (20) 1.83** + 3.12
DMTP 1.29 45.6 100. 26 (20) 1.02 + .57
DMTP .644 67.1 98.1 27 (19) 1.14 + 1.00
NC-1 Control 100. 100. 89 (79) .874 Control
Mean t = 1.71
Trial 2 [107]
B(a)P .00791 5.81 47.3 131 (20) 6.09*** + 5.74
B(a)P .00250 21.2 75.8 122 (20) 5.53*** + 4.05
DMTP 5.15 94.7 64.8 90 (20) 3.26 + .55
DMTP 3.87 94.7 75.2 74 (20) 3.20 + .48
DMTP 2.58 90.8 76.1 77 (20) 3.65 + 1.82
DMTP 1.29 107. 87.2 101 (19) 5.02*** + 4.59
NC-1 Control 100. 100. 274 (80) 2.95 Control
Mean t = 1.86
Diphenylhydantoin [DPH, M.W. = 252.27]
Trial 1 [56]
B(a)P .000791 2.55 32.7 122 (20) 5.54*** + 16.5
B(a)P .000250 2.19 61.0 33 (20) 1.47*** + 6.97
DPH 39.6 52.6 31.4 0 (20) .000 .00(-4.36)
DPH 12.5 55.8 45.7 1 (20) .035 .00(-3.10)
DPH 3.96 57.3 50.4 2 (20) .072 .00(-2.27)
DPH 1.25 66.4 55.1 5 (20) .172 .00(- .79)
NC-1 Control 100. 100. 13 (39) .260 Control
Mean t = .000
Trial 2 [65]
B(a)P .000791 6.95 60.7 85 (18) 4.33*** + 13.9
B(a)P .000250 19.2 90.2 43 (20) 1.80*** + 6.94
(Continued on nextpage)
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Appendix G. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc.i, mM S.A CC.A. III (N) III t-statistic
19.2
31.1
33.8
46.0
100.
27.3
42.4
52.0
54.1
100.
1 (20)
1 (20)
2 (19)
4 (19)
14 (40)
.035
.035
.076
.140
.244
.00(-2.66)
.00(-2.66)
.00(-1 .86)
.00(- .92)
ControL
Mean t = .000
FD & C Yellow No. 6 [FDCY6, M.W. = 452.37]
6.91 58.7
19.3 84.5
167 (20)
138 (20)
8.23***
6.39***
+ 14.5
+ 7.66
6.18
44.0
53.8
78.5
100.
69.5
86.1
92.4
90.4
100.
6.95 60.7
19.2 90.2
.000
70.5
73.5
99.0
100.
47.7
47.4
56.9
56.7
100.
8.60 76.9
23.6 91.5
135 (18)
144 (20)
196 (20)
119 (20)
108 (40)
85 (18)
43 (20)
40 (20)
61 (200
33 (20)
10 (20)
14 (40)
95 (20)
75 (20)
7.02***
6.71***
8.71***
5.67***
2.51
4.38***
1.80***
1.54***
2.25***
1.34***
.762**
.244
4.59***
2.86***
+ 8.24
+ 7.96
+ 9.47
+ 7.06
Control
Mean t = 8.18
+ 13.9
+ 6.94
+ 4.81
+ 6.05
+ 5.27
+ 3.27
Control
Mean t = 4.85
+ 13.7
+ 5.37
2.05***
7.69***
4.61***
4.02***
.874
+ 3.63
+ 16.8
+ 8.38
+ 10.8
Control
Mean t = 9.90
D-Mannitol [MANN, M.W. = 60.07]
Trial 1 [18]
B(a)P .000791
B(a)P .000250
109.8
54.9
27.4
13.7
Control
2 [45]
.000791
.000250
110,
4.00
2.00
1.00
Control
2.24 45.8
8.52 78.5
93.3
108.
102.
105.
100.
86.5
103.
101.
106.
100.
8.74 42.5
28.2 86.4
90.3
94.8
96.8
100.
100.
98.3
104.
98.6
99.0
100.
125 (20)
86 (20)
37 (20)
14 (20)
13 (20)
21 (20)
33 (40)
186 (20)
77 (20)
46 (20)
16 (20)
22 (20)
16 (19)
86 (98)
5.91***
3.36***
1 .27*
.600
.547
.792
.663
8.98***
3.42***
1 .93***
.556
.987**
.677
.732
+ 17.4
+ 6.80
+ 3.06
.00(- .29)
.00(- .58)
+ .38
Control
Mean t = 1.72
+ 19.5
+ 7.04
+ 3.91
.00(- .79)
+ 1.01
.00(- .24)
Control
Mean t = 1.23
(Continued on nextpage)
DPH
DPH
DPH
DPH
NC-1
39.6
12.5
3.96
1.25
Control
Trial 1
B(a)P
B(a)P
[34]
.000791
.000250
FDCY6
FDCY6
FDCY6
FDCY6
NC-1
Trial
B(a)P
B(a)P
FDCY6
FDCY6
FDCY6
FDCY6
NC-1
Trial
B(a)P
B(a)P
88.4
44.2
22.1
11.1
Controt
2 [65]
.000791
.000250
63.2
20.0
6.32
2.00
Control
3 [103]
.000791
.000250
FDCY6
FDCY6
FDCY6
FDCY6
NC-1
88.4
44.2
22.1
11.1
Control
.652
46.5
55.9
75.3
100.
38.0
59.8
91.0
91.5
100.
40 (17)
162 (20)
92 (18)
85 (20)
89 (79)
MANN
MANN
MANN
MANN
NC-1
Trial
B(a)P
B(a)P
MANN
MANN
MANN
MANN
NC-1
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Treatment Cytotoxic Transforming Transformation
Condition' Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Trial 3 [110]
B(a)P .000791
B(a)P .000250
MANN
MANN
MANN
MANN
NC-1
220.0
110.0
54.9
27.4
Control
11.6 61.1
26.7 88.0
114.
100.
111.
168.
100.
101.
100.
92.
100.
100.
116 (18)
75 (18)
68 (20)
50 (20)
28 (20)
28 (20)
65 (75)
5.78***
3.89***
3.00***
2.17***
1 .23**
1.01
.609
+ 17.5
+ 8.98
+ 8.55
+ 5.60
+ 3.06
+ 1.53
Control
Mean t = 4.69
Methyl Methacrylate [794248-L, M.W. = 110.12, Density = 0.9433 g/ml]
Trial 1 [79]
B(a)P .000791 22.7 79.6
B(a)P .000250 39.3 94.2
794248-L
794248-L
794248-L
794248-L
NC-1
17.0
12.8
8.50
4.25
Control
Trial 2 [106]
B(a)P .000791
B(a)P .000250
.000
.000
4.13
45.0
100.
.324
60.7
90.8
100.
100.
19
174
244
83
430
24.8 56.9
40.7 77.9
(13,17)
(18)
(18)
(18)
(62)
134 (18)
91 (18)
.615
8.60**
13. 1***
4.42
5.12
6.88***
4.53***
.00(-6.94)
+ 3.29
+ 9.73
.00(-1 .38)
Control
Mean t = 4.34
+ 8.00
+ 5.56
3 (7)
52 (18)
47 (18)
33 (18)
74 (43)
.00(-2.44)
+ 2.09
+ 1.99
+ .69
Control
Mean t = 1.19
Molybdenum Trioxide [MOTO, M.W. = 144.0]
Trial 1 [47]
B(a)P .00791
B(a)P .00250
173 (20)
88 (20)
7 (9,20)
29 (19,20)
7 (20)
3 (20)
31 (39)
122 (20)
33 (20)
9 (18,20)
12 (18,20)
3 (20)
5 (20)
13 (39)
.661
1 .29**
.238
.110
.579
5.54***
1 .47***
.339
.446
.099
.182
.260
+ .29
+ 2.80
.00(-1 .97)
.00(-3.72)
Control
Mean t = .830
+ 16.5
+ 6.97
+ .57
+ 1.04
.00(-1 .63)
.00(- .79)
Control
Mean t = .000
279 (18)
241 (18)
20.8***
12.9***
+ 13.9
+ 9.34
794248- L
794248- L
794248-L
794248-L
NC-1
16.0
12.0
8.00
4.00
Control
.000
.000
3.98
51.1
100.
1.31
24.7
68.5
95.4
100.
.292
2.28*
2.20
1.57
1.30
.351 28.1
7.72 75.6
.000
2.81
36.1
67.7
100.
8. 10***
3.89***
.000
83.2
96.5
96.0
100.
MOTO
MOTO
MOTO
MOTO
NC-1
Trial 2
B(a)P
B(a)P
MOTO
MOTO
MOTO
MOTO
NC-1
+ 14.6
+ 8.73
9.06
6.80
4.53
2.27
Control
[56]
.000791
.000250
11.0
8.28
5.52
2.76
Control
2.55 32.7
2.19 61.0
1.46
70.8
67.5
93.8
100.
.000
75.3
80.6
94.6
100.
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Appendix G. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc. , mM S.A CC.A. III (N) III t-statistic
4-Nitroanthranilic Acid [4NANA, M.W. = 182.15]
Trial 1 [34]
B(a)P .000791
B(a)P .000250
6.91 58.7
19.3 84.5
9.88
6.59
4.92
3.29
Control
2 [103]
.000791
.000250
9.88
6.59
4.94
3.29
Control
8.36
16.7
38.2
86.9
100.
59.3
81.0
89.8
83.2
100.
8.60 76.9
23.6 91.5
2.58
4.30
5.59
49.5
100.
.000
82.7
85.4
98.9
100.
Penicillin VK+ [519829-S, M.W. = 388.51]
Trial 1 [80]
B(a)P .000791 16.9 65.2
B(a)P .000250 35.6 87.2
41 (19)
55 (20)
41 (20)
45 (20)
108 (40)
95 (20)
75 (20)
24 (20)
75 (20)
55 (19)
12 (20)
89 (79)
261 (20)
185 (20)
1.99
2.53
1.80
2.00
2.51
4.59***
2.86***
.955
2.59***
2.42***
.423
.874
12.9***
8.53***
.00(-1.62)
+ .06
.00(-2.12)
.00(-1.57)
Control
Mean t = .015
+ 13.7
+ 5.37
+ .33
+ 3.79
+ 4.52
.00(-2.18)
Control
Mean t = 2.16
+ 13.0
+ 7.65
519829-S
519829-S
519829-S
519829-S
NC-1
25.6
19.2
12.8
6.41
Control
Trial 2 [101]
B(a)P .000791
B(a)P .000250
.000
15.1
79.2
97.3
100.
1.13
18.6
89.3
98.2
100.
ND 64.8
ND 83.6
29
156
282
144
317
(17,20)
(19)
(20)
(20)
(80)
108 (20)
48 (20)
1.35
7.62***
12.7***
6.22***
3.02
4.63***
2.11***
.00(-3.24)
+ 6.69
+ 8.16
+ 3.80
Control
Mean t = 2.94
+ 12.7
+ 9.73
+ .60
+ 5.03
+ 14.5
+ 2.92
ControL
Mean t = 5.76
Phthal amide [PHAM,
Trial 1 [35]
B(a)P .000791
B(a)P .000250
M.W. = 164.18]
4.51 66.1
12.3 87.5
PHAM
PHAM
PHAM
PHAM
NC-1
48.7
24.5
12.2
6.09
Control
Trial 2 [110]
B(a)P .000791
B(a)P .000250
4.92
20.5
44.3
92.3
100.
97.7
111.
116.
112.
100.
11.6 61.1
26.7 88.0
28 (20)
29 (20)
42 (20)
52 (20)
94 (40)
116 (18)
75 (18)
1.17
1.23
1.92
2.28
1.97
5.78***
3.89***
.00(-2.24)
.00(- .14)
.00(-2.06)
.00(- .70)
Control
Mean t = .000
+ 17.5
+ 8.98
(Continued on nextpage)
167 (20)
138 (20)
8.23***
6.39***
4NANA
4NANA
4NANA
4NANA
NC-1
Trial
B(a)P
B(a)P
4NANA
4NANA
4NANA
4NANA
NC-1
+ 14.5
+ 7.66
519829-S
519829-S
519829-S
519829-S
NC-1
25.6
19.2
12.8
6.41
Control
ND
ND
ND
ND
100.
8.80
54.7
95.8
108.
100.
10 (19)
39 (20)
81 (18)
15 (19)
27 (78)
.334
1 .53***
4.05***
.652**
.260
103 (20)
133 (20)
4.91***
6.01***
+ 6.41
+ 6.34
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Appendix G. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
.29
.75
1.12
1 .87***
.609
.00 (-2.06)
+ .64
+ 1.87
+ 5.55
Control
Mean t = 2.02
Phthalic Anhydride [PHAN, M.W. = 148.12]
Trial 1 [39]
B(a)P .000791
B(a)P .000250
PHAN
PHAN
PHAN
PHAN
NC-1
Trial 2
B(a)P
B(a)P
PHAN
PHAN
PHAN
PHAN
NC-1
27.0
13.5
6.75
3.38
Control
[107]
.000791
.000250
20.3
15.2
10.1
5.06
Control
1.07 23.6
3.56 64.5
.000 6.20
61.9 9.92
97.2 79.3
95.7 96.3
100. 100.
5.81 47.3
21.2 75.8
102.
112.
114.
115.
100.
68.5
75.2
75.8
82.1
100.
172 (20)
145 (20)
26 (15,20)
24 (20)
17 (18)
1 1 (20)
27 (40)
131 (20)
122 (20)
53 (20)
34 (20)
27 (14,19)
46 (20)
274 (80)
8.04***
6.84***
1.22
.955*
.765
.402
.427
6.09***
5.53***
1.87
1.06
1.30
1.91
2.95
+ 14.5
+ 15.8
+ 2.61
+ 2.27
+ 1.53
.00(- .13)
Control
Mean t = 1.27
+ 5.74
+ 4.05
.00(-1 .80)
.00(-3.69)
.00(-3.56)
.00(-2.34)
Control
Mean t = .000
Roxarsone [998307-S, M.W. = 260.??]
Trial 1 [80]
B(a)P .000791 16.9 65.2
B(a)P .000250 35.6 87.2
998307-S
998307-S
998307-S
998307-S
NC-1
40.0
30.0
20.0
10.0
Control
Trial 2 [109]
B(a)P .000791
B(a)P .000250
4.45
13.1
44.2
89.3
100.
68.5
88.7
89.6
112.
100.
51.9 94.3
66.2 108.
117 (18)
122 (20)
79 (20)
142 (20)
317 (80)
99 (20)
81 (20)
5.96***
5.44**
3.75
5.91***
3.02
4.69***
3.91***
+ 3.49
+ 3.11
+ 1.67
+ 3.47
Control
Mean t = 2.94
+ 5.31
+ 4.16
0 (12,20)
3 (20)
19 (20)
28 (20)
237 (80)
.000
.110
.721
1.06
2.55
.00(-23.0)
.00(-14.7)
.00(- 5.74)
.00( -4.28)
Control
Mean t = .000
3-Sulfolene [3SULF, M.W. = 118.15]
Trial 1 [33]
B(a)P .000791
B(a)P .000250
3.44 2.40
5.73 51.4
PHAM
PHAM
PHAM
PHAM
NC-1
60.9
30.5
15.2
7.60
Control
8.68
51.1
87.1
102.
100.
61.5
89.3
97.5
102.
100.
9 (20)
20 (20)
30 (20)
42 (20)
65 (75)
261 (20)
185 (20)
12.9***
8.53***
+ 13.0
+ 7.65
998307-S
998307-S
998307-S
998307-S
NC-1
76.9
57.7
38.5
19.2
Control
.000
.000
6.05
42.7
100.
.000
2.67
28.4
92.6
100.
214 (20)
130 (20)
10. 0***
5.86***
+ 13.6
+ 7.74
(Continued on nextpage)
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Appendix G. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
3SULF 114.3 .000 64.4 59 (20) 2.54** + 5.80
3SULF 76.2 .000 92.9 86 (20) 3.50** + 4.49
3SULF 38.1 13.4 107. 53 (20) 2.32** + 3.63
3SULF 19.0 48.1 101. 26 (20) 1.07 .00(- .39)
NC-1 Control 100. 100. 54 (37) 1.04 Control
Mean t = 3.48
Trial 2 [44]
B(a)P .000791 5.07 25.9 335 (20) 15.8*** + 16.3
B(a)P .000250 14.2 67.2 137 (20) 6.15*** + 7.33
3SULF 76.2 7.09 86.5 166 (20) 7.35*** + 8.22
3SULF 4.00 95.6 90.5 57 (20) 2.02 + 1.11
3SULF 2.00 94.9 94.2 46 (20) 1.80 + .67
3SULF 1.00 95.3 92.9 60 (20) 2.43* + 2.01
NC-1 Control 100. 100. 77 (40) 1.52 Control
Mean t = 3.00
Sulfisoxazole [SULF, M.W. = 267.32]
Trial 1 [19]
B(a)P .000791 .000 62.5 99 (20) 4.61*** + 13.4
B(a)P .000250 1.67 89.0 100 (20) 4.02*** + 10.6
SULF 12.0 14.6 71.5 18 (20) .439 + .37
SULF 5.99 37.5 89.7 16 (18) .682 + 1.73
SULF 2.99 62.1 93.0 12 (19) .471 + .66
SULF 1.50 75.4 103. 5 (19) .182 .00(-1.29)
NC-1 Control 100. 100. 18 (38) .357 Control
Mean t = .690
Trial 2 [26]
B(a)P .000791 .382 13.5 204 (20) 9.88*** + 17.8
B(a)P .000250 1.15 56.2 144 (20) 6.58*** + 10.5
SULF 13.1 30.9 86.1 58 (20) 2.60*** + 4.74
SULF 6.55 66.8 89.7 24 (20) .988 + .31
SULF 3.27 76.4 97.1 18 (20) .713 .00(- .99)
SULF 1.64 73.3 86.5 17 (20) .573 .00(-1.34)
NC-1 Control 100. 100. 46 (40) .907 Control
Mean t = 1.26
Sodiuum(2-ethylhexyl) Alcohol Sulfate [S2EHAS, M.W. = 232.28, Density = 1.114 g/ml]
Trial 1 [82]
B(a)P .000791 46.8 47.2 371 (18) 19.4*** + 7.45
B(a)P .000250 56.3 51.6 288 (18) 15.5*** + 7.97
S2EHAS 17.2 2.82 .0 1 (1,18) .039 .00(-3.44)
S2EHAS 12.9 35.3 1.3 187 (18) 8.13 + .07
S2EHAS 8.61 71.7 95.8 170 (18) 8.58 + .54
S2EHAS 4.31 81.7 90.2 142 (18) 6.69 .00(-1.32)
NC-1 Control 100. 100. 649 (72) 8.01 Control
Mean t = .180
Trial 2 [108]
B(a)P .000791 15.5 31.3 139 (18) 7.38*** + 13.9
B(a)P .000250 30.0 65.7 72 (13) 4.77*** + 5.96
S2EHAS 17.2 17.6 90.3 48 (18) 2.44*** + 4.24
S2EHAS 12.9 33.1 105. 45 (18) 2.27** + 2.96
S2EHAS 8.61 59.4 93.4 61 (18) 3.09*** + 4.64
S2EHAS 4.31 94.9 97.3 41 (18) 1.84 + 1.85
NC-1 Control 100. 100. 108 (70) 1.17 Control
Mean t = 3.42
(Continued on nextpage)
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Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Titanium Dioxide [TIDI, M.W. = 79.90]
Trial 1 [38]
B(a)P .000791
B(a)P .000250
2.10 28.4
9.44 74.7
12.5
6.26
3.13
1.56
Control
2 [109]
.000791
.000250
12.5
6.25
3.13
1.56
Control
98.3
98.6
92.3
101.
100.
54.2
66.8
79.9
88.4
100.
51.9 94.3
66.2 108.
99.0
87.6
97.8
104.
100.
45.7
55.4
72.4
190.9
100.
5 (20)
5 (19)
5 (20)
11 (20)
27 (40)
99 (20)
81 (20)
2 (20)
8 (19)
28 (20)
46 (20)
237 (80)
.189
.182
.189
.394
.496
4.69***
3.91***
.072
.272
.818
2.01
2.55
.00(-2.01)
.00(-1.97)
.00(-2.00)
.00(- .56)
Control
Mean t = .000
+ 5.31
+ 4.16
.00(-16.4)
.00(- 8.31)
.00(- 3.95)
.00(- 1.35)
Control
Mean t = .000
Tetrahydrofuran [THF, M.W. = 72.11, Density = 0.9 g/ml]
1 [82]
.000791
.000250
46.8 47.2
56.3 51.6
371 (18)
288 (18)
19.4***
15.5***
+ 7.45
+ 7.97
.000
6.50
25.1
65.7
100.
63.4
83.1
80.9
76.5
100.
206
155
133
110
649
24.8 56.9
40.7 77.9
.000
.306
3.67
7.34
100.
(18)
(18)
(18)
(18)
(72)
134 (18)
91 (18)
.000
3.06
68.1
82.1
100.
0 (0, 18)
0 (9,13)
15 (14)
35 (10)
74 (43)
9.88
7.99
6.09
5.75
8.01
6.88***
4.53***
.000
.000
.805
3.02**
1.30
+ 1.57
.00(- .01)
.00(-1 .95)
.00(-2.61)
Control
Mean t = .393
+ 8.00
+ 5.56
NA
.00(-9. 15)
.00(-1 .35)
+ 2.72
Control
Mean t = 1.36
Witch Hazel [WH,
Trial 1 [81]
B(a)P .000791
B(a)P .000250
M.W. = 46.07, Density = 0.790 g/ml]
10.2 63.9
28.0 67.8
WH 150000. 1500.EST.
WH 100000. 1000.EST.
WH 50000. 500.EST.
WH 25000. 250.EST.
NC-1 Control
2 [110]
.000791
.000250
1.05
22.4
53.8
75.5
100.
85.2
86.1
91.7
96.9
100.
11.6 61.1
26.7 88.0
167 (18)
213 (18)
148 (17)
149 (18)
583 (72)
116 (18)
75 (18)
8.85
11.2 ***
8.07
7.87
7.36
5.78***
3.89***
+ 1.58
+ 3.55
+ .75
+ .57
Control
Mean t = 1.61
+ 17.5
+ 8.98
(Continued on nextpage)
174 (20)
162 (20)
7.75***
8.17***
TIDI
TIDI
TIDI
TIDI
NC-1
Trial
B(a)P
B(a)P
TIDI
TIDI
TIDI
TIDI
NC-1
+ 15.6
+ 18.0
Trial
B(a)P
B(a)P
THF
THF
THF
THF
NC-1
Trial 2
B(a)P
B(a)P
THF
THF
THF
THF
NC-1
111.
55.5
27.7
13.9
Control
[106]
.000791
.000250
351.
263.
176.
87.8
Control
378 (18)
280 (18)
20.8***
15.3***
Trial
B(a)P
B(a)P
+ 15.5
+ 10.5
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Treatment Cytotoxic Transforming Transformation
Condi_ti_on' Activityb Activityc Responsed Significance"
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
WH 150000. 80.7 97.7 26 (18) 1.11 + 1.99
WH 100000. 99.0 101. 32 (18) 1.34* + 2.36
WH 75000. 97.7 95.3 23 (18) 1.07 + 1.98
WH 50000. 102. 97.8 34 (18) 1.37* + 2.36
NC-1 ControL 100. 100. 65 (71) .609 ControL
Mean t = 2.17
Abbreviations: B(a)P, benzo(a)pyrene; CC.A., co-culture clonal survival assay; Cone., concentration; mM, millimole; M.W., molecular weight; N,
number ofculture vessels, NC, negative control; ND, not determined; %RCE, percent relative cloning efficiency; S.A., standard clonal survival
assay.
aTreatment Condition: The experimental design for the transformation assay is described in detail in the Materials and Methods. The
concentration ofthe positive control and test chemical treatment are presented in mM, but they can be converted to ,ug/ml using the molecular
weight that is provided with each chemical. The solvent vehicles used for the individual test chemicals were listed in Appendix Tables Al and A3,
and the concentrations ofthe solvent vehicles are presented in the Materials and Methods.
bCytotoxic activity: The experimental design for the standard survival assay (SA) and the co-culture clonal survival assay (CCA) were described
in the Materials and Methods. The test chemical cytotoxic response was expressed as & RCE and was calculated as described in the Materials and
Methods.
cThe criteria used to evaluate the transformed foci ofBALB/c-3T3 cells is described in the Materials and Methods. The number oftype III foci
> 2-mm in diameter per culture vessel scored are recorded in this table.
dTransformation response: The transformation responses are expressed as type III foci/vessel and were calculated using alog1o mathematical
transformation procedure (refer to Materials and Methods). The arithmetic value or foci/vessel represents the antilog ofthe log1o mean
transformation response minus one.
eSignificance: The significance oftest chemical transformation responses was calculated by a computer using the SAS statistical software (22),
and the method is described in detail in Materials and Methods. The correct t-statistic according to the F-test is presented in this table. The
t-statistics ofeach treatment dose ofthe test chemical in a single experiment were averaged to determine the mean t-statistic ofthe test chemical
for the experiment (refer to Appendix Tables A2 and A5). The mean t-statistics for two or experiments for each chemical was weighted to the
number oftreatment doses evaluated and averaged to determine the rank t-statistic which was used to rank-order the test chemical
transformation responses in Appendix Tables A3 and A6. Arbitrarily, transformation responses with negative (-) t-statistics were given a value of
zero (0).
*Significant BaP or test chemical transformation response, 0.01 < p < 0.05.
**Significant BaP or test chemical transformation response, 0.001 < p < 0.01.
***Significant or BaP or test chemical transformation response, p < 0.001.
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Summary ofthe transformation responses of7 very noncytotoxic chemicals
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Acetone [ACET, M.W. = 58.08, Density = 0.786 g/ml]
Trial 1 [82]
B(a)P .000791
B(a)P .000250
ACET
ACET
ACET
ACET
NC-1
1377.
1033.
689.
344.
Control
46.8 47.2
56.3 51.6
.000
.000
.000
1.08
100.
Trial 2 [102]
B(a)P .000791
B(a)P .000250
ACET
ACET
ACET
ACET
NC-1
517.
344.
172.
86.1
Control
.000
.000
.000
75.7
100.
9.64 69.9
19.3 93.1
.000
.000
1.26
34.8
100.
.000
37.3
76.8
79.5
100.
371 (18)
288 (18)
0 (0,18)
0 (0,18)
10 (6, 18)
397 (18)
649 (72)
99 (18)
45 (18)
6 (13,18)
28 (18)
55 (18)
22 (18)
64 (72)
19.4***
15.5***
.000
.000
1.15
21 .0***
8.01
4.65***
2.22***
.347
1 .30*
2.67***
.974
.697
+ 7.45
+ 7.97
ND
ND
.00(-4.78)
+ 8.19
Control
Mean t = 8.19
+ 9.48
+ 5.22
.00(-1 .66)
+ 2.40
+ 6.15
+ 1.20
Control
Mean t = 3.25
Dimethyl Sulfoxide [DMSO, M.W. = 78.13, Density = 1.100 g/ml]
Trial 1 [41]
B(a)P .000791
B(a)P .000250
DMSO
DMSO
DMSO
DMSO
NC-1
851.
568.
284.
142.
Control
Trial 2 [100]
B(a)P .000791
B(a)P .000250
1.29 33.6
6.45 78.2
.000
22.9
76.8
88.4
100.
.000
27.4
77.1
89.9
100.
89.7 77.9
81.0 93.8
189 (18)
123 (18)
0 (13,18)
69 (18)
15 (18)
17 (18)
13 (36)
65 (18)
62 (18)
10.2***
6.37***
.000
3. 15***
.587
.754**
.274
3.30***
2.85***
+ 23.1
+ 17.1
.00( -4. 11)
+ 7.36
+ 1.59
+ 2.81
Control
Mean t = 3.92
+ 11.7
+ 7.75
31 (18)
18 (18)
16 (18)
16 (18)
28 (72)
+ 5.84
+ 2.19
+ 2.25
+ 1.61
Control
Mean t = 2.97
Ethanol [ETOH, M.W. = 46.07, Density = 0.790 g/ml]
Trial 1 [81]
B(a)P .000791
B(a)P .000250
378 (18)
280 (18)
ETOH
ETOH
ETOH
ETOH
NC-1
866.
650.
433.
217.
Control
Trial 2 [108]
B(a)P .000791
B(a)P .000250
.000 .000
.000 2.93
.000 49.1
22.7 90.0
100. 100.
15.5 31.3
30.0 65.7
0 (0,18)
6 (11,18)
159 (18)
263 (18)
583 (72)
139 (18)
72 (13)
.000
.422
8.07
13.7***
7.36
7.38***
4.77***
NA
.00(-13.2)
+ .74
+ 5.31
Control
Mean t = 2.01
+ 13.9
+ 5.96
(Continued on nextpage)
DMSO
DMSO
DMSO
DMSO
NC-1
563.
426.
282.
141.
Control
27.1
57.0
91.5
94.3
100.
.000
11.0
83.9
88.7
100.
1.42***
.720*
.634*
.586
.268
10.2 63.9
28.0 67.8
20.8***
15.3***
+ 15.5
+ 10.5
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Appendix H. Continued.
Treatment Cytotoxic Transforming Transformation
Condi_ti_on" Activityb Activityc Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mN S.A CC.A. III (N) III t-statistic
.000 1.68
2.46 47.0
36.5 99.5
114. 91.1
100. 100.
1 (10)
25 (14)
48 (10)
47 (16)
108 (70)
.072
1.59
3.92***
2.61***
1.17
.00(-7.45)
+ 1.15
+ 4.34
+ 3.44
Control
Mean t = 2.23
Glycerol [GLY, M.W. = 92.09, Density = 1.25245 g/ml]
46.8 47.2
56.3 51.6
371 (18)
288 (18)
19.4***
15.5***
+ 7.45
+ 7.97
434.
326.
217.
109.
Control
2 [108]
.000791
.000250
434.
326.
217.
109.
Control
.000
1.30
16.3
70.2
100.
1.31
44.2
91.8
77.8
100.
15.5 31.3
30.0 65.7
30.0
55.6
72.6
102.
100.
56.0
82.0
96.5
92.3
100.
91 (18)
308 (18)
220 (18)
191 (18)
649 (72)
139 (18)
72 (13)
49 (18)
72 (17)
84 (18)
37 (18)
108 (70)
4.04
16.2***
11.5**
9.64
8.01
7.38***
4.77***
2.21**
3.32***
4.01***
1.75
1.17
.00( -3.65)
+ 5.79
+ 2.95
+ 1.47
Control
Mean t = 2.55
+ 13.9
+ 5.96
+ 2.67
+ 4.48
+ 5.74
+ 1.65
Control
Mean t = 3.64
Sodium Chloride [NaCl, M.W. = 58.44]
1 [80]
.000791
.000250
16.9 65.2
35.6 87.2
261 (20)
185 (20)
12.9***
8.53***
+ 13.0
+ 7.65
16.9
68.8
78.3
86.9
100.
56.7
84.9
84.1
100.
100.
496
463
216
86
317
51.9 94.3
66.2 108.
22.9
49.4
69.1
83.8
100.
(20)
(20)
(20)
(20)
(80)
99 (20)
81 (20)
19.4
86.7
86.7
94.5
100.
9
65
84
65
237
NA NA
NA NA
(15,17)
(19)
(20)
(20)
(80)
45 (20)
95 (20)
24. 1***
22.2***
10.0***
4.00*
3.02
4.69***
3.91***
.962
.134
.893*
.641
2.55
1.61**
2.77***
+ 20.6
+ 17.3
+ 8.86
+ 2.04
Control
Mean t = 12.2
+ 5.31
+ 4.16
.00(-6.63)
+ .44
+ 2.13
+ .85
Control
Mean t = .855
+ 3.49
+ 4.53
NACL 128.
NACL 85.6
NACL 42.8
NC-1 Control
NA NA
NA NA
NA NA
100. 100.
35 (20)
32 (20)
7 (20)
23 (40)
3.1 7***
2.07**
.771
.416
+ 8.25
+ 3.45
+ 1.36
Control
Mean t = 4.35
(Continued on nextpage)
ETOH
ETOH
ETOH
ETOH
NC-1
606.
455.
303.
152.
Control
Trial 1
B(a)P
B(a)P
[82]
.000791
.000250
GLY
GLY
GLY
GLY
NC-1
Trial
B(a)P
B(a)P
GLY
GLY
GLY
GLY
NC-1
Trial
B(a)P
B(a)P
NaCl
NaCI
NaCI
NaC I
NC-1
Trial
B(a)P
B(a)P
NaCl
NaC I
NaCl
NaC I
NC-1
Trial
MCA
MNNG
154.
116.
77.0
38.5
Control
2 [109]
.000791
.000250
171.
128.
85.6
42.8
Control
3 [Ri]
.00186
.00850
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Appendix H. Continued.
Treatment Cytotoxic Transforming Transformation
Conditiona Activityb ActivityC Responsed Significance'
RCE (%) Focus Data Foci/Vessel
Type Vessels Focus Type
Drug Conc., mM S.A CC.A. III (N) III t-statistic
Sucrose [SUC, M.W. = 342.30]
Trial 1 [101]
B(a)P .000791 ND 64.8 108 (20) 4.63*** + 12.7
B(a)P .000250 ND 83.6 48 (20) 2.11*** + 9.73
SUC 438. .000 .000 0 (0,20) .000 NA
SUC 219. 28.7 61.1 205 (19) 10.3*** + 25.2
SUC 110. 91.3 112. 38 (18) 1.67*** + 5.19
SUC 54.8 93.4 112. 9 (20) .347 + .75
NC-1 Control 100. 100. 27 (78) .260 Control
Mean t = 10.3
Trial 2 [107]
B(a)P .000791 5.81 47.3 131 (20) 6.09*** + 5.74
B(a)P .000250 21.2 75.8 122 (20) 5.53*** + 4.05
SUC 292. 7.52 38.4 53 (20) 2.45 .00(-1.11)
SUC 219. 31.5 49.8 115 (20) 5.34*** + 3.85
SUC 146. 65.3 77.7 114 (20) 5.37*** + 5.09
SUC 73.0 96.4 93.0 60 (20) 2.60 .00(- .72)
NC-1 Control 100. 100. 274 (80) 2.95 ControL
Mean t = 2.24
Urea [UREA, M.W. = 60.07]
Trial 1 [109]
B(a)P .000791 51.9 94.3 99 (20) 4.69*** + 5.31
B(a)P .000250 66.2 108. 81 (20) 3.91*** + 4.16
UREA 416. .000 .243 0 (20) .000 .00(-23.0)
UREA 312. 43.0 17.5 43 (20) 1.85 .00(- 1.80)
UREA 208. 80.6 69.2 102 (20) 4.40** + 3.39
UREA 104. 90.8 74.1 80 (20) 3.57* + 2.05
NC-1 Control 100. 100. 237 (80) 2.55 ControL
Mean t = 1.81
Abbreviations: B(a)P, benzo(a)pyrene; CC.A., co-culture clonal survival assay; Conc, concentration; mM, millimole; M.W, molecular weight; N,
number ofculture vessels, NC, negative control; ND, not determined; %RCE, percent relative cloning efficiency; S.A, standard clonal survival
assay.
"Treatment Condition: The experimental design for the transformation assay is described in detail in the Materials and Methods. The
concentration ofthe positive control and test chemical treatment are presented in mM, but they can be converted to ,ug/ml using the molecular
weight that is provided with each chemical. The solvent vehicles used for the individual test chemicals were listed in Appendix Tables Al and A3,
and the concentrations ofthe solvent vehicles are presented in the Materials and Methods.
bCytotoxic activity: The experimental design for the standard survival assay (SA) and the co-culture clonal survival assay (CCA) were described
in the Materials and Methods. The test chemical cytotoxic response was expressed as & RCE and was calculated as described in the Materials and
Methods.
cThe criteria used to evaluate the transformed foci ofBALB/c-3T3 cells is described in the Materials and Methods. The number oftype III foci
> 2-mm in diameter per culture vessel scored are recorded in this table.
dTransformation response: The transformation responses are expressed as type III foci/vessel and were calculated using alog1o mathematical
transformation procedure (refer to Materials and Methods). The arithmetic value or foci/vessel represents the antilog ofthe log1o mean
transformation responseminus one.
eSignificance: The significance oftest chemical transformation responses was calculated by a computer using the SAS statistical software (22),
and the method is described in detail in Materials and Methods. The correct t-statistic according to the F-test is presented in this table. The
t-statistics ofeach treatment dose ofthe test chemical in a single experimentwere averaged to determine the mean t-statistic ofthe test chemical
for the experiment (refer to Appendix Tables A2 and A5). The mean t-statistics for two or experiments for each chemical was weighted to the
number oftreatment doses evaluated and averaged to determine the rank t-statistic which was used to rank-order the test chemical
transformation responses in Appendix Tables A3 and A6. Arbitrarily, transformation responses with negative (-) t-statistics were given avalue of
zero (0).
*Significant BaP or testchemical transformation response, 0.01 < p < 0.05.
**Significant BaP or testchemical transformation response, 0.001 < p < 0.01.
***Significant or BaP or test chemical transformation response, p < 0.001.
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